Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

137660341 315362 0 None 141 2 Human 11.0 pEC50 = 11 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1031 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC2CCCCC2)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4102192 315362 0 None 141 2 Human 11.0 pEC50 = 11 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1031 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC2CCCCC2)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
2042 8014 41 None 1 5 Human 11.0 pEC50 = 11 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b01691
2176 8014 41 None 1 5 Human 11.0 pEC50 = 11 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b01691
439302 8014 41 None 1 5 Human 11.0 pEC50 = 11 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b01691
CHEMBL395429 8014 41 None 1 5 Human 11.0 pEC50 = 11 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b01691
90680085 221000 0 None None None Human 10.9 pEC50 = 10.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 951 18 12 14 -3.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL3277916 221000 0 None None None Human 10.9 pEC50 = 10.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 951 18 12 14 -3.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137654006 314620 0 None None None Human 10.9 pEC50 = 10.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 986 17 13 14 -5.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4093931 314620 0 None None None Human 10.9 pEC50 = 10.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 986 17 13 14 -5.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137653847 314808 0 None 309 2 Human 10.9 pEC50 = 10.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1005 17 11 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCCCC2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4095930 314808 0 None 309 2 Human 10.9 pEC50 = 10.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1005 17 11 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCCCC2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137645401 313783 0 None 181 2 Human 10.9 pEC50 = 10.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 977 16 11 14 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)NCC(N)=O)C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4084223 313783 0 None 181 2 Human 10.9 pEC50 = 10.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 977 16 11 14 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)NCC(N)=O)C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137650792 313337 0 None 97 2 Human 10.8 pEC50 = 10.8 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 991 18 11 14 -2.4 CCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
CHEMBL4078856 313337 0 None 97 2 Human 10.8 pEC50 = 10.8 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 991 18 11 14 -2.4 CCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
137653639 314898 0 None 40 2 Human 10.7 pEC50 = 10.7 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 949 15 11 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4096848 314898 0 None 40 2 Human 10.7 pEC50 = 10.7 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 949 15 11 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
76073634 234791 7 None 3981 3 Human 10.6 pEC50 = 10.6 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL3354594 234791 7 None 3981 3 Human 10.6 pEC50 = 10.6 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
DB12932 234791 7 None 3981 3 Human 10.6 pEC50 = 10.6 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
137632034 312207 0 None 48 2 Human 10.6 pEC50 = 10.6 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1019 20 11 14 -1.6 CCCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
137661047 312207 0 None 48 2 Human 10.6 pEC50 = 10.6 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1019 20 11 14 -1.6 CCCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
CHEMBL4065273 312207 0 None 48 2 Human 10.6 pEC50 = 10.6 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1019 20 11 14 -1.6 CCCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
CHEMBL4101771 312207 0 None 48 2 Human 10.6 pEC50 = 10.6 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1019 20 11 14 -1.6 CCCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
155536940 336772 0 None 17 3 Human 10.6 pEC50 = 10.6 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1074 20 12 15 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4474284 336772 0 None 17 3 Human 10.6 pEC50 = 10.6 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1074 20 12 15 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
137652597 314676 0 None 2 2 Human 10.5 pEC50 = 10.5 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1034 19 14 15 -4.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4094454 314676 0 None 2 2 Human 10.5 pEC50 = 10.5 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1034 19 14 15 -4.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137654217 314545 0 None None None Human 10.5 pEC50 = 10.5 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 987 15 14 14 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NNC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4092971 314545 0 None None None Human 10.5 pEC50 = 10.5 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 987 15 14 14 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NNC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
155565903 349729 0 None None None Human 10.5 pEC50 = 10.5 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1024 21 13 16 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4583231 349729 0 None None None Human 10.5 pEC50 = 10.5 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1024 21 13 16 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
2042 8014 41 None 1 5 Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmcl.2017.12.027
2176 8014 41 None 1 5 Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmcl.2017.12.027
439302 8014 41 None 1 5 Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmcl.2017.12.027
CHEMBL395429 8014 41 None 1 5 Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmcl.2017.12.027
449224 333602 12 None 54 4 Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL439044 333602 12 None 54 4 Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
DB13798 333602 12 None 54 4 Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
2042 8014 41 None 1 5 Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2016.05.062
2176 8014 41 None 1 5 Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2016.05.062
439302 8014 41 None 1 5 Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2016.05.062
CHEMBL395429 8014 41 None 1 5 Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2016.05.062
449224 333602 12 None 54 4 Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL439044 333602 12 None 54 4 Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
DB13798 333602 12 None 54 4 Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
137647351 313452 0 None None None Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 995 19 12 15 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(C)[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4080341 313452 0 None None None Human 10.4 pEC50 = 10.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 995 19 12 15 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(C)[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137648677 313850 0 None 44 2 Human 10.3 pEC50 = 10.3 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1025 17 11 14 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4084795 313850 0 None 44 2 Human 10.3 pEC50 = 10.3 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1025 17 11 14 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137634607 312031 0 None 11 2 Human 10.3 pEC50 = 10.3 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 965 16 12 15 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4063150 312031 0 None 11 2 Human 10.3 pEC50 = 10.3 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 965 16 12 15 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
90680084 220999 0 None None None Human 10.2 pEC50 = 10.2 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 965 18 12 14 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL3277915 220999 0 None None None Human 10.2 pEC50 = 10.2 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 965 18 12 14 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137661245 315315 0 None 123 2 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 950 15 11 14 -2.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4101586 315315 0 None 123 2 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 950 15 11 14 -2.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC1=O 10.1016/j.bmcl.2017.04.030
90285421 233973 1 None -9 2 Human 10.1 pEC50 = 10.1 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 334 4 1 5 2.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL3342789 233973 1 None -9 2 Human 10.1 pEC50 = 10.1 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 334 4 1 5 2.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
3601935 317856 1 None 1 2 Human 10.1 pEC50 = 10.1 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 271 3 1 4 1.9 Cn1nccc1NS(=O)(=O)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL4165132 317856 1 None 1 2 Human 10.1 pEC50 = 10.1 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 271 3 1 4 1.9 Cn1nccc1NS(=O)(=O)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
137634089 312221 0 None None None Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 981 19 13 15 -4.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4065416 312221 0 None None None Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 981 19 13 15 -4.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
155527198 335719 0 None 8 3 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1056 20 12 14 -2.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4458988 335719 0 None 8 3 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1056 20 12 14 -2.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
146681949 8624 35 None -97 5 Human 10.0 pEC50 = 10 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
2168 8624 35 None -97 5 Human 10.0 pEC50 = 10 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
2810 8624 35 None -97 5 Human 10.0 pEC50 = 10 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
644077 8624 35 None -97 5 Human 10.0 pEC50 = 10 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
CHEMBL373742 8624 35 None -97 5 Human 10.0 pEC50 = 10 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
DB00067 8624 35 None -97 5 Human 10.0 pEC50 = 10 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
P01185 8624 35 None -97 5 Human 10.0 pEC50 = 10 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
P01186 8624 35 None -97 5 Human 10.0 pEC50 = 10 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
P35455 8624 35 None -97 5 Human 10.0 pEC50 = 10 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
76685194 233974 1 None -5 2 Human 10.0 pEC50 = 10 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 368 4 1 5 3.1 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL3342790 233974 1 None -5 2 Human 10.0 pEC50 = 10 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 368 4 1 5 3.1 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
5014150 327880 1 None 1 2 Human 10.0 pEC50 = 10 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 305 3 1 4 2.2 Cn1nccc1NS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL4173036 327880 1 None 1 2 Human 10.0 pEC50 = 10 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 305 3 1 4 2.2 Cn1nccc1NS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
137631348 312356 0 None None None Human 10.0 pEC50 = 10.0 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 979 18 11 14 -2.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4066923 312356 0 None None None Human 10.0 pEC50 = 10.0 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 979 18 11 14 -2.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137639236 312666 0 None 3 2 Human 10.0 pEC50 = 10.0 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1025 17 11 14 -2.3 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
CHEMBL4070577 312666 0 None 3 2 Human 10.0 pEC50 = 10.0 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1025 17 11 14 -2.3 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
18779926 38349 37 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 34 0 0 0 0.1 S 10.1016/j.bmcl.2017.04.030
402 38349 37 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 34 0 0 0 0.1 S 10.1016/j.bmcl.2017.04.030
5162682 38349 37 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 34 0 0 0 0.1 S 10.1016/j.bmcl.2017.04.030
CHEMBL1200739 38349 37 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 34 0 0 0 0.1 S 10.1016/j.bmcl.2017.04.030
DB03328 38349 37 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 34 0 0 0 0.1 S 10.1016/j.bmcl.2017.04.030
137649234 313046 0 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1005 17 10 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4075102 313046 0 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1005 17 10 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137654919 314555 0 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1041 20 12 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4093088 314555 0 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1041 20 12 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
126705667 314843 0 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 970 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4096331 314843 0 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 970 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
178316717 467830 0 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assay
ChEMBL 628 6 3 10 3.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@@H](n2cc(CO)nn2)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00190
CHEMBL6199441 467830 0 None None None Human 9.9 pEC50 = 9.9 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assay
ChEMBL 628 6 3 10 3.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@@H](n2cc(CO)nn2)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00190
178316487 467835 0 None None None Human 9.8 pEC50 = 9.8 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assay
ChEMBL 628 6 3 10 3.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](n2cc(CO)nn2)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00190
CHEMBL6199678 467835 0 None None None Human 9.8 pEC50 = 9.8 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assay
ChEMBL 628 6 3 10 3.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](n2cc(CO)nn2)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00190
155532160 336257 0 None None None Human 9.8 pEC50 = 9.8 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1006 21 13 15 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4467042 336257 0 None None None Human 9.8 pEC50 = 9.8 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1006 21 13 15 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
137648427 313733 0 None 20 2 Human 9.7 pEC50 = 9.7 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 991 17 11 14 -2.5 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4083700 313733 0 None 20 2 Human 9.7 pEC50 = 9.7 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 991 17 11 14 -2.5 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137652984 314497 0 None None None Human 9.7 pEC50 = 9.7 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 975 17 10 13 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4092407 314497 0 None None None Human 9.7 pEC50 = 9.7 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 975 17 10 13 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137659822 315227 0 None 288 2 Human 9.6 pEC50 = 9.6 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 934 14 10 13 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4100627 315227 0 None 288 2 Human 9.6 pEC50 = 9.6 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 934 14 10 13 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC1=O 10.1016/j.bmcl.2017.04.030
137641012 312956 0 None None None Human 9.6 pEC50 = 9.6 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1007 18 12 15 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4073891 312956 0 None None None Human 9.6 pEC50 = 9.6 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1007 18 12 15 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137639340 312817 0 None None None Human 9.6 pEC50 = 9.6 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 985 16 12 13 -4.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4072207 312817 0 None None None Human 9.6 pEC50 = 9.6 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 985 16 12 13 -4.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
178316493 467836 0 None None None Human 9.6 pEC50 = 9.6 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assay
ChEMBL 710 7 4 11 2.4 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](n2cc(CC3NC(=O)NC3=O)nn2)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00190
CHEMBL6199684 467836 0 None None None Human 9.6 pEC50 = 9.6 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assay
ChEMBL 710 7 4 11 2.4 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](n2cc(CC3NC(=O)NC3=O)nn2)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00190
118720268 234776 0 None 151 3 Human 9.6 pEC50 = 9.6 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL3354579 234776 0 None 151 3 Human 9.6 pEC50 = 9.6 Functional
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
127051498 277875 0 None None None Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1005 17 10 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL3813771 277875 0 None None None Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1005 17 10 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
2042 8014 41 None 1 5 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2018.03.019
2176 8014 41 None 1 5 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2018.03.019
439302 8014 41 None 1 5 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2018.03.019
CHEMBL395429 8014 41 None 1 5 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2018.03.019
178306441 467813 0 None None None Human 9.5 pEC50 = 9.5 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assay
ChEMBL 630 6 2 9 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](n2cc(CF)nn2)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00190
CHEMBL6198760 467813 0 None None None Human 9.5 pEC50 = 9.5 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assay
ChEMBL 630 6 2 9 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](n2cc(CF)nn2)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00190
137654665 314485 0 None None None Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1023 21 13 15 -3.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4092242 314485 0 None None None Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1023 21 13 15 -3.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
177823009 467794 0 None None None Human 9.4 pEC50 = 9.4 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assay
ChEMBL 669 7 4 9 4.8 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](OCc2cc(O)cc(O)c2)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00191
CHEMBL6197983 467794 0 None None None Human 9.4 pEC50 = 9.4 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assay
ChEMBL 669 7 4 9 4.8 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](OCc2cc(O)cc(O)c2)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00191
145964703 329009 0 None None None Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 822 12 8 12 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2COC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4208981 329009 0 None None None Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 822 12 8 12 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2COC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL3814633 487604 0 None None None Human 9.3 pEC50 = 9.3 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1020 17 11 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
145975112 328640 0 None None None Human 9.3 pEC50 = 9.3 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 778 10 8 11 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4204637 328640 0 None None None Human 9.3 pEC50 = 9.3 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 778 10 8 11 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL3814744 487605 0 None None None Human 9.3 pEC50 = 9.3 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1020 17 11 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
137659747 315100 0 None None None Human 9.3 pEC50 = 9.3 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1091 21 14 15 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4099102 315100 0 None None None Human 9.3 pEC50 = 9.3 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1091 21 14 15 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
171649264 467827 0 None None None Human 9.3 pEC50 = 9.3 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assay
ChEMBL 674 9 2 10 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](n2cc(COCCF)nn2)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00190
CHEMBL6199342 467827 0 None None None Human 9.3 pEC50 = 9.3 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assay
ChEMBL 674 9 2 10 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](n2cc(COCCF)nn2)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00190
127049296 277954 0 None None None Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL3815099 277954 0 None None None Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
145978563 328775 0 None None None Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 860 11 8 14 -0.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2c2nnc(C)o2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4206141 328775 0 None None None Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 860 11 8 14 -0.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2c2nnc(C)o2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
145966784 329388 0 None None None Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 792 10 8 11 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@@H]2C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4213896 329388 0 None None None Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 792 10 8 11 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@@H]2C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
2042 8014 41 None 1 5 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b00697
2176 8014 41 None 1 5 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b00697
439302 8014 41 None 1 5 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b00697
CHEMBL395429 8014 41 None 1 5 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b00697
145966470 329271 0 None None None Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 883 13 9 12 0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2CNc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4212399 329271 0 None None None Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 883 13 9 12 0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2CNc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
137654009 314631 0 None 29 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 976 16 10 13 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4094019 314631 0 None 29 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 976 16 10 13 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC1=O 10.1016/j.bmcl.2017.04.030
145974697 329601 0 None None None Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 855 11 8 12 0.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2c2ccccn2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4216826 329601 0 None None None Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 855 11 8 12 0.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2c2ccccn2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL3813894 487597 0 None None None Human 9.0 pEC50 = 9 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1020 17 11 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
137635522 312061 0 None 7 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1019 18 13 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4063521 312061 0 None 7 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1019 18 13 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC1=O 10.1016/j.bmcl.2017.04.030
145976821 328632 0 None None None Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 821 11 9 12 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4204502 328632 0 None None None Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 821 11 9 12 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
137643372 313987 0 None None None Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1005 17 11 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4086714 313987 0 None None None Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1005 17 11 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137638040 312672 0 None None None Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1050 22 15 15 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4070617 312672 0 None None None Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1050 22 15 15 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137635922 311896 0 None None None Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1047 19 11 14 -1.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4061446 311896 0 None None None Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1047 19 11 14 -1.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137647481 313695 0 None None None Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1081 19 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4083280 313695 0 None None None Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1081 19 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
145978698 328581 0 None None None Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 905 14 8 12 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)CCC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4203673 328581 0 None None None Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 905 14 8 12 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)CCC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
145977344 328692 0 None None None Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 934 15 10 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4205163 328692 0 None None None Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 934 15 10 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
178316031 467828 0 None None None Human 8.7 pEC50 = 8.7 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assay
ChEMBL 694 8 3 12 2.9 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](n2cc(CCc3nnn[nH]3)nn2)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00190
CHEMBL6199354 467828 0 None None None Human 8.7 pEC50 = 8.7 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP-1 accumulation assay
ChEMBL 694 8 3 12 2.9 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](n2cc(CCc3nnn[nH]3)nn2)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00190
11169 1650 39 None 1 5 Human 8.0 pEC50 = 8 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
165708555 1650 39 None 1 5 Human 8.0 pEC50 = 8 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
16681432 1650 39 None 1 5 Human 8.0 pEC50 = 8 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
495 1650 39 None 1 5 Human 8.0 pEC50 = 8 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
CHEMBL3301668 1650 39 None 1 5 Human 8.0 pEC50 = 8 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
DB01282 1650 39 None 1 5 Human 8.0 pEC50 = 8 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
178315391 467833 0 None None None Human 8.0 pEC50 = 8.0 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assay
ChEMBL 549 4 2 6 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](F)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00191
CHEMBL6199566 467833 0 None None None Human 8.0 pEC50 = 8.0 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assay
ChEMBL 549 4 2 6 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](F)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00191
CHEMBL3814120 487598 0 None None None Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1034 17 10 15 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
2042 8014 41 None 1 5 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm1016208
2176 8014 41 None 1 5 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm1016208
439302 8014 41 None 1 5 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm1016208
CHEMBL395429 8014 41 None 1 5 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm1016208
CHEMBL1817752 484896 0 None -77 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1019 19 12 15 -4.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819550 484929 0 None -47 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 967 17 12 16 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819550 484929 0 None -47 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 967 17 12 16 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
145960494 317101 0 None 20 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1081 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccc(cc2)SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4128839 317101 0 None 20 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1081 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccc(cc2)SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL1817761 484905 0 None -338 5 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1039 20 12 16 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817752 484896 0 None -77 4 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1019 19 12 15 -4.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817761 484905 0 None -338 5 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1039 20 12 16 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
11454 7271 15 None -93 5 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1047 21 12 15 -3.2 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCNC(C)C)C 10.1021/jm200278m
53330936 7271 15 None -93 5 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1047 21 12 15 -3.2 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCNC(C)C)C 10.1021/jm200278m
CHEMBL1817709 7271 15 None -93 5 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1047 21 12 15 -3.2 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCNC(C)C)C 10.1021/jm200278m
DB12495 7271 15 None -93 5 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1047 21 12 15 -3.2 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCNC(C)C)C 10.1021/jm200278m
5329098 19472 58 None 1 2 Human 4.9 pEC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 238 1 2 1 3.1 Cc1cc(C)c(/C=C2/C(=O)Nc3ccccc32)[nH]1 nan
5800609 19472 58 None 1 2 Human 4.9 pEC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 238 1 2 1 3.1 Cc1cc(C)c(/C=C2/C(=O)Nc3ccccc32)[nH]1 nan
CHEMBL105739 19472 58 None 1 2 Human 4.9 pEC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 238 1 2 1 3.1 Cc1cc(C)c(/C=C2/C(=O)Nc3ccccc32)[nH]1 nan
CHEMBL276711 19472 58 None 1 2 Human 4.9 pEC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 238 1 2 1 3.1 Cc1cc(C)c(/C=C2/C(=O)Nc3ccccc32)[nH]1 nan
DB06436 19472 58 None 1 2 Human 4.9 pEC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 238 1 2 1 3.1 Cc1cc(C)c(/C=C2/C(=O)Nc3ccccc32)[nH]1 nan
137658241 315445 0 None None None Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 964 16 11 14 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4103260 315445 0 None None None Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 964 16 11 14 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL1819547 484926 0 None -63 4 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 984 17 12 17 -5.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cscn2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819547 484926 0 None -63 4 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 984 17 12 17 -5.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cscn2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
90672737 219994 0 None None None Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 970 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCNC(=O)C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL3246917 219994 0 None None None Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 970 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCNC(=O)C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
172444756 389349 0 None None None Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1146 21 13 17 -0.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N\c3ccc(C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5437397 389349 0 None None None Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1146 21 13 17 -0.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N\c3ccc(C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
172455058 388068 0 None None None Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1160 22 13 17 -0.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(/N=N/c3ccccc3)cc2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5409527 388068 0 None None None Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1160 22 13 17 -0.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(/N=N/c3ccccc3)cc2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5424615 388068 0 None None None Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1160 22 13 17 -0.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(/N=N/c3ccccc3)cc2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL3814126 487599 0 None None None Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1020 17 11 15 -3.3 CC[C@H](C)[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1C 10.1016/j.bmc.2016.05.062
1112934 118908 7 None 1 2 Human 4.8 pEC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 425 5 1 5 4.7 N=c1n(CC(=O)c2ccc(Br)s2)c2ccccc2n1Cc1ccccc1 nan
CHEMBL1625302 118908 7 None 1 2 Human 4.8 pEC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 425 5 1 5 4.7 N=c1n(CC(=O)c2ccc(Br)s2)c2ccccc2n1Cc1ccccc1 nan
146681949 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
2168 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
2810 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
644077 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
CHEMBL373742 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
DB00067 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
P01185 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
P01186 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
P35455 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
146681949 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
2168 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
2810 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
644077 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
CHEMBL373742 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
DB00067 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
P01185 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
P01186 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
P35455 8624 35 None -97 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm200278m
CHEMBL1817705 484891 0 None -61 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1005 19 12 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL3813858 487595 0 None None None Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1034 17 10 15 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
135506374 275287 21 None -2 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 275287 21 None -2 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
25161471 117879 13 None -1 2 Human 4.8 pEC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 265 4 2 2 3.5 Oc1ccc(Cl)cc1CNCc1ccc(F)cc1 nan
CHEMBL1616435 117879 13 None -1 2 Human 4.8 pEC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 265 4 2 2 3.5 Oc1ccc(Cl)cc1CNCc1ccc(F)cc1 nan
118716666 233980 0 None None None Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 437 4 1 6 3.5 O=S(=O)(Nc1ccnn1-c1ncc(C(F)(F)F)cn1)c1ccc(C(F)(F)F)cc1 10.1021/ml5004348
CHEMBL3342796 233980 0 None None None Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 437 4 1 6 3.5 O=S(=O)(Nc1ccnn1-c1ncc(C(F)(F)F)cn1)c1ccc(C(F)(F)F)cc1 10.1021/ml5004348
90286664 233982 0 None None None Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 375 6 1 7 3.0 CCc1ccc(S(=O)(=O)Nc2ccnn2-c2nc(C3CC3)ns2)cc1 10.1021/ml5004348
CHEMBL3342798 233982 0 None None None Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 375 6 1 7 3.0 CCc1ccc(S(=O)(=O)Nc2ccnn2-c2nc(C3CC3)ns2)cc1 10.1021/ml5004348
CHEMBL1817705 484891 0 None -61 5 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1005 19 12 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
2369069 353177 3 None -1 2 Human 4.8 pEC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 346 3 0 5 4.0 CCN1C(=S)SC(=O)C1=C1C=C(C)N(Cc2ccco2)C(C)=C1 nan
CHEMBL473106 353177 3 None -1 2 Human 4.8 pEC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 346 3 0 5 4.0 CCN1C(=S)SC(=O)C1=C1C=C(C)N(Cc2ccco2)C(C)=C1 nan
137658004 315510 0 None None None Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 948 15 10 13 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4104022 315510 0 None None None Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 948 15 10 13 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
90286007 233978 0 None None None Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 382 4 1 5 3.4 Cc1ccnc(-n2nccc2NS(=O)(=O)c2ccc(C(F)(F)F)cc2)c1 10.1021/ml5004348
CHEMBL3342794 233978 0 None None None Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 382 4 1 5 3.4 Cc1ccnc(-n2nccc2NS(=O)(=O)c2ccc(C(F)(F)F)cc2)c1 10.1021/ml5004348
53363016 137115 0 None -28 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1005 18 12 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NC)NC1=O 10.1021/jm200278m
CHEMBL1819557 137115 0 None -28 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1005 18 12 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NC)NC1=O 10.1021/jm200278m
CHEMBL3814232 487601 0 None None None Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1034 18 11 15 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
10444 4740 20 None 2 3 Mouse 7.8 pEC50 = 7.8 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145711714 4740 20 None 2 3 Mouse 7.8 pEC50 = 7.8 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4204210 4740 20 None 2 3 Mouse 7.8 pEC50 = 7.8 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL1819556 484934 0 None -190 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 927 15 12 15 -5.7 CC[C@H](C)[C@@H]1NC(=O)C2(CCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
2919564 63850 16 None -1 2 Human 4.7 pEC50 = 4.7 Functional
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 404 9 2 5 4.0 COc1ccc(CCNCC(O)Cn2c3ccccc3c3ccccc32)cc1OC nan
CHEMBL1390471 63850 16 None -1 2 Human 4.7 pEC50 = 4.7 Functional
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 404 9 2 5 4.0 COc1ccc(CCNCC(O)Cn2c3ccccc3c3ccccc32)cc1OC nan
90285421 233973 1 None -9 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assayAgonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assay
ChEMBL 334 4 1 5 2.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL3342789 233973 1 None -9 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assayAgonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assay
ChEMBL 334 4 1 5 2.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
90285421 233973 1 None -9 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 334 4 1 5 2.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1 10.1021/ml5004348
CHEMBL3342789 233973 1 None -9 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 334 4 1 5 2.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1 10.1021/ml5004348
90285984 233977 6 None None None Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 352 4 1 5 2.9 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1F 10.1021/ml5004348
CHEMBL3342793 233977 6 None None None Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 352 4 1 5 2.9 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1F 10.1021/ml5004348
145974945 329641 0 None None None Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 884 13 8 12 0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2COc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4217353 329641 0 None None None Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 884 13 8 12 0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2COc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
42601352 78877 0 None -1 2 Human 4.7 pEC50 = 4.7 Functional
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 282 4 2 3 3.4 Oc1ccc(Cl)cc1CNCc1ccc(Cl)nc1 nan
CHEMBL1437791 78877 0 None -1 2 Human 4.7 pEC50 = 4.7 Functional
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 282 4 2 3 3.4 Oc1ccc(Cl)cc1CNCc1ccc(Cl)nc1 nan
2042 8014 41 None -1 5 Mouse 8.7 pEC50 = 8.7 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b00697
2176 8014 41 None -1 5 Mouse 8.7 pEC50 = 8.7 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b00697
439302 8014 41 None -1 5 Mouse 8.7 pEC50 = 8.7 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b00697
CHEMBL395429 8014 41 None -1 5 Mouse 8.7 pEC50 = 8.7 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b00697
11454 7271 15 None -93 5 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1047 21 12 15 -3.2 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCNC(C)C)C 10.1021/jm200278m
53330936 7271 15 None -93 5 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1047 21 12 15 -3.2 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCNC(C)C)C 10.1021/jm200278m
CHEMBL1817709 7271 15 None -93 5 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1047 21 12 15 -3.2 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCNC(C)C)C 10.1021/jm200278m
DB12495 7271 15 None -93 5 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1047 21 12 15 -3.2 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCNC(C)C)C 10.1021/jm200278m
127049997 277867 0 None None None Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL3813707 277867 0 None None None Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
2042 8014 41 None 1 5 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.3c01415
2176 8014 41 None 1 5 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.3c01415
439302 8014 41 None 1 5 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.3c01415
CHEMBL395429 8014 41 None 1 5 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.3c01415
155555127 348389 0 None None None Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human OTR receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at human OTR receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1485 46 11 17 7.5 CCCCCCCCCCCCCCCC(=O)N[C@H]1CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(OC(=O)OCCCCCCCCCCCCCC)cc2)NC1=O 10.1016/j.bmc.2019.06.018
CHEMBL4550879 348389 0 None None None Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human OTR receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at human OTR receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1485 46 11 17 7.5 CCCCCCCCCCCCCCCC(=O)N[C@H]1CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(OC(=O)OCCCCCCCCCCCCCC)cc2)NC1=O 10.1016/j.bmc.2019.06.018
6174589 217219 5 None -1 2 Human 4.7 pEC50 = 4.7 Functional
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 379 6 2 6 2.0 CCN(CC)c1ccc2cc(C(N)=O)/c(=N\NC(=O)c3ccncc3)oc2c1 nan
CHEMBL3189462 217219 5 None -1 2 Human 4.7 pEC50 = 4.7 Functional
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 379 6 2 6 2.0 CCN(CC)c1ccc2cc(C(N)=O)/c(=N\NC(=O)c3ccncc3)oc2c1 nan
137651797 313029 0 None None None Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1010 16 10 13 -0.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4074898 313029 0 None None None Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1010 16 10 13 -0.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL3814165 487600 0 None None None Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1020 17 11 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
135506374 275287 21 None -2 3 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 275287 21 None -2 3 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
90285817 233975 0 None None None Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 351 4 1 4 3.5 O=S(=O)(Nc1ccnn1-c1ccc(F)cc1)c1ccc(Cl)cc1 10.1021/ml5004348
CHEMBL3342791 233975 0 None None None Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 351 4 1 4 3.5 O=S(=O)(Nc1ccnn1-c1ccc(F)cc1)c1ccc(Cl)cc1 10.1021/ml5004348
10444 4740 20 None -2 3 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145711714 4740 20 None -2 3 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4204210 4740 20 None -2 3 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL3814617 487603 0 None None None Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1020 17 11 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)N(C)C(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL1817756 484900 0 None -426 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1023 20 12 16 -4.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
2042 8014 41 None 1 5 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b00697
2176 8014 41 None 1 5 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b00697
439302 8014 41 None 1 5 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b00697
CHEMBL395429 8014 41 None 1 5 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b00697
CHEMBL1817756 484900 0 None -426 5 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1023 20 12 16 -4.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
172444756 387375 0 None None None Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1146 21 13 17 -0.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N/c3ccc(C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5395020 387375 0 None None None Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1146 21 13 17 -0.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N/c3ccc(C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
23983726 102093 5 None -1 2 Human 5.6 pEC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 472 1 3 3 6.2 CC1(C)CC[C@@]2(C(=O)O)C(C1)C1=CCC3[C@@]4(C)CC[C@H](O)C(C)(C)C4CC[C@@]3(C)[C@]1(C)C[C@H]2O nan
CHEMBL1559201 102093 5 None -1 2 Human 5.6 pEC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 472 1 3 3 6.2 CC1(C)CC[C@@]2(C(=O)O)C(C1)C1=CCC3[C@@]4(C)CC[C@H](O)C(C)(C)C4CC[C@@]3(C)[C@]1(C)C[C@H]2O nan
3650228 118800 6 None -1 2 Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 402 5 2 3 5.1 COc1ccc(C2NCCc3c2[nH]c2ccccc32)cc1COc1ccc(F)cc1 nan
CHEMBL1624349 118800 6 None -1 2 Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 402 5 2 3 5.1 COc1ccc(C2NCCc3c2[nH]c2ccccc32)cc1COc1ccc(F)cc1 nan
921775 85438 5 None None None Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 304 4 2 4 3.7 COc1ccc(CNc2[nH]cnc3c4ccccc4nc2-3)cc1 nan
CHEMBL1495292 85438 5 None None None Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 304 4 2 4 3.7 COc1ccc(CNc2[nH]cnc3c4ccccc4nc2-3)cc1 nan
145973088 329627 0 None None None Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 681 9 8 10 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4217226 329627 0 None None None Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 681 9 8 10 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
135413563 241495 20 None 28 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL360648 241495 20 None 28 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3813879 487596 0 None None None Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1034 17 10 15 -2.9 CC[C@H](C)[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N(C)[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1C 10.1016/j.bmc.2016.05.062
CHEMBL1819548 484927 0 None -53 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 983 17 12 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
135506374 275287 21 None 2 3 Mouse 7.5 pEC50 = 7.5 Functional
Agonist activity at recombinant mouse OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assayAgonist activity at recombinant mouse OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.7b00965
CHEMBL3763342 275287 21 None 2 3 Mouse 7.5 pEC50 = 7.5 Functional
Agonist activity at recombinant mouse OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assayAgonist activity at recombinant mouse OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.7b00965
CHEMBL1819548 484927 0 None -53 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 983 17 12 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819549 484928 0 None -47 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 983 17 12 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccsc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
145963213 317022 0 None 28 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4127791 317022 0 None 28 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
135506374 275287 21 None -2 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 275287 21 None -2 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
2042 8014 41 None 1 5 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.ejmech.2015.11.050
2176 8014 41 None 1 5 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.ejmech.2015.11.050
439302 8014 41 None 1 5 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.ejmech.2015.11.050
CHEMBL395429 8014 41 None 1 5 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.ejmech.2015.11.050
CHEMBL1819541 484920 0 None -14 4 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1007 18 13 16 -4.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819541 484920 0 None -14 4 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1007 18 13 16 -4.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
137640630 312970 0 None None None Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1007 20 12 14 -2.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4074033 312970 0 None None None Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1007 20 12 14 -2.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137656718 315393 0 None None None Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 941 17 10 13 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4102595 315393 0 None None None Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 941 17 10 13 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
145975622 328722 0 None None None Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 918 11 8 13 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N2CCCN(C)CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4205509 328722 0 None None None Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 918 11 8 13 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N2CCCN(C)CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL1819549 484928 0 None -47 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 983 17 12 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccsc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
172442093 387543 0 None None None Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1033 17 12 16 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N\c3ccc(C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5398356 387543 0 None None None Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1033 17 12 16 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N\c3ccc(C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
145972114 329557 0 None None None Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 515 4 2 6 3.4 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=O)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4216174 329557 0 None None None Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 515 4 2 6 3.4 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=O)N(C)C 10.1021/acs.jmedchem.8b00697
178293085 467792 0 None None None Human 7.5 pEC50 = 7.5 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assay
ChEMBL 591 7 3 8 3.2 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](OCCO)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00191
CHEMBL6197957 467792 0 None None None Human 7.5 pEC50 = 7.5 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assay
ChEMBL 591 7 3 8 3.2 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1C[C@H](OCCO)C[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00191
CHEMBL1817707 484893 0 None -194 5 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1019 20 12 15 -4.0 CCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817706 484892 0 None -309 5 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1033 21 12 15 -3.6 CCCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817707 484893 0 None -194 5 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1019 20 12 15 -4.0 CCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817706 484892 0 None -309 5 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1033 21 12 15 -3.6 CCCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817704 484890 0 None -257 5 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1033 20 12 15 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
135413563 241495 20 None 28 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human OTR receptor expressed in CHO cells co-expressing NFAT-luciferase incubated for 5 hrs by luciferase reporter gene assayAgonist activity at human OTR receptor expressed in CHO cells co-expressing NFAT-luciferase incubated for 5 hrs by luciferase reporter gene assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL360648 241495 20 None 28 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human OTR receptor expressed in CHO cells co-expressing NFAT-luciferase incubated for 5 hrs by luciferase reporter gene assayAgonist activity at human OTR receptor expressed in CHO cells co-expressing NFAT-luciferase incubated for 5 hrs by luciferase reporter gene assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL1817704 484890 0 None -257 5 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1033 20 12 15 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
145962220 317117 0 None 87 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2cccc(c2)CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4129142 317117 0 None 87 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2cccc(c2)CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
172455058 388068 0 None None None Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1160 22 13 17 -0.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(/N=N/c3ccccc3)cc2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5409527 388068 0 None None None Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1160 22 13 17 -0.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(/N=N/c3ccccc3)cc2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5424615 388068 0 None None None Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1160 22 13 17 -0.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(/N=N/c3ccccc3)cc2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
172449652 388133 0 None None None Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1094 19 11 16 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(/N=N/c3ccccc3)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5410810 388133 0 None None None Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1094 19 11 16 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(/N=N/c3ccccc3)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5412177 388133 0 None None None Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1094 19 11 16 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(/N=N/c3ccccc3)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
127049996 277885 0 None None None Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL3813883 277885 0 None None None Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
137637782 311929 0 None None None Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 949 15 11 14 -3.6 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
CHEMBL4061946 311929 0 None None None Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 949 15 11 14 -3.6 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
CHEMBL3814395 487602 0 None None None Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1020 18 12 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
137654636 314406 0 None None None Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 965 16 12 15 -4.6 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
CHEMBL4091483 314406 0 None None None Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 965 16 12 15 -4.6 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
11169 1650 39 None 1 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
165708555 1650 39 None 1 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
16681432 1650 39 None 1 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
495 1650 39 None 1 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
CHEMBL3301668 1650 39 None 1 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
DB01282 1650 39 None 1 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
135506374 275287 21 None -2 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human OTR expressed in HEK293 cells assessed as induction of IP1 accumulation after 1 hr by HTRF assayAgonist activity at human OTR expressed in HEK293 cells assessed as induction of IP1 accumulation after 1 hr by HTRF assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2017.10.059
CHEMBL3763342 275287 21 None -2 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human OTR expressed in HEK293 cells assessed as induction of IP1 accumulation after 1 hr by HTRF assayAgonist activity at human OTR expressed in HEK293 cells assessed as induction of IP1 accumulation after 1 hr by HTRF assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2017.10.059
135506374 275287 21 None -2 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human oxytocin receptor expressed in HEK293 cells assessed as increase in IP1 accumulation preincubated for 1 hr followed by addition of Ab-Cryptate and IP1-d2 by HTRF assayAgonist activity at human oxytocin receptor expressed in HEK293 cells assessed as increase in IP1 accumulation preincubated for 1 hr followed by addition of Ab-Cryptate and IP1-d2 by HTRF assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
CHEMBL3763342 275287 21 None -2 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human oxytocin receptor expressed in HEK293 cells assessed as increase in IP1 accumulation preincubated for 1 hr followed by addition of Ab-Cryptate and IP1-d2 by HTRF assayAgonist activity at human oxytocin receptor expressed in HEK293 cells assessed as increase in IP1 accumulation preincubated for 1 hr followed by addition of Ab-Cryptate and IP1-d2 by HTRF assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
CHEMBL1817708 484894 0 None -53 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1062 22 12 15 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNCCC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817708 484894 0 None -53 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1062 22 12 15 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNCCC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
10444 4740 20 None -2 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00191
145711714 4740 20 None -2 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00191
CHEMBL4204210 4740 20 None -2 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assayAgonist activity at oxytocin receptor (unknown origin) expressed in CHO cells by IP1 accumulation assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acsmedchemlett.5c00191
172449652 388133 0 None None None Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1094 19 11 16 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(/N=N/c3ccccc3)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5410810 388133 0 None None None Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1094 19 11 16 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(/N=N/c3ccccc3)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5412177 388133 0 None None None Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1094 19 11 16 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(/N=N/c3ccccc3)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
90285722 233979 0 None None None Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 400 5 1 6 3.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(SC(F)(F)F)cc1 10.1021/ml5004348
CHEMBL3342795 233979 0 None None None Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 400 5 1 6 3.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(SC(F)(F)F)cc1 10.1021/ml5004348
2042 8014 41 None 1 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
2176 8014 41 None 1 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
439302 8014 41 None 1 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
CHEMBL395429 8014 41 None 1 5 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
137648249 313872 0 None None None Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 992 17 11 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4085152 313872 0 None None None Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 992 17 11 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O 10.1016/j.bmcl.2017.04.030
145975847 328690 0 None None None Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 882 13 8 11 1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2CCc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4205128 328690 0 None None None Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 882 13 8 11 1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2CCc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
145977939 328909 0 None None None Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 724 10 9 11 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4207691 328909 0 None None None Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 724 10 9 11 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL3813722 487593 0 None None None Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1034 17 10 15 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
90285477 233976 0 None None None Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 388 4 1 6 3.5 Cc1csc(-n2nccc2NS(=O)(=O)c2ccc(C(F)(F)F)cc2)n1 10.1021/ml5004348
CHEMBL3342792 233976 0 None None None Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 388 4 1 6 3.5 Cc1csc(-n2nccc2NS(=O)(=O)c2ccc(C(F)(F)F)cc2)n1 10.1021/ml5004348
10444 4740 20 None -2 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145711714 4740 20 None -2 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4204210 4740 20 None -2 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145964151 329254 0 None None None Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 958 12 8 13 -0.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N2CCC(N3CCCC3)CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4212247 329254 0 None None None Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 958 12 8 13 -0.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N2CCC(N3CCCC3)CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL3813729 487594 0 None None None Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1034 17 10 15 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
135506374 275287 21 None -2 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
CHEMBL3763342 275287 21 None -2 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
135506374 275287 21 None -2 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at recombinant human OTR expressed in CHO-DUKX-A2 cells assessed as stimulation of intracellular calcium concentration by calcium 3 dye based FLIPR assayAgonist activity at recombinant human OTR expressed in CHO-DUKX-A2 cells assessed as stimulation of intracellular calcium concentration by calcium 3 dye based FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 275287 21 None -2 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at recombinant human OTR expressed in CHO-DUKX-A2 cells assessed as stimulation of intracellular calcium concentration by calcium 3 dye based FLIPR assayAgonist activity at recombinant human OTR expressed in CHO-DUKX-A2 cells assessed as stimulation of intracellular calcium concentration by calcium 3 dye based FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
135506374 275287 21 None -2 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at recombinant human OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assayAgonist activity at recombinant human OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.7b00965
CHEMBL3763342 275287 21 None -2 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at recombinant human OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assayAgonist activity at recombinant human OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.7b00965
10444 4740 20 None -2 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145711714 4740 20 None -2 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4204210 4740 20 None -2 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
11169 1650 39 None -10 5 Mouse 7.2 pEC50 = 7.2 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
165708555 1650 39 None -10 5 Mouse 7.2 pEC50 = 7.2 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
16681432 1650 39 None -10 5 Mouse 7.2 pEC50 = 7.2 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
495 1650 39 None -10 5 Mouse 7.2 pEC50 = 7.2 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
CHEMBL3301668 1650 39 None -10 5 Mouse 7.2 pEC50 = 7.2 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
DB01282 1650 39 None -10 5 Mouse 7.2 pEC50 = 7.2 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
127051499 277888 0 None None None Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL3813982 277888 0 None None None Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL1819440 484917 24 None -204 5 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1041 18 13 16 -4.7 NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
DB13464 484917 24 None -204 5 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1041 18 13 16 -4.7 NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1819440 484917 24 None -204 5 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1041 18 13 16 -4.7 NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
DB13464 484917 24 None -204 5 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1041 18 13 16 -4.7 NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
90285806 233981 0 None None None Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 432 5 1 7 2.4 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(S(=O)(=O)C(F)(F)F)cc1 10.1021/ml5004348
CHEMBL3342797 233981 0 None None None Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 432 5 1 7 2.4 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(S(=O)(=O)C(F)(F)F)cc1 10.1021/ml5004348
CHEMBL1817759 484903 0 None -53 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 953 16 12 16 -5.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
135506374 275287 21 None 2 3 Mouse 7.1 pEC50 = 7.1 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 275287 21 None 2 3 Mouse 7.1 pEC50 = 7.1 Functional
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL1817759 484903 0 None -53 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 953 16 12 16 -5.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
2042 8014 41 None 1 5 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
2176 8014 41 None 1 5 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
439302 8014 41 None 1 5 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
CHEMBL395429 8014 41 None 1 5 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
76685194 233974 1 None -5 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assayAgonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assay
ChEMBL 368 4 1 5 3.1 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL3342790 233974 1 None -5 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assayAgonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assay
ChEMBL 368 4 1 5 3.1 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
76685194 233974 1 None -5 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 368 4 1 5 3.1 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(C(F)(F)F)cc1 10.1021/ml5004348
CHEMBL3342790 233974 1 None -5 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 368 4 1 5 3.1 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(C(F)(F)F)cc1 10.1021/ml5004348
146681949 8624 35 None -97 5 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
2168 8624 35 None -97 5 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
2810 8624 35 None -97 5 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
644077 8624 35 None -97 5 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
CHEMBL373742 8624 35 None -97 5 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
DB00067 8624 35 None -97 5 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
P01185 8624 35 None -97 5 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
P01186 8624 35 None -97 5 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
P35455 8624 35 None -97 5 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
CHEMBL1817763 484907 0 None -63 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1025 19 12 16 -3.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817763 484907 0 None -63 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1025 19 12 16 -3.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
135506374 275287 21 None -2 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human OTR stably expressed in HEK cells by calcium flux assayAgonist activity at human OTR stably expressed in HEK cells by calcium flux assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 275287 21 None -2 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human OTR stably expressed in HEK cells by calcium flux assayAgonist activity at human OTR stably expressed in HEK cells by calcium flux assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
137652261 313042 0 None None None Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1006 18 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4075079 313042 0 None None None Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1006 18 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL1819543 484922 0 None -18 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 977 17 12 15 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819543 484922 0 None -18 4 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 977 17 12 15 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
137653770 314630 0 None None None Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1063 20 12 15 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4094014 314630 0 None None None Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1063 20 12 15 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
172442093 387966 0 None None None Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1033 17 12 16 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N/c3ccc(C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5407278 387966 0 None None None Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1033 17 12 16 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N/c3ccc(C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL1817758 484902 0 None -63 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1009 19 12 16 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817758 484902 0 None -63 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1009 19 12 16 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
90663156 216271 0 None None None Human 9.5 pIC50 = 9.5 Functional
Ability to inhibit OT-induced inositol phosphate accumulation was determined in CHO cells expressing the human OT receptorAbility to inhibit OT-induced inositol phosphate accumulation was determined in CHO cells expressing the human OT receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
CHEMBL3142790 216271 0 None None None Human 9.5 pIC50 = 9.5 Functional
Ability to inhibit OT-induced inositol phosphate accumulation was determined in CHO cells expressing the human OT receptorAbility to inhibit OT-induced inositol phosphate accumulation was determined in CHO cells expressing the human OT receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
44459839 200024 0 None None None Human 9.0 pIC50 = 9 Functional
Inhibitory concentration required for antagonist activity against oxytocin receptorInhibitory concentration required for antagonist activity against oxytocin receptor
ChEMBL 573 12 3 7 2.3 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2cccs2)C(N)=O)C1=O 10.1016/s0960-894x(01)00201-3
CHEMBL285608 200024 0 None None None Human 9.0 pIC50 = 9 Functional
Inhibitory concentration required for antagonist activity against oxytocin receptorInhibitory concentration required for antagonist activity against oxytocin receptor
ChEMBL 573 12 3 7 2.3 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2cccs2)C(N)=O)C1=O 10.1016/s0960-894x(01)00201-3
155520603 335054 0 None None None Human 8.0 pIC50 = 8 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 431 6 0 7 4.0 COCc1nnc(N2CCC(c3ccc(F)cc3Cl)CC2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4449435 335054 0 None None None Human 8.0 pIC50 = 8 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 431 6 0 7 4.0 COCc1nnc(N2CCC(c3ccc(F)cc3Cl)CC2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
10411308 462175 0 None -190 3 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at OXR receptor (unknown origin)Antagonist activity at OXR receptor (unknown origin)
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/acs.jmedchem.8b00697
CHEMBL603708 462175 0 None -190 3 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at OXR receptor (unknown origin)Antagonist activity at OXR receptor (unknown origin)
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/acs.jmedchem.8b00697
2213 1072 37 None 12 2 Rat 7.9 pIC50 = 7.9 Functional
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2005.10.107
3008 1072 37 None 12 2 Rat 7.9 pIC50 = 7.9 Functional
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2005.10.107
5311010 1072 37 None 12 2 Rat 7.9 pIC50 = 7.9 Functional
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2005.10.107
68613 1072 37 None 12 2 Rat 7.9 pIC50 = 7.9 Functional
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2005.10.107
CHEMBL378642 1072 37 None 12 2 Rat 7.9 pIC50 = 7.9 Functional
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2005.10.107
CHEMBL382301 1072 37 None 12 2 Rat 7.9 pIC50 = 7.9 Functional
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2005.10.107
DB09059 1072 37 None 12 2 Rat 7.9 pIC50 = 7.9 Functional
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2005.10.107
155517601 334746 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 444 6 0 8 2.9 COCc1nnc(N2CC3CN(c4ccc(F)cc4Cl)C3C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4444840 334746 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 444 6 0 8 2.9 COCc1nnc(N2CC3CN(c4ccc(F)cc4Cl)C3C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
155516256 334599 0 None None None Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 473 7 0 8 4.2 COCc1nnc(N2C3CCC2CC(Oc2ccc(F)cc2Cl)C3)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4442843 334599 0 None None None Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 473 7 0 8 4.2 COCc1nnc(N2C3CCC2CC(Oc2ccc(F)cc2Cl)C3)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
9824954 155543 0 None -2 3 Rat 5.9 pIC50 = 5.9 Functional
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL 449 2 1 5 5.5 Cc1ccn(-c2ccc(C(=O)N3Cc4cccnc4Nc4ccccc43)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2005.10.107
CHEMBL201889 155543 0 None -2 3 Rat 5.9 pIC50 = 5.9 Functional
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL 449 2 1 5 5.5 Cc1ccn(-c2ccc(C(=O)N3Cc4cccnc4Nc4ccccc43)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2005.10.107
44458614 199317 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonistic activity against Oxytocin receptorAntagonistic activity against Oxytocin receptor
ChEMBL 571 7 2 5 3.7 C[C@@H](O)CN1CCC[C@@H](C(=O)NC2CC3CCC2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1 10.1021/jm970342o
CHEMBL280678 199317 0 None None None Human 6.9 pIC50 = 6.9 Functional
Antagonistic activity against Oxytocin receptorAntagonistic activity against Oxytocin receptor
ChEMBL 571 7 2 5 3.7 C[C@@H](O)CN1CCC[C@@H](C(=O)NC2CC3CCC2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1 10.1021/jm970342o
142391767 334212 0 None 6 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 442 5 0 7 3.7 COCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc2c(c1)OCO2 10.1021/acsmedchemlett.9b00186
CHEMBL4437214 334212 0 None 6 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 442 5 0 7 3.7 COCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc2c(c1)OCO2 10.1021/acsmedchemlett.9b00186
155542139 347192 0 None None None Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 473 7 0 8 3.9 COCc1nnc(N2C[C@H]3C[C@@H](Oc4ccc(F)cc4Cl)C[C@H]3C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4519861 347192 0 None None None Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 473 7 0 8 3.9 COCc1nnc(N2C[C@H]3C[C@@H](Oc4ccc(F)cc4Cl)C[C@H]3C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
135413562 4496 12 None None None Human 7.9 pIC50 = 7.9 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
2194 4496 12 None None None Human 7.9 pIC50 = 7.9 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
CHEMBL445816 4496 12 None None None Human 7.9 pIC50 = 7.9 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
135493119 160559 0 None None None Human 7.9 pIC50 = 7.9 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113201 160559 0 None None None Human 7.9 pIC50 = 7.9 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
135192983 346716 24 None 190 4 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4591825 346716 24 None 190 4 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
135399831 160552 0 None None None Human 7.8 pIC50 = 7.8 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 597 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)NC(=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113189 160552 0 None None None Human 7.8 pIC50 = 7.8 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 597 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)NC(=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
145961670 316908 0 None -123 2 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by oxytocin addition measured for 5 mins by Fluo-4-AM dye based FLIPR assayAntagonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by oxytocin addition measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1139 19 14 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4126100 316908 0 None -123 2 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by oxytocin addition measured for 5 mins by Fluo-4-AM dye based FLIPR assayAntagonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by oxytocin addition measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1139 19 14 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
135192979 349818 0 None 41 4 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 485 7 0 8 3.5 COc1ccc(-n2c(CO[C@H]3CCOC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4585239 349818 0 None 41 4 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 485 7 0 8 3.5 COc1ccc(-n2c(CO[C@H]3CCOC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
135192895 348054 0 None 8 2 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 485 7 0 8 3.5 COc1ccc(-n2c(CO[C@@H]3CCOC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4542267 348054 0 None 8 2 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 485 7 0 8 3.5 COc1ccc(-n2c(CO[C@@H]3CCOC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
135192936 346622 1 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2CC3CC3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4518063 346622 1 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2CC3CC3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
11683187 444222 42 None 20 2 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL594828 444222 42 None 20 2 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
135193003 349387 0 None 3 3 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 424 5 0 7 3.3 COc1ccc(-n2c(CC#N)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4575160 349387 0 None 3 3 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 424 5 0 7 3.3 COc1ccc(-n2c(CC#N)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
155558305 348779 0 None None None Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 459 6 0 8 3.0 COCc1nnc(N2CC3COCC3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4560499 348779 0 None None None Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 459 6 0 8 3.0 COCc1nnc(N2CC3COCC3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
146238444 336202 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 417 6 0 7 3.6 COCc1nnc(N2CCC(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4466263 336202 0 None None None Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 417 6 0 7 3.6 COCc1nnc(N2CCC(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
155554422 348644 0 None None None Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 445 7 0 7 4.0 COCc1nnc(C2CCN(Cc3ccc(F)cc3Cl)CC2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4557241 348644 0 None None None Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 445 7 0 7 4.0 COCc1nnc(C2CCN(Cc3ccc(F)cc3Cl)CC2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
11465834 275790 0 None None None Human 8.4 pIC50 = 8.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as inhibition of oxytocin-induced calcium mobilization by FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as inhibition of oxytocin-induced calcium mobilization by FLIPR assay
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL377414 275790 0 None None None Human 8.4 pIC50 = 8.4 Functional
Agonist activity at human OTR expressed in CHO cells assessed as inhibition of oxytocin-induced calcium mobilization by FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as inhibition of oxytocin-induced calcium mobilization by FLIPR assay
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
135192928 348934 0 None 125 4 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@@H]3C[C@]3(c3cccc(F)c3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4564411 348934 0 None 125 4 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@@H]3C[C@]3(c3cccc(F)c3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
1103817 40884 7 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
CHEMBL1254117 40884 7 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
135530014 160549 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 526 9 3 6 2.9 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(CCCO)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113179 160549 0 None None None Human 7.5 pIC50 = 7.5 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 526 9 3 6 2.9 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(CCCO)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
145976595 328683 0 None -2 3 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at OXR receptor (unknown origin)Antagonist activity at OXR receptor (unknown origin)
ChEMBL 408 2 1 4 4.9 Cc1ccn(C(=O)Nc2ccc(C(=O)N3CCCCc4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL4205046 328683 0 None -2 3 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at OXR receptor (unknown origin)Antagonist activity at OXR receptor (unknown origin)
ChEMBL 408 2 1 4 4.9 Cc1ccn(C(=O)Nc2ccc(C(=O)N3CCCCc4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
2213 1072 37 None -12 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.ejmech.2017.05.013
3008 1072 37 None -12 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.ejmech.2017.05.013
5311010 1072 37 None -12 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.ejmech.2017.05.013
68613 1072 37 None -12 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.ejmech.2017.05.013
CHEMBL378642 1072 37 None -12 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.ejmech.2017.05.013
CHEMBL382301 1072 37 None -12 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.ejmech.2017.05.013
DB09059 1072 37 None -12 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.ejmech.2017.05.013
155564470 349427 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 411 5 0 8 2.5 COCc1nnc(N2CC3(CCc4cc(F)ccc4O3)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4576147 349427 0 None None None Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 411 5 0 8 2.5 COCc1nnc(N2CC3(CCc4cc(F)ccc4O3)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
137212772 275327 0 None -3 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as inhibition of agonist-induced IP1 accumulation preincubated for 30 mins followed by agonist addition measured after 1 hr by HTRF assayAntagonist activity at human OTR expressed in HEK293 cells assessed as inhibition of agonist-induced IP1 accumulation preincubated for 30 mins followed by agonist addition measured after 1 hr by HTRF assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
CHEMBL3763951 275327 0 None -3 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as inhibition of agonist-induced IP1 accumulation preincubated for 30 mins followed by agonist addition measured after 1 hr by HTRF assayAntagonist activity at human OTR expressed in HEK293 cells assessed as inhibition of agonist-induced IP1 accumulation preincubated for 30 mins followed by agonist addition measured after 1 hr by HTRF assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
137212772 275327 0 None -3 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human oxytocin receptor expressed in HEK293 cells assessed as inhibition of oxytocin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assayAntagonist activity at human oxytocin receptor expressed in HEK293 cells assessed as inhibition of oxytocin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
CHEMBL3763951 275327 0 None -3 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human oxytocin receptor expressed in HEK293 cells assessed as inhibition of oxytocin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assayAntagonist activity at human oxytocin receptor expressed in HEK293 cells assessed as inhibition of oxytocin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
135192889 348116 0 None 25 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 425 5 0 6 4.1 COc1ccc(-n2c(C3CC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4543809 348116 0 None 25 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 425 5 0 6 4.1 COc1ccc(-n2c(C3CC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
135192997 347907 0 None 18 4 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 461 8 0 7 3.7 COc1ccc(-n2c(COCCF)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4538696 347907 0 None 18 4 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 461 8 0 7 3.7 COc1ccc(-n2c(COCCF)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
135508167 160548 0 None None None Human 7.3 pIC50 = 7.3 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 596 10 3 8 2.8 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(NCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113177 160548 0 None None None Human 7.3 pIC50 = 7.3 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 596 10 3 8 2.8 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(NCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
44459838 199816 0 None None None Human 8.3 pIC50 = 8.3 Functional
Inhibitory concentration required for antagonist activity against oxytocin receptorInhibitory concentration required for antagonist activity against oxytocin receptor
ChEMBL 635 12 3 6 3.6 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00201-3
CHEMBL284120 199816 0 None None None Human 8.3 pIC50 = 8.3 Functional
Inhibitory concentration required for antagonist activity against oxytocin receptorInhibitory concentration required for antagonist activity against oxytocin receptor
ChEMBL 635 12 3 6 3.6 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00201-3
142391805 348045 0 None 35 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 435 5 0 6 4.2 COc1ccc(-n2c(C(F)F)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4541860 348045 0 None 35 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 435 5 0 6 4.2 COc1ccc(-n2c(C(F)F)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
145952624 317877 0 None -1 3 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence methodAntagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence method
ChEMBL 889 21 2 10 3.3 CC[C@H](C)[C@@H](OC(=O)CCc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC 10.1021/acs.jmedchem.8b00885
CHEMBL4165525 317877 0 None -1 3 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence methodAntagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence method
ChEMBL 889 21 2 10 3.3 CC[C@H](C)[C@@H](OC(=O)CCc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC 10.1021/acs.jmedchem.8b00885
3537 8682 25 None 1 4 Rat 7.3 pIC50 = 7.3 Functional
Antagonist activity at OXR receptor in rat uterusAntagonist activity at OXR receptor in rat uterus
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
5311500 8682 25 None 1 4 Rat 7.3 pIC50 = 7.3 Functional
Antagonist activity at OXR receptor in rat uterusAntagonist activity at OXR receptor in rat uterus
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
CHEMBL363910 8682 25 None 1 4 Rat 7.3 pIC50 = 7.3 Functional
Antagonist activity at OXR receptor in rat uterusAntagonist activity at OXR receptor in rat uterus
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
145957924 317591 0 None -2 3 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence methodAntagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence method
ChEMBL 886 20 2 10 3.4 CC[C@H](C)[C@@H](OC(=O)/C=C\c1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC 10.1021/acs.jmedchem.8b00885
CHEMBL4161021 317591 0 None -2 3 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence methodAntagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence method
ChEMBL 886 20 2 10 3.4 CC[C@H](C)[C@@H](OC(=O)/C=C\c1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC 10.1021/acs.jmedchem.8b00885
2213 1072 37 None -12 2 Human 7.2 pIC50 = 7.2 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
3008 1072 37 None -12 2 Human 7.2 pIC50 = 7.2 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
5311010 1072 37 None -12 2 Human 7.2 pIC50 = 7.2 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
68613 1072 37 None -12 2 Human 7.2 pIC50 = 7.2 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
CHEMBL378642 1072 37 None -12 2 Human 7.2 pIC50 = 7.2 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
CHEMBL382301 1072 37 None -12 2 Human 7.2 pIC50 = 7.2 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
DB09059 1072 37 None -12 2 Human 7.2 pIC50 = 7.2 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
135469700 160561 0 None None None Human 7.2 pIC50 = 7.2 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 555 10 2 7 2.9 CN(C)CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113203 160561 0 None None None Human 7.2 pIC50 = 7.2 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 555 10 2 7 2.9 CN(C)CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
145974527 329683 0 None -67 2 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAntagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 491 5 3 6 3.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4217872 329683 0 None -67 2 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAntagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 491 5 3 6 3.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=S)N(C)C 10.1021/acs.jmedchem.8b00697
11683187 444222 42 None 20 2 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced calcium release by Aequorin based assayAntagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced calcium release by Aequorin based assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acs.jmedchem.8b00697
CHEMBL594828 444222 42 None 20 2 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced calcium release by Aequorin based assayAntagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced calcium release by Aequorin based assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acs.jmedchem.8b00697
135192930 335321 0 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@H]3C[C@@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4452863 335321 0 None None None Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@H]3C[C@@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
11683187 444222 42 None 20 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced response incubated for 30 mins by beta-arrestin recruitment assayAntagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced response incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acs.jmedchem.8b00697
CHEMBL594828 444222 42 None 20 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced response incubated for 30 mins by beta-arrestin recruitment assayAntagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced response incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acs.jmedchem.8b00697
2252 4546 39 None None None Rat 6.2 pIC50 = 6.2 Functional
Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00160-9
6918320 4546 39 None None None Rat 6.2 pIC50 = 6.2 Functional
Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00160-9
CHEMBL24781 4546 39 None None None Rat 6.2 pIC50 = 6.2 Functional
Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00160-9
155537980 336855 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 397 5 0 8 2.2 COCc1nnc(N2CC3(C2)OCc2cc(F)ccc23)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4475530 336855 0 None None None Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 397 5 0 8 2.2 COCc1nnc(N2CC3(C2)OCc2cc(F)ccc23)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
145953024 318077 0 None -15 4 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence methodAntagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence method
ChEMBL 886 20 2 10 3.4 CC[C@H](C)[C@@H](OC(=O)/C=C/c1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC 10.1021/acs.jmedchem.8b00885
CHEMBL4168948 318077 0 None -15 4 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence methodAntagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence method
ChEMBL 886 20 2 10 3.4 CC[C@H](C)[C@@H](OC(=O)/C=C/c1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC 10.1021/acs.jmedchem.8b00885
9871105 198920 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonistic activity against Oxytocin receptorAntagonistic activity against Oxytocin receptor
ChEMBL 513 5 2 4 3.6 CC1(C)C2CCC1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C(NC(=O)C1CCCNC1)C2 10.1021/jm970342o
CHEMBL277400 198920 0 None None None Human 7.2 pIC50 = 7.2 Functional
Antagonistic activity against Oxytocin receptorAntagonistic activity against Oxytocin receptor
ChEMBL 513 5 2 4 3.6 CC1(C)C2CCC1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C(NC(=O)C1CCCNC1)C2 10.1021/jm970342o
135476004 160551 0 None None None Human 8.2 pIC50 = 8.2 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113185 160551 0 None None None Human 8.2 pIC50 = 8.2 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
135414531 160566 0 None None None Human 8.2 pIC50 = 8.2 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 586 13 2 8 3.1 COCCOCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113208 160566 0 None None None Human 8.2 pIC50 = 8.2 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 586 13 2 8 3.1 COCCOCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
145970269 328552 0 None -15 2 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAntagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 475 5 3 6 2.5 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=O)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4203314 328552 0 None -15 2 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAntagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 475 5 3 6 2.5 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=O)N(C)C 10.1021/acs.jmedchem.8b00697
135469685 160569 0 None None None Human 8.1 pIC50 = 8.1 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 542 10 2 7 3.0 COCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113211 160569 0 None None None Human 8.1 pIC50 = 8.1 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 542 10 2 7 3.0 COCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
135192948 349608 0 None 5 2 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 499 7 0 8 3.9 COc1ccc(-n2c(COC3CCOCC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4580413 349608 0 None 5 2 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 499 7 0 8 3.9 COc1ccc(-n2c(COC3CCOCC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
135530164 160558 0 None None None Human 6.1 pIC50 = 6.1 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 570 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113200 160558 0 None None None Human 6.1 pIC50 = 6.1 Functional
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 570 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
155568614 350093 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 444 6 0 8 2.9 COCc1nnc(N2CC3CN(c4ccc(F)cc4Cl)CC32)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4591943 350093 0 None None None Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 444 6 0 8 2.9 COCc1nnc(N2CC3CN(c4ccc(F)cc4Cl)CC32)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
11634973 157006 17 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C 10.1021/acsmedchemlett.9b00186
CHEMBL2037511 157006 17 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C 10.1021/acsmedchemlett.9b00186
DB11934 157006 17 None None None Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C 10.1021/acsmedchemlett.9b00186
135192932 336061 0 None 190 4 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 443 7 0 7 3.8 CCOCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4464246 336061 0 None 190 4 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 443 7 0 7 3.8 CCOCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
155565553 349600 0 None None None Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 446 7 0 8 2.9 COCc1nnc(N2CCN(Cc3ccc(F)cc3Cl)CC2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4580192 349600 0 None None None Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 446 7 0 8 2.9 COCc1nnc(N2CCN(Cc3ccc(F)cc3Cl)CC2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
14981575 160372 0 None None None Rat 9.0 pKd = 9 Functional
In vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 valueIn vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 value
ChEMBL 582 10 1 7 2.1 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(C)C)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112896 160372 0 None None None Rat 9.0 pKd = 9 Functional
In vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 valueIn vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 value
ChEMBL 582 10 1 7 2.1 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(C)C)C3(C)C)CC1 10.1021/jm00031a004
10437668 155157 1 None None None Rat 8.9 pKd = 8.9 Functional
In vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 value which refers to the negative logarithm of the molar concentrationIn vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 value which refers to the negative logarithm of the molar concentration
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112903 155157 1 None None None Rat 8.9 pKd = 8.9 Functional
In vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 value which refers to the negative logarithm of the molar concentrationIn vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 value which refers to the negative logarithm of the molar concentration
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL1790200 484796 0 None None None Rat 8.7 pKd = 8.7 Functional
In vitro Oxytocin receptor antagonistic activity against rat uterine stripsIn vitro Oxytocin receptor antagonistic activity against rat uterine strips
ChEMBL 1032 9 12 15 -3.1 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)C(C)(C)SSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm00087a009
16737617 197207 0 None None None Rat 8.0 pKd = 8 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
16737618 197207 0 None None None Rat 8.0 pKd = 8 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL265630 197207 0 None None None Rat 8.0 pKd = 8 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL415418 197207 0 None None None Rat 8.0 pKd = 8 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL539918 489217 0 None None None Rat 7.0 pKd = 7 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1114 18 13 14 -1.9 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL435159 488611 0 None None None Rat 7.0 pKd = 7 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1068 17 12 15 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL261938 486037 0 None None None Rat 7.0 pKd = 7 Functional
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1159 20 14 16 -3.8 NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](N)CSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm058038f
44429299 333850 0 None None None Rat 7.9 pKd = 7.9 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1035 20 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL441128 333850 0 None None None Rat 7.9 pKd = 7.9 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1035 20 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44429298 294154 0 None None None Rat 7.9 pKd = 7.9 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1033 19 10 14 -1.5 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL393020 294154 0 None None None Rat 7.9 pKd = 7.9 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1033 19 10 14 -1.5 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
16736614 295716 0 None None None Rat 6.9 pKd = 6.9 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 975 16 10 13 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H]2Cc3ccccc3CN2C(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL394268 295716 0 None None None Rat 6.9 pKd = 6.9 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 975 16 10 13 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H]2Cc3ccccc3CN2C(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
44429304 178138 0 None None None Rat 7.9 pKd = 7.9 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1062 19 10 14 -0.7 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N3CCCC[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233080 178138 0 None None None Rat 7.9 pKd = 7.9 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1062 19 10 14 -0.7 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N3CCCC[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL1790192 484794 0 None None None Rat 6.9 pKd = 6.9 Functional
In vitro Oxytocin receptor antagonistic activity against rat uterine stripsIn vitro Oxytocin receptor antagonistic activity against rat uterine strips
ChEMBL 1034 17 12 15 -2.8 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm00087a009
CHEMBL2021547 485016 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1140 21 11 15 -0.6 C=C(C)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
45270786 392045 0 None None None Rat 6.8 pKd = 6.8 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1168 18 12 13 0.8 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL558950 392045 0 None None None Rat 6.8 pKd = 6.8 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1168 18 12 13 0.8 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL2367696 485395 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1140 21 11 15 -0.6 C=C(C)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
42645362 387281 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
42645836 387281 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
CHEMBL538934 387281 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
CHEMBL541246 387281 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
2192 4802 27 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contractionAntagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contraction
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
9690136 4802 27 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contractionAntagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contraction
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
CHEMBL1254024 4802 27 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contractionAntagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contraction
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
44429288 178241 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44429290 178241 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233328 178241 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL234377 178241 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44429307 295715 0 None None None Rat 6.8 pKd = 6.8 Functional
Antagonist activity in phenoxybenzamine-treated rat by Pressor assayAntagonist activity in phenoxybenzamine-treated rat by Pressor assay
ChEMBL 1003 18 10 13 -1.7 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL394266 295715 0 None None None Rat 6.8 pKd = 6.8 Functional
Antagonist activity in phenoxybenzamine-treated rat by Pressor assayAntagonist activity in phenoxybenzamine-treated rat by Pressor assay
ChEMBL 1003 18 10 13 -1.7 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44408817 275347 0 None None None Rat 6.8 pKd = 6.8 Functional
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1050 17 9 14 -2.7 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSC[C@@H](N)C(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm058038f
CHEMBL376412 275347 0 None None None Rat 6.8 pKd = 6.8 Functional
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1050 17 9 14 -2.7 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSC[C@@H](N)C(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm058038f
CHEMBL1790202 484797 0 None None None Rat 5.8 pKd = 5.8 Functional
In vitro Oxytocin receptor antagonistic activity against rat uterine stripsIn vitro Oxytocin receptor antagonistic activity against rat uterine strips
ChEMBL 1050 19 13 16 -3.1 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)O)NC1=O 10.1021/jm00087a009
42645362 387281 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
42645836 387281 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
CHEMBL538934 387281 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
CHEMBL541246 387281 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
42646319 387973 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1099 18 12 13 -0.9 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL540754 387973 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1099 18 12 13 -0.9 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL1790198 484795 0 None None None Rat 7.8 pKd = 7.8 Functional
In vitro Oxytocin receptor antagonistic activity against rat uterine stripsIn vitro Oxytocin receptor antagonistic activity against rat uterine strips
ChEMBL 1049 19 13 16 -3.7 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm00087a009
44429303 294155 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1007 20 11 14 -1.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL393021 294155 0 None None None Rat 7.8 pKd = 7.8 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1007 20 11 14 -1.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44408952 312213 0 None None None Rat 6.7 pKd = 6.7 Functional
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1103 17 8 13 0.1 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSC2(CCCCC2)CC(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm058038f
CHEMBL406533 312213 0 None None None Rat 6.7 pKd = 6.7 Functional
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1103 17 8 13 0.1 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSC2(CCCCC2)CC(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm058038f
CHEMBL558740 489245 0 None None None Rat 5.6 pKd = 5.6 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1016 15 13 14 -3.4 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)C2(CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL397407 487806 0 None None None Rat 5.6 pKd = 5.6 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1068 17 12 15 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2Cc3ccccc3C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
16109438 196913 0 None None None Human 6.6 pKd = 6.6 Functional
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1051 17 11 14 -1.0 NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL263090 196913 0 None None None Human 6.6 pKd = 6.6 Functional
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1051 17 11 14 -1.0 NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
10461270 7472 18 None None None Rat 8.5 pKd = 8.5 Functional
Antagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contractionAntagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contraction
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
2201 7472 18 None None None Rat 8.5 pKd = 8.5 Functional
Antagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contractionAntagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contraction
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
CHEMBL1615640 7472 18 None None None Rat 8.5 pKd = 8.5 Functional
Antagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contractionAntagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contraction
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
16736414 178219 0 None None None Rat 6.5 pKd = 6.5 Functional
Antagonist activity in phenoxybenzamine-treated rat by Pressor assayAntagonist activity in phenoxybenzamine-treated rat by Pressor assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
16736613 178219 0 None None None Rat 6.5 pKd = 6.5 Functional
Antagonist activity in phenoxybenzamine-treated rat by Pressor assayAntagonist activity in phenoxybenzamine-treated rat by Pressor assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233281 178219 0 None None None Rat 6.5 pKd = 6.5 Functional
Antagonist activity in phenoxybenzamine-treated rat by Pressor assayAntagonist activity in phenoxybenzamine-treated rat by Pressor assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL394267 178219 0 None None None Rat 6.5 pKd = 6.5 Functional
Antagonist activity in phenoxybenzamine-treated rat by Pressor assayAntagonist activity in phenoxybenzamine-treated rat by Pressor assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44408951 311220 0 None None None Rat 6.5 pKd = 6.5 Functional
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1035 17 8 13 -1.6 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSCCC(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm058038f
CHEMBL402693 311220 0 None None None Rat 6.5 pKd = 6.5 Functional
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1035 17 8 13 -1.6 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSCCC(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm058038f
16109437 175275 0 None None None Human 6.5 pKd = 6.5 Functional
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1065 18 11 14 -0.6 NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL221485 175275 0 None None None Human 6.5 pKd = 6.5 Functional
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1065 18 11 14 -0.6 NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
16737617 197207 0 None None None Rat 7.5 pKd = 7.5 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
16737618 197207 0 None None None Rat 7.5 pKd = 7.5 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL265630 197207 0 None None None Rat 7.5 pKd = 7.5 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL415418 197207 0 None None None Rat 7.5 pKd = 7.5 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
44429300 177895 0 None None None Rat 6.5 pKd = 6.5 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1035 18 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C(C)(C)C)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL232501 177895 0 None None None Rat 6.5 pKd = 6.5 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1035 18 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C(C)(C)C)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
16736414 178219 0 None None None Rat 7.4 pKd = 7.4 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
16736613 178219 0 None None None Rat 7.4 pKd = 7.4 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233281 178219 0 None None None Rat 7.4 pKd = 7.4 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL394267 178219 0 None None None Rat 7.4 pKd = 7.4 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL267214 486224 0 None None None Rat 6.4 pKd = 6.4 Functional
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1113 20 15 17 -6.0 NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@](N)(CO)CSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm058038f
44429295 333579 0 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1110 19 10 14 -0.1 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL438849 333579 0 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1110 19 10 14 -0.1 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL394411 487777 0 None None None Rat 7.4 pKd = 7.4 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1034 19 11 15 -2.9 CCOc1ccc(C[C@H]2NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
16109444 316992 0 None None None Human 6.4 pKd = 6.4 Functional
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1037 16 11 14 -1.3 NCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL412742 316992 0 None None None Human 6.4 pKd = 6.4 Functional
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1037 16 11 14 -1.3 NCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
16109439 274647 0 None None None Human 6.3 pKd = 6.3 Functional
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1023 15 11 14 -1.7 NC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL375187 274647 0 None None None Human 6.3 pKd = 6.3 Functional
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1023 15 11 14 -1.7 NC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
16736414 178219 0 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
16736613 178219 0 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233281 178219 0 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL394267 178219 0 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
2213 1072 37 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.ejmech.2006.12.016
3008 1072 37 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.ejmech.2006.12.016
5311010 1072 37 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.ejmech.2006.12.016
68613 1072 37 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.ejmech.2006.12.016
CHEMBL378642 1072 37 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.ejmech.2006.12.016
CHEMBL382301 1072 37 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.ejmech.2006.12.016
DB09059 1072 37 None None None Rat 8.3 pKd = 8.3 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.ejmech.2006.12.016
CHEMBL563952 489255 0 None None None Rat 7.3 pKd = 7.3 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1079 17 14 15 -5.0 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)NC2(Cc3ccccc3C2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
44409014 330957 0 None None None Rat 7.2 pKd = 7.2 Functional
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1144 20 13 15 -2.8 NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm058038f
CHEMBL425991 330957 0 None None None Rat 7.2 pKd = 7.2 Functional
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1144 20 13 15 -2.8 NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm058038f
45270785 390330 0 None None None Rat 6.2 pKd = 6.2 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1197 20 13 14 -0.5 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
CHEMBL552946 390330 0 None None None Rat 6.2 pKd = 6.2 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1197 20 13 14 -0.5 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
44429288 178241 0 None None None Rat 8.2 pKd = 8.2 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44429290 178241 0 None None None Rat 8.2 pKd = 8.2 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233328 178241 0 None None None Rat 8.2 pKd = 8.2 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL234377 178241 0 None None None Rat 8.2 pKd = 8.2 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
56668141 125900 0 None None None Rat 8.2 pKd = 8.2 Functional
In vitro Oxytocin receptor antagonistic activity against rat uterine stripsIn vitro Oxytocin receptor antagonistic activity against rat uterine strips
ChEMBL 989 9 11 14 -2.8 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm00087a009
CHEMBL1790201 125900 0 None None None Rat 8.2 pKd = 8.2 Functional
In vitro Oxytocin receptor antagonistic activity against rat uterine stripsIn vitro Oxytocin receptor antagonistic activity against rat uterine strips
ChEMBL 989 9 11 14 -2.8 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm00087a009
42645362 387281 0 None None None Rat 7.2 pKd = 7.2 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
42645836 387281 0 None None None Rat 7.2 pKd = 7.2 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
CHEMBL538934 387281 0 None None None Rat 7.2 pKd = 7.2 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
CHEMBL541246 387281 0 None None None Rat 7.2 pKd = 7.2 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
45267363 390427 0 None None None Rat 8.2 pKd = 8.2 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1107 17 12 14 -1.2 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL553710 390427 0 None None None Rat 8.2 pKd = 8.2 Functional
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1107 17 12 14 -1.2 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL415417 488399 0 None None None Rat 6.1 pKd = 6.1 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1022 16 13 15 -3.1 CC(C)C[C@H](NC(=O)[C@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(C)(C)C)C(=O)NCC(N)=O 10.1016/j.ejmech.2006.12.016
44408750 312534 0 None None None Rat 6.1 pKd = 6.1 Functional
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1213 20 13 15 -1.0 NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm058038f
CHEMBL406896 312534 0 None None None Rat 6.1 pKd = 6.1 Functional
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1213 20 13 15 -1.0 NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm058038f
44429294 333024 0 None None None Rat 8.1 pKd = 8.1 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1184 18 9 14 0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)N3Cc4ccccc4C[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL434193 333024 0 None None None Rat 8.1 pKd = 8.1 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1184 18 9 14 0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)N3Cc4ccccc4C[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44429307 295715 0 None None None Rat 8.1 pKd = 8.1 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1003 18 10 13 -1.7 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL394266 295715 0 None None None Rat 8.1 pKd = 8.1 Functional
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1003 18 10 13 -1.7 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
46225048 465179 0 None None None Human 9.4 pKi = 9.4 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 415 5 0 7 3.6 COc1ccc(-n2c(C)nnc2N2CCC(Oc3cc(F)cc(F)c3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL606976 465179 0 None None None Human 9.4 pKi = 9.4 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 415 5 0 7 3.6 COc1ccc(-n2c(C)nnc2N2CCC(Oc3cc(F)cc(F)c3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
42611262 354432 0 None None None Human 9.1 pKi = 9.1 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 349 6 0 2 4.7 Cc1cc(C(=O)N(CC2CC2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
CHEMBL475395 354432 0 None None None Human 9.1 pKi = 9.1 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 349 6 0 2 4.7 Cc1cc(C(=O)N(CC2CC2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
11848692 352443 1 None None None Human 9.0 pKi = 9 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 396 4 0 7 3.9 COc1ccc(-n2c(C)nnc2-c2cnc(-c3cccc(F)c3Cl)cn2)cn1 10.1016/j.bmcl.2008.06.098
CHEMBL466762 352443 1 None None None Human 9.0 pKi = 9 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 396 4 0 7 3.9 COc1ccc(-n2c(C)nnc2-c2cnc(-c3cccc(F)c3Cl)cn2)cn1 10.1016/j.bmcl.2008.06.098
2202 5638 34 None None None Human 8.8 pKi = 8.8 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.11.061
9895468 5638 34 None None None Human 8.8 pKi = 8.8 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.11.061
CHEMBL582857 5638 34 None None None Human 8.8 pKi = 8.8 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.11.061
DB12643 5638 34 None None None Human 8.8 pKi = 8.8 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.11.061
11465834 275790 0 None None None Human 8.8 pKi = 8.8 Functional
Antagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assayAntagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assay
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL377414 275790 0 None None None Human 8.8 pKi = 8.8 Functional
Antagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assayAntagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assay
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
44581242 349863 0 None None None Human 8.7 pKi = 8.7 Functional
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 475 8 0 6 4.9 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL458635 349863 0 None None None Human 8.7 pKi = 8.7 Functional
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 475 8 0 6 4.9 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44571488 367153 0 None None None Human 6.0 pKi = 6 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 396 6 0 3 5.0 N#Cc1ccccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL480584 367153 0 None None None Human 6.0 pKi = 6 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 396 6 0 3 5.0 N#Cc1ccccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44571389 367387 0 None None None Human 6.0 pKi = 6 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 440 6 0 3 5.6 O=C(c1ccc(-c2ncccc2C(F)(F)F)cc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL482322 367387 0 None None None Human 6.0 pKi = 6 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 440 6 0 3 5.6 O=C(c1ccc(-c2ncccc2C(F)(F)F)cc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
71452693 160180 0 None None None Human 6.0 pKi = 6 Functional
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 711 8 6 7 2.1 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
CHEMBL2112376 160180 0 None None None Human 6.0 pKi = 6 Functional
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 711 8 6 7 2.1 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
44579401 370348 0 None None None Human 7.0 pKi = 7.0 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 354 7 0 7 3.2 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
CHEMBL491422 370348 0 None None None Human 7.0 pKi = 7.0 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 354 7 0 7 3.2 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
46830094 22748 0 None None None Human 8.0 pKi = 8.0 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 392 7 0 6 3.5 COCCN(C(=O)c1cnc(-c2cccc(C)c2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1093599 22748 0 None None None Human 8.0 pKi = 8.0 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 392 7 0 6 3.5 COCCN(C(=O)c1cnc(-c2cccc(C)c2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46881861 22588 0 None None None Human 7.0 pKi = 7.0 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 345 4 0 4 2.9 COc1ccc(N(C)C(=O)N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL1092499 22588 0 None None None Human 7.0 pKi = 7.0 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 345 4 0 4 2.9 COc1ccc(N(C)C(=O)N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2010.01.143
46225023 431903 1 None None None Human 6.9 pKi = 6.9 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 365 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccccc3)CC2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL592250 431903 1 None None None Human 6.9 pKi = 6.9 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 365 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccccc3)CC2)cn1 10.1016/j.bmcl.2009.11.097
46884439 22717 0 None None None Human 6.9 pKi = 6.9 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 378 7 0 6 3.1 COCCN(C(=O)c1cnc(-c2ccccc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1093365 22717 0 None None None Human 6.9 pKi = 6.9 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 378 7 0 6 3.1 COCCN(C(=O)c1cnc(-c2ccccc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
45271574 393549 0 None None None Human 7.9 pKi = 7.9 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 374 5 0 8 3.5 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL563905 393549 0 None None None Human 7.9 pKi = 7.9 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 374 5 0 8 3.5 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
44572048 372639 0 None None None Human 6.9 pKi = 6.9 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 349 6 0 2 4.7 Cc1cc(-c2ccccc2)ccc1C(=O)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL514031 372639 0 None None None Human 6.9 pKi = 6.9 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 349 6 0 2 4.7 Cc1cc(-c2ccccc2)ccc1C(=O)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
46884437 22058 0 None None None Human 6.9 pKi = 6.9 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 348 5 0 5 3.5 CCN(C(=O)c1cnc(-c2ccccc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1089025 22058 0 None None None Human 6.9 pKi = 6.9 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 348 5 0 5 3.5 CCN(C(=O)c1cnc(-c2ccccc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46844643 19935 0 None None None Human 7.9 pKi = 7.9 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 359 5 0 4 3.2 CCN(C(=O)N1CC(Oc2cccc(F)c2C)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
CHEMBL1077300 19935 0 None None None Human 7.9 pKi = 7.9 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 359 5 0 4 3.2 CCN(C(=O)N1CC(Oc2cccc(F)c2C)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
46830095 22579 0 None None None Human 7.9 pKi = 7.9 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 376 5 0 5 4.2 COc1ccc(N(C(=O)c2cnc(-c3cccc(C)c3C)cn2)C(C)C)cn1 10.1016/j.bmcl.2010.02.018
CHEMBL1092459 22579 0 None None None Human 7.9 pKi = 7.9 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 376 5 0 5 4.2 COc1ccc(N(C(=O)c2cnc(-c3cccc(C)c3C)cn2)C(C)C)cn1 10.1016/j.bmcl.2010.02.018
11475469 352696 0 None None None Human 7.9 pKi = 7.9 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 413 6 0 9 3.1 COCc1nnc(-c2cnc(-c3ccc(C#N)cc3C)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL469005 352696 0 None None None Human 7.9 pKi = 7.9 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 413 6 0 9 3.1 COCc1nnc(-c2cnc(-c3ccc(C#N)cc3C)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
45271580 389597 0 None None None Human 7.8 pKi = 7.8 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 392 5 0 8 3.7 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3cccc(F)c3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL549494 389597 0 None None None Human 7.8 pKi = 7.8 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 392 5 0 8 3.7 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3cccc(F)c3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
4353841 372414 0 None None None Human 6.8 pKi = 6.8 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 341 4 0 4 4.9 COc1ccc(-n2c(C)nnc2-c2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2008.06.098
CHEMBL511908 372414 0 None None None Human 6.8 pKi = 6.8 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 341 4 0 4 4.9 COc1ccc(-n2c(C)nnc2-c2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2008.06.098
44579400 370347 0 None None None Human 6.8 pKi = 6.8 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 324 5 0 6 3.4 CCOc1ccc(-c2nnc(C)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
CHEMBL491421 370347 0 None None None Human 6.8 pKi = 6.8 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 324 5 0 6 3.4 CCOc1ccc(-c2nnc(C)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
44579441 370090 0 None None None Human 6.8 pKi = 6.8 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 374 7 0 7 3.5 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1Cl 10.1016/j.bmcl.2008.08.066
CHEMBL489386 370090 0 None None None Human 6.8 pKi = 6.8 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 374 7 0 7 3.5 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1Cl 10.1016/j.bmcl.2008.08.066
44571386 367388 0 None None None Human 7.8 pKi = 7.8 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 403 6 0 2 5.6 Cc1cc(F)ccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL482323 367388 0 None None None Human 7.8 pKi = 7.8 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 403 6 0 2 5.6 Cc1cc(F)ccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
46884438 22059 0 None None None Human 6.8 pKi = 6.8 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 362 5 0 5 3.9 COc1ccc(N(C(=O)c2cnc(-c3ccccc3C)cn2)C(C)C)cn1 10.1016/j.bmcl.2010.02.018
CHEMBL1089026 22059 0 None None None Human 6.8 pKi = 6.8 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 362 5 0 5 3.9 COc1ccc(N(C(=O)c2cnc(-c3ccccc3C)cn2)C(C)C)cn1 10.1016/j.bmcl.2010.02.018
46881859 22586 0 None None None Human 6.8 pKi = 6.8 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 345 4 0 4 2.9 COc1ccc(N(C)C(=O)N2CC(Oc3cccc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL1092497 22586 0 None None None Human 6.8 pKi = 6.8 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 345 4 0 4 2.9 COc1ccc(N(C)C(=O)N2CC(Oc3cccc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
44577937 352493 0 None None None Human 7.8 pKi = 7.8 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 402 7 0 7 4.2 COCc1nnc(-c2ccc(-c3ccccc3OC)cc2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL467185 352493 0 None None None Human 7.8 pKi = 7.8 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 402 7 0 7 4.2 COCc1nnc(-c2ccc(-c3ccccc3OC)cc2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
44577939 372341 0 None None None Human 7.8 pKi = 7.8 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 406 6 0 8 3.4 COCc1nnc(-c2cnc(-c3ccc(F)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL511265 372341 0 None None None Human 7.8 pKi = 7.8 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 406 6 0 8 3.4 COCc1nnc(-c2cnc(-c3ccc(F)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
11667812 443991 0 None None None Human 7.8 pKi = 7.8 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL594591 443991 0 None None None Human 7.8 pKi = 7.8 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
11667812 443991 0 None None None Human 7.8 pKi = 7.8 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL594591 443991 0 None None None Human 7.8 pKi = 7.8 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2010.01.143
46225080 432399 0 None None None Human 7.8 pKi = 7.8 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 413 7 0 8 2.9 COCc1nnc(N2CC[C@@H](Oc3ccc(F)cc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL592732 432399 0 None None None Human 7.8 pKi = 7.8 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 413 7 0 8 2.9 COCc1nnc(N2CC[C@@H](Oc3ccc(F)cc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
46225049 452021 0 None None None Human 6.8 pKi = 6.8 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 351 5 0 7 2.6 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccccc3)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL603205 452021 0 None None None Human 6.8 pKi = 6.8 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 351 5 0 7 2.6 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccccc3)C2)cn1 10.1016/j.bmcl.2009.11.097
46225153 428769 0 None None None Human 7.7 pKi = 7.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 399 7 0 8 2.5 COCc1nnc(N2CC(Oc3ccc(F)cc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL589128 428769 0 None None None Human 7.7 pKi = 7.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 399 7 0 8 2.5 COCc1nnc(N2CC(Oc3ccc(F)cc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
11486351 385523 0 None None None Human 7.7 pKi = 7.7 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 398 10 0 8 3.2 CCOc1ccc(-c2nnc(COCCOC)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
CHEMBL522255 385523 0 None None None Human 7.7 pKi = 7.7 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 398 10 0 8 3.2 CCOc1ccc(-c2nnc(COCCOC)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
46881932 22105 0 None None None Human 7.7 pKi = 7.7 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3cccc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL1089391 22105 0 None None None Human 7.7 pKi = 7.7 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3cccc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
44579402 385200 0 None None None Human 6.7 pKi = 6.7 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 408 7 0 7 3.9 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1C(F)(F)F 10.1016/j.bmcl.2008.08.066
CHEMBL521789 385200 0 None None None Human 6.7 pKi = 6.7 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 408 7 0 7 3.9 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1C(F)(F)F 10.1016/j.bmcl.2008.08.066
45268188 392893 0 None None None Human 6.7 pKi = 6.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 406 6 0 9 4.0 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3SC)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL561520 392893 0 None None None Human 6.7 pKi = 6.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 406 6 0 9 4.0 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3SC)cn2)cn1 10.1016/j.bmcl.2009.03.160
44571492 367292 0 None None None Human 6.7 pKi = 6.7 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 404 6 0 3 4.8 O=C(c1ccc(-c2ncccc2C(F)(F)F)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL481730 367292 0 None None None Human 6.7 pKi = 6.7 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 404 6 0 3 4.8 O=C(c1ccc(-c2ncccc2C(F)(F)F)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
5002508 350034 0 None None None Human 6.7 pKi = 6.7 Functional
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 460 6 0 5 4.4 COc1ccc(N(Cc2cc3cccc4c3n(c2=O)CCC4)S(=O)(=O)c2ccccc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL459073 350034 0 None None None Human 6.7 pKi = 6.7 Functional
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 460 6 0 5 4.4 COc1ccc(N(Cc2cc3cccc4c3n(c2=O)CCC4)S(=O)(=O)c2ccccc2)cc1 10.1016/j.bmcl.2008.11.018
44572047 354576 0 None None None Human 5.7 pKi = 5.7 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 360 6 0 3 4.3 N#Cc1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL475561 354576 0 None None None Human 5.7 pKi = 5.7 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 360 6 0 3 4.3 N#Cc1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
53325929 119569 0 None None None Human 4.7 pKi = 4.7 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 537 11 1 7 5.8 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCc4ccoc4)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643590 119569 0 None None None Human 4.7 pKi = 4.7 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 537 11 1 7 5.8 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCc4ccoc4)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
44577982 352549 0 None None None Human 8.7 pKi = 8.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 378 4 0 7 3.8 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccccc3Cl)cn2)cn1 10.1016/j.bmcl.2008.06.098
CHEMBL467545 352549 0 None None None Human 8.7 pKi = 8.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 378 4 0 7 3.8 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccccc3Cl)cn2)cn1 10.1016/j.bmcl.2008.06.098
11502419 432150 0 None None None Human 8.7 pKi = 8.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 409 7 0 8 3.2 COCc1nnc(N2CCC(Oc3ccccc3C)CC2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL592495 432150 0 None None None Human 8.7 pKi = 8.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 409 7 0 8 3.2 COCc1nnc(N2CCC(Oc3ccccc3C)CC2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
11618185 451415 0 None None None Human 8.6 pKi = 8.6 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 397 5 0 7 3.5 COc1ccc(-n2c(C)nnc2N2CCC(Oc3cccc(F)c3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL602545 451415 0 None None None Human 8.6 pKi = 8.6 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 397 5 0 7 3.5 COc1ccc(-n2c(C)nnc2N2CCC(Oc3cccc(F)c3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
15548578 160182 0 None None None Human 8.6 pKi = 8.6 Functional
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 742 12 8 8 1.8 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
CHEMBL2112378 160182 0 None None None Human 8.6 pKi = 8.6 Functional
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 742 12 8 8 1.8 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
2252 4546 39 None None None Human 7.7 pKi = 7.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/j.bmcl.2008.06.098
6918320 4546 39 None None None Human 7.7 pKi = 7.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/j.bmcl.2008.06.098
CHEMBL24781 4546 39 None None None Human 7.7 pKi = 7.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/j.bmcl.2008.06.098
44578010 372331 0 None None None Human 6.7 pKi = 6.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 402 6 0 8 3.6 COCc1nnc(-c2cnc(-c3ccc(C)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL511215 372331 0 None None None Human 6.7 pKi = 6.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 402 6 0 8 3.6 COCc1nnc(-c2cnc(-c3ccc(C)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
46225082 432402 0 None None None Human 6.7 pKi = 6.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 395 7 0 8 2.8 COCc1nnc(N2CC[C@H](Oc3ccccc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL592733 432402 0 None None None Human 6.7 pKi = 6.7 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 395 7 0 8 2.8 COCc1nnc(N2CC[C@H](Oc3ccccc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
46884440 22718 0 None None None Human 6.7 pKi = 6.7 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 352 4 0 5 3.3 COc1ccc(N(C)C(=O)c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
CHEMBL1093366 22718 0 None None None Human 6.7 pKi = 6.7 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 352 4 0 5 3.3 COc1ccc(N(C)C(=O)c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
45272485 393232 0 None None None Human 7.6 pKi = 7.6 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 394 5 0 8 3.9 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3Cl)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL562946 393232 0 None None None Human 7.6 pKi = 7.6 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 394 5 0 8 3.9 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3Cl)cn2)cn1 10.1016/j.bmcl.2009.03.160
46883884 22714 0 None None None Human 6.6 pKi = 6.6 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 312 4 0 5 3.1 COc1ccc2oc(C(=O)N(C)c3ccc(OC)nc3)cc2c1 10.1016/j.bmcl.2010.02.018
CHEMBL1093340 22714 0 None None None Human 6.6 pKi = 6.6 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 312 4 0 5 3.1 COc1ccc2oc(C(=O)N(C)c3ccc(OC)nc3)cc2c1 10.1016/j.bmcl.2010.02.018
44577983 352550 0 None None None Human 6.6 pKi = 6.6 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 418 6 0 8 4.5 CCSc1ccc(-c2cnc(-c3nnc(C)n3-c3ccc(OC)nc3)cn2)c(C)c1 10.1016/j.bmcl.2008.06.098
CHEMBL467546 352550 0 None None None Human 6.6 pKi = 6.6 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 418 6 0 8 4.5 CCSc1ccc(-c2cnc(-c3nnc(C)n3-c3ccc(OC)nc3)cn2)c(C)c1 10.1016/j.bmcl.2008.06.098
46881860 22587 0 None None None Human 6.6 pKi = 6.6 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 363 4 0 4 3.0 COc1ccc(N(C)C(=O)N2CC(Oc3cc(F)cc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL1092498 22587 0 None None None Human 6.6 pKi = 6.6 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 363 4 0 4 3.0 COc1ccc(N(C)C(=O)N2CC(Oc3cc(F)cc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
46830096 22312 0 None None None Human 7.6 pKi = 7.6 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 362 5 0 5 3.8 CCN(C(=O)c1cnc(-c2cccc(C)c2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1090654 22312 0 None None None Human 7.6 pKi = 7.6 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 362 5 0 5 3.8 CCN(C(=O)c1cnc(-c2cccc(C)c2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46883886 22716 0 None None None Human 6.6 pKi = 6.6 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 328 7 0 4 3.6 CCN(C(=O)COc1ccc(C(C)C)cc1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1093342 22716 0 None None None Human 6.6 pKi = 6.6 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 328 7 0 4 3.6 CCN(C(=O)COc1ccc(C(C)C)cc1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
53316694 119564 0 None None None Human 5.6 pKi = 5.6 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 11 1 6 5.7 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC(C)C)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643585 119564 0 None None None Human 5.6 pKi = 5.6 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 11 1 6 5.7 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC(C)C)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
53316695 119566 0 None None None Human 4.6 pKi = 4.6 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 527 10 1 6 6.1 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC(C)(C)C)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643587 119566 0 None None None Human 4.6 pKi = 4.6 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 527 10 1 6 6.1 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC(C)(C)C)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
45270760 389620 0 None None None Human 6.6 pKi = 6.6 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 390 6 0 9 3.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3OC)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL549633 389620 0 None None None Human 6.6 pKi = 6.6 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 390 6 0 9 3.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3OC)cn2)cn1 10.1016/j.bmcl.2009.03.160
15548579 221104 0 None None None Human 7.6 pKi = 7.6 Functional
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 728 11 8 8 1.4 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@H](CCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
CHEMBL328348 221104 0 None None None Human 7.6 pKi = 7.6 Functional
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 728 11 8 8 1.4 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@H](CCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
44579399 370412 0 None None None Human 7.6 pKi = 7.6 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 368 8 0 7 3.6 CCOCc1nnc(-c2ccc(OCC)c(C)c2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.08.066
CHEMBL492029 370412 0 None None None Human 7.6 pKi = 7.6 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 368 8 0 7 3.6 CCOCc1nnc(-c2ccc(OCC)c(C)c2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.08.066
11574636 428764 0 None None None Human 7.6 pKi = 7.6 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 389 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL589125 428764 0 None None None Human 7.6 pKi = 7.6 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 389 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2009.11.097
11574636 428764 0 None None None Human 7.6 pKi = 7.6 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 389 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL589125 428764 0 None None None Human 7.6 pKi = 7.6 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 389 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2010.01.143
46225079 429761 0 None None None Human 7.5 pKi = 7.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 395 7 0 8 2.8 COCc1nnc(N2CC[C@@H](Oc3ccccc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL590097 429761 0 None None None Human 7.5 pKi = 7.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 395 7 0 8 2.8 COCc1nnc(N2CC[C@@H](Oc3ccccc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
46884480 22578 0 None None None Human 7.5 pKi = 7.5 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 366 5 0 5 3.7 CCN(C(=O)c1cnc(-c2cccc(F)c2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1092458 22578 0 None None None Human 7.5 pKi = 7.5 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 366 5 0 5 3.7 CCN(C(=O)c1cnc(-c2cccc(F)c2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
11260438 197937 0 None None None Human 8.5 pKi = 8.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 494 6 1 6 2.0 Cc1nc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2008.06.098
44577873 197937 0 None None None Human 8.5 pKi = 8.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 494 6 1 6 2.0 Cc1nc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2008.06.098
CHEMBL271039 197937 0 None None None Human 8.5 pKi = 8.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 494 6 1 6 2.0 Cc1nc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2008.06.098
CHEMBL513488 197937 0 None None None Human 8.5 pKi = 8.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 494 6 1 6 2.0 Cc1nc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2008.06.098
44571491 367271 0 None None None Human 8.5 pKi = 8.5 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 367 6 0 2 4.8 Cc1cc(F)ccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL481569 367271 0 None None None Human 8.5 pKi = 8.5 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 367 6 0 2 4.8 Cc1cc(F)ccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44572003 372756 0 None None None Human 8.5 pKi = 8.5 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 369 6 0 2 5.0 O=C(c1ccc(-c2ccccc2Cl)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL514975 372756 0 None None None Human 8.5 pKi = 8.5 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 369 6 0 2 5.0 O=C(c1ccc(-c2ccccc2Cl)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
44581241 349862 0 None None None Human 8.5 pKi = 8.5 Functional
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 495 8 0 6 5.2 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3Cl)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL458634 349862 0 None None None Human 8.5 pKi = 8.5 Functional
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 495 8 0 6 5.2 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3Cl)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
11488952 159212 0 None None None Human 8.4 pKi = 8.4 Functional
Antagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assayAntagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assay
ChEMBL 501 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc2occc2c1 10.1021/jm060073e
CHEMBL208787 159212 0 None None None Human 8.4 pKi = 8.4 Functional
Antagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assayAntagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assay
ChEMBL 501 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc2occc2c1 10.1021/jm060073e
46225083 443763 0 None None None Human 6.5 pKi = 6.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 337 5 0 7 2.2 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccccc3)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL594361 443763 0 None None None Human 6.5 pKi = 6.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 337 5 0 7 2.2 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccccc3)C2)cn1 10.1016/j.bmcl.2009.11.097
44215484 352491 0 None None None Human 6.5 pKi = 6.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 440 7 0 6 4.6 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCN1CCOCC1 10.1016/j.bmcl.2008.06.098
CHEMBL467154 352491 0 None None None Human 6.5 pKi = 6.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 440 7 0 6 4.6 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCN1CCOCC1 10.1016/j.bmcl.2008.06.098
46225051 430998 0 None None None Human 7.5 pKi = 7.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 383 5 0 7 3.1 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL591310 430998 0 None None None Human 7.5 pKi = 7.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 383 5 0 7 3.1 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
44571529 372818 0 None None None Human 6.5 pKi = 6.5 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 404 6 0 3 4.8 O=C(c1ccc(-c2ccccc2C(F)(F)F)nc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL515447 372818 0 None None None Human 6.5 pKi = 6.5 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 404 6 0 3 4.8 O=C(c1ccc(-c2ccccc2C(F)(F)F)nc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
45483204 404679 0 None None None Human 6.5 pKi = 6.5 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2010.11.061
CHEMBL572709 404679 0 None None None Human 6.5 pKi = 6.5 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2010.11.061
44572105 336967 0 None None None Human 5.5 pKi = 5.5 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 336 6 0 3 3.8 O=C(c1ccc(-c2ccccc2)nc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL447916 336967 0 None None None Human 5.5 pKi = 5.5 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 336 6 0 3 3.8 O=C(c1ccc(-c2ccccc2)nc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
44571489 375318 0 None None None Human 5.5 pKi = 5.5 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 372 6 0 3 4.6 O=C(c1ccc(-c2ccccc2)nc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL520595 375318 0 None None None Human 5.5 pKi = 5.5 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 372 6 0 3 4.6 O=C(c1ccc(-c2ccccc2)nc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
46225117 430007 0 None None None Human 7.5 pKi = 7.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 401 7 0 8 2.7 COCc1nnc(N2CC(Oc3ccccc3Cl)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL590349 430007 0 None None None Human 7.5 pKi = 7.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 401 7 0 8 2.7 COCc1nnc(N2CC(Oc3ccccc3Cl)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
46225050 432397 0 None None None Human 7.5 pKi = 7.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 365 5 0 7 2.9 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccccc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL592731 432397 0 None None None Human 7.5 pKi = 7.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 365 5 0 7 2.9 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccccc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
16062053 387456 0 None None None Human 6.5 pKi = 6.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 360 5 0 8 3.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL539665 387456 0 None None None Human 6.5 pKi = 6.5 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 360 5 0 8 3.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3)cn2)cn1 10.1016/j.bmcl.2009.03.160
46881890 22763 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 377 5 0 4 3.4 CCN(C(=O)N1CC(Oc2cc(F)cc(F)c2C)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
CHEMBL1093744 22763 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 377 5 0 4 3.4 CCN(C(=O)N1CC(Oc2cc(F)cc(F)c2C)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
45272491 393499 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 428 5 0 8 4.5 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccc(Cl)cc3Cl)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL563613 393499 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 428 5 0 8 4.5 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccc(Cl)cc3Cl)cn2)cn1 10.1016/j.bmcl.2009.03.160
44572107 353814 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 385 6 0 2 5.5 Cc1cc(C(=O)N(Cc2ccccc2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
CHEMBL474621 353814 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 385 6 0 2 5.5 Cc1cc(C(=O)N(Cc2ccccc2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
46884478 22804 0 None None None Human 6.4 pKi = 6.4 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 373 5 0 6 3.4 CCN(C(=O)c1cnc(-c2ccc(C#N)cc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1094002 22804 0 None None None Human 6.4 pKi = 6.4 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 373 5 0 6 3.4 CCN(C(=O)c1cnc(-c2ccc(C#N)cc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
53317994 119565 0 None None None Human 5.4 pKi = 5.4 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 11 0 6 5.8 CCN(CC)Cc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643586 119565 0 None None None Human 5.4 pKi = 5.4 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 11 0 6 5.8 CCN(CC)Cc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
11384094 352494 0 None None None Human 8.4 pKi = 8.4 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 402 6 0 8 3.6 COCc1nnc(-c2cnc(-c3cccc(C)c3C)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL467186 352494 0 None None None Human 8.4 pKi = 8.4 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 402 6 0 8 3.6 COCc1nnc(-c2cnc(-c3cccc(C)c3C)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
15548579 221104 0 None None None Human 8.4 pKi = 8.4 Functional
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 728 11 8 8 1.4 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@H](CCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
CHEMBL328348 221104 0 None None None Human 8.4 pKi = 8.4 Functional
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 728 11 8 8 1.4 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@H](CCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
11538526 432148 0 None None None Human 8.4 pKi = 8.4 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 397 5 0 7 3.5 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccc(F)cc3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL592494 432148 0 None None None Human 8.4 pKi = 8.4 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 397 5 0 7 3.5 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccc(F)cc3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
46225118 451494 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3cc(F)ccc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL602641 451494 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3cc(F)ccc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
46883829 22767 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 336 5 1 4 3.5 CCN(C(=O)c1cc(-c2ccc(C)cc2)n[nH]1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1093776 22767 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 336 5 1 4 3.5 CCN(C(=O)c1cc(-c2ccc(C)cc2)n[nH]1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46881892 22471 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 387 5 0 7 2.8 COc1ccc(-n2c(C)nnc2N2CC(Oc3cc(F)cc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL1091817 22471 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 387 5 0 7 2.8 COc1ccc(-n2c(C)nnc2N2CC(Oc3cc(F)cc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
44577938 372442 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 374 6 0 8 2.9 COCc1nnc(-c2cnc(-c3ccccc3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL512257 372442 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 374 6 0 8 2.9 COCc1nnc(-c2cnc(-c3ccccc3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
46844644 22812 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 359 5 0 4 3.2 CCN(C(=O)N1CC(Oc2ccc(F)cc2C)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
CHEMBL1094050 22812 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 359 5 0 4 3.2 CCN(C(=O)N1CC(Oc2ccc(F)cc2C)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
46884479 22577 0 None None None Human 6.4 pKi = 6.4 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 403 7 0 7 3.0 COCCN(C(=O)c1cnc(-c2ccc(C#N)cc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1092457 22577 0 None None None Human 6.4 pKi = 6.4 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 403 7 0 7 3.0 COCCN(C(=O)c1cnc(-c2ccc(C#N)cc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
44579442 370091 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 391 7 0 9 2.7 CCOc1ccc(-c2nnc(Cn3nccn3)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
CHEMBL489387 370091 0 None None None Human 7.4 pKi = 7.4 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 391 7 0 9 2.7 CCOc1ccc(-c2nnc(Cn3nccn3)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
46883887 22090 0 None None None Human 7.3 pKi = 7.3 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 336 6 0 4 3.7 CCN(C(=O)COc1ccc2ccccc2c1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1089272 22090 0 None None None Human 7.3 pKi = 7.3 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 336 6 0 4 3.7 CCN(C(=O)COc1ccc2ccccc2c1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46881891 22810 0 None None None Human 7.3 pKi = 7.3 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 379 5 0 4 3.6 CCN(C(=O)N1CC(Oc2ccc(F)cc2Cl)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
CHEMBL1094049 22810 0 None None None Human 7.3 pKi = 7.3 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 379 5 0 4 3.6 CCN(C(=O)N1CC(Oc2ccc(F)cc2Cl)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
11625088 432146 0 None None None Human 8.3 pKi = 8.3 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 379 5 0 7 3.3 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccccc3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL592493 432146 0 None None None Human 8.3 pKi = 8.3 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 379 5 0 7 3.3 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccccc3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
46225081 465739 0 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 431 7 0 8 3.1 COCc1nnc(N2CC[C@@H](Oc3cc(F)cc(F)c3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL609848 465739 0 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 431 7 0 8 3.1 COCc1nnc(N2CC[C@@H](Oc3cc(F)cc(F)c3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
44186995 389894 0 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 388 5 0 8 3.8 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3c(C)cccc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL550244 389894 0 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 388 5 0 8 3.8 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3c(C)cccc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
44577874 352490 0 None None None Human 7.3 pKi = 7.3 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 376 4 0 6 3.6 CO/N=C1/C[C@H](c2ncno2)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1016/j.bmcl.2008.06.098
CHEMBL467153 352490 0 None None None Human 7.3 pKi = 7.3 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 376 4 0 6 3.6 CO/N=C1/C[C@H](c2ncno2)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1016/j.bmcl.2008.06.098
4017619 354281 20 None None None Human 7.3 pKi = 7.3 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 335 6 0 2 4.4 O=C(c1ccc(-c2ccccc2)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL475207 354281 20 None None None Human 7.3 pKi = 7.3 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 335 6 0 2 4.4 O=C(c1ccc(-c2ccccc2)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
50941635 119563 0 None None None Human 5.3 pKi = 5.3 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 12 1 6 5.8 CCCCNCc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643584 119563 0 None None None Human 5.3 pKi = 5.3 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 12 1 6 5.8 CCCCNCc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
53324622 119570 0 None None None Human 4.3 pKi = 4.3 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 577 12 1 7 6.3 COc1ccc(CNCc2ccc(-c3nc(CN(C4CCCC4)S(=O)(=O)c4ccc(OC)cc4)cs3)cc2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643591 119570 0 None None None Human 4.3 pKi = 4.3 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 577 12 1 7 6.3 COc1ccc(CNCc2ccc(-c3nc(CN(C4CCCC4)S(=O)(=O)c4ccc(OC)cc4)cs3)cc2)cc1 10.1016/j.bmcl.2010.11.061
45269934 390070 0 None None None Human 7.3 pKi = 7.3 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 388 6 0 8 3.8 CCc1ccccc1Oc1cnc(-c2nnc(C)n2-c2ccc(OC)nc2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL551395 390070 0 None None None Human 7.3 pKi = 7.3 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 388 6 0 8 3.8 CCc1ccccc1Oc1cnc(-c2nnc(C)n2-c2ccc(OC)nc2)cn1 10.1016/j.bmcl.2009.03.160
44577984 372415 0 None None None Human 6.3 pKi = 6.3 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 418 7 0 9 3.3 COCc1nnc(-c2cnc(-c3ccc(OC)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL511917 372415 0 None None None Human 6.3 pKi = 6.3 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 418 7 0 9 3.3 COCc1nnc(-c2cnc(-c3ccc(OC)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
46225116 429762 0 None None None Human 7.3 pKi = 7.3 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 371 5 0 7 2.9 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccccc3Cl)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL590099 429762 0 None None None Human 7.3 pKi = 7.3 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 371 5 0 7 2.9 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccccc3Cl)C2)cn1 10.1016/j.bmcl.2009.11.097
44577936 352492 0 None None None Human 7.3 pKi = 7.3 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 371 5 0 5 4.9 COc1ccc(-n2c(C)nnc2-c2ccc(-c3ccccc3OC)cc2)cc1 10.1016/j.bmcl.2008.06.098
CHEMBL467184 352492 0 None None None Human 7.3 pKi = 7.3 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 371 5 0 5 4.9 COc1ccc(-n2c(C)nnc2-c2ccc(-c3ccccc3OC)cc2)cc1 10.1016/j.bmcl.2008.06.098
11257380 352525 0 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL467378 352525 0 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.11.097
11257380 352525 0 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2008.06.098
CHEMBL467378 352525 0 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2008.06.098
11257380 352525 0 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL467378 352525 0 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
135461089 145109 4 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 478 8 2 6 4.8 CCOc1ccc(S(=O)(=O)N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)c2ccccc2)cc1 10.1016/j.bmcl.2008.08.066
CHEMBL200403 145109 4 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 478 8 2 6 4.8 CCOc1ccc(S(=O)(=O)N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)c2ccccc2)cc1 10.1016/j.bmcl.2008.08.066
CHEMBL491224 145109 4 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 478 8 2 6 4.8 CCOc1ccc(S(=O)(=O)N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)c2ccccc2)cc1 10.1016/j.bmcl.2008.08.066
44581240 372840 0 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 486 8 0 7 4.4 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C#N)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL515660 372840 0 None None None Human 8.2 pKi = 8.2 Functional
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 486 8 0 7 4.4 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C#N)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
46884441 22719 0 None None None Human 6.2 pKi = 6.2 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 359 4 0 6 3.0 COc1ccc(N(C)C(=O)c2cnc(-c3ccc(C#N)cc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
CHEMBL1093367 22719 0 None None None Human 6.2 pKi = 6.2 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 359 4 0 6 3.0 COc1ccc(N(C)C(=O)c2cnc(-c3ccc(C#N)cc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
44571387 367386 0 None None None Human 7.2 pKi = 7.2 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 401 7 0 3 5.2 COc1ccccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL482321 367386 0 None None None Human 7.2 pKi = 7.2 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 401 7 0 3 5.2 COc1ccccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44572045 372772 0 None None None Human 7.2 pKi = 7.2 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 365 7 0 3 4.4 COc1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL515111 372772 0 None None None Human 7.2 pKi = 7.2 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 365 7 0 3 4.4 COc1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44572046 353486 0 None None None Human 6.2 pKi = 6.2 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 413 7 0 4 3.8 CS(=O)(=O)c1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL474219 353486 0 None None None Human 6.2 pKi = 6.2 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 413 7 0 4 3.8 CS(=O)(=O)c1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44571388 385141 0 None None None Human 6.2 pKi = 6.2 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 385 6 0 2 5.5 Cc1cc(-c2ccccc2)ccc1C(=O)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL521444 385141 0 None None None Human 6.2 pKi = 6.2 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 385 6 0 2 5.5 Cc1cc(-c2ccccc2)ccc1C(=O)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
44571530 353800 0 None None None Human 5.2 pKi = 5.2 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 379 7 0 3 4.7 COc1ccc(C)cc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL474609 353800 0 None None None Human 5.2 pKi = 5.2 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 379 7 0 3 4.7 COc1ccc(C)cc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44571490 367270 0 None None None Human 5.2 pKi = 5.2 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 415 7 0 3 5.5 COc1ccc(C)cc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL481568 367270 0 None None None Human 5.2 pKi = 5.2 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 415 7 0 3 5.5 COc1ccc(C)cc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
53323297 119567 0 None None None Human 5.2 pKi = 5.2 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 499 11 1 6 5.5 CCCNCc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643588 119567 0 None None None Human 5.2 pKi = 5.2 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 499 11 1 6 5.5 CCCNCc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
53323298 119568 0 None None None Human 5.2 pKi = 5.2 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 553 11 1 6 6.6 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC4CCCCC4)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643589 119568 0 None None None Human 5.2 pKi = 5.2 Functional
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 553 11 1 6 6.6 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC4CCCCC4)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
46881862 22255 0 None None None Human 7.2 pKi = 7.2 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 365 4 0 4 3.2 COc1ccc(N(C)C(=O)N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL1090417 22255 0 None None None Human 7.2 pKi = 7.2 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 365 4 0 4 3.2 COc1ccc(N(C)C(=O)N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2010.01.143
44572103 353218 0 None None None Human 8.1 pKi = 8.1 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 369 6 0 2 5.0 O=C(c1ccc(-c2cccc(Cl)c2)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL473442 353218 0 None None None Human 8.1 pKi = 8.1 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 369 6 0 2 5.0 O=C(c1ccc(-c2cccc(Cl)c2)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
44581266 349398 0 None None None Human 8.1 pKi = 8.1 Functional
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 479 8 0 6 4.7 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3F)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL457544 349398 0 None None None Human 8.1 pKi = 8.1 Functional
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 479 8 0 6 4.7 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3F)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44572104 353219 0 None None None Human 7.1 pKi = 7.1 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 369 6 0 2 5.0 O=C(c1ccc(-c2ccc(Cl)cc2)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL473443 353219 0 None None None Human 7.1 pKi = 7.1 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 369 6 0 2 5.0 O=C(c1ccc(-c2ccc(Cl)cc2)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
44571429 367146 0 None None None Human 7.1 pKi = 7.1 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 440 6 0 3 5.6 O=C(c1ccc(-c2ccccc2C(F)(F)F)nc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL480546 367146 0 None None None Human 7.1 pKi = 7.1 Functional
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 440 6 0 3 5.6 O=C(c1ccc(-c2ccccc2C(F)(F)F)nc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
10437668 155157 1 None None None Human 8.1 pKi = 8.1 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1016/j.bmcl.2008.06.098
CHEMBL2112903 155157 1 None None None Human 8.1 pKi = 8.1 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1016/j.bmcl.2008.06.098
45268191 393840 0 None None None Human 8.1 pKi = 8.1 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 430 5 0 8 4.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3c(F)ccc(F)c3Cl)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL565189 393840 0 None None None Human 8.1 pKi = 8.1 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 430 5 0 8 4.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3c(F)ccc(F)c3Cl)cn2)cn1 10.1016/j.bmcl.2009.03.160
46883925 22759 0 None None None Human 7.1 pKi = 7.1 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 379 6 1 5 3.1 CCN(C(=O)c1ccc(-c2ccc(OC)cc2)[nH]c1=O)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1093709 22759 0 None None None Human 7.1 pKi = 7.1 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 379 6 1 5 3.1 CCN(C(=O)c1ccc(-c2ccc(OC)cc2)[nH]c1=O)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
44577981 372427 0 None None None Human 7.1 pKi = 7.1 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 369 5 0 8 2.8 COCc1nnc(-c2cnc(-c3cccc(C#N)c3)cn2)n1-c1cccnc1 10.1016/j.bmcl.2008.06.098
CHEMBL512105 372427 0 None None None Human 7.1 pKi = 7.1 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 369 5 0 8 2.8 COCc1nnc(-c2cnc(-c3cccc(C#N)c3)cn2)n1-c1cccnc1 10.1016/j.bmcl.2008.06.098
46883830 22012 0 None None None Human 7.1 pKi = 7.1 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 336 5 0 5 3.3 CCN(C(=O)c1cnn(-c2ccccc2)c1C)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1088765 22012 0 None None None Human 7.1 pKi = 7.1 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 336 5 0 5 3.3 CCN(C(=O)c1cnn(-c2ccccc2)c1C)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46883885 22715 0 None None None Human 7.1 pKi = 7.1 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 326 5 0 5 3.5 CCN(C(=O)c1cc2cc(OC)ccc2o1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1093341 22715 0 None None None Human 7.1 pKi = 7.1 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 326 5 0 5 3.5 CCN(C(=O)c1cc2cc(OC)ccc2o1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
45273367 393525 0 None None None Human 8.0 pKi = 8.0 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 392 5 0 8 3.7 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL563771 393525 0 None None None Human 8.0 pKi = 8.0 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 392 5 0 8 3.7 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
11683187 444222 42 None None None Human 8.0 pKi = 8.0 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL594828 444222 42 None None None Human 8.0 pKi = 8.0 Functional
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
46884413 22512 0 None None None Human 7.1 pKi = 7.1 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 318 4 0 3 4.0 COc1ccc(N(C)C(=O)c2ccc(-c3ccccc3)cc2)cn1 10.1016/j.bmcl.2010.02.018
CHEMBL1092098 22512 0 None None None Human 7.1 pKi = 7.1 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 318 4 0 3 4.0 COc1ccc(N(C)C(=O)c2ccc(-c3ccccc3)cc2)cn1 10.1016/j.bmcl.2010.02.018
46883832 22014 0 None None None Human 7.0 pKi = 7.0 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 366 6 0 6 3.3 CCN(C(=O)c1cnn(-c2ccc(OC)cc2)c1C)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1088767 22014 0 None None None Human 7.0 pKi = 7.0 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 366 6 0 6 3.3 CCN(C(=O)c1cnn(-c2ccc(OC)cc2)c1C)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46884414 22155 0 None None None Human 7.0 pKi = 7.0 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 334 4 0 5 3.1 COc1ccc(N(C)C(=O)c2cnc(-c3ccccc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
CHEMBL1089682 22155 0 None None None Human 7.0 pKi = 7.0 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 334 4 0 5 3.1 COc1ccc(N(C)C(=O)c2cnc(-c3ccccc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
46883888 22455 0 None None None Human 7.0 pKi = 7.0 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 349 5 1 4 3.1 CCN(C(=O)c1ccc(-c2ccccc2)[nH]c1=O)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1091770 22455 0 None None None Human 7.0 pKi = 7.0 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 349 5 1 4 3.1 CCN(C(=O)c1ccc(-c2ccccc2)[nH]c1=O)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46883831 22013 0 None None None Human 7.0 pKi = 7.0 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 366 7 0 6 2.9 COCCN(C(=O)c1cnn(-c2ccccc2)c1C)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1088766 22013 0 None None None Human 7.0 pKi = 7.0 Functional
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 366 7 0 6 2.9 COCCN(C(=O)c1cnn(-c2ccccc2)c1C)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
11169 1650 39 None -10 5 Mouse 7.2 pEC50 = 7.2 Functional
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
165708555 1650 39 None -10 5 Mouse 7.2 pEC50 = 7.2 Functional
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
16681432 1650 39 None -10 5 Mouse 7.2 pEC50 = 7.2 Functional
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
495 1650 39 None -10 5 Mouse 7.2 pEC50 = 7.2 Functional
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
CHEMBL3301668 1650 39 None -10 5 Mouse 7.2 pEC50 = 7.2 Functional
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
DB01282 1650 39 None -10 5 Mouse 7.2 pEC50 = 7.2 Functional
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
11169 1650 39 None 1 5 Human 8.0 pEC50 = 8 Functional
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
165708555 1650 39 None 1 5 Human 8.0 pEC50 = 8 Functional
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
16681432 1650 39 None 1 5 Human 8.0 pEC50 = 8 Functional
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
495 1650 39 None 1 5 Human 8.0 pEC50 = 8 Functional
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
CHEMBL3301668 1650 39 None 1 5 Human 8.0 pEC50 = 8 Functional
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
DB01282 1650 39 None 1 5 Human 8.0 pEC50 = 8 Functional
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
14550 3029 0 None None None Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
2255 5308 0 None None None Human 7.1 pIC50 None 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 17316912
2256 5310 0 None None None Human 7.3 pIC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 17316912
2254 5312 0 None None None Human 7.6 pIC50 None 7.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 17316912




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

118719819 234679 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1005 20 11 14 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CC2CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353930 234679 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1005 20 11 14 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CC2CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719821 234681 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1005 19 11 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353932 234681 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1005 19 11 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719828 234688 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1019 19 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353939 234688 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1019 19 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719829 234689 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1035 23 11 14 -1.1 CCCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3353940 234689 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1035 23 11 14 -1.1 CCCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118719835 234695 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353946 234695 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719837 234697 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1059 20 11 14 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353948 234697 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1059 20 11 14 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719845 234705 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1047 20 11 15 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353956 234705 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1047 20 11 15 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720268 234776 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354579 234776 0 None None None Human 11.0 pEC50 = 11 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
155560248 349072 0 None None None Human 11.0 pEC50 = 11.0 Binding
Agonist activity at human oxytocin receptor V43A/C47A double mutant high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4567752 349072 0 None None None Human 11.0 pEC50 = 11.0 Binding
Agonist activity at human oxytocin receptor V43A/C47A double mutant high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155542264 347207 0 None None None Human 10.9 pEC50 = 10.9 Binding
Agonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520170 347207 0 None None None Human 10.9 pEC50 = 10.9 Binding
Agonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
118719844 234704 0 None None None Human 10.7 pEC50 = 10.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1056 21 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccncc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353955 234704 0 None None None Human 10.7 pEC50 = 10.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1056 21 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccncc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720260 234768 0 None None None Human 10.7 pEC50 = 10.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1061 21 11 15 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2cccs2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354571 234768 0 None None None Human 10.7 pEC50 = 10.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1061 21 11 15 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2cccs2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720282 234789 0 None None None Human 10.7 pEC50 = 10.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 20 11 13 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354592 234789 0 None None None Human 10.7 pEC50 = 10.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 20 11 13 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719831 234691 0 None None None Human 10.5 pEC50 = 10.5 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1009 21 11 15 -3.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353942 234691 0 None None None Human 10.5 pEC50 = 10.5 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1009 21 11 15 -3.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720278 234785 0 None None None Human 10.4 pEC50 = 10.4 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1023 20 11 13 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354588 234785 0 None None None Human 10.4 pEC50 = 10.4 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1023 20 11 13 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720284 234792 0 None None None Human 10.4 pEC50 = 10.4 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354595 234792 0 None None None Human 10.4 pEC50 = 10.4 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
44232512 234794 0 None None None Human 10.4 pEC50 = 10.4 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 21 11 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354597 234794 0 None None None Human 10.4 pEC50 = 10.4 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 21 11 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719818 234678 0 None None None Human 10.3 pEC50 = 10.3 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 19 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353929 234678 0 None None None Human 10.3 pEC50 = 10.3 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 19 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720279 234786 0 None None None Human 10.3 pEC50 = 10.3 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1023 20 11 13 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354589 234786 0 None None None Human 10.3 pEC50 = 10.3 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1023 20 11 13 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720286 234795 0 None None None Human 10.3 pEC50 = 10.3 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 21 11 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354598 234795 0 None None None Human 10.3 pEC50 = 10.3 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 21 11 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
171345673 386814 0 None None None Human 10.2 pEC50 = 10.2 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1221 21 18 21 -9.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)NC(C)(C)C(=O)NCC(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5286119 386814 0 None None None Human 10.2 pEC50 = 10.2 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1221 21 18 21 -9.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)NC(C)(C)C(=O)NCC(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
118719820 234680 0 None None None Human 10.2 pEC50 = 10.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1007 21 11 14 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3353931 234680 0 None None None Human 10.2 pEC50 = 10.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1007 21 11 14 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118719824 234684 0 None None None Human 10.2 pEC50 = 10.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1017 19 11 14 -3.1 CCOc1ccc(C[C@@H]2NC(=O)CCCSC[C@@H](C(=O)N3C[C@@H](O)C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm500365s
CHEMBL3353935 234684 0 None None None Human 10.2 pEC50 = 10.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1017 19 11 14 -3.1 CCOc1ccc(C[C@@H]2NC(=O)CCCSC[C@@H](C(=O)N3C[C@@H](O)C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm500365s
118719838 234698 0 None None None Human 10.2 pEC50 = 10.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1071 21 11 15 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(OC)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353949 234698 0 None None None Human 10.2 pEC50 = 10.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1071 21 11 15 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(OC)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720261 234769 0 None None None Human 10.2 pEC50 = 10.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1035 20 11 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CC2CCCO2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354572 234769 0 None None None Human 10.2 pEC50 = 10.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1035 20 11 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CC2CCCO2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720277 234784 0 None None None Human 10.2 pEC50 = 10.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 988 22 10 12 -1.5 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354587 234784 0 None None None Human 10.2 pEC50 = 10.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 988 22 10 12 -1.5 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118720281 234788 0 None None None Human 10.1 pEC50 = 10.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 20 11 13 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354591 234788 0 None None None Human 10.1 pEC50 = 10.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 20 11 13 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
76073634 234791 7 None None None Human 10.1 pEC50 = 10.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354594 234791 7 None None None Human 10.1 pEC50 = 10.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
DB12932 234791 7 None None None Human 10.1 pEC50 = 10.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720274 234781 0 None None None Human 10.1 pEC50 = 10.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 974 21 10 12 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354584 234781 0 None None None Human 10.1 pEC50 = 10.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 974 21 10 12 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118720288 234797 0 None None None Human 10.1 pEC50 = 10.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1029 20 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354600 234797 0 None None None Human 10.1 pEC50 = 10.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1029 20 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
449224 333602 12 None None None Human 10.0 pEC50 = 10 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL439044 333602 12 None None None Human 10.0 pEC50 = 10 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
DB13798 333602 12 None None None Human 10.0 pEC50 = 10 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719833 234693 0 None None None Human 10.0 pEC50 = 10.0 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353944 234693 0 None None None Human 10.0 pEC50 = 10.0 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720259 234767 0 None None None Human 10.0 pEC50 = 10.0 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1031 20 11 15 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccco2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354570 234767 0 None None None Human 10.0 pEC50 = 10.0 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1031 20 11 15 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccco2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720264 234772 0 None None None Human 10.0 pEC50 = 10.0 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 11 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354575 234772 0 None None None Human 10.0 pEC50 = 10.0 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 11 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720275 234782 0 None None None Human 10.0 pEC50 = 10.0 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1004 22 11 13 -1.8 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354585 234782 0 None None None Human 10.0 pEC50 = 10.0 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1004 22 11 13 -1.8 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118719834 234694 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353945 234694 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719842 234702 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 21 11 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353953 234702 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 21 11 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719843 234703 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1056 21 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccccn2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353954 234703 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1056 21 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccccn2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720271 234778 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 990 21 11 13 -2.2 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354581 234778 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 990 21 11 13 -2.2 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118719827 234687 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1021 22 11 14 -1.5 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3353938 234687 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1021 22 11 14 -1.5 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118720269 234777 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354580 234777 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720272 234779 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 990 21 11 13 -2.2 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354582 234779 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 990 21 11 13 -2.2 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118720289 234798 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1029 20 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354601 234798 0 None None None Human 9.9 pEC50 = 9.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1029 20 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719836 234696 0 None None None Human 9.8 pEC50 = 9.8 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(C)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353947 234696 0 None None None Human 9.8 pEC50 = 9.8 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(C)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720265 234773 0 None None None Human 9.8 pEC50 = 9.8 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 11 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354576 234773 0 None None None Human 9.8 pEC50 = 9.8 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 11 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719825 234685 0 None None None Human 9.7 pEC50 = 9.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1032 20 10 14 -2.5 CCOc1ccc(C[C@@H]2NC(=O)CCCSC[C@@H](C(=O)N3C[C@@H](OC)C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm500365s
CHEMBL3353936 234685 0 None None None Human 9.7 pEC50 = 9.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1032 20 10 14 -2.5 CCOc1ccc(C[C@@H]2NC(=O)CCCSC[C@@H](C(=O)N3C[C@@H](OC)C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm500365s
118720273 234780 0 None None None Human 9.6 pEC50 = 9.6 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 974 21 10 12 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354583 234780 0 None None None Human 9.6 pEC50 = 9.6 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 974 21 10 12 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118720285 234793 0 None None None Human 9.6 pEC50 = 9.6 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1025 20 10 12 -1.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354596 234793 0 None None None Human 9.6 pEC50 = 9.6 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1025 20 10 12 -1.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720276 234783 0 None None None Human 9.6 pEC50 = 9.6 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1004 22 11 13 -1.8 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354586 234783 0 None None None Human 9.6 pEC50 = 9.6 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1004 22 11 13 -1.8 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
155559767 348923 1 None None None Human 9.6 pEC50 = 9.6 Binding
Agonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4564152 348923 1 None None None Human 9.6 pEC50 = 9.6 Binding
Agonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
171357037 386541 0 None None None Human 9.6 pEC50 = 9.6 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1150 19 17 20 -8.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)NC(C)(C)C(=O)N[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5280014 386541 0 None None None Human 9.6 pEC50 = 9.6 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1150 19 17 20 -8.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)NC(C)(C)C(=O)N[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
118720290 234799 0 None None None Human 9.5 pEC50 = 9.5 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1013 20 10 13 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354602 234799 0 None None None Human 9.5 pEC50 = 9.5 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1013 20 10 13 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719826 234686 0 None None None Human 9.4 pEC50 = 9.4 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 947 19 11 13 -3.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353937 234686 0 None None None Human 9.4 pEC50 = 9.4 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 947 19 11 13 -3.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719832 234692 0 None None None Human 9.4 pEC50 = 9.4 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1009 21 12 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353943 234692 0 None None None Human 9.4 pEC50 = 9.4 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1009 21 12 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720280 234787 0 None None None Human 9.4 pEC50 = 9.4 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1007 20 10 12 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354590 234787 0 None None None Human 9.4 pEC50 = 9.4 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1007 20 10 12 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719841 234701 0 None None None Human 9.3 pEC50 = 9.3 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccncc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353952 234701 0 None None None Human 9.3 pEC50 = 9.3 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccncc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
171347098 386267 0 None None None Human 9.3 pEC50 = 9.3 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1340 24 20 25 -10.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5273426 386267 0 None None None Human 9.3 pEC50 = 9.3 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1340 24 20 25 -10.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
118720283 234790 0 None None None Human 9.3 pEC50 = 9.3 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1022 20 10 12 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354593 234790 0 None None None Human 9.3 pEC50 = 9.3 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1022 20 10 12 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
11169 1650 39 None None None Human 9.2 pEC50 = 9.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
165708555 1650 39 None None None Human 9.2 pEC50 = 9.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
16681432 1650 39 None None None Human 9.2 pEC50 = 9.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
495 1650 39 None None None Human 9.2 pEC50 = 9.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
CHEMBL3301668 1650 39 None None None Human 9.2 pEC50 = 9.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
DB01282 1650 39 None None None Human 9.2 pEC50 = 9.2 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
171352228 386359 0 None None None Human 9.1 pEC50 = 9.1 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1192 21 17 20 -7.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5275543 386359 0 None None None Human 9.1 pEC50 = 9.1 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1192 21 17 20 -7.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
155559767 348923 1 None None None Human 9.1 pEC50 = 9.1 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4564152 348923 1 None None None Human 9.1 pEC50 = 9.1 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
118720287 234796 0 None None None Human 9.1 pEC50 = 9.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1022 21 10 12 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354599 234796 0 None None None Human 9.1 pEC50 = 9.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1022 21 10 12 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719823 234683 0 None None None Human 9.1 pEC50 = 9.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1033 19 10 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2C[C@H](SC)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353934 234683 0 None None None Human 9.1 pEC50 = 9.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1033 19 10 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2C[C@H](SC)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720267 234775 0 None None None Human 9.1 pEC50 = 9.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 975 21 10 13 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354578 234775 0 None None None Human 9.1 pEC50 = 9.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 975 21 10 13 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720270 234452 0 None None None Human 9.1 pEC50 = 9.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 975 21 11 13 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3352839 234452 0 None None None Human 9.1 pEC50 = 9.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 975 21 11 13 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
155559767 348923 1 None None None Human 9.0 pEC50 = 9.0 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4564152 348923 1 None None None Human 9.0 pEC50 = 9.0 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
118720266 234774 0 None None None Human 9.0 pEC50 = 9.0 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 975 21 10 13 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCCSC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354577 234774 0 None None None Human 9.0 pEC50 = 9.0 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 975 21 10 13 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCCSC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719822 234682 0 None None None Human 9.0 pEC50 = 9.0 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1017 19 10 14 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2C[C@H](OC)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353933 234682 0 None None None Human 9.0 pEC50 = 9.0 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1017 19 10 14 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2C[C@H](OC)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
2042 8014 41 None None None Human 8.9 pEC50 = 8.9 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.9b01862
2176 8014 41 None None None Human 8.9 pEC50 = 8.9 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.9b01862
439302 8014 41 None None None Human 8.9 pEC50 = 8.9 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.9b01862
CHEMBL395429 8014 41 None None None Human 8.9 pEC50 = 8.9 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.9b01862
118719830 234690 0 None None None Human 8.9 pEC50 = 8.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1033 19 11 14 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353941 234690 0 None None None Human 8.9 pEC50 = 8.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1033 19 11 14 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719839 234699 0 None None None Human 8.9 pEC50 = 8.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccn2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353950 234699 0 None None None Human 8.9 pEC50 = 8.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccn2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719840 234700 0 None None None Human 8.9 pEC50 = 8.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccnc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353951 234700 0 None None None Human 8.9 pEC50 = 8.9 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccnc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720263 234771 0 None None None Human 8.0 pEC50 = 8 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1064 21 11 16 -3.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCN2CCOCC2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354574 234771 0 None None None Human 8.0 pEC50 = 8 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1064 21 11 16 -3.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCN2CCOCC2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
155515303 334552 0 None None None Human 8.0 pEC50 = 8.0 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1336 41 13 18 -0.7 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)N(C)CC(N)=O 10.1021/acs.jmedchem.9b01862
CHEMBL4442222 334552 0 None None None Human 8.0 pEC50 = 8.0 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1336 41 13 18 -0.7 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)N(C)CC(N)=O 10.1021/acs.jmedchem.9b01862
155551252 348013 0 None None None Human 8.0 pEC50 = 8.0 Binding
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4541104 348013 0 None None None Human 8.0 pEC50 = 8.0 Binding
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155553462 348194 0 None None None Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2123 45 24 30 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4546103 348194 0 None None None Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2123 45 24 30 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
5311065 484177 30 None None None Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b00132
817 484177 30 None None None Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b00132
CHEMBL1429 484177 30 None None None Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b00132
DB00035 484177 30 None None None Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b00132
155542264 347207 0 None None None Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520170 347207 0 None None None Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
3537 8682 25 None None None Human 6.9 pEC50 = 6.9 Binding
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
5311500 8682 25 None None None Human 6.9 pEC50 = 6.9 Binding
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
CHEMBL363910 8682 25 None None None Human 6.9 pEC50 = 6.9 Binding
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
155551252 348013 0 None None None Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4541104 348013 0 None None None Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155542151 347209 0 None None None Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520203 347209 0 None None None Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155542151 347209 0 None None None Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520203 347209 0 None None None Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155555256 348386 0 None None None Human 7.8 pEC50 = 7.8 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1005 18 11 14 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CSCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4550811 348386 0 None None None Human 7.8 pEC50 = 7.8 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1005 18 11 14 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CSCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
118476348 347615 0 None None None Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1096 17 11 13 0.6 CC(C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CSC[C@H]2C(=O)N[C@H](CCCNC(=N)N)C(=O)NCc2ccccc2)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
CHEMBL4531053 347615 0 None None None Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1096 17 11 13 0.6 CC(C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CSC[C@H]2C(=O)N[C@H](CCCNC(=N)N)C(=O)NCc2ccccc2)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
2042 8014 41 None None None Human 7.8 pEC50 = 7.8 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm100989w
2176 8014 41 None None None Human 7.8 pEC50 = 7.8 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm100989w
439302 8014 41 None None None Human 7.8 pEC50 = 7.8 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm100989w
CHEMBL395429 8014 41 None None None Human 7.8 pEC50 = 7.8 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm100989w
155560248 349072 0 None None None Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4567752 349072 0 None None None Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
44393941 335393 0 None None None Human 5.8 pEC50 = 5.8 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 595 8 2 6 4.4 CO[C@@H]1C[C@@H](C(=O)NCCc2ccccn2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
CHEMBL445393 335393 0 None None None Human 5.8 pEC50 = 5.8 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 595 8 2 6 4.4 CO[C@@H]1C[C@@H](C(=O)NCCc2ccccn2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
53317550 119139 0 None None None Human 6.8 pEC50 = 6.8 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CS[Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630523 119139 0 None None None Human 6.8 pEC50 = 6.8 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CS[Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
171357008 386523 0 None None None Human 6.8 pEC50 = 6.8 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1397 26 21 26 -11.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5279634 386523 0 None None None Human 6.8 pEC50 = 6.8 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1397 26 21 26 -11.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
155523986 335455 0 None None None Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 957 15 12 13 -1.5 CC(C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
CHEMBL4454891 335455 0 None None None Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 957 15 12 13 -1.5 CC(C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
155551252 348013 0 None None None Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4541104 348013 0 None None None Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155552392 348214 0 None None None Human 6.8 pEC50 = 6.8 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1452 49 15 20 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4546597 348214 0 None None None Human 6.8 pEC50 = 6.8 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1452 49 15 20 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
53320505 119140 0 None None None Human 7.8 pEC50 = 7.8 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1074 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se][Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630524 119140 0 None None None Human 7.8 pEC50 = 7.8 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1074 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se][Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
155553492 348195 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1322 41 14 18 -1.0 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b01862
CHEMBL4546106 348195 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1322 41 14 18 -1.0 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b01862
155542151 347209 0 None None None Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520203 347209 0 None None None Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
118720262 234770 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1048 21 12 15 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCC2CCCN2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354573 234770 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1048 21 12 15 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCC2CCCN2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
155542264 347207 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520170 347207 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155548766 347846 0 None None None Human 6.7 pEC50 = 6.7 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1724 62 18 24 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4537162 347846 0 None None None Human 6.7 pEC50 = 6.7 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1724 62 18 24 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
2042 8014 41 None None None Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.6b00564
2176 8014 41 None None None Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.6b00564
439302 8014 41 None None None Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.6b00564
CHEMBL395429 8014 41 None None None Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.6b00564
2042 8014 41 None None None Human 8.6 pEC50 = 8.6 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.9b01862
2176 8014 41 None None None Human 8.6 pEC50 = 8.6 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.9b01862
439302 8014 41 None None None Human 8.6 pEC50 = 8.6 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.9b01862
CHEMBL395429 8014 41 None None None Human 8.6 pEC50 = 8.6 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.9b01862
2042 8014 41 None None None Human 8.6 pEC50 = 8.6 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acsmedchemlett.2c00455
2176 8014 41 None None None Human 8.6 pEC50 = 8.6 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acsmedchemlett.2c00455
439302 8014 41 None None None Human 8.6 pEC50 = 8.6 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acsmedchemlett.2c00455
CHEMBL395429 8014 41 None None None Human 8.6 pEC50 = 8.6 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acsmedchemlett.2c00455
2042 8014 41 None None None Human 8.6 pEC50 = 8.6 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm500365s
2176 8014 41 None None None Human 8.6 pEC50 = 8.6 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm500365s
439302 8014 41 None None None Human 8.6 pEC50 = 8.6 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm500365s
CHEMBL395429 8014 41 None None None Human 8.6 pEC50 = 8.6 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm500365s
155548766 347846 0 None None None Human 8.6 pEC50 = 8.6 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1724 62 18 24 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4537162 347846 0 None None None Human 8.6 pEC50 = 8.6 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1724 62 18 24 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
53316559 119138 0 None None None Human 8.6 pEC50 = 8.6 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se]SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630522 119138 0 None None None Human 8.6 pEC50 = 8.6 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se]SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
155559767 348923 1 None None None Human 8.6 pEC50 = 8.6 Binding
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4564152 348923 1 None None None Human 8.6 pEC50 = 8.6 Binding
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
11169 1650 39 None None None Human 8.5 pEC50 = 8.5 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
165708555 1650 39 None None None Human 8.5 pEC50 = 8.5 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
16681432 1650 39 None None None Human 8.5 pEC50 = 8.5 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
495 1650 39 None None None Human 8.5 pEC50 = 8.5 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
CHEMBL3301668 1650 39 None None None Human 8.5 pEC50 = 8.5 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
DB01282 1650 39 None None None Human 8.5 pEC50 = 8.5 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
155542151 347209 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520203 347209 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155551252 348013 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4541104 348013 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155553462 348194 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2123 45 24 30 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4546103 348194 0 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2123 45 24 30 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
146681949 8624 35 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm500365s
2168 8624 35 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm500365s
2810 8624 35 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm500365s
644077 8624 35 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm500365s
CHEMBL373742 8624 35 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm500365s
DB00067 8624 35 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm500365s
P01185 8624 35 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm500365s
P01186 8624 35 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm500365s
P35455 8624 35 None None None Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm500365s
171344442 386179 0 None None None Human 6.7 pEC50 = 6.7 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1164 19 17 20 -8.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)NC(C)(C)C(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5271164 386179 0 None None None Human 6.7 pEC50 = 6.7 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1164 19 17 20 -8.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)NC(C)(C)C(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
44394045 334075 0 None None None Human 5.7 pEC50 = 5.7 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 641 6 1 6 5.2 CO[C@@H]1C[C@@H](C(=O)N2CCC(N3CCCCC3)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
CHEMBL443300 334075 0 None None None Human 5.7 pEC50 = 5.7 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 641 6 1 6 5.2 CO[C@@H]1C[C@@H](C(=O)N2CCC(N3CCCCC3)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
118476338 347488 0 None None None Human 6.6 pEC50 = 6.6 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 957 15 12 13 -1.5 CC(C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CO)CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
CHEMBL4528032 347488 0 None None None Human 6.6 pEC50 = 6.6 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 957 15 12 13 -1.5 CC(C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CO)CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
10282736 251877 0 None None None Human 5.6 pEC50 = 5.6 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 627 6 1 6 4.8 CO[C@@H]1C[C@@H](C(=O)N2CCC(N3CCCC3)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
CHEMBL362382 251877 0 None None None Human 5.6 pEC50 = 5.6 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 627 6 1 6 4.8 CO[C@@H]1C[C@@H](C(=O)N2CCC(N3CCCC3)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
155553462 348194 0 None None None Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2123 45 24 30 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4546103 348194 0 None None None Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2123 45 24 30 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
53319051 119141 0 None None None Human 7.6 pEC50 = 7.6 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1174 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Te][Te]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630525 119141 0 None None None Human 7.6 pEC50 = 7.6 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1174 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Te][Te]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
44393965 254175 0 None None None Human 5.6 pEC50 = 5.6 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 587 5 1 6 3.8 CO[C@@H]1C[C@@H](C(=O)N2CCCN(C)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
CHEMBL364994 254175 0 None None None Human 5.6 pEC50 = 5.6 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 587 5 1 6 3.8 CO[C@@H]1C[C@@H](C(=O)N2CCCN(C)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
155560248 349072 0 None None None Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4567752 349072 0 None None None Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155552392 348214 0 None None None Human 8.5 pEC50 = 8.5 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1452 49 15 20 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4546597 348214 0 None None None Human 8.5 pEC50 = 8.5 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1452 49 15 20 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
155560248 349072 0 None None None Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4567752 349072 0 None None None Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
73346893 180194 0 None None None Human 7.5 pEC50 = 7.5 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 989 17 12 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)CCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL2369425 180194 0 None None None Human 7.5 pEC50 = 7.5 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 989 17 12 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)CCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
135413563 241495 20 None None None Human 7.5 pEC50 = 7.5 Binding
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
CHEMBL360648 241495 20 None None None Human 7.5 pEC50 = 7.5 Binding
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
135413563 241495 20 None None None Human 7.5 pEC50 = 7.5 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1016/j.bmcl.2004.04.107
CHEMBL360648 241495 20 None None None Human 7.5 pEC50 = 7.5 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1016/j.bmcl.2004.04.107
155559767 348923 1 None None None Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4564152 348923 1 None None None Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155542264 347207 0 None None None Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520170 347207 0 None None None Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
44419025 175267 18 None None None Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
44419026 175267 18 None None None Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
74992363 175267 18 None None None Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
CHEMBL221436 175267 18 None None None Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
CHEMBL435323 175267 18 None None None Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
CHEMBL6015151 175267 18 None None None Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
155542151 347209 0 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520203 347209 0 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
171355737 386627 0 None None None Human 5.4 pEC50 = 5.4 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 985 17 13 14 -5.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5281925 386627 0 None None None Human 5.4 pEC50 = 5.4 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 985 17 13 14 -5.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
155559767 348923 1 None None None Human 8.4 pEC50 = 8.4 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4564152 348923 1 None None None Human 8.4 pEC50 = 8.4 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155547725 347659 0 None None None Human 8.4 pEC50 = 8.4 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1133 26 12 15 -0.9 CCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.6b00564
CHEMBL4532537 347659 0 None None None Human 8.4 pEC50 = 8.4 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1133 26 12 15 -0.9 CCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.6b00564
2252 4546 39 None None None Human 8.3 pEC50 = 8.3 Binding
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901084f
6918320 4546 39 None None None Human 8.3 pEC50 = 8.3 Binding
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901084f
CHEMBL24781 4546 39 None None None Human 8.3 pEC50 = 8.3 Binding
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901084f
155527834 335829 0 None None None Human 8.3 pEC50 = 8.3 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1020 19 12 15 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CSCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4460622 335829 0 None None None Human 8.3 pEC50 = 8.3 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1020 19 12 15 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CSCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
155542264 347207 0 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520170 347207 0 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155551252 348013 0 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4541104 348013 0 None None None Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
146681949 8624 35 None None None Human 7.4 pEC50 = 7.4 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
2168 8624 35 None None None Human 7.4 pEC50 = 7.4 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
2810 8624 35 None None None Human 7.4 pEC50 = 7.4 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
644077 8624 35 None None None Human 7.4 pEC50 = 7.4 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
CHEMBL373742 8624 35 None None None Human 7.4 pEC50 = 7.4 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
DB00067 8624 35 None None None Human 7.4 pEC50 = 7.4 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
P01185 8624 35 None None None Human 7.4 pEC50 = 7.4 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
P01186 8624 35 None None None Human 7.4 pEC50 = 7.4 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
P35455 8624 35 None None None Human 7.4 pEC50 = 7.4 Binding
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
44394044 251895 0 None None None Human 6.4 pEC50 = 6.4 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 603 5 1 6 4.6 CO[C@@H]1C[C@@H](C(=S)N2CCCN(C)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
CHEMBL362483 251895 0 None None None Human 6.4 pEC50 = 6.4 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 603 5 1 6 4.6 CO[C@@H]1C[C@@H](C(=S)N2CCCN(C)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
155524463 335557 0 None None None Human 6.3 pEC50 = 6.3 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1738 62 17 24 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4456573 335557 0 None None None Human 6.3 pEC50 = 6.3 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1738 62 17 24 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
44393911 137526 0 None None None Human 6.3 pEC50 = 6.3 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 611 8 2 6 5.7 CO[C@@H]1C[C@@H](/C(S)=N/CCc2ccccn2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
CHEMBL182627 137526 0 None None None Human 6.3 pEC50 = 6.3 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 611 8 2 6 5.7 CO[C@@H]1C[C@@H](/C(S)=N/CCc2ccccn2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
44393912 136872 0 None None None Human 6.3 pEC50 = 6.3 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 643 6 1 6 5.6 CO[C@@H]1C[C@@H](C(=S)N2CCC(N3CCCC3)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
CHEMBL181487 136872 0 None None None Human 6.3 pEC50 = 6.3 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 643 6 1 6 5.6 CO[C@@H]1C[C@@H](C(=S)N2CCC(N3CCCC3)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
155553492 348195 0 None None None Human 8.3 pEC50 = 8.3 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1322 41 14 18 -1.0 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b01862
CHEMBL4546106 348195 0 None None None Human 8.3 pEC50 = 8.3 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1322 41 14 18 -1.0 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b01862
155529697 335981 0 None None None Human 8.3 pEC50 = 8.3 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1362 40 13 18 -0.2 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b01862
CHEMBL4463103 335981 0 None None None Human 8.3 pEC50 = 8.3 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1362 40 13 18 -0.2 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b01862
155558494 348777 0 None None None Human 7.3 pEC50 = 7.3 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1466 49 14 20 -0.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4560445 348777 0 None None None Human 7.3 pEC50 = 7.3 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1466 49 14 20 -0.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
155515303 334552 0 None None None Human 7.3 pEC50 = 7.3 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1336 41 13 18 -0.7 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)N(C)CC(N)=O 10.1021/acs.jmedchem.9b01862
CHEMBL4442222 334552 0 None None None Human 7.3 pEC50 = 7.3 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1336 41 13 18 -0.7 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)N(C)CC(N)=O 10.1021/acs.jmedchem.9b01862
155560248 349072 0 None None None Human 7.2 pEC50 = 7.2 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4567752 349072 0 None None None Human 7.2 pEC50 = 7.2 Binding
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
10411308 462175 0 None None None Human 7.2 pEC50 = 7.2 Binding
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm901084f
CHEMBL603708 462175 0 None None None Human 7.2 pEC50 = 7.2 Binding
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm901084f
10187625 255252 0 None None None Human 6.2 pEC50 = 6.2 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 553 4 1 5 4.7 Cc1cc(C(=O)N2CCCCc3sccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1016/j.bmcl.2004.04.107
CHEMBL365862 255252 0 None None None Human 6.2 pEC50 = 6.2 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 553 4 1 5 4.7 Cc1cc(C(=O)N2CCCCc3sccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1016/j.bmcl.2004.04.107
155524463 335557 0 None None None Human 7.2 pEC50 = 7.2 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1738 62 17 24 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4456573 335557 0 None None None Human 7.2 pEC50 = 7.2 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1738 62 17 24 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
155542264 347207 0 None None None Human 7.2 pEC50 = 7.2 Binding
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520170 347207 0 None None None Human 7.2 pEC50 = 7.2 Binding
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
171349253 386006 0 None None None Human 5.2 pEC50 = 5.2 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1000 17 13 14 -5.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5266871 386006 0 None None None Human 5.2 pEC50 = 5.2 Binding
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1000 17 13 14 -5.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
5311065 484177 30 None None None Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm500365s
817 484177 30 None None None Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm500365s
CHEMBL1429 484177 30 None None None Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm500365s
DB00035 484177 30 None None None Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm500365s
155559767 348923 1 None None None Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4564152 348923 1 None None None Human 7.1 pEC50 = 7.1 Binding
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
44394063 138653 0 None None None Human 6.1 pEC50 = 6.1 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 573 4 1 5 5.0 CN1CCCN(C(=S)[C@@H]2CCCN2C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)CC1 10.1016/j.bmcl.2004.04.107
CHEMBL185152 138653 0 None None None Human 6.1 pEC50 = 6.1 Binding
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 573 4 1 5 5.0 CN1CCCN(C(=S)[C@@H]2CCCN2C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)CC1 10.1016/j.bmcl.2004.04.107
155558494 348777 0 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1466 49 14 20 -0.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4560445 348777 0 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1466 49 14 20 -0.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
155560248 349072 0 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human oxytocin receptor V43A/C47A double mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4567752 349072 0 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human oxytocin receptor V43A/C47A double mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
135506374 275287 21 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.bmcl.2017.04.030
CHEMBL3763342 275287 21 None None None Human 6.1 pEC50 = 6.1 Binding
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.bmcl.2017.04.030
2042 8014 41 None None None Human 8.1 pEC50 = 8.1 Binding
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmcl.2017.04.030
2176 8014 41 None None None Human 8.1 pEC50 = 8.1 Binding
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmcl.2017.04.030
439302 8014 41 None None None Human 8.1 pEC50 = 8.1 Binding
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmcl.2017.04.030
CHEMBL395429 8014 41 None None None Human 8.1 pEC50 = 8.1 Binding
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmcl.2017.04.030
44352184 235844 0 None None None Rat 9.2 pIC50 = 9.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 687 11 2 8 2.5 Cn1cnc(CC(=O)NC(CCS(C)(=O)=O)C(=O)N[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
CHEMBL338711 235844 0 None None None Rat 9.2 pIC50 = 9.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 687 11 2 8 2.5 Cn1cnc(CC(=O)NC(CCS(C)(=O)=O)C(=O)N[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
44352185 45253 0 None None None Rat 8.9 pIC50 = 8.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 673 11 3 7 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(CCS(C)(=O)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL131477 45253 0 None None None Rat 8.9 pIC50 = 8.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 673 11 3 7 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(CCS(C)(=O)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
14981580 160371 0 None None None Rat 8.9 pIC50 = 8.9 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 637 11 3 8 1.9 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCNCC2)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112895 160371 0 None None None Rat 8.9 pIC50 = 8.9 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 637 11 3 8 1.9 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCNCC2)C3(C)C)CC1 10.1021/jm00031a004
14981581 160369 0 None None None Rat 8.9 pIC50 = 8.9 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 686 11 2 9 1.7 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCS(=O)(=O)CC2)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112893 160369 0 None None None Rat 8.9 pIC50 = 8.9 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 686 11 2 9 1.7 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCS(=O)(=O)CC2)C3(C)C)CC1 10.1021/jm00031a004
10394512 235879 0 None None None Rat 8.8 pIC50 = 8.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 652 11 3 7 2.3 Cn1cnc(CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
CHEMBL338921 235879 0 None None None Rat 8.8 pIC50 = 8.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 652 11 3 7 2.3 Cn1cnc(CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
CHEMBL2112247 485095 0 None None None Rat 8.0 pIC50 = 8 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 769 6 4 8 2.0 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cn(C)c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44273425 199139 0 None None None Rat 8.0 pIC50 = 8 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 2 6 2.6 C[C@@H](O)CNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL279281 199139 0 None None None Rat 8.0 pIC50 = 8 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 2 6 2.6 C[C@@H](O)CNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44352453 42824 0 None None None Rat 7.0 pIC50 = 7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 6 2 5 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1cccnc1)C2 10.1021/jm00077a002
CHEMBL128726 42824 0 None None None Rat 7.0 pIC50 = 7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 6 2 5 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1cccnc1)C2 10.1021/jm00077a002
10073512 44390 0 None None None Rat 7.0 pIC50 = 7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 471 4 1 3 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1CCNC1=O)C2 10.1021/jm00077a002
CHEMBL130768 44390 0 None None None Rat 7.0 pIC50 = 7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 471 4 1 3 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1CCNC1=O)C2 10.1021/jm00077a002
10393719 46153 0 None None None Rat 7.0 pIC50 = 7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 595 8 2 5 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)CC1CN3CCC1CC3)C2 10.1021/jm00077a002
CHEMBL132391 46153 0 None None None Rat 7.0 pIC50 = 7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 595 8 2 5 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)CC1CN3CCC1CC3)C2 10.1021/jm00077a002
44352490 236785 0 None None None Rat 7.0 pIC50 = 7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 577 6 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CC(S(C)(=O)=O)CN1)C2 10.1021/jm00077a002
CHEMBL340362 236785 0 None None None Rat 7.0 pIC50 = 7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 577 6 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CC(S(C)(=O)=O)CN1)C2 10.1021/jm00077a002
44433367 180676 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 489 3 1 3 5.0 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CC3C=CC(=O)N3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2007.08.053
CHEMBL237772 180676 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 489 3 1 3 5.0 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CC3C=CC(=O)N3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2007.08.053
44433372 180754 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 426 5 3 3 5.0 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)Nc2ccccc2C(=O)O)c(Cl)c1 10.1016/j.bmcl.2007.08.053
CHEMBL237987 180754 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 426 5 3 3 5.0 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)Nc2ccccc2C(=O)O)c(Cl)c1 10.1016/j.bmcl.2007.08.053
44433375 181015 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 505 7 3 4 5.8 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)Nc2ccccc2Cn2cccc2C(=O)O)c(Cl)c1 10.1016/j.bmcl.2007.08.053
CHEMBL238206 181015 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 505 7 3 4 5.8 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)Nc2ccccc2Cn2cccc2C(=O)O)c(Cl)c1 10.1016/j.bmcl.2007.08.053
44433363 293356 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 489 3 1 3 5.7 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2C=C3CCC(=O)N3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2007.08.053
CHEMBL392363 293356 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 489 3 1 3 5.7 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2C=C3CCC(=O)N3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2007.08.053
44350917 41945 0 None None None Rat 6.0 pIC50 = 6 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 1 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCCc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
CHEMBL126709 41945 0 None None None Rat 6.0 pIC50 = 6 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 1 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCCc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
10256140 45363 0 None None None Rat 6.0 pIC50 = 6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 520 6 1 3 4.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](NC(=O)Cc1ccccc1)C2 10.1021/jm00077a002
CHEMBL131613 45363 0 None None None Rat 6.0 pIC50 = 6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 520 6 1 3 4.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](NC(=O)Cc1ccccc1)C2 10.1021/jm00077a002
11755934 236944 0 None None None Rat 6.0 pIC50 = 6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 506 5 1 3 4.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1ccccc1)C2 10.1021/jm00077a002
CHEMBL340772 236944 0 None None None Rat 6.0 pIC50 = 6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 506 5 1 3 4.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1ccccc1)C2 10.1021/jm00077a002
44351224 236849 0 None None None Rat 5.0 pIC50 = 5 Binding
Compound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissueCompound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissue
ChEMBL 351 3 0 2 4.0 O=S(=O)(/C=C/c1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL340383 236849 0 None None None Rat 5.0 pIC50 = 5 Binding
Compound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissueCompound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissue
ChEMBL 351 3 0 2 4.0 O=S(=O)(/C=C/c1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
10358978 40829 0 None None None Rat 5.0 pIC50 = 5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 325 2 0 2 3.4 O=S(=O)(c1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL125358 40829 0 None None None Rat 5.0 pIC50 = 5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 325 2 0 2 3.4 O=S(=O)(c1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
9996817 41962 0 None None None Rat 5.0 pIC50 = 5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 331 2 0 3 3.5 O=S(=O)(c1cccs1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL126796 41962 0 None None None Rat 5.0 pIC50 = 5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 331 2 0 3 3.5 O=S(=O)(c1cccs1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
19908315 42234 0 None None None Rat 5.0 pIC50 = 5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 362 1 1 1 4.6 O=C(NC1C2CC3CC(C2)CC1C3)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL127119 42234 0 None None None Rat 5.0 pIC50 = 5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 362 1 1 1 4.6 O=C(NC1C2CC3CC(C2)CC1C3)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
11778918 43269 0 None None None Rat 5.0 pIC50 = 5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 289 1 0 1 3.9 O=C(c1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL129413 43269 0 None None None Rat 5.0 pIC50 = 5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 289 1 0 1 3.9 O=C(c1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
10402786 235714 0 None None None Rat 5.0 pIC50 = 5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 304 1 1 1 4.3 O=C(Nc1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL337976 235714 0 None None None Rat 5.0 pIC50 = 5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 304 1 1 1 4.3 O=C(Nc1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
10404941 235821 0 None None None Rat 5.0 pIC50 = 5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 339 2 0 2 3.7 Cc1ccccc1S(=O)(=O)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL338605 235821 0 None None None Rat 5.0 pIC50 = 5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 339 2 0 2 3.7 Cc1ccccc1S(=O)(=O)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
10403606 236556 0 None None None Rat 5.0 pIC50 = 5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 318 1 1 1 4.6 Cc1ccc(NC(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
CHEMBL340149 236556 0 None None None Rat 5.0 pIC50 = 5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 318 1 1 1 4.6 Cc1ccc(NC(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
10432863 193666 0 None None None Rat 5.0 pIC50 = 5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 430 4 2 4 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@](O)(CN)C2 10.1021/jm00077a002
CHEMBL274955 193666 0 None None None Rat 5.0 pIC50 = 5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 430 4 2 4 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@](O)(CN)C2 10.1021/jm00077a002
10391626 232078 0 None None None Rat 5.0 pIC50 = 5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 CC1(C)[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL338362 232078 0 None None None Rat 5.0 pIC50 = 5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 CC1(C)[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
44429299 333850 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1035 20 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL441128 333850 0 None None None Human 6.0 pIC50 = 6 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1035 20 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
16737617 197207 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
16737618 197207 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL265630 197207 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL415418 197207 0 None None None Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
10483940 236124 0 None None None Rat 8.0 pIC50 = 8.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 616 9 2 6 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(CCS(C)(=O)=O)c1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL339497 236124 0 None None None Rat 8.0 pIC50 = 8.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 616 9 2 6 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(CCS(C)(=O)=O)c1c[nH]cn1)C2 10.1021/jm00077a002
10368075 333140 0 None None None Rat 8.0 pIC50 = 8.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 484 4 0 4 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CCC1=O)C2 10.1021/jm00077a002
CHEMBL435019 333140 0 None None None Rat 8.0 pIC50 = 8.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 484 4 0 4 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CCC1=O)C2 10.1021/jm00077a002
44352360 42727 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 5 1 5 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CN1C(=O)CCC1=O)C2 10.1021/jm00077a002
CHEMBL128216 42727 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 5 1 5 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CN1C(=O)CCC1=O)C2 10.1021/jm00077a002
44352425 44871 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 501 6 2 4 3.6 CC(C)[C@@H](N)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL131168 44871 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 501 6 2 4 3.6 CC(C)[C@@H](N)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44352371 45175 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 593 9 3 7 1.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C(N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
CHEMBL131388 45175 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 593 9 3 7 1.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C(N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
44352438 234204 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 6 3 5 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C1CCCNC1)C2 10.1021/jm00077a002
CHEMBL334610 234204 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 6 3 5 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C1CCCNC1)C2 10.1021/jm00077a002
9985844 235551 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 588 6 2 4 4.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1[nH]cnc1Br)C2 10.1021/jm00077a002
CHEMBL336992 235551 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 588 6 2 4 4.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1[nH]cnc1Br)C2 10.1021/jm00077a002
10099421 329796 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 563 8 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)Cc1ccncc1)C2 10.1021/jm00077a002
CHEMBL422080 329796 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 563 8 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)Cc1ccncc1)C2 10.1021/jm00077a002
44350931 41946 0 None None None Rat 6.0 pIC50 = 6.0 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 0 3 4.1 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCCc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL126717 41946 0 None None None Rat 6.0 pIC50 = 6.0 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 0 3 4.1 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCCc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
44351066 43243 0 None None None Rat 6.0 pIC50 = 6.0 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 0 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL129268 43243 0 None None None Rat 6.0 pIC50 = 6.0 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 0 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
132072820 354798 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 610 8 0 7 5.4 COC(=O)[C@H]1[C@@H](OCc2cccc(OC)c2)CC[C@H]2CN3CC[C@@]4(C(=O)N(Cc5cccc(OC)c5)c5ccccc54)[C@@H]3C[C@@H]21 10.1016/j.bmc.2020.115546
CHEMBL4758081 354798 0 None None None Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 610 8 0 7 5.4 COC(=O)[C@H]1[C@@H](OCc2cccc(OC)c2)CC[C@H]2CN3CC[C@@]4(C(=O)N(Cc5cccc(OC)c5)c5ccccc54)[C@@H]3C[C@@H]21 10.1016/j.bmc.2020.115546
71458039 155156 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 530 8 3 5 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C2 10.1021/jm00031a004
CHEMBL2112899 155156 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 530 8 3 5 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C2 10.1021/jm00031a004
71449109 160378 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 565 8 2 6 2.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCS(C)(=O)=O)C2 10.1021/jm00031a004
CHEMBL2112902 160378 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 565 8 2 6 2.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCS(C)(=O)=O)C2 10.1021/jm00031a004
44272997 143949 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
9805972 143949 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL19658 143949 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL276990 143949 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
10075696 44357 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 3 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCC(N)=O)C2 10.1021/jm00077a002
10256467 44357 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 3 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCC(N)=O)C2 10.1021/jm00077a002
CHEMBL130742 44357 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 3 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCC(N)=O)C2 10.1021/jm00077a002
CHEMBL131650 44357 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 3 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCC(N)=O)C2 10.1021/jm00077a002
10257352 160035 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 8 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
10483039 160035 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 8 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
CHEMBL2111851 160035 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 8 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
CHEMBL2112666 160035 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 8 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
10370697 237189 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 1 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
CHEMBL341049 237189 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 1 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
11756081 42758 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 1 5 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cn1ccnc1)C2 10.1021/jm00077a002
CHEMBL128398 42758 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 1 5 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cn1ccnc1)C2 10.1021/jm00077a002
10436744 45019 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 521 6 1 4 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1ccncc1)C2 10.1021/jm00077a002
CHEMBL131269 45019 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 521 6 1 4 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1ccncc1)C2 10.1021/jm00077a002
10415138 235828 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1ccccn1)C2 10.1021/jm00077a002
CHEMBL338636 235828 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1ccccn1)C2 10.1021/jm00077a002
CHEMBL339493 487019 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 664 4 2 6 1.9 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](C)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10386478 235854 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 403 2 0 2 4.2 O=S(=O)(c1ccc(Br)cc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL338757 235854 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 403 2 0 2 4.2 O=S(=O)(c1ccc(Br)cc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
9983834 232062 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 CC1(C)[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL337519 232062 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 CC1(C)[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
10026508 236756 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 444 4 1 3 3.6 CC(=O)N[C@@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL340320 236756 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 444 4 1 3 3.6 CC(=O)N[C@@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10031108 235468 0 None None None Rat 4.9 pIC50 = 4.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 578 6 1 3 6.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C[C@]13C[C@H]4C[C@H](C[C@H](C4)C1)C3)C2 10.1021/jm00077a002
CHEMBL336362 235468 0 None None None Rat 4.9 pIC50 = 4.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 578 6 1 3 6.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C[C@]13C[C@H]4C[C@H](C[C@H](C4)C1)C3)C2 10.1021/jm00077a002
44273173 199254 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44273417 199254 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL280202 199254 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL283317 199254 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL338018 486995 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 807 10 4 7 3.5 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCCN)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44273080 198876 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 571 7 1 7 2.4 COC(=O)CNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL277022 198876 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 571 7 1 7 2.4 COC(=O)CNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
10031372 42735 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 592 7 2 6 2.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CCS(N)(=O)=O)C1=O)C2 10.1021/jm00077a002
CHEMBL128258 42735 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 592 7 2 6 2.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CCS(N)(=O)=O)C1=O)C2 10.1021/jm00077a002
10347928 237266 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
CHEMBL341289 237266 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
10326385 311623 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 609 7 2 8 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(CC(=O)Nc3nn[nH]n3)C1=O)C2 10.1021/jm00077a002
CHEMBL405016 311623 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 609 7 2 8 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(CC(=O)Nc3nn[nH]n3)C1=O)C2 10.1021/jm00077a002
CHEMBL406351 487907 0 None None None Human 6.9 pIC50 = 6.9 Binding
Binding affinity towards oxytocin receptorBinding affinity towards oxytocin receptor
ChEMBL 1032 9 12 15 -3.1 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)C(C)(C)SSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm0303103
CHEMBL397407 487806 0 None None None Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1068 17 12 15 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2Cc3ccccc3C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
10052640 44977 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 527 6 2 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CC1CCCNC1)C2 10.1021/jm00077a002
CHEMBL131239 44977 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 527 6 2 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CC1CCCNC1)C2 10.1021/jm00077a002
44352497 235921 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 472 5 2 4 3.1 CC(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL339151 235921 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 472 5 2 4 3.1 CC(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44350953 42165 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.0 CC1C(=O)[C@]2(CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
CHEMBL127063 42165 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.0 CC1C(=O)[C@]2(CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
10455392 42708 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 430 4 2 4 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CN)C2 10.1021/jm00077a002
CHEMBL128124 42708 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 430 4 2 4 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CN)C2 10.1021/jm00077a002
CHEMBL234363 485347 0 None None None Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1022 18 13 15 -3.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
10458629 42820 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 4 1 4 3.4 CC1NC(=O)N([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
CHEMBL128712 42820 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 4 1 4 3.4 CC1NC(=O)N([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
10074681 235917 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 4 0 4 3.4 CN1CC(=O)N([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
CHEMBL339132 235917 0 None None None Rat 7.9 pIC50 = 7.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 4 0 4 3.4 CN1CC(=O)N([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
10435004 42747 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 473 6 2 4 3.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCN)C2 10.1021/jm00077a002
CHEMBL128328 42747 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 473 6 2 4 3.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCN)C2 10.1021/jm00077a002
10075516 329159 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 7 1 5 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCn1ccnc1)C2 10.1021/jm00077a002
CHEMBL421090 329159 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 7 1 5 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCn1ccnc1)C2 10.1021/jm00077a002
10324129 333224 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 6 1 7 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cn1cnnn1)C2 10.1021/jm00077a002
CHEMBL435613 333224 0 None None None Rat 6.9 pIC50 = 6.9 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 6 1 7 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cn1cnnn1)C2 10.1021/jm00077a002
44351212 328368 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 473 5 2 4 3.7 CC(C(=O)O)[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
CHEMBL419422 328368 0 None None None Rat 5.9 pIC50 = 5.9 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 473 5 2 4 3.7 CC(C(=O)O)[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
CHEMBL1790937 484815 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 755 6 5 7 1.9 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
CHEMBL2370623 485596 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 739 6 2 7 2.7 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
CHEMBL338308 487001 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 742 9 4 8 1.5 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCN)NC(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
14981577 160376 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 636 11 2 7 3.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCCCC2)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112900 160376 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 636 11 2 7 3.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCCCC2)C3(C)C)CC1 10.1021/jm00031a004
44273368 199036 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 584 9 1 6 3.2 CN(C)CCCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL278377 199036 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 584 9 1 6 3.2 CN(C)CCCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
10347928 237266 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
CHEMBL341289 237266 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
121301508 350186 8 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)
ChEMBL 542 7 2 9 3.6 C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1 10.6019/CHEMBL5463729
CHEMBL4594444 350186 8 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)
ChEMBL 542 7 2 9 3.6 C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1 10.6019/CHEMBL5463729
DB16279 350186 8 None None None Human 7.8 pIC50 = 7.8 Binding
Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)
ChEMBL 542 7 2 9 3.6 C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1 10.6019/CHEMBL5463729
44273173 199254 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44273417 199254 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL280202 199254 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL283317 199254 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
10029340 42746 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 5 2 4 4.0 Cc1[nH]cnc1C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL128327 42746 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 5 2 4 4.0 Cc1[nH]cnc1C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10052468 44972 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 522 6 2 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)/C=C/c1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL131235 44972 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 522 6 2 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)/C=C/c1c[nH]cn1)C2 10.1021/jm00077a002
10414877 45322 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 6 2 4 4.3 CC(C)(C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C)c1c[nH]cn1 10.1021/jm00077a002
CHEMBL131564 45322 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 6 2 4 4.3 CC(C)(C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C)c1c[nH]cn1 10.1021/jm00077a002
44352353 235999 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 500 5 1 4 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@](O)(CN1CCCC1=O)C2 10.1021/jm00077a002
CHEMBL339357 235999 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 500 5 1 4 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@](O)(CN1CCCC1=O)C2 10.1021/jm00077a002
9982888 333139 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 486 6 2 4 3.5 CC(=O)NCC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL435009 333139 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 486 6 2 4 3.5 CC(=O)NCC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL339452 487017 0 None None None Rat 5.8 pIC50 = 5.8 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 714 6 2 6 2.5 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@@H](C)N(C)C1=O 10.1021/jm00099a019
CHEMBL436397 488628 0 None None None Rat 5.8 pIC50 = 5.8 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 744 8 4 7 1.7 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CC(=O)O)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10054982 235818 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 645 10 2 6 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)N(CCc1c[nH]cn1)CCS(C)(=O)=O)C2 10.1021/jm00077a002
CHEMBL338576 235818 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 645 10 2 6 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)N(CCc1c[nH]cn1)CCS(C)(=O)=O)C2 10.1021/jm00077a002
10347928 237266 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
CHEMBL341289 237266 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
CHEMBL2369135 485403 0 None None None Human 6.8 pIC50 = 6.8 Binding
Binding affinity towards oxytocin receptorBinding affinity towards oxytocin receptor
ChEMBL 1089 10 11 15 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H]([C@H](C)c2c(C)cc(OC)cc2C)NC(=O)[C@H](N)C(C)(C)SSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm0303103
CHEMBL338294 486999 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 757 10 4 7 2.3 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCCN)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10006805 330168 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 517 6 2 5 3.0 COC(=O)CNC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL423156 330168 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 517 6 2 5 3.0 COC(=O)CNC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10361799 41898 0 None None None Rat 4.8 pIC50 = 4.8 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 370 3 0 4 3.3 O=[N+]([O-])c1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
CHEMBL126453 41898 0 None None None Rat 4.8 pIC50 = 4.8 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 370 3 0 4 3.3 O=[N+]([O-])c1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
44272990 199743 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
44273369 199743 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL283524 199743 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL283994 199743 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
44352150 42724 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 515 7 2 5 2.8 CC(C(N)=O)[C@@H](N)C(=O)[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL128194 42724 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 515 7 2 5 2.8 CC(C(N)=O)[C@@H](N)C(=O)[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10098227 42814 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 521 6 1 4 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1cccnc1)C2 10.1021/jm00077a002
CHEMBL128680 42814 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 521 6 1 4 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1cccnc1)C2 10.1021/jm00077a002
10053091 44436 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 6 2 6 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1csc(N)n1)C2 10.1021/jm00077a002
CHEMBL130803 44436 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 6 2 6 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1csc(N)n1)C2 10.1021/jm00077a002
10098755 45332 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 7 2 4 4.5 CCC(C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C)c1c[nH]cn1 10.1021/jm00077a002
CHEMBL131581 45332 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 7 2 4 4.5 CCC(C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C)c1c[nH]cn1 10.1021/jm00077a002
44352393 235748 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 555 6 3 4 4.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)NC1CCCCC1)C2 10.1021/jm00077a002
CHEMBL338177 235748 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 555 6 3 4 4.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)NC1CCCCC1)C2 10.1021/jm00077a002
44429288 178241 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44429290 178241 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233328 178241 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL234377 178241 0 None None None Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
2241 4522 5 None None None Rat 7.8 pIC50 = 7.8 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 738 6 2 8 2.3 CC[C@@H]([C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N(C(=O)[C@H]2N(C(=O)[C@@H]3N(C1=O)N=CCC3)N=CCC2)C)Cc1ccccc1)C 10.1021/jm00099a019
9810632 4522 5 None None None Rat 7.8 pIC50 = 7.8 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 738 6 2 8 2.3 CC[C@@H]([C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N(C(=O)[C@H]2N(C(=O)[C@@H]3N(C1=O)N=CCC3)N=CCC2)C)Cc1ccccc1)C 10.1021/jm00099a019
CHEMBL127686 4522 5 None None None Rat 7.8 pIC50 = 7.8 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 738 6 2 8 2.3 CC[C@@H]([C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N(C(=O)[C@H]2N(C(=O)[C@@H]3N(C1=O)N=CCC3)N=CCC2)C)Cc1ccccc1)C 10.1021/jm00099a019
CHEMBL1790938 484816 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 769 6 4 7 2.3 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
14981576 160370 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 610 12 1 7 2.9 CCN(CC)[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1CC2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1021/jm00031a004
CHEMBL2112894 160370 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 610 12 1 7 2.9 CCN(CC)[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1CC2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1021/jm00031a004
44273346 327964 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 570 8 1 6 2.8 CN(C)CCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL417458 327964 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 570 8 1 6 2.8 CN(C)CCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
10051081 235777 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 485 4 1 4 3.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CNC1=O)C2 10.1021/jm00077a002
CHEMBL338383 235777 0 None None None Rat 7.8 pIC50 = 7.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 485 4 1 4 3.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CNC1=O)C2 10.1021/jm00077a002
44352441 44539 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 6 2 5 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1ccccn1)C2 10.1021/jm00077a002
CHEMBL130887 44539 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 6 2 5 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1ccccn1)C2 10.1021/jm00077a002
44352440 235661 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 6 2 5 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1ccncc1)C2 10.1021/jm00077a002
CHEMBL337667 235661 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 6 2 5 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1ccncc1)C2 10.1021/jm00077a002
10345259 235827 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 484 4 0 3 4.5 CC1CCC(=O)N1[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL338635 235827 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 484 4 0 3 4.5 CC1CCC(=O)N1[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10323684 235909 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 4 1 5 2.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(=O)C1=O)C2 10.1021/jm00077a002
CHEMBL339096 235909 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 4 1 5 2.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(=O)C1=O)C2 10.1021/jm00077a002
10347089 333133 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 7 1 4 4.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCc1cccnc1)C2 10.1021/jm00077a002
CHEMBL434993 333133 0 None None None Rat 6.8 pIC50 = 6.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 7 1 4 4.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCc1cccnc1)C2 10.1021/jm00077a002
44351086 42022 0 None None None Rat 5.8 pIC50 = 5.8 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 399 3 0 3 3.8 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL126962 42022 0 None None None Rat 5.8 pIC50 = 5.8 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 399 3 0 3 3.8 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
10069537 327527 0 None None None Rat 5.8 pIC50 = 5.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 399 3 0 3 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00077a002
CHEMBL420144 327527 0 None None None Rat 5.8 pIC50 = 5.8 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 399 3 0 3 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00077a002
10054203 236875 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 593 8 0 6 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CCCn3ccnc3)C1=O)C2 10.1021/jm00077a002
CHEMBL340388 236875 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 593 8 0 6 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CCCn3ccnc3)C1=O)C2 10.1021/jm00077a002
CHEMBL338020 486996 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 755 6 5 7 1.9 CC(C)C[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
CHEMBL340479 487026 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 766 8 2 6 3.6 C=CCN1C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H]1Cc1ccccc1 10.1021/jm00099a019
10436274 198767 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 507 5 1 4 4.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1ccncc1)C2 10.1021/jm00077a002
CHEMBL276079 198767 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 507 5 1 4 4.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1ccncc1)C2 10.1021/jm00077a002
44351071 43881 0 None None None Rat 5.7 pIC50 = 5.7 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(F)ccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
CHEMBL130351 43881 0 None None None Rat 5.7 pIC50 = 5.7 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(F)ccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
44351053 237264 0 None None None Rat 5.7 pIC50 = 5.7 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(F)cc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
CHEMBL341274 237264 0 None None None Rat 5.7 pIC50 = 5.7 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(F)cc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
CHEMBL2370761 485613 0 None None None Human 4.7 pIC50 = 4.7 Binding
Binding affinity towards oxytocin receptorBinding affinity towards oxytocin receptor
ChEMBL 1089 10 11 15 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H]([C@H](C)c2c(C)cc(OC)cc2C)NC(=O)[C@H](N)C(C)(C)SSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm0303103
CHEMBL2112249 485097 2 None None None Rat 8.7 pIC50 = 8.7 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 766 6 4 7 2.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
11764710 235356 0 None None None Rat 8.7 pIC50 = 8.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 638 11 4 6 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL336082 235356 0 None None None Rat 8.7 pIC50 = 8.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 638 11 4 6 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
10078034 236315 0 None None None Rat 8.6 pIC50 = 8.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 652 11 3 7 2.3 Cn1cncc1CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL339929 236315 0 None None None Rat 8.6 pIC50 = 8.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 652 11 3 7 2.3 Cn1cncc1CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
14981578 160373 0 None None None Rat 8.6 pIC50 = 8.6 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 638 11 2 8 2.3 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCOCC2)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112897 160373 0 None None None Rat 8.6 pIC50 = 8.6 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 638 11 2 8 2.3 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCOCC2)C3(C)C)CC1 10.1021/jm00031a004
10483586 44546 0 None None None Rat 8.6 pIC50 = 8.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 591 7 1 6 2.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CCS(C)(=O)=O)C1=O)C2 10.1021/jm00077a002
CHEMBL130891 44546 0 None None None Rat 8.6 pIC50 = 8.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 591 7 1 6 2.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CCS(C)(=O)=O)C1=O)C2 10.1021/jm00077a002
2042 8014 41 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.ejmech.2006.12.016
2176 8014 41 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.ejmech.2006.12.016
439302 8014 41 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.ejmech.2006.12.016
CHEMBL395429 8014 41 None None None Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.ejmech.2006.12.016
71450903 160377 0 None None None Rat 8.6 pIC50 = 8.6 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 614 12 3 9 0.8 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(CO)CO)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112901 160377 0 None None None Rat 8.6 pIC50 = 8.6 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 614 12 3 9 0.8 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(CO)CO)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112651 485103 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 779 6 3 6 3.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44273259 155213 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 1 6 2.5 CN(CCO)C1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20171 155213 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 1 6 2.5 CN(CCO)C1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44273355 156615 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 587 8 0 6 3.9 CN(C)CCSC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20319 156615 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 587 8 0 6 3.9 CN(C)CCSC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44273426 158748 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 2 6 2.6 C[C@H](CO)NC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20757 158748 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 2 6 2.6 C[C@H](CO)NC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44272990 199743 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
44273369 199743 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL283524 199743 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL283994 199743 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
44352164 42753 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 4 1 5 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C3CC(O)CN3C1=O)C2 10.1021/jm00077a002
CHEMBL128383 42753 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 4 1 5 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C3CC(O)CN3C1=O)C2 10.1021/jm00077a002
CHEMBL339118 487010 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 740 6 2 6 3.1 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44273077 199110 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
44273316 199110 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL279022 199110 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL281361 199110 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
44352165 237351 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 552 7 3 6 1.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CS(N)(=O)=O)C2 10.1021/jm00077a002
CHEMBL341507 237351 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 552 7 3 6 1.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CS(N)(=O)=O)C2 10.1021/jm00077a002
44350916 232105 0 None None None Rat 5.7 pIC50 = 5.7 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 1 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCCc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL340102 232105 0 None None None Rat 5.7 pIC50 = 5.7 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 1 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCCc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
44352496 43411 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 4 1 5 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C3CCC(=N)N3C1=O)C2 10.1021/jm00077a002
CHEMBL129983 43411 0 None None None Rat 7.7 pIC50 = 7.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 4 1 5 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C3CCC(=N)N3C1=O)C2 10.1021/jm00077a002
10391259 42755 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 5 1 4 3.3 CNC1CCN([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
CHEMBL128388 42755 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 5 1 4 3.3 CNC1CCN([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
44342196 220380 0 None None None Rat 4.7 pIC50 = 4.7 Binding
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 428 6 0 7 5.1 COc1cc(C)cc2c1Oc1ccc([C@H](CC(C)C)OC(C)=O)c(OC)c1C(=O)OC2 10.1016/S0960-894X(01)80905-7
CHEMBL326085 220380 0 None None None Rat 4.7 pIC50 = 4.7 Binding
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 428 6 0 7 5.1 COc1cc(C)cc2c1Oc1ccc([C@H](CC(C)C)OC(C)=O)c(OC)c1C(=O)OC2 10.1016/S0960-894X(01)80905-7
CHEMBL339450 487016 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 766 8 4 7 2.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10007685 198858 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 548 7 2 4 4.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1ccccc1)C2 10.1021/jm00077a002
CHEMBL276906 198858 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 548 7 2 4 4.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1ccccc1)C2 10.1021/jm00077a002
10052134 236769 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 6 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1nnn[nH]1)C2 10.1021/jm00077a002
CHEMBL340334 236769 0 None None None Rat 6.7 pIC50 = 6.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 6 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1nnn[nH]1)C2 10.1021/jm00077a002
44350954 42233 0 None None None Rat 5.7 pIC50 = 5.7 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
CHEMBL127118 42233 0 None None None Rat 5.7 pIC50 = 5.7 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
44350850 235908 0 None None None Rat 5.7 pIC50 = 5.7 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 375 6 1 3 3.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)NCCC1CCc3ccccc31)C(=O)C2 10.1021/jm00099a020
CHEMBL339093 235908 0 None None None Rat 5.7 pIC50 = 5.7 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 375 6 1 3 3.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)NCCC1CCc3ccccc31)C(=O)C2 10.1021/jm00099a020
10386343 42776 0 None None None Rat 5.7 pIC50 = 5.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00077a002
CHEMBL128497 42776 0 None None None Rat 5.7 pIC50 = 5.7 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00077a002
10315031 237145 0 None None None Rat 4.7 pIC50 = 4.7 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 337 2 0 1 5.3 O=C(CC1CCCCCCC1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL341021 237145 0 None None None Rat 4.7 pIC50 = 4.7 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 337 2 0 1 5.3 O=C(CC1CCCCCCC1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
10393977 333197 0 None None None Rat 7.6 pIC50 = 7.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 611 10 3 5 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)N(CCC(=O)O)CCc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL435409 333197 0 None None None Rat 7.6 pIC50 = 7.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 611 10 3 5 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)N(CCC(=O)O)CCc1c[nH]cn1)C2 10.1021/jm00077a002
44351231 43288 0 None None None Rat 5.6 pIC50 = 5.6 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 0 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(F)cc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL129498 43288 0 None None None Rat 5.6 pIC50 = 5.6 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 0 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(F)cc43)CC1)C(=O)C2 10.1021/jm00099a020
44351156 235747 0 None None None Rat 5.6 pIC50 = 5.6 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 0 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(F)ccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL338170 235747 0 None None None Rat 5.6 pIC50 = 5.6 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 0 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(F)ccc43)CC1)C(=O)C2 10.1021/jm00099a020
44273459 155610 0 None None None Rat 6.6 pIC50 = 6.6 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 482 4 0 4 3.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C=CC1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL20205 155610 0 None None None Rat 6.6 pIC50 = 6.6 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 482 4 0 4 3.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C=CC1=O)C2 10.1016/0960-894X(94)00469-V
10459672 236333 0 None None None Rat 6.6 pIC50 = 6.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 1 5 4.0 CCOC(=O)CCC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL340016 236333 0 None None None Rat 6.6 pIC50 = 6.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 1 5 4.0 CCOC(=O)CCC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44351226 232116 0 None None None Rat 5.6 pIC50 = 5.6 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 399 3 0 3 3.8 CC1(C)C2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL341267 232116 0 None None None Rat 5.6 pIC50 = 5.6 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 399 3 0 3 3.8 CC1(C)C2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL126765 484594 0 None None None Rat 7.6 pIC50 = 7.6 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 781 9 5 8 2.0 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCN)NC(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
44429294 333024 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1184 18 9 14 0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)N3Cc4ccccc4C[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL434193 333024 0 None None None Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1184 18 9 14 0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)N3Cc4ccccc4C[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44273473 144997 0 None None None Rat 7.6 pIC50 = 7.6 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 542 5 0 6 3.2 CC(=O)OC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20002 144997 0 None None None Rat 7.6 pIC50 = 7.6 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 542 5 0 6 3.2 CC(=O)OC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
10369423 327749 0 None None None Rat 6.6 pIC50 = 6.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 520 6 1 3 4.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1ccccc1)C2 10.1021/jm00077a002
CHEMBL435815 327749 0 None None None Rat 6.6 pIC50 = 6.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 520 6 1 3 4.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1ccccc1)C2 10.1021/jm00077a002
44351087 232076 0 None None None Rat 5.6 pIC50 = 5.6 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL338336 232076 0 None None None Rat 5.6 pIC50 = 5.6 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL338221 486998 0 None None None Rat 4.6 pIC50 = 4.6 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 754 6 1 6 3.4 CC[C@H](C)[C@H]1C(=O)N2CCCC[C@@H]2C(=O)N2CCCC[C@H]2C(=O)N(C)[C@H](Cc2ccccc2)C(=O)N2CCC[C@H]2C(=O)N[C@H](Cc2ccccc2)C(=O)N1C 10.1021/jm00099a019
10391520 44394 0 None None None Rat 6.6 pIC50 = 6.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 507 5 1 4 4.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1cccnc1)C2 10.1021/jm00077a002
CHEMBL130770 44394 0 None None None Rat 6.6 pIC50 = 6.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 507 5 1 4 4.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1cccnc1)C2 10.1021/jm00077a002
44352363 235192 0 None None None Rat 7.6 pIC50 = 7.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 626 6 2 6 3.7 COC(=O)[N+]12CCC(CC1)C(C(=O)NC[C@@]1(O)C[C@H]3CC[C@]1(CS(=O)(=O)N1CCC4(C=Cc5ccccc54)CC1)C3(C)C)C2 10.1021/jm00077a002
CHEMBL335886 235192 0 None None None Rat 7.6 pIC50 = 7.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 626 6 2 6 3.7 COC(=O)[N+]12CCC(CC1)C(C(=O)NC[C@@]1(O)C[C@H]3CC[C@]1(CS(=O)(=O)N1CCC4(C=Cc5ccccc54)CC1)C3(C)C)C2 10.1021/jm00077a002
11756226 45791 0 None None None Rat 6.6 pIC50 = 6.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 514 5 1 4 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CCC1C(=O)O)C2 10.1021/jm00077a002
CHEMBL132064 45791 0 None None None Rat 6.6 pIC50 = 6.6 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 514 5 1 4 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CCC1C(=O)O)C2 10.1021/jm00077a002
CHEMBL129414 484607 0 None None None Rat 5.6 pIC50 = 5.6 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 714 6 2 6 2.5 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10459923 235261 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 539 5 1 4 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CN3CCC1CC3)C2 10.1021/jm00077a002
CHEMBL335944 235261 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 539 5 1 4 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CN3CCC1CC3)C2 10.1021/jm00077a002
10415322 332953 0 None None None Rat 8.5 pIC50 = 8.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 556 7 2 5 2.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CCC(N)=O)C1=O)C2 10.1021/jm00077a002
CHEMBL433662 332953 0 None None None Rat 8.5 pIC50 = 8.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 556 7 2 5 2.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CCC(N)=O)C1=O)C2 10.1021/jm00077a002
10393965 45889 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 610 7 3 8 2.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CC(=O)Nc3nn[nH]n3)C1=O)C2 10.1021/jm00077a002
CHEMBL132157 45889 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 610 7 3 8 2.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CC(=O)Nc3nn[nH]n3)C1=O)C2 10.1021/jm00077a002
10392579 235593 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 6 1 5 3.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(CC(=O)O)C1=O)C2 10.1021/jm00077a002
CHEMBL337221 235593 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 6 1 5 3.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(CC(=O)O)C1=O)C2 10.1021/jm00077a002
44352481 235886 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 621 11 1 6 3.8 CCN(CC)C(CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL338951 235886 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 621 11 1 6 3.8 CCN(CC)C(CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
9984805 235922 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 7 2 4 4.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCC1CCCNC1)C2 10.1021/jm00077a002
CHEMBL339155 235922 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 7 2 4 4.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCC1CCCNC1)C2 10.1021/jm00077a002
10053396 234103 0 None None None Rat 6.5 pIC50 = 6.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 554 8 3 7 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)Cc1nnn[nH]1)C2 10.1021/jm00077a002
CHEMBL334332 234103 0 None None None Rat 6.5 pIC50 = 6.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 554 8 3 7 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)Cc1nnn[nH]1)C2 10.1021/jm00077a002
137485426 405655 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 496 3 0 7 4.9 CCOC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3ccc(F)cn3)C4)nnc2C1C nan
CHEMBL5747690 405655 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 496 3 0 7 4.9 CCOC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3ccc(F)cn3)C4)nnc2C1C nan
137485564 405962 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 542 4 0 7 5.6 CC1c2nnc(C3CC4(C3)CN(c3ccc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)OC(C)(C)CF nan
CHEMBL5750443 405962 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 542 4 0 7 5.6 CC1c2nnc(C3CC4(C3)CN(c3ccc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)OC(C)(C)CF nan
137357530 406425 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 508 3 0 7 5.0 CC1c2nnc(C3CC4(C3)CN(c3ccc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)OC1CC1 nan
CHEMBL5754963 406425 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 508 3 0 7 5.0 CC1c2nnc(C3CC4(C3)CN(c3ccc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)OC1CC1 nan
137485144 409231 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 489 2 0 6 4.6 O=C(N1Cc2cc(Cl)ccc2-c2c(C3CC4(C3)CN(c3cccnn3)C4)noc2C1)C(F)(F)F nan
CHEMBL5783623 409231 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 489 2 0 6 4.6 O=C(N1Cc2cc(Cl)ccc2-c2c(C3CC4(C3)CN(c3cccnn3)C4)noc2C1)C(F)(F)F nan
137484998 410615 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 532 5 0 7 4.6 O=C(OC(CF)CF)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccc(F)cn2)C3)C1 nan
CHEMBL5798429 410615 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 532 5 0 7 4.6 O=C(OC(CF)CF)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccc(F)cn2)C3)C1 nan
137485029 413448 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 482 3 0 7 4.3 CCOC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccc(F)cn2)C3)C1 nan
CHEMBL5829896 413448 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 482 3 0 7 4.3 CCOC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccc(F)cn2)C3)C1 nan
137485455 413454 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 492 3 0 6 4.6 CC1c2nnc(C3CC4(C3)CN(c3ccccn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)C1(F)CC1 nan
CHEMBL5829963 413454 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 492 3 0 6 4.6 CC1c2nnc(C3CC4(C3)CN(c3ccccn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)C1(F)CC1 nan
137485333 427110 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 512 3 0 6 5.0 CC1c2nnc(C3CC4(C3)CN(c3ccc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)C(C)(C)F nan
CHEMBL5872268 427110 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 512 3 0 6 5.0 CC1c2nnc(C3CC4(C3)CN(c3ccc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)C(C)(C)F nan
137485199 427154 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 493 3 0 8 4.5 CC(C)OC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3cnccn3)C4)nnc2C1C nan
CHEMBL5872742 427154 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 493 3 0 8 4.5 CC(C)OC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3cnccn3)C4)nnc2C1C nan
137485194 427433 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 510 3 0 7 5.3 CC(C)OC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3ccc(F)cn3)C4)nnc2C1C nan
CHEMBL5875761 427433 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 510 3 0 7 5.3 CC(C)OC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3ccc(F)cn3)C4)nnc2C1C nan
137484973 431151 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 494 3 0 7 4.5 O=C(OC1CC1)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccc(F)cn2)C3)C1 nan
CHEMBL5914733 431151 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 494 3 0 7 4.5 O=C(OC1CC1)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccc(F)cn2)C3)C1 nan
137485004 431494 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 478 3 0 7 4.6 CC(C)OC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2cccnc2)C3)C1 nan
CHEMBL5918284 431494 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 478 3 0 7 4.6 CC(C)OC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2cccnc2)C3)C1 nan
137485329 432207 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 478 2 0 7 4.7 COC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3cccc(C)n3)C4)nnc2C1C nan
CHEMBL5925462 432207 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 478 2 0 7 4.7 COC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3cccc(C)n3)C4)nnc2C1C nan
137485282 445178 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 546 5 0 7 5.2 CC1c2nnc(C3CC4(C3)CN(c3ccc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)OC(CF)CF nan
CHEMBL5958710 445178 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 546 5 0 7 5.2 CC1c2nnc(C3CC4(C3)CN(c3ccc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)OC(CF)CF nan
137484991 445375 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 496 3 0 7 4.7 CC(C)OC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccc(F)cn2)C3)C1 nan
CHEMBL5960656 445375 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 496 3 0 7 4.7 CC(C)OC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccc(F)cn2)C3)C1 nan
137485107 447239 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 517 3 0 8 5.0 CC(C)OC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3cccc(C#N)n3)C4)nnc2C1C nan
CHEMBL5981302 447239 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 517 3 0 8 5.0 CC(C)OC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3cccc(C#N)n3)C4)nnc2C1C nan
137485118 447598 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 514 4 0 7 4.6 CC(CF)OC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccc(F)cn2)C3)C1 nan
CHEMBL5985111 447598 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 514 4 0 7 4.6 CC(CF)OC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccc(F)cn2)C3)C1 nan
137485305 448665 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 523 3 0 8 4.8 CC1c2nnc(C3CC4(C3)CN(c3ncc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)OC1(C)CC1 nan
CHEMBL5996010 448665 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 523 3 0 8 4.8 CC1c2nnc(C3CC4(C3)CN(c3ncc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)OC1(C)CC1 nan
137485053 449039 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 510 3 0 6 4.7 CC1c2nnc(C3CC4(C3)CN(c3ccc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)C1(F)CC1 nan
CHEMBL6000224 449039 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 510 3 0 6 4.7 CC1c2nnc(C3CC4(C3)CN(c3ccc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)C1(F)CC1 nan
137485083 463429 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 483 2 0 8 3.9 COC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3ncncc3F)C4)nnc2C1C nan
CHEMBL6049639 463429 0 None None None Human 6.5 pIC50 = 6.5 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 483 2 0 8 3.9 COC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3ncncc3F)C4)nnc2C1C nan
10407141 40882 0 None None None Rat 5.5 pIC50 = 5.5 Binding
Compound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissueCompound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissue
ChEMBL 375 2 0 2 4.6 O=S(=O)(c1ccc2ccccc2c1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL125406 40882 0 None None None Rat 5.5 pIC50 = 5.5 Binding
Compound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissueCompound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissue
ChEMBL 375 2 0 2 4.6 O=S(=O)(c1ccc2ccccc2c1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
44351225 41884 0 None None None Rat 5.5 pIC50 = 5.5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 403 3 1 3 3.5 CC1(C)C2CC[C@](CS(=O)(=O)N3CCC4(CCc5ccccc54)CC3)(C2)C1O 10.1021/jm00099a020
CHEMBL126371 41884 0 None None None Rat 5.5 pIC50 = 5.5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 403 3 1 3 3.5 CC1(C)C2CC[C@](CS(=O)(=O)N3CCC4(CCc5ccccc54)CC3)(C2)C1O 10.1021/jm00099a020
10068542 41919 0 None None None Rat 5.5 pIC50 = 5.5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 383 3 0 4 3.2 COC(=O)c1ccccc1S(=O)(=O)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL126565 41919 0 None None None Rat 5.5 pIC50 = 5.5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 383 3 0 4 3.2 COC(=O)c1ccccc1S(=O)(=O)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
44351265 236910 0 None None None Rat 5.5 pIC50 = 5.5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 486 5 1 4 3.4 CC(C)C(=O)NC1C(=O)[C@]2(CS(=O)(=O)N3CCC4(CCc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
CHEMBL340589 236910 0 None None None Rat 5.5 pIC50 = 5.5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 486 5 1 4 3.4 CC(C)C(=O)NC1C(=O)[C@]2(CS(=O)(=O)N3CCC4(CCc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
CHEMBL2112656 485106 0 None None None Rat 4.5 pIC50 = 4.5 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 698 4 2 6 2.1 C[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10250542 232031 0 None None None Rat 4.5 pIC50 = 4.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 402 3 1 3 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N)C2 10.1021/jm00077a002
CHEMBL335170 232031 0 None None None Rat 4.5 pIC50 = 4.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 402 3 1 3 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N)C2 10.1021/jm00077a002
10416272 214451 4 None None None Rat 5.5 pIC50 = 5.5 Binding
Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL31065 214451 4 None None None Rat 5.5 pIC50 = 5.5 Binding
Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
9983763 43239 0 None None None Rat 6.5 pIC50 = 6.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 508 7 1 4 3.8 CCCS(=O)(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL129234 43239 0 None None None Rat 6.5 pIC50 = 6.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 508 7 1 4 3.8 CCCS(=O)(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44272960 145473 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 527 6 1 5 3.2 CCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20126 145473 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 527 6 1 5 3.2 CCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44352311 42809 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 638 11 4 6 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)CCC(N)=O)C2 10.1021/jm00077a002
CHEMBL128652 42809 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 638 11 4 6 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)CCC(N)=O)C2 10.1021/jm00077a002
10100280 197144 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 610 9 0 7 3.9 COC(=O)CCN(C(=O)Cc1cn(C)cn1)[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL265073 197144 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 610 9 0 7 3.9 COC(=O)CCN(C(=O)Cc1cn(C)cn1)[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10392298 235699 0 None None None Rat 6.5 pIC50 = 6.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 532 8 2 6 2.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CC[N+](=O)[O-])C2 10.1021/jm00077a002
CHEMBL337888 235699 0 None None None Rat 6.5 pIC50 = 6.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 532 8 2 6 2.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CC[N+](=O)[O-])C2 10.1021/jm00077a002
CHEMBL129733 484608 0 None None None Rat 6.5 pIC50 = 6.5 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 726 6 3 6 2.7 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44350982 42065 0 None None None Rat 6.5 pIC50 = 6.5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 403 3 1 3 3.5 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL126999 42065 0 None None None Rat 6.5 pIC50 = 6.5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 403 3 1 3 3.5 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL52813 489209 0 None None None Rat 5.5 pIC50 = 5.5 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 712 6 2 6 2.3 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O 10.1021/jm00099a019
44268726 197677 0 None None None Rat 5.5 pIC50 = 5.5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 427 3 0 3 4.4 CC1(C)C(=O)[C@]2(CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
CHEMBL269624 197677 0 None None None Rat 5.5 pIC50 = 5.5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 427 3 0 3 4.4 CC1(C)C(=O)[C@]2(CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
44351266 237056 0 None None None Rat 5.5 pIC50 = 5.5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 458 4 1 4 2.8 CC(=O)NC1C(=O)[C@]2(CS(=O)(=O)N3CCC4(CCc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
CHEMBL340920 237056 0 None None None Rat 5.5 pIC50 = 5.5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 458 4 1 4 2.8 CC(=O)NC1C(=O)[C@]2(CS(=O)(=O)N3CCC4(CCc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
10029477 44560 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 514 5 2 5 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CN)C1=O)C2 10.1021/jm00077a002
CHEMBL130905 44560 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 514 5 2 5 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CN)C1=O)C2 10.1021/jm00077a002
44352412 234438 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1ccncc1)C2 10.1021/jm00077a002
CHEMBL335182 234438 0 None None None Rat 7.5 pIC50 = 7.5 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1ccncc1)C2 10.1021/jm00077a002
44351232 44295 0 None None None Rat 6.5 pIC50 = 6.5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 473 5 1 5 3.5 COC(=O)C[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
CHEMBL130695 44295 0 None None None Rat 6.5 pIC50 = 6.5 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 473 5 1 5 3.5 COC(=O)C[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
3537 8682 25 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1016/j.bmcl.2007.08.053
5311500 8682 25 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1016/j.bmcl.2007.08.053
CHEMBL363910 8682 25 None None None Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1016/j.bmcl.2007.08.053
10393379 44028 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 576 6 1 5 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3cccnc3)C1=O)C2 10.1021/jm00077a002
CHEMBL130476 44028 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 576 6 1 5 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3cccnc3)C1=O)C2 10.1021/jm00077a002
CHEMBL2370768 485614 0 None None None Human 4.4 pIC50 = 4.4 Binding
Binding affinity towards oxytocin receptorBinding affinity towards oxytocin receptor
ChEMBL 1089 10 11 15 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H]([C@@H](C)c2c(C)cc(OC)cc2C)NC(=O)[C@H](N)C(C)(C)SSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm0303103
10030575 45952 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 554 5 2 4 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)NC1CN3CCC1CC3)C2 10.1021/jm00077a002
CHEMBL132210 45952 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 554 5 2 4 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)NC1CN3CCC1CC3)C2 10.1021/jm00077a002
44351052 41259 0 None None None Rat 5.4 pIC50 = 5.4 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.0 CC1CN(S(=O)(=O)C[C@]23CCC(CC2=O)C3(C)C)CCC12C=Cc1ccccc12 10.1021/jm00099a020
CHEMBL125748 41259 0 None None None Rat 5.4 pIC50 = 5.4 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.0 CC1CN(S(=O)(=O)C[C@]23CCC(CC2=O)C3(C)C)CCC12C=Cc1ccccc12 10.1021/jm00099a020
44352123 236918 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 566 8 3 6 1.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CCS(N)(=O)=O)C2 10.1021/jm00077a002
CHEMBL340639 236918 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 566 8 3 6 1.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CCS(N)(=O)=O)C2 10.1021/jm00077a002
16737617 197207 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
16737618 197207 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL265630 197207 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL415418 197207 0 None None None Human 6.4 pIC50 = 6.4 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
10366192 235590 0 None None None Rat 6.4 pIC50 = 6.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 444 4 1 3 3.6 CC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL337212 235590 0 None None None Rat 6.4 pIC50 = 6.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 444 4 1 3 3.6 CC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44351229 232075 0 None None None Rat 5.4 pIC50 = 5.4 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
CHEMBL338324 232075 0 None None None Rat 5.4 pIC50 = 5.4 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
44352433 236125 0 None None None Rat 8.4 pIC50 = 8.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 622 10 3 7 1.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(CCS(C)(=O)=O)NC(=O)CN)C2 10.1021/jm00077a002
CHEMBL339498 236125 0 None None None Rat 8.4 pIC50 = 8.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 622 10 3 7 1.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(CCS(C)(=O)=O)NC(=O)CN)C2 10.1021/jm00077a002
10346739 235892 0 None None None Rat 8.4 pIC50 = 8.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 5 0 5 3.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CC#N)C1=O)C2 10.1021/jm00077a002
CHEMBL338984 235892 0 None None None Rat 8.4 pIC50 = 8.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 5 0 5 3.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CC#N)C1=O)C2 10.1021/jm00077a002
9893887 97049 2 None None None Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)CC23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1016/j.bmc.2020.115546
CHEMBL154668 97049 2 None None None Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)CC23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1016/j.bmc.2020.115546
14981575 160372 0 None None None Rat 8.3 pIC50 = 8.3 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 582 10 1 7 2.1 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(C)C)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112896 160372 0 None None None Rat 8.3 pIC50 = 8.3 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 582 10 1 7 2.1 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(C)C)C3(C)C)CC1 10.1021/jm00031a004
44352492 42827 0 None None None Rat 8.3 pIC50 = 8.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 593 9 1 6 3.0 CN(C)C(CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL128749 42827 0 None None None Rat 8.3 pIC50 = 8.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 593 9 1 6 3.0 CN(C)C(CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44429298 294154 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1033 19 10 14 -1.5 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL393020 294154 0 None None None Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1033 19 10 14 -1.5 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44273321 332274 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 542 7 2 6 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCCN)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL429971 332274 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 542 7 2 6 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCCN)C1=O)C2 10.1016/0960-894X(94)00469-V
71449094 160290 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 581 8 3 7 1.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@](O)(CNC(=O)C(N)CS(C)(=O)=O)C2 10.1021/jm00077a002
CHEMBL2112663 160290 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 581 8 3 7 1.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@](O)(CNC(=O)C(N)CS(C)(=O)=O)C2 10.1021/jm00077a002
9797987 237306 1 None None None Rat 5.4 pIC50 = 5.4 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 339 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
CHEMBL341490 237306 1 None None None Rat 5.4 pIC50 = 5.4 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 339 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
CHEMBL2112655 485105 0 None None None Rat 6.4 pIC50 = 6.4 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 707 8 4 7 1.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCCCN)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10323799 235515 0 None None None Rat 6.4 pIC50 = 6.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 502 7 2 4 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCC(=O)O)C2 10.1021/jm00077a002
CHEMBL336742 235515 0 None None None Rat 6.4 pIC50 = 6.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 502 7 2 4 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCC(=O)O)C2 10.1021/jm00077a002
44352373 46150 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 543 8 3 5 3.4 CC(C)C[C@H](N)C(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL132389 46150 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 543 8 3 5 3.4 CC(C)C[C@H](N)C(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
11757440 235803 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 556 7 1 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(CCC(=O)O)C1=O)C2 10.1021/jm00077a002
CHEMBL338503 235803 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 556 7 1 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(CCC(=O)O)C1=O)C2 10.1021/jm00077a002
44352374 42388 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 529 7 3 5 3.0 CC(C)[C@H](N)C(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL127445 42388 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 529 7 3 5 3.0 CC(C)[C@H](N)C(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44273034 199276 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 2 6 2.3 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCC(=O)O)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL280356 199276 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 2 6 2.3 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCC(=O)O)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL340204 487025 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 807 10 4 7 3.5 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cccc3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCCN)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44352431 42762 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 7 3 5 3.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL128417 42762 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 7 3 5 3.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
10257352 160035 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 8 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
10483039 160035 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 8 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
CHEMBL2111851 160035 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 8 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
CHEMBL2112666 160035 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 8 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
10347314 235801 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 8 2 4 4.9 CCC(C)(C)C(=O)NCC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL338499 235801 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 8 2 4 4.9 CCC(C)(C)C(=O)NCC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44352443 237270 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 539 7 3 5 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL341311 237270 0 None None None Rat 7.4 pIC50 = 7.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 539 7 3 5 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)Cc1c[nH]cn1)C2 10.1021/jm00077a002
44352299 235691 0 None None None Rat 6.4 pIC50 = 6.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 416 3 1 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)/C(=N\O)C2 10.1021/jm00077a002
CHEMBL337842 235691 0 None None None Rat 6.4 pIC50 = 6.4 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 416 3 1 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)/C(=N\O)C2 10.1021/jm00077a002
44351210 236156 0 None None None Rat 5.4 pIC50 = 5.4 Binding
Compound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissueCompound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissue
ChEMBL 557 3 0 3 5.0 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CC1)c1ccccc1C(Br)C3Br)C(=O)C2 10.1021/jm00099a020
CHEMBL339698 236156 0 None None None Rat 5.4 pIC50 = 5.4 Binding
Compound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissueCompound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissue
ChEMBL 557 3 0 3 5.0 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CC1)c1ccccc1C(Br)C3Br)C(=O)C2 10.1021/jm00099a020
44352124 235916 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 7 2 5 3.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CCC#N)C2 10.1021/jm00077a002
CHEMBL339124 235916 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 7 2 5 3.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CCC#N)C2 10.1021/jm00077a002
44351215 236562 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 477 4 1 3 5.1 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(c1ccccc1)C2 10.1021/jm00099a020
CHEMBL340153 236562 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 477 4 1 3 5.1 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(c1ccccc1)C2 10.1021/jm00099a020
10321314 236561 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 445 4 2 3 3.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(N)=O)C2 10.1021/jm00077a002
CHEMBL340150 236561 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 445 4 2 3 3.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(N)=O)C2 10.1021/jm00077a002
10030575 45952 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 554 5 2 4 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)NC1CN3CCC1CC3)C2 10.1021/jm00077a002
CHEMBL132210 45952 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 554 5 2 4 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)NC1CN3CCC1CC3)C2 10.1021/jm00077a002
44351034 232074 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL338318 232074 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
10046632 232009 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00077a002
CHEMBL334953 232009 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00077a002
10370147 42713 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 543 6 1 5 2.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CC(=O)O)C1=O)C2 10.1021/jm00077a002
CHEMBL128163 42713 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 543 6 1 5 2.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CC(=O)O)C1=O)C2 10.1021/jm00077a002
10369550 237275 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 6 1 5 3.6 Cn1cncc1CC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL341338 237275 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 6 1 5 3.6 Cn1cncc1CC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44352473 236077 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 606 7 2 4 5.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)CC13CC4CC(CC(C4)C1)C3)C2 10.1021/jm00077a002
CHEMBL339464 236077 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 606 7 2 4 5.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)CC13CC4CC(CC(C4)C1)C3)C2 10.1021/jm00077a002
44429303 294155 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1007 20 11 14 -1.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL393021 294155 0 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1007 20 11 14 -1.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44352171 44665 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 7 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)C1=CCC(=O)N=C1)C2 10.1021/jm00077a002
CHEMBL130993 44665 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 7 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)C1=CCC(=O)N=C1)C2 10.1021/jm00077a002
44352442 328436 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 567 8 2 5 3.5 CN(C)[C@H](Cc1c[nH]cn1)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL419973 328436 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 567 8 2 5 3.5 CN(C)[C@H](Cc1c[nH]cn1)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10460610 337143 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 567 6 1 7 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(Cc3nn[nH]n3)C1=O)C2 10.1021/jm00077a002
CHEMBL449399 337143 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 567 6 1 7 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(Cc3nn[nH]n3)C1=O)C2 10.1021/jm00077a002
9986160 236217 0 None None None Rat 8.2 pIC50 = 8.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 608 7 2 6 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CC(=O)Nc3ncc[nH]3)C1=O)C2 10.1021/jm00077a002
CHEMBL339768 236217 0 None None None Rat 8.2 pIC50 = 8.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 608 7 2 6 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CC(=O)Nc3ncc[nH]3)C1=O)C2 10.1021/jm00077a002
44352347 235693 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 540 6 4 7 2.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1n[nH]c(N)n1)C2 10.1021/jm00077a002
CHEMBL337853 235693 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 540 6 4 7 2.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1n[nH]c(N)n1)C2 10.1021/jm00077a002
11757133 235813 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 543 6 2 5 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CC(=O)O)C1=O)C2 10.1021/jm00077a002
CHEMBL338548 235813 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 543 6 2 5 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CC(=O)O)C1=O)C2 10.1021/jm00077a002
44352146 236069 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 513 5 2 5 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CN1C(=O)CNC1=O)C2 10.1021/jm00077a002
CHEMBL339433 236069 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 513 5 2 5 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CN1C(=O)CNC1=O)C2 10.1021/jm00077a002
10258572 236926 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 638 11 4 6 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CC(CC(N)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL340676 236926 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 638 11 4 6 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CC(CC(N)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
44342185 24364 0 None None None Rat 5.3 pIC50 = 5.3 Binding
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 456 6 0 8 5.0 COc1c([C@H](CC(C)C)OC(C)=O)ccc2c1C(=O)OCc1cc(C)cc(OC(C)=O)c1O2 10.1016/S0960-894X(01)80905-7
CHEMBL115277 24364 0 None None None Rat 5.3 pIC50 = 5.3 Binding
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 456 6 0 8 5.0 COc1c([C@H](CC(C)C)OC(C)=O)ccc2c1C(=O)OCc1cc(C)cc(OC(C)=O)c1O2 10.1016/S0960-894X(01)80905-7
10357626 237215 0 None None None Rat 5.3 pIC50 = 5.3 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 303 2 0 1 3.8 O=C(Cc1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL341077 237215 0 None None None Rat 5.3 pIC50 = 5.3 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 303 2 0 1 3.8 O=C(Cc1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
44429288 178241 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44429290 178241 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233328 178241 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL234377 178241 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL415417 488399 0 None None None Human 4.3 pIC50 = 4.3 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1022 16 13 15 -3.1 CC(C)C[C@H](NC(=O)[C@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(C)(C)C)C(=O)NCC(N)=O 10.1016/j.ejmech.2006.12.016
172997 4754 54 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.08.053
2238 4754 54 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.08.053
CHEMBL49429 4754 54 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.08.053
DB06666 4754 54 None None None Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.08.053
10436379 155022 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 510 6 2 4 3.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1c[nH]cn1)C2 10.1016/0960-894X(94)00469-V
CHEMBL20230 155022 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 510 6 2 4 3.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1c[nH]cn1)C2 10.1016/0960-894X(94)00469-V
10413997 4534 5 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 10.1021/jm00077a002
2246 4534 5 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 10.1021/jm00077a002
CHEMBL338522 4534 5 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 10.1021/jm00077a002
44352413 45311 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1cccnc1)C2 10.1021/jm00077a002
CHEMBL131551 45311 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1cccnc1)C2 10.1021/jm00077a002
10052855 235532 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 534 7 1 3 5.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCc1ccccc1)C2 10.1021/jm00077a002
CHEMBL336857 235532 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 534 7 1 3 5.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCc1ccccc1)C2 10.1021/jm00077a002
44352491 237052 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 8 2 5 2.7 C[S+]([O-])CCC(N)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL340915 237052 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 8 2 5 2.7 C[S+]([O-])CCC(N)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL127056 484595 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 726 6 2 6 2.7 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCN2C1=O 10.1021/jm00099a019
10046625 333106 0 None None None Rat 5.3 pIC50 = 5.3 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 5 0 4 3.5 CCOC(=O)C1(c2ccccc2)CCN(S(=O)(=O)c2ccc(C)cc2)CC1C 10.1021/jm00099a020
CHEMBL434825 333106 0 None None None Rat 5.3 pIC50 = 5.3 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 5 0 4 3.5 CCOC(=O)C1(c2ccccc2)CCN(S(=O)(=O)c2ccc(C)cc2)CC1C 10.1021/jm00099a020
44429304 178138 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1062 19 10 14 -0.7 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N3CCCC[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233080 178138 0 None None None Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1062 19 10 14 -0.7 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N3CCCC[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
10075696 44357 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 3 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCC(N)=O)C2 10.1021/jm00077a002
10256467 44357 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 3 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCC(N)=O)C2 10.1021/jm00077a002
CHEMBL130742 44357 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 3 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCC(N)=O)C2 10.1021/jm00077a002
CHEMBL131650 44357 0 None None None Rat 7.3 pIC50 = 7.3 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 3 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCC(N)=O)C2 10.1021/jm00077a002
44351092 42089 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(F)ccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL127016 42089 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(F)ccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
44351219 235950 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(F)cc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL339302 235950 0 None None None Rat 6.3 pIC50 = 6.3 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(F)cc43)CC1)[C@H](O)C2 10.1021/jm00099a020
44352392 235739 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 567 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C1CN3CCC1CC3)C2 10.1021/jm00077a002
CHEMBL338118 235739 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 567 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C1CN3CCC1CC3)C2 10.1021/jm00077a002
9984984 235797 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 548 8 1 3 5.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCCc1ccccc1)C2 10.1021/jm00077a002
CHEMBL338490 235797 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 548 8 1 3 5.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCCc1ccccc1)C2 10.1021/jm00077a002
9974603 42230 0 None None None Rat 5.2 pIC50 = 5.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 341 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(CCc4ccccc43)CC2)cc1 10.1021/jm00099a020
CHEMBL127117 42230 0 None None None Rat 5.2 pIC50 = 5.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 341 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(CCc4ccccc43)CC2)cc1 10.1021/jm00099a020
44352428 236001 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 515 7 2 4 4.0 CC(C)C[C@@H](N)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL339366 236001 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 515 7 2 4 4.0 CC(C)C[C@@H](N)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44350978 41552 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 1 3 3.8 C[C@@H]1C2CC[C@@](CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)([C@H]1O)C2(C)C 10.1021/jm00099a020
CHEMBL125847 41552 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 1 3 3.8 C[C@@H]1C2CC[C@@](CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)([C@H]1O)C2(C)C 10.1021/jm00099a020
CHEMBL2112248 485096 0 None None None Rat 8.2 pIC50 = 8.2 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 754 6 5 8 1.5 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
11764606 236211 0 None None None Rat 8.2 pIC50 = 8.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 630 9 0 7 3.3 Cn1cnc(CC(=O)N(CCS(C)(=O)=O)[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
CHEMBL339756 236211 0 None None None Rat 8.2 pIC50 = 8.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 630 9 0 7 3.3 Cn1cnc(CC(=O)N(CCS(C)(=O)=O)[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
10258045 42728 0 None None None Rat 8.2 pIC50 = 8.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 601 11 4 6 1.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CCN)C2 10.1021/jm00077a002
CHEMBL128219 42728 0 None None None Rat 8.2 pIC50 = 8.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 601 11 4 6 1.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CCN)C2 10.1021/jm00077a002
10461149 236130 0 None None None Rat 8.2 pIC50 = 8.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 596 7 4 8 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CNc3n[nH]c(N)n3)C1=O)C2 10.1021/jm00077a002
CHEMBL339524 236130 0 None None None Rat 8.2 pIC50 = 8.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 596 7 4 8 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CNc3n[nH]c(N)n3)C1=O)C2 10.1021/jm00077a002
10324965 43404 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 6 1 5 4.1 CC(C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C)c1cn(C)cn1 10.1021/jm00077a002
CHEMBL129971 43404 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 6 1 5 4.1 CC(C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C)c1cn(C)cn1 10.1021/jm00077a002
10480543 235438 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 485 4 1 4 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1CCC(N)C1=O)C2 10.1021/jm00077a002
CHEMBL336195 235438 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 485 4 1 4 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1CCC(N)C1=O)C2 10.1021/jm00077a002
44351264 43219 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 1 3 4.0 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@](C)(O)C2 10.1021/jm00099a020
CHEMBL129104 43219 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 1 3 4.0 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@](C)(O)C2 10.1021/jm00099a020
10021111 41849 3 None None None Rat 5.2 pIC50 = 5.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 355 3 0 3 3.4 COc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
CHEMBL126195 41849 3 None None None Rat 5.2 pIC50 = 5.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 355 3 0 3 3.4 COc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
10370127 42730 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 6 2 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CN1CC[C@H](N)C1=O)C2 10.1021/jm00077a002
CHEMBL128228 42730 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 6 2 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CN1CC[C@H](N)C1=O)C2 10.1021/jm00077a002
10460052 45953 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 544 8 2 5 2.3 CN(C)CC(=O)NCC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL132211 45953 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 544 8 2 5 2.3 CN(C)CC(=O)NCC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10255857 236219 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 5 1 4 5.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1cccs1)C2 10.1021/jm00077a002
CHEMBL339783 236219 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 5 1 4 5.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1cccs1)C2 10.1021/jm00077a002
44351057 41967 0 None None None Rat 5.2 pIC50 = 5.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.1 Cc1cccc2c1C1(C=C2)CCN(S(=O)(=O)C[C@]23CCC(CC2=O)C3(C)C)CC1 10.1021/jm00099a020
CHEMBL126824 41967 0 None None None Rat 5.2 pIC50 = 5.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.1 Cc1cccc2c1C1(C=C2)CCN(S(=O)(=O)C[C@]23CCC(CC2=O)C3(C)C)CC1 10.1021/jm00099a020
44351155 43299 0 None None None Rat 5.2 pIC50 = 5.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.1 Cc1cccc2c1C=CC21CCN(S(=O)(=O)C[C@]23CCC(CC2=O)C3(C)C)CC1 10.1021/jm00099a020
CHEMBL129581 43299 0 None None None Rat 5.2 pIC50 = 5.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.1 Cc1cccc2c1C=CC21CCN(S(=O)(=O)C[C@]23CCC(CC2=O)C3(C)C)CC1 10.1021/jm00099a020
44351235 235755 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 429 4 1 3 4.3 CC[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
CHEMBL338235 235755 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 429 4 1 3 4.3 CC[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
44273077 199110 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
44273316 199110 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL279022 199110 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL281361 199110 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
15011336 43241 0 None None None Rat 5.2 pIC50 = 5.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 359 3 0 3 3.1 O=C1CCCCC1CS(=O)(=O)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL129246 43241 0 None None None Rat 5.2 pIC50 = 5.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 359 3 0 3 3.1 O=C1CCCCC1CS(=O)(=O)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL419793 488423 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 796 10 5 7 2.8 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCCN)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10098332 46276 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 6 1 5 3.6 Cn1cnc(CC(=O)N[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
CHEMBL132496 46276 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 6 1 5 3.6 Cn1cnc(CC(=O)N[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
44352189 237299 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 414 3 1 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)/C(=N\O)C2 10.1021/jm00077a002
CHEMBL341470 237299 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 414 3 1 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)/C(=N\O)C2 10.1021/jm00077a002
10414067 333194 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 5 1 3 5.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CCCCC1)C2 10.1021/jm00077a002
CHEMBL435398 333194 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 5 1 3 5.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CCCCC1)C2 10.1021/jm00077a002
44351192 236892 0 None None None Rat 5.2 pIC50 = 5.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 430 3 0 4 2.7 CN1C(=O)C2(CCN(S(=O)(=O)C[C@]34CCC(CC3=O)C4(C)C)CC2)c2ccccc21 10.1021/jm00099a020
CHEMBL340465 236892 0 None None None Rat 5.2 pIC50 = 5.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 430 3 0 4 2.7 CN1C(=O)C2(CCN(S(=O)(=O)C[C@]34CCC(CC3=O)C4(C)C)CC2)c2ccccc21 10.1021/jm00099a020
10363767 43388 0 None None None Rat 5.2 pIC50 = 5.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 402 3 1 3 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](N)C2 10.1021/jm00077a002
CHEMBL129955 43388 0 None None None Rat 5.2 pIC50 = 5.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 402 3 1 3 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](N)C2 10.1021/jm00077a002
CHEMBL129089 484604 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 754 6 2 6 3.5 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
CHEMBL338981 487006 0 None None None Rat 6.2 pIC50 = 6.2 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 726 6 2 6 2.7 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
124213 220165 18 None None None Rat 4.2 pIC50 = 4.2 Binding
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 372 4 2 6 4.3 COc1c([C@@H](O)CC(C)C)ccc2c1C(=O)OCc1cc(C)cc(O)c1O2 10.1016/S0960-894X(01)80905-7
CHEMBL325752 220165 18 None None None Rat 4.2 pIC50 = 4.2 Binding
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 372 4 2 6 4.3 COc1c([C@@H](O)CC(C)C)ccc2c1C(=O)OCc1cc(C)cc(O)c1O2 10.1016/S0960-894X(01)80905-7
10324995 329279 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 539 7 3 4 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)NCCc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL421248 329279 0 None None None Rat 7.2 pIC50 = 7.2 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 539 7 3 4 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)NCCc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL395290 487787 0 None None None Human 8.2 pIC50 = 8.2 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1020 17 12 15 -3.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
44272997 143949 0 None None None Rat 8.2 pIC50 = 8.2 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
9805972 143949 0 None None None Rat 8.2 pIC50 = 8.2 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL19658 143949 0 None None None Rat 8.2 pIC50 = 8.2 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL276990 143949 0 None None None Rat 8.2 pIC50 = 8.2 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
44352455 333293 0 None None None Rat 8.1 pIC50 = 8.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 701 12 4 8 1.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C(CCS(C)(=O)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL436189 333293 0 None None None Rat 8.1 pIC50 = 8.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 701 12 4 8 1.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C(CCS(C)(=O)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
9997556 237245 0 None None None Rat 5.2 pIC50 = 5.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 343 2 0 2 3.6 O=S(=O)(c1ccc(F)cc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL341108 237245 0 None None None Rat 5.2 pIC50 = 5.2 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 343 2 0 2 3.6 O=S(=O)(c1ccc(F)cc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL405289 487856 0 None None None Rat 7.1 pIC50 = 7.1 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 755 7 5 7 2.1 CCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
CHEMBL435159 488611 0 None None None Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1068 17 12 15 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
11758421 199862 0 None None None Rat 6.1 pIC50 = 6.1 Binding
Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)
ChEMBL 609 6 1 8 4.1 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cnc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL284442 199862 0 None None None Rat 6.1 pIC50 = 6.1 Binding
Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)
ChEMBL 609 6 1 8 4.1 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cnc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL395430 487790 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 994 18 13 15 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
137357530 406425 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 508 3 0 7 5.0 CC1c2nnc(C3CC4(C3)CN(c3ccc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)OC1CC1 nan
CHEMBL5754963 406425 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 508 3 0 7 5.0 CC1c2nnc(C3CC4(C3)CN(c3ccc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)OC1CC1 nan
137485061 409182 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 456 4 0 6 4.3 FC(F)CN1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccccn2)C3)C1 nan
CHEMBL5783103 409182 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 456 4 0 6 4.3 FC(F)CN1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccccn2)C3)C1 nan
137485239 410767 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 482 2 0 7 4.5 COC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3ncccc3F)C4)nnc2C1C nan
CHEMBL5800135 410767 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 482 2 0 7 4.5 COC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3ncccc3F)C4)nnc2C1C nan
137484963 412090 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 432 3 0 6 4.2 Clc1ccc2c(c1)CN(C1CC1)Cc1nnc(C3CC4(C3)CN(c3ccccn3)C4)n1-2 nan
CHEMBL5815032 412090 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 432 3 0 6 4.2 Clc1ccc2c(c1)CN(C1CC1)Cc1nnc(C3CC4(C3)CN(c3ccccn3)C4)n1-2 nan
137485050 425997 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 464 3 0 6 4.7 Fc1ccc(N2CC3(CC(c4nnc5n4-c4ccc(Cl)cc4CN(C4CCC4)C5)C3)C2)nc1 nan
CHEMBL5859746 425997 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 464 3 0 6 4.7 Fc1ccc(N2CC3(CC(c4nnc5n4-c4ccc(Cl)cc4CN(C4CCC4)C5)C3)C2)nc1 nan
137484954 429118 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 468 2 0 7 3.9 COC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccc(F)cn2)C3)C1 nan
CHEMBL5894664 429118 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 468 2 0 7 3.9 COC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccc(F)cn2)C3)C1 nan
137485051 431213 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 479 3 0 8 4.1 CCOC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3ncccn3)C4)nnc2C1C nan
CHEMBL5915381 431213 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 479 3 0 8 4.1 CCOC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3ncccn3)C4)nnc2C1C nan
137357380 431224 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 475 2 0 8 3.7 COC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2cccc(C#N)n2)C3)C1 nan
CHEMBL5915440 431224 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 475 2 0 8 3.7 COC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2cccc(C#N)n2)C3)C1 nan
137357498 444583 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 482 2 0 7 4.5 COC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3ccc(F)cn3)C4)nnc2C1C nan
CHEMBL5952089 444583 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 482 2 0 7 4.5 COC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3ccc(F)cn3)C4)nnc2C1C nan
137484931 446197 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 446 3 0 6 4.6 Clc1ccc2c(c1)CN(C1CCC1)Cc1nnc(C3CC4(C3)CN(c3ccccn3)C4)n1-2 nan
CHEMBL5969398 446197 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 446 3 0 6 4.6 Clc1ccc2c(c1)CN(C1CCC1)Cc1nnc(C3CC4(C3)CN(c3ccccn3)C4)n1-2 nan
137485460 446378 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 464 3 0 6 4.6 Cc1nc(N2CC3(CC(c4nnc5n4-c4ccc(Cl)cc4CN(C4CC4)C5)C3)C2)ccc1F nan
CHEMBL5971402 446378 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 464 3 0 6 4.6 Cc1nc(N2CC3(CC(c4nnc5n4-c4ccc(Cl)cc4CN(C4CC4)C5)C3)C2)ccc1F nan
137485233 446450 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 451 2 0 8 3.2 COC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ncccn2)C3)C1 nan
CHEMBL5972042 446450 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 451 2 0 8 3.2 COC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ncccn2)C3)C1 nan
137357495 446566 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 429 1 0 6 4.0 CN1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(C(=O)OC(C)(C)C)C3)C1 nan
CHEMBL5973453 446566 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 429 1 0 6 4.0 CN1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(C(=O)OC(C)(C)C)C3)C1 nan
137485262 446814 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 497 3 0 8 4.1 CC(C)OC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ncncc2F)C3)C1 nan
CHEMBL5976554 446814 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 497 3 0 8 4.1 CC(C)OC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ncncc2F)C3)C1 nan
137485053 449039 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 510 3 0 6 4.7 CC1c2nnc(C3CC4(C3)CN(c3ccc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)C1(F)CC1 nan
CHEMBL6000224 449039 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 510 3 0 6 4.7 CC1c2nnc(C3CC4(C3)CN(c3ccc(F)cn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)C1(F)CC1 nan
137485028 450320 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 450 2 0 7 3.8 COC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccccn2)C3)C1 nan
CHEMBL6014034 450320 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 450 2 0 7 3.8 COC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CC3(C2)CN(c2ccccn2)C3)C1 nan
137485285 451043 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 505 3 0 8 4.7 CC1c2nnc(C3CC4(C3)CN(c3ncccn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)OC1(C)CC1 nan
CHEMBL6021426 451043 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 505 3 0 8 4.7 CC1c2nnc(C3CC4(C3)CN(c3ncccn3)C4)n2-c2ccc(Cl)cc2CN1C(=O)OC1(C)CC1 nan
137485308 464440 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 493 3 0 8 4.5 CC(C)OC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3ncccn3)C4)nnc2C1C nan
CHEMBL6059862 464440 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 493 3 0 8 4.5 CC(C)OC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3ncccn3)C4)nnc2C1C nan
137485025 464610 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 465 2 0 8 3.7 COC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3cnccn3)C4)nnc2C1C nan
CHEMBL6061948 464610 0 None None None Human 6.1 pIC50 = 6.1 Binding
Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.Oxytocin Receptor Antagonist Assay: This assay was performed in CHEM-1 cells expressing the human Oxytocin Receptor (hOTR) to determine the inhibitory effect of the compounds of the invention on the human Oxytocin receptor. Oxytocin evokes an increase in intracellular calcium in CHEM-1-hOTR cells which is measured in a fluorescence assay on the FLIPRTETRA using calcium sensitive dyes. Test compounds were assessed for their ability to affect the magnitude of the response to oxytocin, with antagonists showing a concentration-dependent reduction in the oxytocin-mediated fluorescence. Compounds displaying potency at the vasopressin V1a receptor of <100 nM were progressed to selectivity testing against hOTR and were tested in triplicate in a 10-point, 1:3 dilution series starting at a nominal concentration of 3 μM in the assay.CHEM-1-hOTR ready was used to assay frozen cells (Eurofins #HTS090RTA) which are supplied with a proprietary Media Component.
ChEMBL 465 2 0 8 3.7 COC(=O)N1Cc2cc(Cl)ccc2-n2c(C3CC4(C3)CN(c3cnccn3)C4)nnc2C1C nan
44351004 43290 0 None None None Rat 6.1 pIC50 = 6.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 363 2 0 2 4.4 CC1(C)C2CC[C@@]1(CC(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL129513 43290 0 None None None Rat 6.1 pIC50 = 6.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 363 2 0 2 4.4 CC1(C)C2CC[C@@]1(CC(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
44351157 43050 0 None None None Rat 5.1 pIC50 = 5.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 433 3 0 3 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(Cl)ccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL128978 43050 0 None None None Rat 5.1 pIC50 = 5.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 433 3 0 3 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(Cl)ccc43)CC1)C(=O)C2 10.1021/jm00099a020
44351065 236909 0 None None None Rat 5.1 pIC50 = 5.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 433 3 0 3 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(Cl)cc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL340588 236909 0 None None None Rat 5.1 pIC50 = 5.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 433 3 0 3 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(Cl)cc43)CC1)C(=O)C2 10.1021/jm00099a020
44351251 42149 0 None None None Rat 6.1 pIC50 = 6.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 440 4 1 4 3.8 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC#N)C2 10.1021/jm00099a020
CHEMBL127049 42149 0 None None None Rat 6.1 pIC50 = 6.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 440 4 1 4 3.8 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC#N)C2 10.1021/jm00099a020
10026274 45268 0 None None None Rat 6.1 pIC50 = 6.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 440 4 1 4 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC#N)C2 10.1021/jm00077a002
CHEMBL131499 45268 0 None None None Rat 6.1 pIC50 = 6.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 440 4 1 4 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC#N)C2 10.1021/jm00077a002
44351204 232099 3 None None None Rat 6.1 pIC50 = 6.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 459 5 2 4 3.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm00099a020
CHEMBL339681 232099 3 None None None Rat 6.1 pIC50 = 6.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 459 5 2 4 3.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm00099a020
44429300 177895 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1035 18 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C(C)(C)C)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL232501 177895 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1035 18 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C(C)(C)C)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
10030443 235652 0 None None None Rat 7.1 pIC50 = 7.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1ccncc1)C2 10.1021/jm00077a002
CHEMBL337615 235652 0 None None None Rat 7.1 pIC50 = 7.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1ccncc1)C2 10.1021/jm00077a002
CHEMBL2369136 485404 0 None None None Human 8.1 pIC50 = 8.1 Binding
Binding affinity towards oxytocin receptorBinding affinity towards oxytocin receptor
ChEMBL 1089 10 11 15 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H]([C@@H](C)c2c(C)cc(OC)cc2C)NC(=O)[C@H](N)C(C)(C)SSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm0303103
CHEMBL2112250 485098 0 None None None Rat 8.1 pIC50 = 8.1 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 766 6 4 7 2.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cccc3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44352427 235700 0 None None None Rat 8.1 pIC50 = 8.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 637 10 4 6 3.2 CC(C)[C@H](NC(=O)Cc1c[nH]cn1)C(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL337889 235700 0 None None None Rat 8.1 pIC50 = 8.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 637 10 4 6 3.2 CC(C)[C@H](NC(=O)Cc1c[nH]cn1)C(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL435021 488610 4 None None None Rat 8.1 pIC50 = 8.1 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 780 6 4 7 2.0 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CNCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10437668 155157 1 None None None Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112903 155157 1 None None None Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1021/jm00031a004
2249 4540 14 None None None Rat 8.1 pIC50 = 8.1 Binding
Inhibition of rat uterus OT receptorInhibition of rat uterus OT receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
9872389 4540 14 None None None Rat 8.1 pIC50 = 8.1 Binding
Inhibition of rat uterus OT receptorInhibition of rat uterus OT receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
CHEMBL1253853 4540 14 None None None Rat 8.1 pIC50 = 8.1 Binding
Inhibition of rat uterus OT receptorInhibition of rat uterus OT receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
44429295 333579 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1110 19 10 14 -0.1 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL438849 333579 0 None None None Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1110 19 10 14 -0.1 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44352114 45897 0 None None None Rat 7.1 pIC50 = 7.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 517 8 3 5 2.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CCCO)C2 10.1021/jm00077a002
CHEMBL132165 45897 0 None None None Rat 7.1 pIC50 = 7.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 517 8 3 5 2.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CCCO)C2 10.1021/jm00077a002
9981665 232117 5 None None None Rat 6.1 pIC50 = 6.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 459 5 2 4 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm00077a002
CHEMBL341339 232117 5 None None None Rat 6.1 pIC50 = 6.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 459 5 2 4 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm00077a002
44352400 42764 0 None None None Rat 7.1 pIC50 = 7.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1ccccn1)C2 10.1021/jm00077a002
CHEMBL128423 42764 0 None None None Rat 7.1 pIC50 = 7.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1ccccn1)C2 10.1021/jm00077a002
10413998 37968 0 None None None Rat 6.1 pIC50 = 6.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL128879 37968 0 None None None Rat 6.1 pIC50 = 6.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
10341722 24663 4 None None None Rat 5.1 pIC50 = 5.1 Binding
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 414 5 1 7 4.8 COc1c([C@H](CC(C)C)OC(C)=O)ccc2c1C(=O)OCc1cc(C)cc(O)c1O2 10.1016/S0960-894X(01)80905-7
CHEMBL116226 24663 4 None None None Rat 5.1 pIC50 = 5.1 Binding
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 414 5 1 7 4.8 COc1c([C@H](CC(C)C)OC(C)=O)ccc2c1C(=O)OCc1cc(C)cc(O)c1O2 10.1016/S0960-894X(01)80905-7
16736614 295716 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 975 16 10 13 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H]2Cc3ccccc3CN2C(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL394268 295716 0 None None None Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 975 16 10 13 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H]2Cc3ccccc3CN2C(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
44351033 41944 0 None None None Rat 5.1 pIC50 = 5.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 475 4 0 3 5.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)C(c3ccccc3)C1)C(=O)C2 10.1021/jm00099a020
CHEMBL126708 41944 0 None None None Rat 5.1 pIC50 = 5.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 475 4 0 3 5.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)C(c3ccccc3)C1)C(=O)C2 10.1021/jm00099a020
71456175 155132 0 None None None Rat 5.1 pIC50 = 5.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 363 2 0 2 4.4 CC1(C)C2CC[C@]1(CC(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL2111847 155132 0 None None None Rat 5.1 pIC50 = 5.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 363 2 0 2 4.4 CC1(C)C2CC[C@]1(CC(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL2112654 485104 0 None None None Rat 7.1 pIC50 = 7.1 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 716 6 4 7 1.5 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44351248 235785 0 None None None Rat 6.1 pIC50 = 6.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 501 6 1 5 4.1 CCOC(=O)C(C)[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
CHEMBL338409 235785 0 None None None Rat 6.1 pIC50 = 6.1 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 501 6 1 5 4.1 CCOC(=O)C(C)[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
44273013 199670 0 None None None Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 543 7 2 6 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCCO)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL283126 199670 0 None None None Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 543 7 2 6 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCCO)C1=O)C2 10.1016/0960-894X(94)00469-V
14981574 160374 0 None None None Rat 8.0 pIC50 = 8.0 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1CC2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1021/jm00031a004
CHEMBL2112898 160374 0 None None None Rat 8.0 pIC50 = 8.0 Binding
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1CC2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1021/jm00031a004
10483105 174420 1 None None None Rat 8.0 pIC50 = 8.0 Binding
Inhibition of rat uterus OT receptorInhibition of rat uterus OT receptor
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1016/j.bmcl.2012.10.116
CHEMBL2391300 174420 1 None None None Rat 8.0 pIC50 = 8.0 Binding
Inhibition of rat uterus OT receptorInhibition of rat uterus OT receptor
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1016/j.bmcl.2012.10.116
44352372 44491 0 None None None Rat 7.1 pIC50 = 7.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 558 9 4 6 1.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)[C@@H](N)CCC(N)=O)C2 10.1021/jm00077a002
CHEMBL130848 44491 0 None None None Rat 7.1 pIC50 = 7.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 558 9 4 6 1.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)[C@@H](N)CCC(N)=O)C2 10.1021/jm00077a002
44352141 45297 0 None None None Rat 7.1 pIC50 = 7.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 501 7 2 5 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](C(=O)[C@H](N)CC(N)=O)C2 10.1021/jm00077a002
CHEMBL131538 45297 0 None None None Rat 7.1 pIC50 = 7.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 501 7 2 5 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](C(=O)[C@H](N)CC(N)=O)C2 10.1021/jm00077a002
10347587 329938 0 None None None Rat 7.1 pIC50 = 7.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 552 8 3 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL422612 329938 0 None None None Rat 7.1 pIC50 = 7.1 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 552 8 3 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
10030231 42775 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 6 1 4 4.5 CC(C)CC1NC(=O)N([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
CHEMBL128489 42775 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 6 1 4 4.5 CC(C)CC1NC(=O)N([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
10097994 235191 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 514 5 3 4 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CNC(=O)N1)C2 10.1021/jm00077a002
CHEMBL335876 235191 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 514 5 3 4 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CNC(=O)N1)C2 10.1021/jm00077a002
CHEMBL2112650 485102 0 None None None Rat 6.0 pIC50 = 6.0 Binding
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL 728 6 2 6 2.9 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](C)N(C)C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10256281 42763 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 7 2 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL128422 42763 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 7 2 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCc1c[nH]cn1)C2 10.1021/jm00077a002
10414380 234995 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 521 6 1 4 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1ccccn1)C2 10.1021/jm00077a002
CHEMBL335634 234995 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 521 6 1 4 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1ccccn1)C2 10.1021/jm00077a002
10392781 237099 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1cccnc1)C2 10.1021/jm00077a002
CHEMBL340964 237099 0 None None None Rat 7.0 pIC50 = 7.0 Binding
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1cccnc1)C2 10.1021/jm00077a002
44350979 232109 0 None None None Rat 6.0 pIC50 = 6.0 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 1 3 3.8 C[C@H]1C2CC[C@@](CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)([C@@H]1O)C2(C)C 10.1021/jm00099a020
CHEMBL340237 232109 0 None None None Rat 6.0 pIC50 = 6.0 Binding
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 1 3 3.8 C[C@H]1C2CC[C@@](CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)([C@@H]1O)C2(C)C 10.1021/jm00099a020
90663156 216271 0 None None None Human 9.6 pKd = 9.6 Binding
Dissociation constant value for human OT-receptorDissociation constant value for human OT-receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
CHEMBL3142790 216271 0 None None None Human 9.6 pKd = 9.6 Binding
Dissociation constant value for human OT-receptorDissociation constant value for human OT-receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
136961688 237391 0 None 14 3 Human 8.9 pKd = 8.9 Binding
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1206 23 5 13 7.4 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCNC(=O)CCc2ccc(S(=O)(=O)N(CC(=O)N/N=C3\C(=O)Nc4ccccc43)c3ccc(Cl)cc3)cc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
CHEMBL3416750 237391 0 None 14 3 Human 8.9 pKd = 8.9 Binding
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1206 23 5 13 7.4 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCNC(=O)CCc2ccc(S(=O)(=O)N(CC(=O)N/N=C3\C(=O)Nc4ccccc43)c3ccc(Cl)cc3)cc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
118753720 239499 0 None None None Human 8.8 pKd = 8.8 Binding
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1051 28 4 17 6.7 COc1ccc(-n2c(COCCOCCOCCOCCNC(=O)CCCCCNC(=O)c3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1021/jm501395b
CHEMBL3559144 239499 0 None None None Human 8.8 pKd = 8.8 Binding
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1051 28 4 17 6.7 COc1ccc(-n2c(COCCOCCOCCOCCNC(=O)CCCCCNC(=O)c3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1021/jm501395b
145947419 332426 0 None 323 2 Human 8.8 pKd = 8.8 Binding
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1204 30 2 18 7.6 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCOCc2nnc(N3CC(Oc4ccc(F)cc4Cl)C3)n2-c2ccc(OC)nc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
CHEMBL4301807 332426 0 None 323 2 Human 8.8 pKd = 8.8 Binding
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1204 30 2 18 7.6 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCOCc2nnc(N3CC(Oc4ccc(F)cc4Cl)C3)n2-c2ccc(OC)nc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
136961687 237390 0 None 35 3 Human 8.8 pKd = 8.8 Binding
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1053 21 7 12 6.4 O=C(CCCCCNC(=O)c1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)NCCNC(=O)CCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm501395b
CHEMBL3416749 237390 0 None 35 3 Human 8.8 pKd = 8.8 Binding
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1053 21 7 12 6.4 O=C(CCCCCNC(=O)c1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)NCCNC(=O)CCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm501395b
145947801 332482 0 None 190 2 Human 8.7 pKd = 8.7 Binding
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1381 42 2 22 7.7 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCc2nnc(N3CC(Oc4ccc(F)cc4Cl)C3)n2-c2ccc(OC)nc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
CHEMBL4302530 332482 0 None 190 2 Human 8.7 pKd = 8.7 Binding
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1381 42 2 22 7.7 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCc2nnc(N3CC(Oc4ccc(F)cc4Cl)C3)n2-c2ccc(OC)nc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
44324579 197358 0 None None None Rat 8.0 pKd = 8.0 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1157 31 15 14 -1.2 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C(C)(C)S 10.1021/jm00014a022
CHEMBL266898 197358 0 None None None Rat 8.0 pKd = 8.0 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1157 31 15 14 -1.2 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C(C)(C)S 10.1021/jm00014a022
10011419 197335 0 None 1 3 Rat 8.0 pKd = 8.0 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
44294474 197335 0 None 1 3 Rat 8.0 pKd = 8.0 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL266643 197335 0 None 1 3 Rat 8.0 pKd = 8.0 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350125 197335 0 None 1 3 Rat 8.0 pKd = 8.0 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
118718384 234321 0 None 7 3 Rat 8.0 pKd = 8.0 Binding
In vitro antioxycic activity with out Mg2+.In vitro antioxycic activity with out Mg2+.
ChEMBL 1154 18 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349465 234321 0 None 7 3 Rat 8.0 pKd = 8.0 Binding
In vitro antioxycic activity with out Mg2+.In vitro antioxycic activity with out Mg2+.
ChEMBL 1154 18 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
56671727 125949 0 None None None Rat 5.0 pKd = 5.0 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1101 29 15 14 -2.5 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)[C@@H](C)O 10.1021/jm00014a022
CHEMBL1790762 125949 0 None None None Rat 5.0 pKd = 5.0 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1101 29 15 14 -2.5 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)[C@@H](C)O 10.1021/jm00014a022
90669116 219284 0 None 2 2 Human 6.9 pKd = 6.9 Binding
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
CHEMBL3229632 219284 0 None 2 2 Human 6.9 pKd = 6.9 Binding
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
90669116 219284 0 None -2 2 Rat 6.9 pKd = 6.9 Binding
Antagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysisAntagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysis
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
CHEMBL3229632 219284 0 None -2 2 Rat 6.9 pKd = 6.9 Binding
Antagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysisAntagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysis
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
90669121 219289 0 None None None Rat 7.9 pKd = 7.9 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1032 15 11 14 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229637 219289 0 None None None Rat 7.9 pKd = 7.9 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1032 15 11 14 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
44324578 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324596 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324601 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324625 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL263153 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL268779 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL386547 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL439482 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
10463677 234323 4 None 38 3 Rat 7.9 pKd = 7.9 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 991 15 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349468 234323 4 None 38 3 Rat 7.9 pKd = 7.9 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 991 15 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
90669124 219292 0 None None None Rat 6.9 pKd = 6.9 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1048 18 11 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229640 219292 0 None None None Rat 6.9 pKd = 6.9 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1048 18 11 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL2370976 477420 13 None -2 3 Rat 7.9 pKd = 7.9 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1136 19 11 14 -0.6 CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00010a020
71312201 234350 14 None 1 2 Rat 7.9 pKd = 7.9 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1074 19 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350118 234350 14 None 1 2 Rat 7.9 pKd = 7.9 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1074 19 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
118718750 234352 0 None -3 3 Rat 7.9 pKd = 7.9 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
118718751 234352 0 None -3 3 Rat 7.9 pKd = 7.9 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350120 234352 0 None -3 3 Rat 7.9 pKd = 7.9 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350123 234352 0 None -3 3 Rat 7.9 pKd = 7.9 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3245748 486666 1 None -4 3 Human 6.9 pKd = 6.9 Binding
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1034 17 12 15 -2.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
CHEMBL3245748 486666 1 None -4 3 Rat 6.9 pKd = 6.9 Binding
Antagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysisAntagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysis
ChEMBL 1034 17 12 15 -2.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
44324578 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324596 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324601 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324625 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL263153 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL268779 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL386547 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL439482 196924 0 None None None Rat 7.9 pKd = 7.9 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
118718383 234320 0 None 66 3 Rat 7.8 pKd = 7.8 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
118718385 234320 0 None 66 3 Rat 7.8 pKd = 7.8 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349464 234320 0 None 66 3 Rat 7.8 pKd = 7.8 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349466 234320 0 None 66 3 Rat 7.8 pKd = 7.8 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
44320759 316382 0 None 8 2 Human 7.8 pKd = 7.8 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1036 22 12 15 -4.4 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm00028a008
CHEMBL411420 316382 0 None 8 2 Human 7.8 pKd = 7.8 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1036 22 12 15 -4.4 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm00028a008
90669121 219289 0 None None None Rat 7.8 pKd = 7.8 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1032 15 11 14 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229637 219289 0 None None None Rat 7.8 pKd = 7.8 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1032 15 11 14 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
90669122 219290 0 None None None Rat 7.8 pKd = 7.8 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1033 18 10 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229638 219290 0 None None None Rat 7.8 pKd = 7.8 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1033 18 10 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
90669118 219286 0 None -1 2 Rat 6.8 pKd = 6.8 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1047 19 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229634 219286 0 None -1 2 Rat 6.8 pKd = 6.8 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1047 19 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
90669123 219291 0 None None None Rat 7.8 pKd = 7.8 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1006 16 10 14 -1.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229639 219291 0 None None None Rat 7.8 pKd = 7.8 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1006 16 10 14 -1.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
44324578 196924 0 None None None Rat 7.8 pKd = 7.8 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324596 196924 0 None None None Rat 7.8 pKd = 7.8 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324601 196924 0 None None None Rat 7.8 pKd = 7.8 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324625 196924 0 None None None Rat 7.8 pKd = 7.8 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL263153 196924 0 None None None Rat 7.8 pKd = 7.8 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL268779 196924 0 None None None Rat 7.8 pKd = 7.8 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL386547 196924 0 None None None Rat 7.8 pKd = 7.8 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL439482 196924 0 None None None Rat 7.8 pKd = 7.8 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
118718747 234349 0 None 1 2 Rat 7.8 pKd = 7.8 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
118718748 234349 0 None 1 2 Rat 7.8 pKd = 7.8 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350115 234349 0 None 1 2 Rat 7.8 pKd = 7.8 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350116 234349 0 None 1 2 Rat 7.8 pKd = 7.8 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
44320761 197170 0 None 1 2 Human 6.8 pKd = 6.8 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1110 20 13 15 -3.2 CN(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C(=O)[C@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00028a008
44321207 197170 0 None 1 2 Human 6.8 pKd = 6.8 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1110 20 13 15 -3.2 CN(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C(=O)[C@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00028a008
CHEMBL265264 197170 0 None 1 2 Human 6.8 pKd = 6.8 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1110 20 13 15 -3.2 CN(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C(=O)[C@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00028a008
CHEMBL384292 197170 0 None 1 2 Human 6.8 pKd = 6.8 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1110 20 13 15 -3.2 CN(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C(=O)[C@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00028a008
CHEMBL3245750 486667 0 None None None Human 6.8 pKd = 6.8 Binding
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1019 16 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC1=O 10.1021/jm00187a002
90669122 219290 0 None None None Rat 7.8 pKd = 7.8 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1033 18 10 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229638 219290 0 None None None Rat 7.8 pKd = 7.8 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1033 18 10 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
44321134 222042 0 None 45 2 Human 7.8 pKd = 7.8 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 963 16 9 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N(C)CC(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
CHEMBL330022 222042 0 None 45 2 Human 7.8 pKd = 7.8 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 963 16 9 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N(C)CC(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
10011419 197335 0 None 1 3 Rat 7.7 pKd = 7.7 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
44294474 197335 0 None 1 3 Rat 7.7 pKd = 7.7 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL266643 197335 0 None 1 3 Rat 7.7 pKd = 7.7 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350125 197335 0 None 1 3 Rat 7.7 pKd = 7.7 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
118718386 234322 0 None 12 3 Rat 7.7 pKd = 7.7 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 991 14 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349467 234322 0 None 12 3 Rat 7.7 pKd = 7.7 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 991 14 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
90678222 220926 0 None None None Rat 6.7 pKd = 6.7 Binding
Antagonist activity at oxytocin receptor in rat uterus assessed as inhibition of synthetic oxytocin-induced response treated 1.5 to 2 mins prior to oxytocin challengeAntagonist activity at oxytocin receptor in rat uterus assessed as inhibition of synthetic oxytocin-induced response treated 1.5 to 2 mins prior to oxytocin challenge
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00224a010
CHEMBL3273609 220926 0 None None None Rat 6.7 pKd = 6.7 Binding
Antagonist activity at oxytocin receptor in rat uterus assessed as inhibition of synthetic oxytocin-induced response treated 1.5 to 2 mins prior to oxytocin challengeAntagonist activity at oxytocin receptor in rat uterus assessed as inhibition of synthetic oxytocin-induced response treated 1.5 to 2 mins prior to oxytocin challenge
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00224a010
90669119 219287 0 None None None Rat 7.7 pKd = 7.7 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1020 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229635 219287 0 None None None Rat 7.7 pKd = 7.7 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1020 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
70693566 159935 0 None 2 2 Human 5.7 pKd = 5.7 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1018 18 12 14 -4.5 CC[C@H](C)[C@H]1NC(=O)[C@]2(CCc3ccccc3C2)NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
CHEMBL2110297 159935 0 None 2 2 Human 5.7 pKd = 5.7 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1018 18 12 14 -4.5 CC[C@H](C)[C@H]1NC(=O)[C@]2(CCc3ccccc3C2)NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
118753721 239500 0 None None None Human 8.7 pKd = 8.7 Binding
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1227 40 4 21 6.8 COc1ccc(-n2c(COCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCCCCNC(=O)c3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1021/jm501395b
CHEMBL3559145 239500 0 None None None Human 8.7 pKd = 8.7 Binding
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1227 40 4 21 6.8 COc1ccc(-n2c(COCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCCCCNC(=O)c3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1021/jm501395b
44320718 333533 0 None 1 2 Human 7.7 pKd = 7.7 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1139 22 12 15 -2.5 CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00028a008
CHEMBL438387 333533 0 None 1 2 Human 7.7 pKd = 7.7 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1139 22 12 15 -2.5 CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00028a008
CHEMBL3350121 486861 0 None None None Rat 6.7 pKd = 6.7 Binding
Compound was evaluated for the oxytocic activity with out Mg2+.Compound was evaluated for the oxytocic activity with out Mg2+.
ChEMBL 1083 19 14 16 -5.4 NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)CSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00010a020
118718383 234320 0 None 66 3 Rat 7.7 pKd = 7.7 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
118718385 234320 0 None 66 3 Rat 7.7 pKd = 7.7 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349464 234320 0 None 66 3 Rat 7.7 pKd = 7.7 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349466 234320 0 None 66 3 Rat 7.7 pKd = 7.7 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
118718753 234353 0 None 1 3 Rat 7.7 pKd = 7.7 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1074 18 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350126 234353 0 None 1 3 Rat 7.7 pKd = 7.7 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1074 18 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
90669123 219291 0 None None None Rat 7.6 pKd = 7.6 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1006 16 10 14 -1.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229639 219291 0 None None None Rat 7.6 pKd = 7.6 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1006 16 10 14 -1.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
118718383 234320 0 None 66 3 Rat 7.6 pKd = 7.6 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
118718385 234320 0 None 66 3 Rat 7.6 pKd = 7.6 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349464 234320 0 None 66 3 Rat 7.6 pKd = 7.6 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349466 234320 0 None 66 3 Rat 7.6 pKd = 7.6 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
10396464 234324 1 None 8 2 Rat 7.6 pKd = 7.6 Binding
In vitro antioxycic activity with out Mg2+.In vitro antioxycic activity with out Mg2+.
ChEMBL 1154 19 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349469 234324 1 None 8 2 Rat 7.6 pKd = 7.6 Binding
In vitro antioxycic activity with out Mg2+.In vitro antioxycic activity with out Mg2+.
ChEMBL 1154 19 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
90669116 219284 0 None -2 2 Rat 5.6 pKd = 5.6 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229632 219284 0 None -2 2 Rat 5.6 pKd = 5.6 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
90669120 219288 1 None None None Rat 7.6 pKd = 7.6 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229636 219288 1 None None None Rat 7.6 pKd = 7.6 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL2372311 477732 6 None None None Rat 7.6 pKd = 7.6 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1110 20 12 15 -3.3 COc1ccc(C[C@@H]2NC(=O)CC(C)(C)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00191a019
90669124 219292 0 None None None Rat 6.6 pKd = 6.6 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1048 18 11 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229640 219292 0 None None None Rat 6.6 pKd = 6.6 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1048 18 11 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
118718750 234352 0 None -3 3 Rat 7.6 pKd = 7.6 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
118718751 234352 0 None -3 3 Rat 7.6 pKd = 7.6 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350120 234352 0 None -3 3 Rat 7.6 pKd = 7.6 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350123 234352 0 None -3 3 Rat 7.6 pKd = 7.6 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
118718386 234322 0 None 12 3 Rat 7.6 pKd = 7.6 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 991 14 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349467 234322 0 None 12 3 Rat 7.6 pKd = 7.6 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 991 14 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
90669117 219285 1 None None None Rat 7.6 pKd = 7.6 Binding
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00200a007
CHEMBL3229633 219285 1 None None None Rat 7.6 pKd = 7.6 Binding
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00200a007
118718749 234351 0 None -1 3 Rat 7.6 pKd = 7.6 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
118718752 234351 0 None -1 3 Rat 7.6 pKd = 7.6 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350119 234351 0 None -1 3 Rat 7.6 pKd = 7.6 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350124 234351 0 None -1 3 Rat 7.6 pKd = 7.6 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
56678404 126039 0 None -1 2 Human 6.6 pKd = 6.6 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1060 20 12 14 -3.1 CC[C@H](C)[C@@H]1NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC1=O 10.1021/jm00028a008
CHEMBL1793955 126039 0 None -1 2 Human 6.6 pKd = 6.6 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1060 20 12 14 -3.1 CC[C@H](C)[C@@H]1NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC1=O 10.1021/jm00028a008
44321188 317415 0 None 1 2 Human 7.6 pKd = 7.6 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1105 22 12 15 -2.7 CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm00028a008
CHEMBL415230 317415 0 None 1 2 Human 7.6 pKd = 7.6 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1105 22 12 15 -2.7 CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm00028a008
90669118 219286 0 None -1 2 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1047 19 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229634 219286 0 None -1 2 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1047 19 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
118718747 234349 0 None 1 2 Rat 7.5 pKd = 7.5 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
118718748 234349 0 None 1 2 Rat 7.5 pKd = 7.5 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350115 234349 0 None 1 2 Rat 7.5 pKd = 7.5 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350116 234349 0 None 1 2 Rat 7.5 pKd = 7.5 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL2370976 477420 13 None -2 3 Rat 7.5 pKd = 7.5 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1136 19 11 14 -0.6 CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00010a020
71312201 234350 14 None 1 2 Rat 8.5 pKd = 8.5 Binding
In vitro antioxycic activity with out Mg2+.In vitro antioxycic activity with out Mg2+.
ChEMBL 1074 19 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350118 234350 14 None 1 2 Rat 8.5 pKd = 8.5 Binding
In vitro antioxycic activity with out Mg2+.In vitro antioxycic activity with out Mg2+.
ChEMBL 1074 19 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
90669117 219285 1 None None None Rat 7.5 pKd = 7.5 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229633 219285 1 None None None Rat 7.5 pKd = 7.5 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
44324600 333609 0 None None None Rat 5.5 pKd = 5.5 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1157 32 16 14 -2.4 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL439098 333609 0 None None None Rat 5.5 pKd = 5.5 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1157 32 16 14 -2.4 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL3245748 486666 1 None 4 3 Chicken 7.5 pKd = 7.5 Binding
Antagonist activity at oxytocin receptor in conscious chicken assessed as inhibition of oxytocin-induced vaspdepressor responseAntagonist activity at oxytocin receptor in conscious chicken assessed as inhibition of oxytocin-induced vaspdepressor response
ChEMBL 1034 17 12 15 -2.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00201a017
90669117 219285 1 None None None Rat 7.5 pKd = 7.5 Binding
Antagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic response
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00187a002
CHEMBL3229633 219285 1 None None None Rat 7.5 pKd = 7.5 Binding
Antagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic response
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00187a002
118718747 234349 0 None 1 2 Rat 7.5 pKd = 7.5 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
118718748 234349 0 None 1 2 Rat 7.5 pKd = 7.5 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350115 234349 0 None 1 2 Rat 7.5 pKd = 7.5 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350116 234349 0 None 1 2 Rat 7.5 pKd = 7.5 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
90669117 219285 1 None None None Rat 7.5 pKd = 7.5 Binding
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00200a007
CHEMBL3229633 219285 1 None None None Rat 7.5 pKd = 7.5 Binding
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00200a007
CHEMBL3229641 486644 0 None None None Rat 7.4 pKd = 7.4 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1097 20 14 16 -4.9 COc1ccc(C[C@@H]2NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00191a019
118718753 234353 0 None 1 3 Rat 7.4 pKd = 7.4 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1074 18 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350126 234353 0 None 1 3 Rat 7.4 pKd = 7.4 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1074 18 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
70693557 159925 0 None 6 2 Human 6.4 pKd = 6.4 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1018 18 12 14 -4.5 CC[C@H](C)[C@H]1NC(=O)[C@@]2(CCc3ccccc3C2)NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
CHEMBL2110163 159925 0 None 6 2 Human 6.4 pKd = 6.4 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1018 18 12 14 -4.5 CC[C@H](C)[C@H]1NC(=O)[C@@]2(CCc3ccccc3C2)NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
90669120 219288 1 None None None Rat 7.4 pKd = 7.4 Binding
Antagonist activity at oxytocin receptor in isolated rat uterus assessed as inhibition of oxytocin-induced oxytocic responseAntagonist activity at oxytocin receptor in isolated rat uterus assessed as inhibition of oxytocin-induced oxytocic response
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
CHEMBL3229636 219288 1 None None None Rat 7.4 pKd = 7.4 Binding
Antagonist activity at oxytocin receptor in isolated rat uterus assessed as inhibition of oxytocin-induced oxytocic responseAntagonist activity at oxytocin receptor in isolated rat uterus assessed as inhibition of oxytocin-induced oxytocic response
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
90669120 219288 1 None None None Rat 7.4 pKd = 7.4 Binding
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
CHEMBL3229636 219288 1 None None None Rat 7.4 pKd = 7.4 Binding
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
90669120 219288 1 None None None Rat 7.4 pKd = 7.4 Binding
Antagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysisAntagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysis
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
CHEMBL3229636 219288 1 None None None Rat 7.4 pKd = 7.4 Binding
Antagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysisAntagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysis
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
118718749 234351 0 None -1 3 Rat 7.4 pKd = 7.4 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
118718752 234351 0 None -1 3 Rat 7.4 pKd = 7.4 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350119 234351 0 None -1 3 Rat 7.4 pKd = 7.4 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350124 234351 0 None -1 3 Rat 7.4 pKd = 7.4 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
44373715 311636 0 None 131 2 Human 7.4 pKd = 7.4 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1031 20 13 14 -4.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CCSSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
CHEMBL405165 311636 0 None 131 2 Human 7.4 pKd = 7.4 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1031 20 13 14 -4.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CCSSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
118718384 234321 0 None 7 3 Rat 7.4 pKd = 7.4 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1154 18 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349465 234321 0 None 7 3 Rat 7.4 pKd = 7.4 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1154 18 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
44324574 197195 0 None None None Rat 5.4 pKd = 5.4 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1114 30 15 14 -3.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL265490 197195 0 None None None Rat 5.4 pKd = 5.4 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1114 30 15 14 -3.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL2370617 477411 0 None 1 3 Rat 8.4 pKd = 8.4 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1136 19 11 14 -0.6 CCOc1ccc(C[C@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00010a020
CHEMBL2370617 477411 0 None 1 3 Rat 8.3 pKd = 8.3 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1136 19 11 14 -0.6 CCOc1ccc(C[C@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00010a020
90669119 219287 0 None None None Rat 7.4 pKd = 7.4 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1020 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229635 219287 0 None None None Rat 7.4 pKd = 7.4 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1020 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
10011419 197335 0 None 1 3 Rat 7.4 pKd = 7.4 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
44294474 197335 0 None 1 3 Rat 7.4 pKd = 7.4 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL266643 197335 0 None 1 3 Rat 7.4 pKd = 7.4 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350125 197335 0 None 1 3 Rat 7.4 pKd = 7.4 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
44324578 196924 0 None None None Rat 8.3 pKd = 8.3 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324596 196924 0 None None None Rat 8.3 pKd = 8.3 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324601 196924 0 None None None Rat 8.3 pKd = 8.3 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324625 196924 0 None None None Rat 8.3 pKd = 8.3 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL263153 196924 0 None None None Rat 8.3 pKd = 8.3 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL268779 196924 0 None None None Rat 8.3 pKd = 8.3 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL386547 196924 0 None None None Rat 8.3 pKd = 8.3 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL439482 196924 0 None None None Rat 8.3 pKd = 8.3 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
10011419 197335 0 None 1 3 Rat 8.3 pKd = 8.3 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
44294474 197335 0 None 1 3 Rat 8.3 pKd = 8.3 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL266643 197335 0 None 1 3 Rat 8.3 pKd = 8.3 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350125 197335 0 None 1 3 Rat 8.3 pKd = 8.3 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
118718747 234349 0 None 1 2 Rat 8.3 pKd = 8.3 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
118718748 234349 0 None 1 2 Rat 8.3 pKd = 8.3 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350115 234349 0 None 1 2 Rat 8.3 pKd = 8.3 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350116 234349 0 None 1 2 Rat 8.3 pKd = 8.3 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
10396464 234324 1 None 8 2 Rat 8.3 pKd = 8.3 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1154 19 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349469 234324 1 None 8 2 Rat 8.3 pKd = 8.3 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1154 19 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
10463677 234323 4 None 38 3 Rat 8.2 pKd = 8.2 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 991 15 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349468 234323 4 None 38 3 Rat 8.2 pKd = 8.2 Binding
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 991 15 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
90673598 220033 0 None None None Chicken 7.3 pKd = 7.3 Binding
Antagonist activity at oxytocin receptor in conscious chicken assessed as inhibition of oxytocin-induced vaspdepressor responseAntagonist activity at oxytocin receptor in conscious chicken assessed as inhibition of oxytocin-induced vaspdepressor response
ChEMBL 957 17 12 12 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)NCCCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00201a017
CHEMBL3249128 220033 0 None None None Chicken 7.3 pKd = 7.3 Binding
Antagonist activity at oxytocin receptor in conscious chicken assessed as inhibition of oxytocin-induced vaspdepressor responseAntagonist activity at oxytocin receptor in conscious chicken assessed as inhibition of oxytocin-induced vaspdepressor response
ChEMBL 957 17 12 12 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)NCCCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00201a017
90669118 219286 0 None 1 2 Human 7.2 pKd = 7.2 Binding
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1047 19 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
CHEMBL3229634 219286 0 None 1 2 Human 7.2 pKd = 7.2 Binding
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1047 19 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
118718749 234351 0 None -1 3 Rat 7.2 pKd = 7.2 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
118718752 234351 0 None -1 3 Rat 7.2 pKd = 7.2 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350119 234351 0 None -1 3 Rat 7.2 pKd = 7.2 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350124 234351 0 None -1 3 Rat 7.2 pKd = 7.2 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
118718750 234352 0 None -3 3 Rat 7.2 pKd = 7.2 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
118718751 234352 0 None -3 3 Rat 7.2 pKd = 7.2 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350120 234352 0 None -3 3 Rat 7.2 pKd = 7.2 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350123 234352 0 None -3 3 Rat 7.2 pKd = 7.2 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL2371240 477685 0 None None None Human 4.2 pKd = 4.2 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1043 18 12 14 -3.9 CC[C@H](C)[C@@H]1NC(=O)[C@@H]2c3[nH]c4ccccc4c3CCN2C(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
44324577 196784 0 None None None Rat 5.2 pKd = 5.2 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1128 31 15 14 -2.6 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL262157 196784 0 None None None Rat 5.2 pKd = 5.2 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1128 31 15 14 -2.6 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL3350121 486861 0 None None None Rat 5.2 pKd = 5.2 Binding
Compound was evaluated for the oxytocic activity with 0.5 mM Mg2+.Compound was evaluated for the oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1083 19 14 16 -5.4 NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)CSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00010a020
90669117 219285 1 None None None Rat 6.2 pKd = 6.2 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229633 219285 1 None None None Rat 6.2 pKd = 6.2 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
44324597 197562 0 None None None Rat 5.2 pKd = 5.2 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@@H](C)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL268778 197562 0 None None None Rat 5.2 pKd = 5.2 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@@H](C)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44373714 197048 0 None -1 2 Human 8.2 pKd = 8.2 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1148 32 14 16 -3.1 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(=O)oc2cc(OC)ccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O 10.1016/s0960-894x(99)00041-4
CHEMBL264208 197048 0 None -1 2 Human 8.2 pKd = 8.2 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1148 32 14 16 -3.1 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(=O)oc2cc(OC)ccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O 10.1016/s0960-894x(99)00041-4
44321189 198523 0 None None None Human 8.2 pKd = 8.2 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1017 20 14 14 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCSSC[C@H](C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
CHEMBL274397 198523 0 None None None Human 8.2 pKd = 8.2 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1017 20 14 14 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCSSC[C@H](C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
118718749 234351 0 None -1 3 Rat 8.2 pKd = 8.2 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
118718752 234351 0 None -1 3 Rat 8.2 pKd = 8.2 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350119 234351 0 None -1 3 Rat 8.2 pKd = 8.2 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350124 234351 0 None -1 3 Rat 8.2 pKd = 8.2 Binding
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
2042 8014 41 None 40 4 Human 8.2 pKd = 8.2 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/s0960-894x(99)00041-4
2176 8014 41 None 40 4 Human 8.2 pKd = 8.2 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/s0960-894x(99)00041-4
439302 8014 41 None 40 4 Human 8.2 pKd = 8.2 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/s0960-894x(99)00041-4
CHEMBL395429 8014 41 None 40 4 Human 8.2 pKd = 8.2 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/s0960-894x(99)00041-4
2042 8014 41 None 40 4 Human 8.2 pKd = 8.2 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm00028a008
2176 8014 41 None 40 4 Human 8.2 pKd = 8.2 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm00028a008
439302 8014 41 None 40 4 Human 8.2 pKd = 8.2 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm00028a008
CHEMBL395429 8014 41 None 40 4 Human 8.2 pKd = 8.2 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm00028a008
90678222 220926 0 None None None Rat 5.2 pKd = 5.2 Binding
Antagonist activity at oxytocin receptor in rat assessed as inhibition of synthetic lysine vasopressin-induced pressor responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of synthetic lysine vasopressin-induced pressor response
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00224a010
CHEMBL3273609 220926 0 None None None Rat 5.2 pKd = 5.2 Binding
Antagonist activity at oxytocin receptor in rat assessed as inhibition of synthetic lysine vasopressin-induced pressor responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of synthetic lysine vasopressin-induced pressor response
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00224a010
44321206 197129 0 None 13 2 Human 8.2 pKd = 8.2 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1094 20 12 14 -2.9 CN(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00028a008
CHEMBL265017 197129 0 None 13 2 Human 8.2 pKd = 8.2 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1094 20 12 14 -2.9 CN(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00028a008
118718750 234352 0 None -3 3 Rat 8.1 pKd = 8.1 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+In vitro activity for the anti-oxytocic activity with out Mg2+
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
118718751 234352 0 None -3 3 Rat 8.1 pKd = 8.1 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+In vitro activity for the anti-oxytocic activity with out Mg2+
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350120 234352 0 None -3 3 Rat 8.1 pKd = 8.1 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+In vitro activity for the anti-oxytocic activity with out Mg2+
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350123 234352 0 None -3 3 Rat 8.1 pKd = 8.1 Binding
In vitro activity for the anti-oxytocic activity with out Mg2+In vitro activity for the anti-oxytocic activity with out Mg2+
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
90669120 219288 1 None None None Rat 7.2 pKd = 7.2 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229636 219288 1 None None None Rat 7.2 pKd = 7.2 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3245755 486668 0 None None None Rat 7.1 pKd = 7.1 Binding
Antagonist activity at oxytocin receptor in isolated rat uterus assessed as inhibition of oxytocin-induced oxytocic responseAntagonist activity at oxytocin receptor in isolated rat uterus assessed as inhibition of oxytocin-induced oxytocic response
ChEMBL 984 17 11 14 -2.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
90669116 219284 0 None -2 2 Rat 7.1 pKd = 7.1 Binding
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
CHEMBL3229632 219284 0 None -2 2 Rat 7.1 pKd = 7.1 Binding
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
90669116 219284 0 None -2 2 Rat 7.1 pKd = 7.1 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229632 219284 0 None -2 2 Rat 7.1 pKd = 7.1 Binding
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
44324578 196924 0 None None None Rat 5.1 pKd = 5.1 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324596 196924 0 None None None Rat 5.1 pKd = 5.1 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324601 196924 0 None None None Rat 5.1 pKd = 5.1 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44324625 196924 0 None None None Rat 5.1 pKd = 5.1 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL263153 196924 0 None None None Rat 5.1 pKd = 5.1 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL268779 196924 0 None None None Rat 5.1 pKd = 5.1 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL386547 196924 0 None None None Rat 5.1 pKd = 5.1 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL439482 196924 0 None None None Rat 5.1 pKd = 5.1 Binding
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44373744 104407 0 None 52 2 Human 8.1 pKd = 8.1 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 993 20 12 14 -4.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
CHEMBL157988 104407 0 None 52 2 Human 8.1 pKd = 8.1 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 993 20 12 14 -4.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
44321133 317350 0 None 38 2 Human 8.1 pKd = 8.1 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1060 20 12 14 -3.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
CHEMBL414582 317350 0 None 38 2 Human 8.1 pKd = 8.1 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1060 20 12 14 -3.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
44320760 473352 0 None 52 2 Human 8.1 pKd = 8.1 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 992 20 12 14 -4.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
CHEMBL87636 473352 0 None 52 2 Human 8.1 pKd = 8.1 Binding
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 992 20 12 14 -4.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
90672304 219968 0 None None None Rat 7.1 pKd = 7.1 Binding
Antagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1203 19 11 14 0.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc(Br)c(O)c(Br)c2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
CHEMBL3245753 219968 0 None None None Rat 7.1 pKd = 7.1 Binding
Antagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1203 19 11 14 0.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc(Br)c(O)c(Br)c2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
CHEMBL2371240 477685 0 None None None Human 5.1 pKd = 5.1 Binding
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1043 18 12 14 -3.9 CC[C@H](C)[C@@H]1NC(=O)[C@@H]2c3[nH]c4ccccc4c3CCN2C(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
90672303 219967 0 None None None Rat 7.1 pKd = 7.1 Binding
Antagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1147 17 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc(Br)c(O)c(Br)c2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
CHEMBL3245752 219967 0 None None None Rat 7.1 pKd = 7.1 Binding
Antagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1147 17 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc(Br)c(O)c(Br)c2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
118718383 234320 0 None 66 3 Rat 8.0 pKd = 8.0 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
118718385 234320 0 None 66 3 Rat 8.0 pKd = 8.0 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349464 234320 0 None 66 3 Rat 8.0 pKd = 8.0 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349466 234320 0 None 66 3 Rat 8.0 pKd = 8.0 Binding
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
90672302 219966 0 None None None Human 7.0 pKd = 7.0 Binding
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1033 18 10 13 0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC1=O 10.1021/jm00187a002
CHEMBL3245751 219966 0 None None None Human 7.0 pKd = 7.0 Binding
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1033 18 10 13 0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC1=O 10.1021/jm00187a002
CHEMBL3273606 486700 0 None None None Rat 6.0 pKd = 6.0 Binding
Antagonist activity at oxytocin receptor in rat uterus assessed as inhibition of synthetic oxytocin-induced response treated 1.5 to 2 mins prior to oxytocin challengeAntagonist activity at oxytocin receptor in rat uterus assessed as inhibition of synthetic oxytocin-induced response treated 1.5 to 2 mins prior to oxytocin challenge
ChEMBL 1034 17 12 15 -2.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00224a010
56950588 157009 0 None None None Human 10.6 pKi = 10.6 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 7 1 5 2.8 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1 10.1021/jm201287w
CHEMBL2037514 157009 0 None None None Human 10.6 pKi = 10.6 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 7 1 5 2.8 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1 10.1021/jm201287w
11554957 157011 0 None None None Human 10.5 pKi = 10.5 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 490 7 1 4 3.4 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1C 10.1021/jm201287w
CHEMBL2037516 157011 0 None None None Human 10.5 pKi = 10.5 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 490 7 1 4 3.4 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1C 10.1021/jm201287w
11570070 157012 0 None None None Human 10.5 pKi = 10.5 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 532 7 1 5 3.1 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C 10.1021/jm201287w
CHEMBL2037517 157012 0 None None None Human 10.5 pKi = 10.5 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 532 7 1 5 3.1 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C 10.1021/jm201287w
11605341 157002 0 None None None Human 10.4 pKi = 10.4 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 6 1 4 3.0 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1cnc(C)cc1C 10.1021/jm201287w
CHEMBL2037507 157002 0 None None None Human 10.4 pKi = 10.4 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 6 1 4 3.0 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1cnc(C)cc1C 10.1021/jm201287w
57722466 157003 0 None None None Human 10.3 pKi = 10.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1cnc(C)cc1C 10.1021/jm201287w
CHEMBL2037508 157003 0 None None None Human 10.3 pKi = 10.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1cnc(C)cc1C 10.1021/jm201287w
11547430 157008 0 None None None Human 10.3 pKi = 10.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 7 1 4 3.1 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1 10.1021/jm201287w
CHEMBL2037513 157008 0 None None None Human 10.3 pKi = 10.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 7 1 4 3.1 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1 10.1021/jm201287w
11691437 157010 0 None None None Human 10.3 pKi = 10.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 7 2 4 3.0 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1ccc(C)nc1C 10.1021/jm201287w
CHEMBL2037515 157010 0 None None None Human 10.3 pKi = 10.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 7 2 4 3.0 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1ccc(C)nc1C 10.1021/jm201287w
56950040 156991 0 None None None Human 10.2 pKi = 10.2 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 5 1 4 3.1 Cc1ccc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)(C)C)cn1 10.1021/jm201287w
CHEMBL2037496 156991 0 None None None Human 10.2 pKi = 10.2 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 5 1 4 3.1 Cc1ccc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)(C)C)cn1 10.1021/jm201287w
11669836 157001 0 None None None Human 10.2 pKi = 10.2 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 2 4 2.6 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1cnc(C)cc1C 10.1021/jm201287w
CHEMBL2037506 157001 0 None None None Human 10.2 pKi = 10.2 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 2 4 2.6 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1cnc(C)cc1C 10.1021/jm201287w
56950041 156992 0 None None None Human 10.1 pKi = 10.1 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 5 1 5 2.8 Cc1ccc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)(C)C)cn1 10.1021/jm201287w
CHEMBL2037497 156992 0 None None None Human 10.1 pKi = 10.1 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 5 1 5 2.8 Cc1ccc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)(C)C)cn1 10.1021/jm201287w
11719871 157005 0 None None None Human 10.1 pKi = 10.1 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 6 1 4 3.0 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1C 10.1021/jm201287w
CHEMBL2037510 157005 0 None None None Human 10.1 pKi = 10.1 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 6 1 4 3.0 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1C 10.1021/jm201287w
11465834 275790 0 None 23 4 Human 10.1 pKi = 10.1 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm201287w
CHEMBL377414 275790 0 None 23 4 Human 10.1 pKi = 10.1 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm201287w
56675150 125937 0 None 85 2 Human 10.1 pKi = 10.1 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1382 21 14 19 -1.2 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc(C3=C4C=CC(N(C)C)=CC4OC4=CC(=[N+](C)C)C=CC43)c(C(=O)O)c2)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790723 125937 0 None 85 2 Human 10.1 pKi = 10.1 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1382 21 14 19 -1.2 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc(C3=C4C=CC(N(C)C)=CC4OC4=CC(=[N+](C)C)C=CC43)c(C(=O)O)c2)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
11421025 311103 0 None None None Human 10.0 pKi = 10 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 519 7 2 4 4.0 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(C(F)(F)F)o1 10.1016/j.bmcl.2007.11.008
CHEMBL401960 311103 0 None None None Human 10.0 pKi = 10 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 519 7 2 4 4.0 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(C(F)(F)F)o1 10.1016/j.bmcl.2007.11.008
11576272 157007 0 None None None Human 10.0 pKi = 10 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 7 2 4 2.7 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1ccc(C)nc1 10.1021/jm201287w
CHEMBL2037512 157007 0 None None None Human 10.0 pKi = 10 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 7 2 4 2.7 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1ccc(C)nc1 10.1021/jm201287w
11598736 159647 0 None None None Human 9.9 pKi = 9.9 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 513 8 2 4 2.6 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)CCO)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL210029 159647 0 None None None Human 9.9 pKi = 9.9 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 513 8 2 4 2.6 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)CCO)c1ccc(F)cc1F 10.1021/jm060073e
11634973 157006 17 None 31622 2 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C 10.1021/jm201287w
CHEMBL2037511 157006 17 None 31622 2 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C 10.1021/jm201287w
DB11934 157006 17 None 31622 2 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C 10.1021/jm201287w
44456151 196002 0 None None None Human 9.8 pKi = 9.8 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 520 7 2 5 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1coc(C(F)(F)F)n1 10.1016/j.bmcl.2007.11.008
CHEMBL257916 196002 0 None None None Human 9.8 pKi = 9.8 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 520 7 2 5 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1coc(C(F)(F)F)n1 10.1016/j.bmcl.2007.11.008
56950167 156996 0 None None None Human 9.8 pKi = 9.8 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 504 6 1 5 2.4 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1 10.1021/jm201287w
CHEMBL2037501 156996 0 None None None Human 9.8 pKi = 9.8 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 504 6 1 5 2.4 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1 10.1021/jm201287w
56657868 125932 0 None 69 3 Human 9.8 pKi = 9.8 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1297 16 15 21 -0.8 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
CHEMBL1790719 125932 0 None 69 3 Human 9.8 pKi = 9.8 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1297 16 15 21 -0.8 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
56671720 125934 0 None 67 3 Human 9.7 pKi = 9.7 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1324 18 15 21 -0.9 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790720 125934 0 None 67 3 Human 9.7 pKi = 9.7 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1324 18 15 21 -0.9 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
56950311 156994 0 None None None Human 9.7 pKi = 9.7 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 1 4 2.7 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1 10.1021/jm201287w
CHEMBL2037499 156994 0 None None None Human 9.7 pKi = 9.7 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 1 4 2.7 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1 10.1021/jm201287w
56678446 125925 0 None 18 3 Human 9.7 pKi = 9.7 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1125 16 13 16 -0.3 CC[C@@H](C)[C@H]1NC(=O)[C@@](C)(c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N)=O)c2ccc(O)cc2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@@H](C)O)NC1=O 10.1021/jm010526+
CHEMBL1790712 125925 0 None 18 3 Human 9.7 pKi = 9.7 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1125 16 13 16 -0.3 CC[C@@H](C)[C@H]1NC(=O)[C@@](C)(c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N)=O)c2ccc(O)cc2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@@H](C)O)NC1=O 10.1021/jm010526+
118734326 237393 0 None None None Human 9.7 pKi = 9.7 Binding
Competitive binding to human oxytocin receptor by radioligand binding assayCompetitive binding to human oxytocin receptor by radioligand binding assay
ChEMBL 1203 19 13 17 -1.3 COc1ccc(C[C@@H]2NC(=O)C(N)C3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm501395b
CHEMBL3416758 237393 0 None None None Human 9.7 pKi = 9.7 Binding
Competitive binding to human oxytocin receptor by radioligand binding assayCompetitive binding to human oxytocin receptor by radioligand binding assay
ChEMBL 1203 19 13 17 -1.3 COc1ccc(C[C@@H]2NC(=O)C(N)C3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm501395b
56664849 125935 0 None 426 3 Human 9.6 pKi = 9.6 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1308 18 14 20 0.2 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790721 125935 0 None 426 3 Human 9.6 pKi = 9.6 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1308 18 14 20 0.2 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
56949758 156982 0 None None None Human 9.6 pKi = 9.6 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 520 7 1 6 2.1 COc1ccc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
CHEMBL2037487 156982 0 None None None Human 9.6 pKi = 9.6 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 520 7 1 6 2.1 COc1ccc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
56949760 156984 0 None None None Human 9.6 pKi = 9.6 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 491 7 1 5 2.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(N(C)C)nc1 10.1021/jm201287w
CHEMBL2037489 156984 0 None None None Human 9.6 pKi = 9.6 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 491 7 1 5 2.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(N(C)C)nc1 10.1021/jm201287w
56664848 125931 0 None 199 3 Human 9.5 pKi = 9.5 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1322 19 14 20 0.5 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790718 125931 0 None 199 3 Human 9.5 pKi = 9.5 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1322 19 14 20 0.5 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
53316559 119138 0 None None None Human 9.5 pKi = 9.5 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se]SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630522 119138 0 None None None Human 9.5 pKi = 9.5 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se]SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
90663156 216271 0 None None None Human 9.5 pKi = 9.5 Binding
Binding affinity towards OT receptor in CHO cells expressing the human OT receptorBinding affinity towards OT receptor in CHO cells expressing the human OT receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
CHEMBL3142790 216271 0 None None None Human 9.5 pKi = 9.5 Binding
Binding affinity towards OT receptor in CHO cells expressing the human OT receptorBinding affinity towards OT receptor in CHO cells expressing the human OT receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
56950039 156985 0 None None None Human 9.5 pKi = 9.5 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 533 7 1 6 2.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(N(C)C)nc1 10.1021/jm201287w
CHEMBL2037490 156985 0 None None None Human 9.5 pKi = 9.5 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 533 7 1 6 2.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(N(C)C)nc1 10.1021/jm201287w
56671723 125939 0 None 53 3 Human 9.5 pKi = 9.5 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1311 17 15 21 -0.4 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
CHEMBL1790729 125939 0 None 53 3 Human 9.5 pKi = 9.5 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1311 17 15 21 -0.4 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
449224 333602 12 None None None Human 9.5 pKi = 9.5 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL439044 333602 12 None None None Human 9.5 pKi = 9.5 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
DB13798 333602 12 None None None Human 9.5 pKi = 9.5 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
56657867 125930 0 None 40 3 Human 9.5 pKi = 9.5 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1338 19 15 21 -0.5 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790717 125930 0 None 40 3 Human 9.5 pKi = 9.5 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1338 19 15 21 -0.5 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
44456352 313996 0 None None None Human 9.4 pKi = 9.4 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 468 6 1 5 2.7 Cc1nc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cs1 10.1016/j.bmcl.2007.11.008
CHEMBL408691 313996 0 None None None Human 9.4 pKi = 9.4 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 468 6 1 5 2.7 Cc1nc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cs1 10.1016/j.bmcl.2007.11.008
11662784 276618 0 None None None Human 9.4 pKi = 9.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 469 6 2 3 2.9 CNC(=O)[C@@H](c1ccc(F)cc1F)N1C(=O)[C@@H](C2Cc3ccccc3C2)NC(=O)[C@H]1CC(C)C 10.1021/jm060073e
CHEMBL379192 276618 0 None None None Human 9.4 pKi = 9.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 469 6 2 3 2.9 CNC(=O)[C@@H](c1ccc(F)cc1F)N1C(=O)[C@@H](C2Cc3ccccc3C2)NC(=O)[C@H]1CC(C)C 10.1021/jm060073e
56949757 156981 0 None None None Human 9.4 pKi = 9.4 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 478 7 1 5 2.4 COc1ccc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
CHEMBL2037486 156981 0 None None None Human 9.4 pKi = 9.4 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 478 7 1 5 2.4 COc1ccc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
56949906 156987 0 None None None Human 9.4 pKi = 9.4 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 504 6 1 5 2.4 Cc1ccc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
CHEMBL2037492 156987 0 None None None Human 9.4 pKi = 9.4 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 504 6 1 5 2.4 Cc1ccc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
11705315 157004 0 None None None Human 9.4 pKi = 9.4 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 2 4 2.6 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1ccc(C)nc1C 10.1021/jm201287w
CHEMBL2037509 157004 0 None None None Human 9.4 pKi = 9.4 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 2 4 2.6 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1ccc(C)nc1C 10.1021/jm201287w
56657866 125924 0 None 75 3 Human 9.4 pKi = 9.4 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1281 16 14 20 0.3 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@H](C)O)NC1=O 10.1021/jm010526+
CHEMBL1790711 125924 0 None 75 3 Human 9.4 pKi = 9.4 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1281 16 14 20 0.3 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@H](C)O)NC1=O 10.1021/jm010526+
2042 8014 41 None -1 6 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2016.05.062
2176 8014 41 None -1 6 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2016.05.062
439302 8014 41 None -1 6 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2016.05.062
CHEMBL395429 8014 41 None -1 6 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2016.05.062
118734326 237393 0 None None None Human 9.4 pKi = 9.4 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetate
ChEMBL 1203 19 13 17 -1.3 COc1ccc(C[C@@H]2NC(=O)C(N)C3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm501395b
CHEMBL3416758 237393 0 None None None Human 9.4 pKi = 9.4 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetate
ChEMBL 1203 19 13 17 -1.3 COc1ccc(C[C@@H]2NC(=O)C(N)C3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm501395b
10461270 7472 18 None 2 5 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
2201 7472 18 None 2 5 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
CHEMBL1615640 7472 18 None 2 5 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
44279520 200209 0 None None None Human 9.3 pKi = 9.3 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 7 1 10 2.9 O=C(Cn1ccc(N2CCOCC2)nc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL286895 200209 0 None None None Human 9.3 pKi = 9.3 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 7 1 10 2.9 O=C(Cn1ccc(N2CCOCC2)nc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
11590596 333551 0 None None None Human 9.3 pKi = 9.3 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 455 6 2 3 2.6 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(N)=O)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL438609 333551 0 None None None Human 9.3 pKi = 9.3 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 455 6 2 3 2.6 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(N)=O)c1ccc(F)cc1F 10.1021/jm060073e
56949907 156988 0 None None None Human 9.3 pKi = 9.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 488 6 1 4 3.2 Cc1ccc([C@H](C(=O)N2CCCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
CHEMBL2037493 156988 0 None None None Human 9.3 pKi = 9.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 488 6 1 4 3.2 Cc1ccc([C@H](C(=O)N2CCCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
56950043 156995 0 None None None Human 9.3 pKi = 9.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 504 6 1 5 2.4 CC[C@@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1 10.1021/jm201287w
CHEMBL2037500 156995 0 None None None Human 9.3 pKi = 9.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 504 6 1 5 2.4 CC[C@@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1 10.1021/jm201287w
155536940 336772 0 None None None Human 9.3 pKi = 9.3 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1074 20 12 15 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4474284 336772 0 None None None Human 9.3 pKi = 9.3 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1074 20 12 15 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
2042 8014 41 None -1 6 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b01691
2176 8014 41 None -1 6 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b01691
439302 8014 41 None -1 6 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b01691
CHEMBL395429 8014 41 None -1 6 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/acs.jmedchem.8b01691
18700180 195209 0 None 1 2 Rat 9.2 pKi = 9.2 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 533 6 0 6 4.2 O=C(Cc1ccc(N2CCOCC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL25353 195209 0 None 1 2 Rat 9.2 pKi = 9.2 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 533 6 0 6 4.2 O=C(Cc1ccc(N2CCOCC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
90663155 216270 0 None None None Human 9.2 pKi = 9.2 Binding
Binding affinity towards OT receptor in CHO cells expressing the human OT receptorBinding affinity towards OT receptor in CHO cells expressing the human OT receptor
ChEMBL 1363 35 14 17 0.3 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
CHEMBL3142789 216270 0 None None None Human 9.2 pKi = 9.2 Binding
Binding affinity towards OT receptor in CHO cells expressing the human OT receptorBinding affinity towards OT receptor in CHO cells expressing the human OT receptor
ChEMBL 1363 35 14 17 0.3 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
11340891 6755 33 None 891 2 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
8403 6755 33 None 891 2 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
CHEMBL429736 6755 33 None 891 2 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
DB11818 6755 33 None 891 2 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
11590614 161183 0 None None None Human 9.2 pKi = 9.2 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 456 6 2 3 3.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)O)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL211556 161183 0 None None None Human 9.2 pKi = 9.2 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 456 6 2 3 3.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)O)c1ccc(F)cc1F 10.1021/jm060073e
11295207 275772 0 None None None Human 9.2 pKi = 9.2 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 511 6 2 4 2.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CC(O)C1)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL377315 275772 0 None None None Human 9.2 pKi = 9.2 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 511 6 2 4 2.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CC(O)C1)c1ccc(F)cc1F 10.1021/jm060073e
11465834 275790 0 None 23 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL377414 275790 0 None 23 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
11569527 276489 0 None None None Human 9.2 pKi = 9.2 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 495 6 1 3 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCC1)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL378718 276489 0 None None None Human 9.2 pKi = 9.2 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 495 6 1 3 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCC1)c1ccc(F)cc1F 10.1021/jm060073e
11340891 6755 33 None 891 2 Human 9.2 pKi = 9.2 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
8403 6755 33 None 891 2 Human 9.2 pKi = 9.2 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
CHEMBL429736 6755 33 None 891 2 Human 9.2 pKi = 9.2 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
DB11818 6755 33 None 891 2 Human 9.2 pKi = 9.2 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
135413562 4496 12 None 1 5 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
2194 4496 12 None 1 5 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
CHEMBL445816 4496 12 None 1 5 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
135413562 4496 12 None 1 5 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
2194 4496 12 None 1 5 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
CHEMBL445816 4496 12 None 1 5 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
44297449 333859 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
Tested for inhibition constant at OT receptor of rat mammary glandsTested for inhibition constant at OT receptor of rat mammary glands
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL441195 333859 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
Tested for inhibition constant at OT receptor of rat mammary glandsTested for inhibition constant at OT receptor of rat mammary glands
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
118734326 237393 0 None None None Human 9.2 pKi = 9.2 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetate
ChEMBL 1203 19 13 17 -1.3 COc1ccc(C[C@@H]2NC(=O)C(N)C3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm501395b
CHEMBL3416758 237393 0 None None None Human 9.2 pKi = 9.2 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetate
ChEMBL 1203 19 13 17 -1.3 COc1ccc(C[C@@H]2NC(=O)C(N)C3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm501395b
135413562 4496 12 None -1 5 Rat 9.2 pKi = 9.2 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
2194 4496 12 None -1 5 Rat 9.2 pKi = 9.2 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
CHEMBL445816 4496 12 None -1 5 Rat 9.2 pKi = 9.2 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
135413562 4496 12 None -1 5 Rat 9.2 pKi = 9.2 Binding
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
2194 4496 12 None -1 5 Rat 9.2 pKi = 9.2 Binding
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
CHEMBL445816 4496 12 None -1 5 Rat 9.2 pKi = 9.2 Binding
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
1103817 40884 7 None 3 4 Rat 9.2 pKi = 9.2 Binding
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm901812z
CHEMBL1254117 40884 7 None 3 4 Rat 9.2 pKi = 9.2 Binding
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm901812z
CHEMBL2112249 485097 2 None 8 2 Rat 9.2 pKi = 9.2 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from pregnant ratsCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from pregnant rats
ChEMBL 766 6 4 7 2.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
9938406 184110 1 None 1 6 Rat 9.2 pKi = 9.2 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 589 7 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OCC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL24526 184110 1 None 1 6 Rat 9.2 pKi = 9.2 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 589 7 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OCC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
53317550 119139 0 None None None Human 9.1 pKi = 9.1 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CS[Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630523 119139 0 None None None Human 9.1 pKi = 9.1 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CS[Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
2042 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Binding affinity to OTR (unknown origin)Binding affinity to OTR (unknown origin)
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
2176 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Binding affinity to OTR (unknown origin)Binding affinity to OTR (unknown origin)
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
439302 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Binding affinity to OTR (unknown origin)Binding affinity to OTR (unknown origin)
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
CHEMBL395429 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Binding affinity to OTR (unknown origin)Binding affinity to OTR (unknown origin)
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
2042 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Competitive binding to oxytocin receptor (unknown origin) by radioligand binding assayCompetitive binding to oxytocin receptor (unknown origin) by radioligand binding assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
2176 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Competitive binding to oxytocin receptor (unknown origin) by radioligand binding assayCompetitive binding to oxytocin receptor (unknown origin) by radioligand binding assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
439302 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Competitive binding to oxytocin receptor (unknown origin) by radioligand binding assayCompetitive binding to oxytocin receptor (unknown origin) by radioligand binding assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
CHEMBL395429 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Competitive binding to oxytocin receptor (unknown origin) by radioligand binding assayCompetitive binding to oxytocin receptor (unknown origin) by radioligand binding assay
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
2042 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm100989w
2176 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm100989w
439302 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm100989w
CHEMBL395429 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm100989w
44456194 195726 0 None None None Human 9.1 pKi = 9.1 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 478 7 1 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1coc(C2CC2)n1 10.1016/j.bmcl.2007.11.008
CHEMBL256692 195726 0 None None None Human 9.1 pKi = 9.1 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 478 7 1 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1coc(C2CC2)n1 10.1016/j.bmcl.2007.11.008
44455964 197859 0 None None None Human 9.1 pKi = 9.1 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 529 7 2 4 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(Br)o1 10.1016/j.bmcl.2007.11.008
CHEMBL270624 197859 0 None None None Human 9.1 pKi = 9.1 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 529 7 2 4 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(Br)o1 10.1016/j.bmcl.2007.11.008
25212177 348862 6 None 7 4 Human 9.1 pKi = 9.1 Binding
Displacement of 3H-oxytocin from human recombinant oxytocin receptor expressed in CHO cells by filtration binding assayDisplacement of 3H-oxytocin from human recombinant oxytocin receptor expressed in CHO cells by filtration binding assay
ChEMBL 463 7 0 7 3.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)c(C)n2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL456263 348862 6 None 7 4 Human 9.1 pKi = 9.1 Binding
Displacement of 3H-oxytocin from human recombinant oxytocin receptor expressed in CHO cells by filtration binding assayDisplacement of 3H-oxytocin from human recombinant oxytocin receptor expressed in CHO cells by filtration binding assay
ChEMBL 463 7 0 7 3.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)c(C)n2)cn1 10.1016/j.bmcl.2008.11.018
56950170 156999 0 None None None Human 9.1 pKi = 9.1 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 6 1 4 3.0 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1cc(C)cnc1C 10.1021/jm201287w
CHEMBL2037504 156999 0 None None None Human 9.1 pKi = 9.1 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 6 1 4 3.0 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1cc(C)cnc1C 10.1021/jm201287w
56950171 157000 0 None None None Human 9.1 pKi = 9.1 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1cc(C)cnc1C 10.1021/jm201287w
CHEMBL2037505 157000 0 None None None Human 9.1 pKi = 9.1 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1cc(C)cnc1C 10.1021/jm201287w
2042 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm010526+
2176 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm010526+
439302 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm010526+
CHEMBL395429 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm010526+
2042 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Displacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysisDisplacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysis
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.ejmech.2015.11.050
2176 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Displacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysisDisplacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysis
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.ejmech.2015.11.050
439302 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Displacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysisDisplacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysis
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.ejmech.2015.11.050
CHEMBL395429 8014 41 None -1 6 Human 9.1 pKi = 9.1 Binding
Displacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysisDisplacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysis
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.ejmech.2015.11.050
10627984 468607 0 None 4 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 646 8 0 7 5.5 CCc1c(CN2CCC(Oc3cc(OC)c(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)cc3F)CC2)c(C)cc(C)[n+]1[O-] 10.1021/jm9800797
CHEMBL66985 468607 0 None 4 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 646 8 0 7 5.5 CCc1c(CN2CCC(Oc3cc(OC)c(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)cc3F)CC2)c(C)cc(C)[n+]1[O-] 10.1021/jm9800797
10723001 202424 0 None 3 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 658 7 0 7 5.3 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C(F)(F)F)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL303700 202424 0 None 3 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 658 7 0 7 5.3 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C(F)(F)F)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
18700180 195209 0 None -1 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 533 6 0 6 4.2 O=C(Cc1ccc(N2CCOCC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL25353 195209 0 None -1 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 533 6 0 6 4.2 O=C(Cc1ccc(N2CCOCC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
2042 8014 41 None 1 6 Rat 9.1 pKi = 9.1 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm00171a003
2176 8014 41 None 1 6 Rat 9.1 pKi = 9.1 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm00171a003
439302 8014 41 None 1 6 Rat 9.1 pKi = 9.1 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm00171a003
CHEMBL395429 8014 41 None 1 6 Rat 9.1 pKi = 9.1 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm00171a003
135476004 160551 0 None 8 3 Human 9.1 pKi = 9.1 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1039/C5MD00566C
CHEMBL2113185 160551 0 None 8 3 Human 9.1 pKi = 9.1 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1039/C5MD00566C
3126 484342 1 None None None Rat 9.1 pKi = 9.1 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm9607156
CHEMBL435716 484342 1 None None None Rat 9.1 pKi = 9.1 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm9607156
135491819 160550 0 None 104 2 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 12 4 7 2.4 O=C(CCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1)NCCCO 10.1021/jm050645f
CHEMBL2113181 160550 0 None 104 2 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 12 4 7 2.4 O=C(CCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1)NCCCO 10.1021/jm050645f
135476004 160551 0 None 8 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113185 160551 0 None 8 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
155527198 335719 0 None None None Human 9.1 pKi = 9.1 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1056 20 12 14 -2.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4458988 335719 0 None None None Human 9.1 pKi = 9.1 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1056 20 12 14 -2.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL3814744 487605 0 None None None Human 9.0 pKi = 9.0 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1020 17 11 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
5311065 484177 30 None -2 8 Rat 9.0 pKi = 9.0 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
817 484177 30 None -2 8 Rat 9.0 pKi = 9.0 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL1429 484177 30 None -2 8 Rat 9.0 pKi = 9.0 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
DB00035 484177 30 None -2 8 Rat 9.0 pKi = 9.0 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
10555563 202203 0 None 4 2 Human 9.0 pKi = 9 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 600 7 0 7 4.8 COc1cc(OC2CCN(Cc3c(C)cc[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL302297 202203 0 None 4 2 Human 9.0 pKi = 9 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 600 7 0 7 4.8 COc1cc(OC2CCN(Cc3c(C)cc[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10579886 213336 0 None 4 2 Human 9.0 pKi = 9 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 632 7 0 7 5.2 COc1cc(OC2CCN(Cc3c(C)cc(C)[n+]([O-])c3C)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL308673 213336 0 None 4 2 Human 9.0 pKi = 9 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 632 7 0 7 5.2 COc1cc(OC2CCN(Cc3c(C)cc(C)[n+]([O-])c3C)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
15840423 184002 0 None 1 2 Human 9.0 pKi = 9 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 601 9 0 6 5.6 O=C(Cc1ccc(OC2CCN(CC3CC3)CC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL24456 184002 0 None 1 2 Human 9.0 pKi = 9 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 601 9 0 6 5.6 O=C(Cc1ccc(OC2CCN(CC3CC3)CC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
11340891 6755 33 None 891 2 Human 9.0 pKi = 9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
8403 6755 33 None 891 2 Human 9.0 pKi = 9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
CHEMBL429736 6755 33 None 891 2 Human 9.0 pKi = 9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
DB11818 6755 33 None 891 2 Human 9.0 pKi = 9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
11511019 159607 0 None None None Human 9.0 pKi = 9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 465 7 2 4 3.3 Cc1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)o1 10.1016/j.bmcl.2007.11.008
CHEMBL209864 159607 0 None None None Human 9.0 pKi = 9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 465 7 2 4 3.3 Cc1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)o1 10.1016/j.bmcl.2007.11.008
44456383 195929 0 None None None Human 9.0 pKi = 9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 545 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1cc(Br)cs1 10.1016/j.bmcl.2007.11.008
CHEMBL257660 195929 0 None None None Human 9.0 pKi = 9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 545 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1cc(Br)cs1 10.1016/j.bmcl.2007.11.008
44279572 202816 0 None None None Human 9.0 pKi = 9 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 617 7 1 8 4.7 O=C(Cn1ccc(-c2ccccc2)nc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL30510 202816 0 None None None Human 9.0 pKi = 9 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 617 7 1 8 4.7 O=C(Cn1ccc(-c2ccccc2)nc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
11488952 159212 0 None 31 3 Human 9.0 pKi = 9 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 501 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc2occc2c1 10.1021/jm060073e
CHEMBL208787 159212 0 None 31 3 Human 9.0 pKi = 9 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 501 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc2occc2c1 10.1021/jm060073e
56950042 156993 0 None None None Human 9.0 pKi = 9 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 1 4 2.7 CC[C@@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1 10.1021/jm201287w
CHEMBL2037498 156993 0 None None None Human 9.0 pKi = 9 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 1 4 2.7 CC[C@@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1 10.1021/jm201287w
56950168 156997 0 None None None Human 9.0 pKi = 9 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 478 6 1 4 1.9 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)[n+]([O-])c1 10.1021/jm201287w
CHEMBL2037502 156997 0 None None None Human 9.0 pKi = 9 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 478 6 1 4 1.9 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)[n+]([O-])c1 10.1021/jm201287w
44428107 24608 0 None -11 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 2058 46 18 25 6.0 CC1CC(C)(C)Nc2c1cc1c(c2S(=O)(=O)O)OC2C(=C1c1c(Cl)c(SCC(=O)NCCCCCC(=O)N(C(=O)[C@H]3CCN(C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](Cc4ccc(O)cc4)N(C)C(=O)CCc4ccc(O)cc4)C3)[C@@H](CCCCN)C(N)=O)c(Cl)c(Cl)c1C(=O)O)CC1C(=NC(C)(C)CC1C)C2S(=O)(=O)O 10.1021/jm061404q
91935616 24608 0 None -11 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 2058 46 18 25 6.0 CC1CC(C)(C)Nc2c1cc1c(c2S(=O)(=O)O)OC2C(=C1c1c(Cl)c(SCC(=O)NCCCCCC(=O)N(C(=O)[C@H]3CCN(C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](Cc4ccc(O)cc4)N(C)C(=O)CCc4ccc(O)cc4)C3)[C@@H](CCCCN)C(N)=O)c(Cl)c(Cl)c1C(=O)O)CC1C(=NC(C)(C)CC1C)C2S(=O)(=O)O 10.1021/jm061404q
CHEMBL1161978 24608 0 None -11 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 2058 46 18 25 6.0 CC1CC(C)(C)Nc2c1cc1c(c2S(=O)(=O)O)OC2C(=C1c1c(Cl)c(SCC(=O)NCCCCCC(=O)N(C(=O)[C@H]3CCN(C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](Cc4ccc(O)cc4)N(C)C(=O)CCc4ccc(O)cc4)C3)[C@@H](CCCCN)C(N)=O)c(Cl)c(Cl)c1C(=O)O)CC1C(=NC(C)(C)CC1C)C2S(=O)(=O)O 10.1021/jm061404q
CHEMBL3813894 487597 0 None None None Human 9.0 pKi = 9.0 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1020 17 11 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
135493119 160559 0 None 4 3 Human 9.0 pKi = 9.0 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
CHEMBL2113201 160559 0 None 4 3 Human 9.0 pKi = 9.0 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
56665480 125919 0 None 91 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 754 6 2 8 3.5 CC[C@@H](C)[C@@H]1/N=C(\S)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCC=NN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00171a003
CHEMBL1790544 125919 0 None 91 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 754 6 2 8 3.5 CC[C@@H](C)[C@@H]1/N=C(\S)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCC=NN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00171a003
10531717 203009 0 None 4 2 Human 9.0 pKi = 9.0 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 604 7 0 7 4.6 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL306416 203009 0 None 4 2 Human 9.0 pKi = 9.0 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 604 7 0 7 4.6 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
135493119 160559 0 None 4 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113201 160559 0 None 4 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
76073634 234791 7 None None None Human 9.0 pKi = 9.0 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL3354594 234791 7 None None None Human 9.0 pKi = 9.0 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
DB12932 234791 7 None None None Human 9.0 pKi = 9.0 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
44275447 196766 0 None -1 4 Human 9.0 pKi = 9.0 Binding
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1111 32 13 13 -3.6 CN(C(=O)Cc1ccccc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(N)=O 10.1021/jm9804782
CHEMBL262035 196766 0 None -1 4 Human 9.0 pKi = 9.0 Binding
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1111 32 13 13 -3.6 CN(C(=O)Cc1ccccc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(N)=O 10.1021/jm9804782
146681949 8624 35 None -4 8 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm060928n
2168 8624 35 None -4 8 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm060928n
2810 8624 35 None -4 8 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm060928n
644077 8624 35 None -4 8 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm060928n
CHEMBL373742 8624 35 None -4 8 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm060928n
DB00067 8624 35 None -4 8 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm060928n
P01185 8624 35 None -4 8 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm060928n
P01186 8624 35 None -4 8 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm060928n
P35455 8624 35 None -4 8 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm060928n
10556286 469253 0 None 10 2 Human 8.9 pKi = 8.9 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 658 7 0 7 5.3 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C(F)(F)F)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL71540 469253 0 None 10 2 Human 8.9 pKi = 8.9 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 658 7 0 7 5.3 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C(F)(F)F)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
15840423 184002 0 None -1 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 601 9 0 6 5.6 O=C(Cc1ccc(OC2CCN(CC3CC3)CC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL24456 184002 0 None -1 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 601 9 0 6 5.6 O=C(Cc1ccc(OC2CCN(CC3CC3)CC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
2042 8014 41 None -1 6 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2018.03.019
2176 8014 41 None -1 6 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2018.03.019
439302 8014 41 None -1 6 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2018.03.019
CHEMBL395429 8014 41 None -1 6 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmc.2018.03.019
44275525 387710 0 None -16 4 Human 8.9 pKi = 8.9 Binding
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2cc(C(=O)N(C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(N)=O)ccc21 10.1021/jm9804782
91931055 387710 0 None -16 4 Human 8.9 pKi = 8.9 Binding
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2cc(C(=O)N(C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(N)=O)ccc21 10.1021/jm9804782
CHEMBL540192 387710 0 None -16 4 Human 8.9 pKi = 8.9 Binding
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2cc(C(=O)N(C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(N)=O)ccc21 10.1021/jm9804782
2239 2222 0 None 501 3 Human 8.9 pKi = 8.9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
6918854 2222 0 None 501 3 Human 8.9 pKi = 8.9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
CHEMBL196478 2222 0 None 501 3 Human 8.9 pKi = 8.9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
44456109 195664 0 None None None Human 8.9 pKi = 8.9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 482 8 2 6 1.6 Cc1nc([C@H](C(=O)N(C)CCO)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
CHEMBL256391 195664 0 None None None Human 8.9 pKi = 8.9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 482 8 2 6 1.6 Cc1nc([C@H](C(=O)N(C)CCO)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
44456004 198058 0 None None None Human 8.9 pKi = 8.9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 479 7 2 4 3.6 Cc1cc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)oc1C 10.1016/j.bmcl.2007.11.008
CHEMBL271657 198058 0 None None None Human 8.9 pKi = 8.9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 479 7 2 4 3.6 Cc1cc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)oc1C 10.1016/j.bmcl.2007.11.008
44456229 311095 0 None None None Human 8.9 pKi = 8.9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 466 7 2 5 2.7 Cc1nc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
CHEMBL401910 311095 0 None None None Human 8.9 pKi = 8.9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 466 7 2 5 2.7 Cc1nc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
44279607 200050 0 None None None Human 8.9 pKi = 8.9 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 595 6 1 10 3.0 Cn1ncc2c(=O)n(CC(=O)NCc3cc4cc(C(=O)N5CCC(N6C(=O)OCc7ccccc76)CC5)ccc4o3)cnc21 10.1016/s0960-894x(02)00160-9
CHEMBL285820 200050 0 None None None Human 8.9 pKi = 8.9 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 595 6 1 10 3.0 Cn1ncc2c(=O)n(CC(=O)NCc3cc4cc(C(=O)N5CCC(N6C(=O)OCc7ccccc76)CC5)ccc4o3)cnc21 10.1016/s0960-894x(02)00160-9
2239 2222 0 None 501 3 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-oxytocin from human oxytocin receptorDisplacement of [3H]-oxytocin from human oxytocin receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
6918854 2222 0 None 501 3 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-oxytocin from human oxytocin receptorDisplacement of [3H]-oxytocin from human oxytocin receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
CHEMBL196478 2222 0 None 501 3 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-oxytocin from human oxytocin receptorDisplacement of [3H]-oxytocin from human oxytocin receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
2239 2222 0 None 501 3 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm060073e
6918854 2222 0 None 501 3 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm060073e
CHEMBL196478 2222 0 None 501 3 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm060073e
11685100 161073 0 None None None Human 8.9 pKi = 8.9 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 525 6 1 4 3.0 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL211443 161073 0 None None None Human 8.9 pKi = 8.9 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 525 6 1 4 3.0 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(F)cc1F 10.1021/jm060073e
56950169 156998 0 None None None Human 8.9 pKi = 8.9 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 2 4 2.6 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1cc(C)cnc1C 10.1021/jm201287w
CHEMBL2037503 156998 0 None None None Human 8.9 pKi = 8.9 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 2 4 2.6 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1cc(C)cnc1C 10.1021/jm201287w
42611262 354432 0 None 31 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells by filtration binding assayDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells by filtration binding assay
ChEMBL 349 6 0 2 4.7 Cc1cc(C(=O)N(CC2CC2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
CHEMBL475395 354432 0 None 31 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells by filtration binding assayDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells by filtration binding assay
ChEMBL 349 6 0 2 4.7 Cc1cc(C(=O)N(CC2CC2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
CHEMBL2112248 485096 0 None -1 2 Human 8.9 pKi = 8.9 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from nonlabor pregnant womenCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from nonlabor pregnant women
ChEMBL 754 6 5 8 1.5 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
CHEMBL2112248 485096 0 None 1 2 Rat 8.9 pKi = 8.9 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from pregnant ratsCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from pregnant rats
ChEMBL 754 6 5 8 1.5 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
CHEMBL3814633 487604 0 None None None Human 8.9 pKi = 8.9 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1020 17 11 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
10699322 468600 0 None None None Human 8.9 pKi = 8.9 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 640 7 0 7 5.2 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C(F)(F)F)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL66931 468600 0 None None None Human 8.9 pKi = 8.9 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 640 7 0 7 5.2 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C(F)(F)F)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
9938406 184110 1 None -1 6 Human 8.9 pKi = 8.9 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 589 7 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OCC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL24526 184110 1 None -1 6 Human 8.9 pKi = 8.9 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 589 7 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OCC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
18700187 199084 0 None 1 2 Human 8.9 pKi = 8.9 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 577 9 0 7 4.0 O=C(Cc1ccc(OCCN2CCOCC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL278818 199084 0 None 1 2 Human 8.9 pKi = 8.9 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 577 9 0 7 4.0 O=C(Cc1ccc(OCCN2CCOCC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
118720268 234776 0 None None None Human 8.9 pKi = 8.9 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL3354579 234776 0 None None None Human 8.9 pKi = 8.9 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
155565903 349729 0 None None None Human 8.9 pKi = 8.9 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1024 21 13 16 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4583231 349729 0 None None None Human 8.9 pKi = 8.9 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1024 21 13 16 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
44297525 197135 0 None -7 3 Rat 8.9 pKi = 8.9 Binding
Tested for inhibition constant at OT receptor of rat mammary glandsTested for inhibition constant at OT receptor of rat mammary glands
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL265048 197135 0 None -7 3 Rat 8.9 pKi = 8.9 Binding
Tested for inhibition constant at OT receptor of rat mammary glandsTested for inhibition constant at OT receptor of rat mammary glands
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
10817776 468809 0 None 5 2 Human 8.8 pKi = 8.8 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 628 8 0 7 5.3 CCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)c(C)cc(C)[n+]1[O-] 10.1021/jm9800797
CHEMBL68480 468809 0 None 5 2 Human 8.8 pKi = 8.8 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 628 8 0 7 5.3 CCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)c(C)cc(C)[n+]1[O-] 10.1021/jm9800797
73346893 180194 0 None None None Human 8.8 pKi = 8.8 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 989 17 12 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)CCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL2369425 180194 0 None None None Human 8.8 pKi = 8.8 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 989 17 12 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)CCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
44456070 311306 0 None None None Human 8.8 pKi = 8.8 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 464 6 1 5 2.4 Cc1nc([C@H](C(=O)N2CCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
CHEMBL403149 311306 0 None None None Human 8.8 pKi = 8.8 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 464 6 1 5 2.4 Cc1nc([C@H](C(=O)N2CCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
44581267 348857 0 None None None Human 8.8 pKi = 8.8 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 505 9 0 7 4.9 COc1ccc(OC)c(S(=O)(=O)N(Cc2ccc(-c3ccccc3C)cn2)c2ccc(OC)nc2)c1 10.1016/j.bmcl.2008.11.018
CHEMBL456254 348857 0 None None None Human 8.8 pKi = 8.8 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 505 9 0 7 4.9 COc1ccc(OC)c(S(=O)(=O)N(Cc2ccc(-c3ccccc3C)cn2)c2ccc(OC)nc2)c1 10.1016/j.bmcl.2008.11.018
44413575 331151 0 None None None Human 8.8 pKi = 8.8 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 546 8 2 5 3.2 CC[C@@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N2CCOCC2)cc1 10.1021/jm060073e
CHEMBL427227 331151 0 None None None Human 8.8 pKi = 8.8 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 546 8 2 5 3.2 CC[C@@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N2CCOCC2)cc1 10.1021/jm060073e
11519207 271035 0 None None None Human 8.8 pKi = 8.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 518 8 3 4 3.4 CC(=O)Nc1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
11577215 271035 0 None None None Human 8.8 pKi = 8.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 518 8 3 4 3.4 CC(=O)Nc1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL371008 271035 0 None None None Human 8.8 pKi = 8.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 518 8 3 4 3.4 CC(=O)Nc1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL372619 271035 0 None None None Human 8.8 pKi = 8.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 518 8 3 4 3.4 CC(=O)Nc1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
56949905 156986 0 None None None Human 8.8 pKi = 8.8 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 1 4 2.7 Cc1ccc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
CHEMBL2037491 156986 0 None None None Human 8.8 pKi = 8.8 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 1 4 2.7 Cc1ccc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
135399831 160552 0 None 1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)NC(=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113189 160552 0 None 1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)NC(=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
10461270 7472 18 None -2 5 Rat 8.8 pKi = 8.8 Binding
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
2201 7472 18 None -2 5 Rat 8.8 pKi = 8.8 Binding
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
CHEMBL1615640 7472 18 None -2 5 Rat 8.8 pKi = 8.8 Binding
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
CHEMBL2372927 485915 0 None 199 2 Rat 8.8 pKi = 8.8 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 766 6 4 7 2.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]2CCCCN2C1=O 10.1021/jm00169a001
44275524 316842 0 None -9 4 Human 8.8 pKi = 8.8 Binding
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N(C(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(N)=O 10.1021/jm9804782
91931053 316842 0 None -9 4 Human 8.8 pKi = 8.8 Binding
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N(C(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(N)=O 10.1021/jm9804782
CHEMBL412210 316842 0 None -9 4 Human 8.8 pKi = 8.8 Binding
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N(C(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(N)=O 10.1021/jm9804782
146681949 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm3006146
2168 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm3006146
2810 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm3006146
644077 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm3006146
CHEMBL373742 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm3006146
DB00067 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm3006146
P01185 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm3006146
P01186 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm3006146
P35455 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm3006146
2042 8014 41 None 1 6 Rat 8.8 pKi = 8.8 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm9607156
2176 8014 41 None 1 6 Rat 8.8 pKi = 8.8 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm9607156
439302 8014 41 None 1 6 Rat 8.8 pKi = 8.8 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm9607156
CHEMBL395429 8014 41 None 1 6 Rat 8.8 pKi = 8.8 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm9607156
10675476 461752 0 None 5 2 Human 8.8 pKi = 8.8 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 630 6 0 7 5.2 COc1cc(OC2CCN([C@H]3CCCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL68800 461752 0 None 5 2 Human 8.8 pKi = 8.8 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 630 6 0 7 5.2 COc1cc(OC2CCN([C@H]3CCCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
146681949 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
2168 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
2810 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
644077 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
CHEMBL373742 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
DB00067 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
P01185 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
P01186 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
P35455 8624 35 None -5 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm1016208
56675151 125938 0 None 14 3 Human 8.7 pKi = 8.7 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1295 17 14 20 0.7 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
CHEMBL1790728 125938 0 None 14 3 Human 8.7 pKi = 8.7 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1295 17 14 20 0.7 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
11169 1650 39 None 1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
165708555 1650 39 None 1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
16681432 1650 39 None 1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
495 1650 39 None 1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
CHEMBL3301668 1650 39 None 1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
DB01282 1650 39 None 1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
44428109 24609 0 None 1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 1629 38 18 23 -0.0 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N(C(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)[C@@H](CCCCN)C(N)=O)C1 10.1021/jm061404q
91935618 24609 0 None 1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 1629 38 18 23 -0.0 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N(C(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)[C@@H](CCCCN)C(N)=O)C1 10.1021/jm061404q
CHEMBL1161979 24609 0 None 1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 1629 38 18 23 -0.0 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N(C(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)[C@@H](CCCCN)C(N)=O)C1 10.1021/jm061404q
11260438 197937 0 None None None Human 8.7 pKi = 8.7 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 Cc1nc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
44577873 197937 0 None None None Human 8.7 pKi = 8.7 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 Cc1nc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
CHEMBL271039 197937 0 None None None Human 8.7 pKi = 8.7 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 Cc1nc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
CHEMBL513488 197937 0 None None None Human 8.7 pKi = 8.7 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 Cc1nc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
44456424 315524 0 None None None Human 8.7 pKi = 8.7 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 545 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(Br)s1 10.1016/j.bmcl.2007.11.008
CHEMBL410420 315524 0 None None None Human 8.7 pKi = 8.7 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 545 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(Br)s1 10.1016/j.bmcl.2007.11.008
44279908 199783 0 None 794 2 Human 8.7 pKi = 8.7 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 585 8 1 9 3.5 CCOc1ccn(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)c(=O)n1 10.1016/s0960-894x(02)00160-9
CHEMBL283894 199783 0 None 794 2 Human 8.7 pKi = 8.7 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 585 8 1 9 3.5 CCOc1ccn(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)c(=O)n1 10.1016/s0960-894x(02)00160-9
10416272 214451 4 None 630 2 Human 8.7 pKi = 8.7 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL31065 214451 4 None 630 2 Human 8.7 pKi = 8.7 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
11685194 272701 0 None None None Human 8.7 pKi = 8.7 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 532 7 3 4 3.8 CC(=O)Nc1ccc([C@H](C(=O)NC(C)(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL372554 272701 0 None None None Human 8.7 pKi = 8.7 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 532 7 3 4 3.8 CC(=O)Nc1ccc([C@H](C(=O)NC(C)(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
21886866 272712 17 None None None Human 8.7 pKi = 8.7 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 135 0 1 2 1.1 c1ccc2c(c1)CNCO2 10.1021/jm050557v
CHEMBL372615 272712 17 None None None Human 8.7 pKi = 8.7 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 135 0 1 2 1.1 c1ccc2c(c1)CNCO2 10.1021/jm050557v
2252 4546 39 None -1 5 Human 8.0 pKi = 8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00159-2
6918320 4546 39 None -1 5 Human 8.0 pKi = 8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00159-2
CHEMBL24781 4546 39 None -1 5 Human 8.0 pKi = 8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00159-2
44279637 220934 0 None None None Human 8.0 pKi = 8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 550 5 0 6 4.1 Cc1cc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc2ccn(C[C@H]3CCCN3S(C)(=O)=O)c12 10.1016/s0960-894x(02)00159-2
CHEMBL32745 220934 0 None None None Human 8.0 pKi = 8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 550 5 0 6 4.1 Cc1cc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc2ccn(C[C@H]3CCCN3S(C)(=O)=O)c12 10.1016/s0960-894x(02)00159-2
44308876 468866 0 None 2 2 Human 8.0 pKi = 8 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 556 7 0 7 4.9 COc1cc(OC2CCN(Cc3cccnc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL68914 468866 0 None 2 2 Human 8.0 pKi = 8 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 556 7 0 7 4.9 COc1cc(OC2CCN(Cc3cccnc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
44581687 349592 0 None None None Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 445 7 0 5 4.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2ccccc2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL457998 349592 0 None None None Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 445 7 0 5 4.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2ccccc2)cn1 10.1016/j.bmcl.2008.11.018
44581240 372840 0 None 6 3 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 486 8 0 7 4.4 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C#N)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL515660 372840 0 None 6 3 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 486 8 0 7 4.4 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C#N)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44279573 199363 0 None None None Human 8.0 pKi = 8 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 625 6 1 8 4.6 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1nc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2s1 10.1016/s0960-894x(02)00160-9
CHEMBL281081 199363 0 None None None Human 8.0 pKi = 8 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 625 6 1 8 4.6 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1nc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2s1 10.1016/s0960-894x(02)00160-9
44279846 199767 0 None None None Human 8.0 pKi = 8 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 648 6 0 7 6.4 O=C(c1ccc2oc(CN3CCCC[C@H]3Cn3cc(C(F)(F)F)ccc3=O)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
CHEMBL283676 199767 0 None None None Human 8.0 pKi = 8 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 648 6 0 7 6.4 O=C(c1ccc2oc(CN3CCCC[C@H]3Cn3cc(C(F)(F)F)ccc3=O)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
44280354 335700 0 None None None Human 8.0 pKi = 8 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 628 5 0 7 6.5 O=C(c1ccc2oc(-c3cccc(Cn4cc(C(F)(F)F)ccc4=O)n3)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
CHEMBL445875 335700 0 None None None Human 8.0 pKi = 8 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 628 5 0 7 6.5 O=C(c1ccc2oc(-c3cccc(Cn4cc(C(F)(F)F)ccc4=O)n3)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
135520376 160567 0 None 138 2 Human 8.0 pKi = 8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 526 9 2 6 3.8 CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113209 160567 0 None 138 2 Human 8.0 pKi = 8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 526 9 2 6 3.8 CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
44404012 142664 0 None None None Human 8.0 pKi = 8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 539 8 2 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm050557v
44404027 142664 0 None None None Human 8.0 pKi = 8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 539 8 2 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm050557v
CHEMBL194584 142664 0 None None None Human 8.0 pKi = 8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 539 8 2 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm050557v
CHEMBL197833 142664 0 None None None Human 8.0 pKi = 8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 539 8 2 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm050557v
70685417 155339 0 None 79 3 Human 8.0 pKi = 8 Binding
Displacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 707 9 0 6 4.3 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OC/C=C/I)c2)CC1 10.1016/j.bmc.2012.02.019
CHEMBL2017867 155339 0 None 79 3 Human 8.0 pKi = 8 Binding
Displacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 707 9 0 6 4.3 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OC/C=C/I)c2)CC1 10.1016/j.bmc.2012.02.019
11465834 275790 0 None -23 4 Rat 8.0 pKi = 8 Binding
Displacement of [3H]oxytocin from rat OTRDisplacement of [3H]oxytocin from rat OTR
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL377414 275790 0 None -23 4 Rat 8.0 pKi = 8 Binding
Displacement of [3H]oxytocin from rat OTRDisplacement of [3H]oxytocin from rat OTR
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
135520376 160567 0 None 138 2 Human 8.0 pKi = 8 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 526 9 2 6 3.8 CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
CHEMBL2113209 160567 0 None 138 2 Human 8.0 pKi = 8 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 526 9 2 6 3.8 CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
67839485 329150 0 None -4 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 327 2 0 1 5.3 O=C(c1ccc(-c2ccccc2)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
CHEMBL4210854 329150 0 None -4 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 327 2 0 1 5.3 O=C(c1ccc(-c2ccccc2)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
CHEMBL3813722 487593 0 None None None Human 8.0 pKi = 8.0 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1034 17 10 15 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
44279688 200303 0 None None None Human 7.0 pKi = 7 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 6 1 7 4.8 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5c(F)cccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL287628 200303 0 None None None Human 7.0 pKi = 7 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 6 1 7 4.8 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5c(F)cccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
44279997 202882 0 None None None Human 7.0 pKi = 7 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL30550 202882 0 None None None Human 7.0 pKi = 7 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2o1 10.1016/s0960-894x(02)00160-9
1134581 24197 7 None 3 2 Human 7.0 pKi = 7 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 444 7 1 4 4.5 COc1ccc(N(CC(=O)Nc2cccc(Cl)c2C)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
CHEMBL114302 24197 7 None 3 2 Human 7.0 pKi = 7 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 444 7 1 4 4.5 COc1ccc(N(CC(=O)Nc2cccc(Cl)c2C)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
44404012 142664 0 None None None Human 7.0 pKi = 7 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 539 8 2 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm050557v
44404027 142664 0 None None None Human 7.0 pKi = 7 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 539 8 2 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm050557v
CHEMBL194584 142664 0 None None None Human 7.0 pKi = 7 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 539 8 2 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm050557v
CHEMBL197833 142664 0 None None None Human 7.0 pKi = 7 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 539 8 2 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm050557v
11569194 144330 0 None 63 2 Human 7.0 pKi = 7 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 479 7 2 3 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(F)cc1 10.1021/jm050557v
11619939 144330 0 None 63 2 Human 7.0 pKi = 7 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 479 7 2 3 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(F)cc1 10.1021/jm050557v
CHEMBL197793 144330 0 None 63 2 Human 7.0 pKi = 7 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 479 7 2 3 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(F)cc1 10.1021/jm050557v
CHEMBL427353 144330 0 None 63 2 Human 7.0 pKi = 7 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 479 7 2 3 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(F)cc1 10.1021/jm050557v
44275026 182394 0 None None None Human 7.0 pKi = 7 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 488 7 2 4 3.3 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2cccc(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL24074 182394 0 None None None Human 7.0 pKi = 7 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 488 7 2 4 3.3 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2cccc(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
44274724 193876 0 None None None Human 7.0 pKi = 7 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 522 7 2 4 4.0 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2ccc(Cl)c(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL24605 193876 0 None None None Human 7.0 pKi = 7 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 522 7 2 4 4.0 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2ccc(Cl)c(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
44274675 194063 0 None None None Human 7.0 pKi = 7 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 572 12 2 5 4.5 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCCc2cccc(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL24678 194063 0 None None None Human 7.0 pKi = 7 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 572 12 2 5 4.5 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCCc2cccc(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
44274994 194327 0 None None None Human 7.0 pKi = 7 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 504 7 2 4 3.8 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2cccc3ccccc23)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL24816 194327 0 None None None Human 7.0 pKi = 7 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 504 7 2 4 3.8 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2cccc3ccccc23)C1=O 10.1016/s0960-894x(01)00202-5
9797987 237306 1 None 1 3 Human 6.0 pKi = 6 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 339 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm901812z
CHEMBL341490 237306 1 None 1 3 Human 6.0 pKi = 6 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 339 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm901812z
56682530 125921 0 None -245 4 Human 7.0 pKi = 7.0 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1053 18 12 14 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL1790575 125921 0 None -245 4 Human 7.0 pKi = 7.0 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1053 18 12 14 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL2369841 477601 0 None -301 4 Human 6.0 pKi = 6.0 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1026 17 13 15 -4.6 NC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
135510027 278317 0 None None None Human 7.0 pKi = 7.0 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 524 7 2 5 6.4 Cc1ccc(N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)S(=O)(=O)c2ccc(-c3ccccc3)cc2)cc1 10.1021/jm050645f
CHEMBL382515 278317 0 None None None Human 7.0 pKi = 7.0 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 524 7 2 5 6.4 Cc1ccc(N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)S(=O)(=O)c2ccc(-c3ccccc3)cc2)cc1 10.1021/jm050645f
145976648 328808 0 None -1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 293 3 0 1 4.6 CCCc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
CHEMBL4206482 328808 0 None -1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 293 3 0 1 4.6 CCCc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
44419039 274799 0 None -8511 8 Human 6.0 pKi = 6.0 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1096 20 14 15 -4.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
CHEMBL375324 274799 0 None -8511 8 Human 6.0 pKi = 6.0 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1096 20 14 15 -4.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
135489430 160554 0 None 11 2 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 627 12 2 9 3.1 COC(=O)c1cccc2c1NC(=O)/C2=N\NC(=O)CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCCN(C)C)cc1 10.1021/jm050645f
CHEMBL2113195 160554 0 None 11 2 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 627 12 2 9 3.1 COC(=O)c1cccc2c1NC(=O)/C2=N\NC(=O)CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCCN(C)C)cc1 10.1021/jm050645f
10411308 462175 0 None -39 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/acs.jmedchem.8b00697
CHEMBL603708 462175 0 None -39 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/acs.jmedchem.8b00697
10411308 462175 0 None -39 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm3006146
CHEMBL603708 462175 0 None -39 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm3006146
10411308 462175 0 None -39 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm901084f
CHEMBL603708 462175 0 None -39 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm901084f
10507277 468944 0 None 2 2 Human 8.0 pKi = 8.0 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 570 7 0 7 5.2 COc1cc(OC2CCN(Cc3cccnc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL69520 468944 0 None 2 2 Human 8.0 pKi = 8.0 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 570 7 0 7 5.2 COc1cc(OC2CCN(Cc3cccnc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10793202 468947 0 None 2 2 Human 8.0 pKi = 8.0 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 572 7 0 7 4.1 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL69539 468947 0 None 2 2 Human 8.0 pKi = 8.0 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 572 7 0 7 4.1 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10507800 468517 0 None -5 2 Rat 8.0 pKi = 8.0 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 600 8 0 7 4.7 CCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)ccc[n+]1[O-] 10.1021/jm9800797
CHEMBL66240 468517 0 None -5 2 Rat 8.0 pKi = 8.0 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 600 8 0 7 4.7 CCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)ccc[n+]1[O-] 10.1021/jm9800797
2213 1072 37 None -22 5 Human 8.0 pKi = 8.0 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2007.11.008
3008 1072 37 None -22 5 Human 8.0 pKi = 8.0 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2007.11.008
5311010 1072 37 None -22 5 Human 8.0 pKi = 8.0 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2007.11.008
68613 1072 37 None -22 5 Human 8.0 pKi = 8.0 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2007.11.008
CHEMBL378642 1072 37 None -22 5 Human 8.0 pKi = 8.0 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2007.11.008
CHEMBL382301 1072 37 None -22 5 Human 8.0 pKi = 8.0 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2007.11.008
DB09059 1072 37 None -22 5 Human 8.0 pKi = 8.0 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2007.11.008
53320505 119140 0 None None None Human 7.9 pKi = 7.9 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1074 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se][Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630524 119140 0 None None None Human 7.9 pKi = 7.9 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1074 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se][Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
135513039 160563 0 None 63 2 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 473 6 2 6 2.5 Cc1ccc(N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)S(=O)(=O)c2ccc(C#N)cc2)cc1 10.1021/jm050645f
CHEMBL2113205 160563 0 None 63 2 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 473 6 2 6 2.5 Cc1ccc(N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)S(=O)(=O)c2ccc(C#N)cc2)cc1 10.1021/jm050645f
135916059 451719 0 None -16 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 513 4 2 5 6.6 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1NC(=O)c1ccccc1-c1ccccc1 10.1021/jm901084f
CHEMBL602872 451719 0 None -16 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 513 4 2 5 6.6 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1NC(=O)c1ccccc1-c1ccccc1 10.1021/jm901084f
CHEMBL3814126 487599 0 None None None Human 7.0 pKi = 7.0 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1020 17 11 15 -3.3 CC[C@H](C)[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1C 10.1016/j.bmc.2016.05.062
135530164 160558 0 None 1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 570 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113200 160558 0 None 1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 570 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
54581533 125127 0 None -57 3 Human 6.9 pKi = 6.9 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 636 9 0 9 5.2 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN(C)C)ccc3OC)(N3CCC[C@H]3c3ncco3)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779418 125127 0 None -57 3 Human 6.9 pKi = 6.9 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 636 9 0 9 5.2 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN(C)C)ccc3OC)(N3CCC[C@H]3c3ncco3)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
10005688 19410 0 None -2 2 Rat 7.9 pKi = 7.9 Binding
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 487 6 0 6 5.0 COc1cc(OC(C)c2cccnc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL105406 19410 0 None -2 2 Rat 7.9 pKi = 7.9 Binding
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 487 6 0 6 5.0 COc1cc(OC(C)c2cccnc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
10841081 202393 0 None -3 2 Rat 7.9 pKi = 7.9 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL303487 202393 0 None -3 2 Rat 7.9 pKi = 7.9 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10651439 202957 0 None -2 2 Rat 7.9 pKi = 7.9 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 614 7 0 7 5.1 COc1cc(OC2CCN(Cc3c(C)cc(C)[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL306010 202957 0 None -2 2 Rat 7.9 pKi = 7.9 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 614 7 0 7 5.1 COc1cc(OC2CCN(Cc3c(C)cc(C)[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
135414531 160566 0 None -3 3 Rat 7.9 pKi = 7.9 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 586 13 2 8 3.1 COCCOCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113208 160566 0 None -3 3 Rat 7.9 pKi = 7.9 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 586 13 2 8 3.1 COCCOCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
146681949 8624 35 None -5 8 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
2168 8624 35 None -5 8 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
2810 8624 35 None -5 8 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
644077 8624 35 None -5 8 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
CHEMBL373742 8624 35 None -5 8 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
DB00067 8624 35 None -5 8 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
P01185 8624 35 None -5 8 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
P01186 8624 35 None -5 8 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
P35455 8624 35 None -5 8 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/jm100989w
44456072 198020 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 465 6 2 4 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccoc1 10.1016/j.bmcl.2007.11.008
CHEMBL271456 198020 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 465 6 2 4 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccoc1 10.1016/j.bmcl.2007.11.008
25212177 348862 6 None 7 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 463 7 0 7 3.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)c(C)n2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL456263 348862 6 None 7 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 463 7 0 7 3.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)c(C)n2)cn1 10.1016/j.bmcl.2008.11.018
44581241 349862 0 None 3 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 495 8 0 6 5.2 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3Cl)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL458634 349862 0 None 3 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 495 8 0 6 5.2 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3Cl)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44581719 349869 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 451 7 0 6 4.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cccs2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL458654 349869 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 451 7 0 6 4.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cccs2)cn1 10.1016/j.bmcl.2008.11.018
44581720 349956 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 523 8 0 7 4.3 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cccc(S(C)(=O)=O)c2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL458872 349956 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 523 8 0 7 4.3 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cccc(S(C)(=O)=O)c2)cn1 10.1016/j.bmcl.2008.11.018
44581718 372649 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 480 7 0 7 4.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2sc(C)nc2C)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL514123 372649 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 480 7 0 7 4.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2sc(C)nc2C)cn1 10.1016/j.bmcl.2008.11.018
25212178 372873 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 449 7 0 7 3.6 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)cn2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL515975 372873 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 449 7 0 7 3.6 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)cn2)cn1 10.1016/j.bmcl.2008.11.018
11495934 159620 0 None None None Human 7.9 pKi = 7.9 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 442 6 2 3 3.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](CO)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL209917 159620 0 None None None Human 7.9 pKi = 7.9 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 442 6 2 3 3.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](CO)c1ccc(F)cc1F 10.1021/jm060073e
54581307 123944 0 None -9 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1097 21 12 15 -1.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765666 123944 0 None -9 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1097 21 12 15 -1.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
44275618 198042 0 None -1 2 Rat 6.9 pKi = 6.9 Binding
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 396 4 0 5 3.5 COc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(98)00568-x
CHEMBL27157 198042 0 None -1 2 Rat 6.9 pKi = 6.9 Binding
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 396 4 0 5 3.5 COc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(98)00568-x
44275618 198042 0 None -1 2 Rat 6.9 pKi = 6.9 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 396 4 0 5 3.5 COc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(99)00181-x
CHEMBL27157 198042 0 None -1 2 Rat 6.9 pKi = 6.9 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 396 4 0 5 3.5 COc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(99)00181-x
16109439 274647 0 None -120 4 Rat 5.9 pKi = 5.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1023 15 11 14 -1.7 NC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL375187 274647 0 None -120 4 Rat 5.9 pKi = 5.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1023 15 11 14 -1.7 NC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL2372932 485917 0 None None None Rat 4.9 pKi = 4.9 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 698 4 2 6 2.1 C[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00169a001
3537 8682 25 None -3 3 Human 6.9 pKi = 6.9 Binding
Binding affinity to OTR receptor (unknown origin)Binding affinity to OTR receptor (unknown origin)
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
5311500 8682 25 None -3 3 Human 6.9 pKi = 6.9 Binding
Binding affinity to OTR receptor (unknown origin)Binding affinity to OTR receptor (unknown origin)
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
CHEMBL363910 8682 25 None -3 3 Human 6.9 pKi = 6.9 Binding
Binding affinity to OTR receptor (unknown origin)Binding affinity to OTR receptor (unknown origin)
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
16109442 274800 0 None -208 4 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1068 20 14 15 -3.3 N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL375325 274800 0 None -208 4 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1068 20 14 15 -3.3 N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
44279330 200254 0 None None None Human 6.9 pKi = 6.9 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 389 2 0 4 3.9 Cn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
CHEMBL287293 200254 0 None None None Human 6.9 pKi = 6.9 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 389 2 0 4 3.9 Cn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
44278983 218020 0 None None None Human 6.9 pKi = 6.9 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 434 3 0 6 4.3 Cc1nc(-c2ccncc2)sc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
CHEMBL31986 218020 0 None None None Human 6.9 pKi = 6.9 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 434 3 0 6 4.3 Cc1nc(-c2ccncc2)sc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
44279329 220932 0 None None None Human 6.9 pKi = 6.9 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 389 2 1 3 4.2 Cc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2[nH]1 10.1016/s0960-894x(02)00159-2
CHEMBL32740 220932 0 None None None Human 6.9 pKi = 6.9 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 389 2 1 3 4.2 Cc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2[nH]1 10.1016/s0960-894x(02)00159-2
44581685 349590 0 None None None Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 461 8 0 6 4.6 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL457997 349590 0 None None None Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 461 8 0 6 4.6 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44279580 200227 0 None None None Human 6.9 pKi = 6.9 Binding
Compound was tested for its ability to displace [3H]oxytocin from human Oxytocin receptorCompound was tested for its ability to displace [3H]oxytocin from human Oxytocin receptor
ChEMBL 536 5 0 6 3.8 CS(=O)(=O)N1CCC[C@H]1Cn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
CHEMBL287042 200227 0 None None None Human 6.9 pKi = 6.9 Binding
Compound was tested for its ability to displace [3H]oxytocin from human Oxytocin receptorCompound was tested for its ability to displace [3H]oxytocin from human Oxytocin receptor
ChEMBL 536 5 0 6 3.8 CS(=O)(=O)N1CCC[C@H]1Cn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
11519207 271035 0 None None None Human 6.9 pKi = 6.9 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 518 8 3 4 3.4 CC(=O)Nc1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
11577215 271035 0 None None None Human 6.9 pKi = 6.9 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 518 8 3 4 3.4 CC(=O)Nc1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL371008 271035 0 None None None Human 6.9 pKi = 6.9 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 518 8 3 4 3.4 CC(=O)Nc1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL372619 271035 0 None None None Human 6.9 pKi = 6.9 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 518 8 3 4 3.4 CC(=O)Nc1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL2369842 477602 0 None -8 4 Human 6.9 pKi = 6.9 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1103 18 13 15 -2.7 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
56671721 125936 0 None 5 2 Human 6.9 pKi = 6.9 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1321 15 13 19 3.0 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
CHEMBL1790722 125936 0 None 5 2 Human 6.9 pKi = 6.9 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1321 15 13 19 3.0 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
10507580 468850 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(OC2CCN(Cc3cc(C)c[n+]([O-])c3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL68752 468850 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(OC2CCN(Cc3cc(C)c[n+]([O-])c3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10556286 469253 0 None -10 2 Rat 7.9 pKi = 7.9 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 658 7 0 7 5.3 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C(F)(F)F)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL71540 469253 0 None -10 2 Rat 7.9 pKi = 7.9 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 658 7 0 7 5.3 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C(F)(F)F)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
2249 4540 14 None -2 7 Human 7.9 pKi = 7.9 Binding
Binding affinity to human OT receptorBinding affinity to human OT receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
9872389 4540 14 None -2 7 Human 7.9 pKi = 7.9 Binding
Binding affinity to human OT receptorBinding affinity to human OT receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
CHEMBL1253853 4540 14 None -2 7 Human 7.9 pKi = 7.9 Binding
Binding affinity to human OT receptorBinding affinity to human OT receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
2249 4540 14 None -2 7 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1021/jm901812z
9872389 4540 14 None -2 7 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1021/jm901812z
CHEMBL1253853 4540 14 None -2 7 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1021/jm901812z
44361406 78503 0 None -4 5 Human 6.9 pKi = 6.9 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human. Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human.
ChEMBL 451 7 1 5 3.4 CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
CHEMBL143304 78503 0 None -4 5 Human 6.9 pKi = 6.9 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human. Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human.
ChEMBL 451 7 1 5 3.4 CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
44361387 238172 0 None -8 5 Rat 6.9 pKi = 6.9 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 505 6 0 5 4.6 CC(=O)N1CCCCC1CCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
CHEMBL344752 238172 0 None -8 5 Rat 6.9 pKi = 6.9 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 505 6 0 5 4.6 CC(=O)N1CCCCC1CCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
16109448 278813 0 None -213 4 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1054 19 14 15 -3.7 N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL385068 278813 0 None -213 4 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1054 19 14 15 -3.7 N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL2369845 477603 0 None -169 4 Human 6.9 pKi = 6.9 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1039 18 12 14 -2.8 CCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
145971417 329607 0 None -1 2 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 374 3 0 4 4.2 Cc1ccn(-c2ccc(C(=O)N3CCCC(N(C)C)c4ccccc43)cc2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL4216926 329607 0 None -1 2 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 374 3 0 4 4.2 Cc1ccn(-c2ccc(C(=O)N3CCCC(N(C)C)c4ccccc43)cc2)n1 10.1021/acs.jmedchem.8b00697
16109446 274035 0 None -354 4 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 983 15 11 14 -2.7 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL373968 274035 0 None -354 4 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 983 15 11 14 -2.7 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
2192 4802 27 None -5 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cells
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
9690136 4802 27 None -5 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cells
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
CHEMBL1254024 4802 27 None -5 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cells
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
54582526 125128 0 None -34 3 Human 6.9 pKi = 6.9 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 622 9 1 9 4.9 CNCc1ccc(OC)c([C@@]2(N3CCC[C@H]3c3ncco3)C(=O)N(S(=O)(=O)c3ccc(OC)cc3)c3ccc(Cl)cc32)c1 10.1016/j.bmcl.2011.03.012
CHEMBL1779419 125128 0 None -34 3 Human 6.9 pKi = 6.9 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 622 9 1 9 4.9 CNCc1ccc(OC)c([C@@]2(N3CCC[C@H]3c3ncco3)C(=O)N(S(=O)(=O)c3ccc(OC)cc3)c3ccc(Cl)cc32)c1 10.1016/j.bmcl.2011.03.012
44419025 175267 18 None -537 8 Human 6.9 pKi = 6.9 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
44419026 175267 18 None -537 8 Human 6.9 pKi = 6.9 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
74992363 175267 18 None -537 8 Human 6.9 pKi = 6.9 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL221436 175267 18 None -537 8 Human 6.9 pKi = 6.9 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL435323 175267 18 None -537 8 Human 6.9 pKi = 6.9 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL6015151 175267 18 None -537 8 Human 6.9 pKi = 6.9 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL2369836 477596 0 None -2570 4 Human 5.9 pKi = 5.9 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1110 21 14 15 -4.2 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
135520200 160556 0 None None None Human 5.9 pKi = 5.9 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 522 9 3 7 2.4 CCOc1ccc(S(=O)(=O)N(c2ccc(C)cc2)C(CO)C(=O)N/N=C2\C(=O)Nc3ccccc32)cc1 10.1021/jm050645f
CHEMBL2113197 160556 0 None None None Human 5.9 pKi = 5.9 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 522 9 3 7 2.4 CCOc1ccc(S(=O)(=O)N(c2ccc(C)cc2)C(CO)C(=O)N/N=C2\C(=O)Nc3ccccc32)cc1 10.1021/jm050645f
10698572 468794 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(OC2CCN(Cc3ccc(C)[n+]([O-])c3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL68373 468794 0 None None None Human 7.9 pKi = 7.9 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(OC2CCN(Cc3ccc(C)[n+]([O-])c3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10746141 468478 0 None -2 2 Rat 7.9 pKi = 7.9 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 600 6 0 7 4.1 COc1cc(OC2CCN(C(=O)c3ccc[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL65950 468478 0 None -2 2 Rat 7.9 pKi = 7.9 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 600 6 0 7 4.1 COc1cc(OC2CCN(C(=O)c3ccc[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
1103817 40884 7 None -3 4 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
CHEMBL1254117 40884 7 None -3 4 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
1103817 40884 7 None -3 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm901812z
CHEMBL1254117 40884 7 None -3 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm901812z
2253 4548 22 None -19 6 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm901812z
5311202 4548 22 None -19 6 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm901812z
CHEMBL306645 4548 22 None -19 6 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm901812z
135530164 160558 0 None -1 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 570 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113200 160558 0 None -1 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 570 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL297725 486403 0 None 31 2 Rat 6.9 pKi = 6.9 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 726 6 3 6 2.7 CC[C@H](C)[C@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00169a001
CHEMBL52813 489209 0 None 23 2 Rat 5.9 pKi = 5.9 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 712 6 2 6 2.3 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O 10.1021/jm00169a001
53321821 119142 0 None None None Human 5.9 pKi = 5.9 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 975 10 11 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](C(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N2 10.1021/jm100989w
CHEMBL1630532 119142 0 None None None Human 5.9 pKi = 5.9 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 975 10 11 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](C(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N2 10.1021/jm100989w
135413563 241495 20 None 1 8 Human 6.9 pKi = 6.9 Binding
Displacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL360648 241495 20 None 1 8 Human 6.9 pKi = 6.9 Binding
Displacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/acs.jmedchem.8b00697
145960494 317101 0 None 13 2 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1081 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccc(cc2)SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4128839 317101 0 None 13 2 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1081 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccc(cc2)SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL2369837 477597 0 None -794 4 Human 5.8 pKi = 5.8 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1068 20 13 15 -3.5 NCCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL2369830 477592 0 None -338 4 Human 6.8 pKi = 6.8 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1053 19 12 14 -2.4 CCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL429161 488539 0 None None None Rat 5.8 pKi = 5.8 Binding
Binding affinity against oxytocin receptorBinding affinity against oxytocin receptor
ChEMBL 1062 17 12 15 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)CSSC[C@@H](C(=O)N2[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CC[C@@H]2C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm990090m
44419028 197233 21 None -1202 8 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1093 18 12 14 -1.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm060928n
CHEMBL265858 197233 21 None -1202 8 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1093 18 12 14 -1.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm060928n
135413563 241495 20 None 1 8 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
CHEMBL360648 241495 20 None 1 8 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
44335268 19240 0 None None None Human 7.8 pKi = 7.8 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 410 5 0 5 3.9 CCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(98)00568-x
CHEMBL104530 19240 0 None None None Human 7.8 pKi = 7.8 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 410 5 0 5 3.9 CCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(98)00568-x
2253 4548 22 None -19 6 Rat 7.8 pKi = 7.8 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm9800797
5311202 4548 22 None -19 6 Rat 7.8 pKi = 7.8 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm9800797
CHEMBL306645 4548 22 None -19 6 Rat 7.8 pKi = 7.8 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm9800797
73350823 202597 0 None 5 9 Human 7.8 pKi = 7.8 Binding
Binding affinity to human OTR by competitive binding assayBinding affinity to human OTR by competitive binding assay
ChEMBL 509 8 1 5 3.7 O=C(Cc1ccc(OC2CCNCC2)cc1OCCF)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmcl.2013.07.045
CHEMBL3040578 202597 0 None 5 9 Human 7.8 pKi = 7.8 Binding
Binding affinity to human OTR by competitive binding assayBinding affinity to human OTR by competitive binding assay
ChEMBL 509 8 1 5 3.7 O=C(Cc1ccc(OC2CCNCC2)cc1OCCF)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmcl.2013.07.045
135438560 272650 0 None 42 2 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 487 9 2 6 3.8 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccc2O)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL372122 272650 0 None 42 2 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 487 9 2 6 3.8 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccc2O)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
135469700 160561 0 None -7 3 Rat 7.8 pKi = 7.8 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 555 10 2 7 2.9 CN(C)CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113203 160561 0 None -7 3 Rat 7.8 pKi = 7.8 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 555 10 2 7 2.9 CN(C)CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
135438560 272650 0 None 42 2 Human 7.8 pKi = 7.8 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 487 9 2 6 3.8 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccc2O)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
CHEMBL372122 272650 0 None 42 2 Human 7.8 pKi = 7.8 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 487 9 2 6 3.8 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccc2O)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
44279692 199860 0 None None None Human 7.8 pKi = 7.8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 504 6 2 6 2.9 CC(=O)NCC(=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
CHEMBL284419 199860 0 None None None Human 7.8 pKi = 7.8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 504 6 2 6 2.9 CC(=O)NCC(=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
44279390 199896 0 None None None Human 7.8 pKi = 7.8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 573 6 2 7 3.1 CC1(C)NC(=O)N(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)C1=O 10.1016/s0960-894x(02)00159-2
CHEMBL284688 199896 0 None None None Human 7.8 pKi = 7.8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 573 6 2 7 3.1 CC1(C)NC(=O)N(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)C1=O 10.1016/s0960-894x(02)00159-2
56950451 156712 0 None None None Human 7.8 pKi = 7.8 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 489 8 2 3 4.0 CCc1ccccc1[C@H](C(=O)NC(C)C)N1C(=O)[C@@H](C2Cc3ccccc3C2)NC(=O)[C@H]1CC(C)C 10.1021/jm201287w
CHEMBL2035011 156712 0 None None None Human 7.8 pKi = 7.8 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 489 8 2 3 4.0 CCc1ccccc1[C@H](C(=O)NC(C)C)N1C(=O)[C@@H](C2Cc3ccccc3C2)NC(=O)[C@H]1CC(C)C 10.1021/jm201287w
10031014 194267 0 None None None Human 7.8 pKi = 7.8 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 574 11 2 5 4.6 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2cccc3ccccc23)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL24786 194267 0 None None None Human 7.8 pKi = 7.8 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 574 11 2 5 4.6 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2cccc3ccccc23)C1=O 10.1016/s0960-894x(01)00202-5
11757835 199981 0 None None None Human 7.8 pKi = 7.8 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 574 11 2 5 4.6 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2ccc3ccccc3c2)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL285312 199981 0 None None None Human 7.8 pKi = 7.8 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 574 11 2 5 4.6 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2ccc3ccccc3c2)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL1790549 484808 0 None 18 2 Rat 6.8 pKi = 6.8 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 758 6 4 9 1.4 CC[C@@H](C)[C@H]1C(=O)N2NCCC[C@@H]2C(=O)N2NCCC[C@H]2C(=O)N(C)[C@H](Cc2ccccc2)C(=O)N2CCC[C@H]2C(=O)N[C@H](Cc2ccccc2)C(=O)N1O 10.1021/jm00171a003
44361387 238172 0 None -10 5 Human 6.8 pKi = 6.8 Binding
Binding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from humanBinding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from human
ChEMBL 505 6 0 5 4.6 CC(=O)N1CCCCC1CCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
CHEMBL344752 238172 0 None -10 5 Human 6.8 pKi = 6.8 Binding
Binding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from humanBinding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from human
ChEMBL 505 6 0 5 4.6 CC(=O)N1CCCCC1CCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
145975166 328759 0 None -2 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 328 2 0 2 4.7 O=C(c1ccc(-c2cccnc2)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
CHEMBL4205970 328759 0 None -2 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 328 2 0 2 4.7 O=C(c1ccc(-c2cccnc2)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
73346892 180193 0 None None None Human 5.8 pKi = 5.8 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 975 17 12 14 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL2369424 180193 0 None None None Human 5.8 pKi = 5.8 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 975 17 12 14 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
44279433 199938 0 None None None Human 6.8 pKi = 6.8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 524 7 0 6 3.7 CN(CCCn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21)S(C)(=O)=O 10.1016/s0960-894x(02)00159-2
CHEMBL285012 199938 0 None None None Human 6.8 pKi = 6.8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 524 7 0 6 3.7 CN(CCCn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21)S(C)(=O)=O 10.1016/s0960-894x(02)00159-2
44279772 200144 0 None None None Human 6.8 pKi = 6.8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 500 4 0 5 4.4 CC(=O)N1CCC[C@@H]1Cn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
CHEMBL286476 200144 0 None None None Human 6.8 pKi = 6.8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 500 4 0 5 4.4 CC(=O)N1CCC[C@@H]1Cn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
44279000 216853 0 None None None Human 6.8 pKi = 6.8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 434 3 0 6 4.3 Cc1nc(-c2cccs2)ncc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
CHEMBL31665 216853 0 None None None Human 6.8 pKi = 6.8 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 434 3 0 6 4.3 Cc1nc(-c2cccs2)ncc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
70694330 156717 0 None None None Human 6.8 pKi = 6.8 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 519 8 2 5 3.2 COC(=O)c1ccccc1[C@@H](C(=O)NC(C)C)N1C(=O)[C@@H](C2Cc3ccccc3C2)NC(=O)[C@H]1CC(C)C 10.1021/jm201287w
CHEMBL2035016 156717 0 None None None Human 6.8 pKi = 6.8 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 519 8 2 5 3.2 COC(=O)c1ccccc1[C@@H](C(=O)NC(C)C)N1C(=O)[C@@H](C2Cc3ccccc3C2)NC(=O)[C@H]1CC(C)C 10.1021/jm201287w
44404013 143997 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 3 4 2.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(N)=O)cc1 10.1021/jm050557v
44404031 143997 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 3 4 2.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(N)=O)cc1 10.1021/jm050557v
CHEMBL196688 143997 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 3 4 2.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(N)=O)cc1 10.1021/jm050557v
CHEMBL197298 143997 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 3 4 2.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(N)=O)cc1 10.1021/jm050557v
11577662 144024 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 559 7 2 4 4.7 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc(OC(F)(F)F)cc1 10.1021/jm050557v
11606502 144024 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 559 7 2 4 4.7 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc(OC(F)(F)F)cc1 10.1021/jm050557v
CHEMBL196780 144024 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 559 7 2 4 4.7 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc(OC(F)(F)F)cc1 10.1021/jm050557v
CHEMBL372516 144024 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 559 7 2 4 4.7 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc(OC(F)(F)F)cc1 10.1021/jm050557v
11677875 144698 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 509 6 2 3 4.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)(C)C)c1ccc(Cl)cc1 10.1021/jm050557v
11706166 144698 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 509 6 2 3 4.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)(C)C)c1ccc(Cl)cc1 10.1021/jm050557v
CHEMBL198964 144698 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 509 6 2 3 4.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)(C)C)c1ccc(Cl)cc1 10.1021/jm050557v
CHEMBL381024 144698 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 509 6 2 3 4.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)(C)C)c1ccc(Cl)cc1 10.1021/jm050557v
11534310 272633 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 573 7 2 5 3.6 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1cccc(N2CCN(C)CC2)c1 10.1021/jm050557v
CHEMBL371983 272633 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 573 7 2 5 3.6 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1cccc(N2CCN(C)CC2)c1 10.1021/jm050557v
44274970 331744 0 None None None Human 5.8 pKi = 5.8 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 502 7 1 4 3.7 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N(C)CCc2cccc(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL428694 331744 0 None None None Human 5.8 pKi = 5.8 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 502 7 1 4 3.7 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N(C)CCc2cccc(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
10650710 468577 0 None 3 2 Human 7.8 pKi = 7.8 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 570 7 0 7 5.5 COc1cc(OC2CCN(C(C)c3cccnc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL66749 468577 0 None 3 2 Human 7.8 pKi = 7.8 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 570 7 0 7 5.5 COc1cc(OC2CCN(C(C)c3cccnc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10675477 197143 0 None -6 2 Rat 7.8 pKi = 7.8 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 630 6 0 7 5.2 COc1cc(OC2CCN([C@@H]3CCCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL265070 197143 0 None -6 2 Rat 7.8 pKi = 7.8 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 630 6 0 7 5.2 COc1cc(OC2CCN([C@@H]3CCCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10699323 468907 0 None -2 2 Rat 7.8 pKi = 7.8 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 640 7 0 7 5.2 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C(F)(F)F)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL69265 468907 0 None -2 2 Rat 7.8 pKi = 7.8 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 640 7 0 7 5.2 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C(F)(F)F)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
57519948 155341 4 None 112 3 Human 7.8 pKi = 7.8 Binding
Binding affinity to human OTR by competitive binding assayBinding affinity to human OTR by competitive binding assay
ChEMBL 587 9 0 6 3.4 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OCCF)c2)CC1 10.1016/j.bmcl.2013.07.045
CHEMBL2017869 155341 4 None 112 3 Human 7.8 pKi = 7.8 Binding
Binding affinity to human OTR by competitive binding assayBinding affinity to human OTR by competitive binding assay
ChEMBL 587 9 0 6 3.4 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OCCF)c2)CC1 10.1016/j.bmcl.2013.07.045
57519948 155341 4 None 112 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]Oxytocin from human OXTR expressed in CHO cell membranes after 90 mins by liquid scintillation counting methodDisplacement of [3H]Oxytocin from human OXTR expressed in CHO cell membranes after 90 mins by liquid scintillation counting method
ChEMBL 587 9 0 6 3.4 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OCCF)c2)CC1 10.1016/j.bmc.2016.10.035
CHEMBL2017869 155341 4 None 112 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]Oxytocin from human OXTR expressed in CHO cell membranes after 90 mins by liquid scintillation counting methodDisplacement of [3H]Oxytocin from human OXTR expressed in CHO cell membranes after 90 mins by liquid scintillation counting method
ChEMBL 587 9 0 6 3.4 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OCCF)c2)CC1 10.1016/j.bmc.2016.10.035
57519948 155341 4 None 112 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 587 9 0 6 3.4 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OCCF)c2)CC1 10.1016/j.bmc.2012.02.019
CHEMBL2017869 155341 4 None 112 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 587 9 0 6 3.4 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OCCF)c2)CC1 10.1016/j.bmc.2012.02.019
155753110 392355 5 None -53 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human Oxytocin receptor assessed as inhibition constantBinding affinity to human Oxytocin receptor assessed as inhibition constant
ChEMBL 452 3 0 7 4.3 Clc1ccc2c(c1)CC1(Cc3nnc([C@H]4CC[C@H](Oc5ccccn5)CC4)n3-2)OCCO1 10.1021/acs.jmedchem.3c01868
CHEMBL5594994 392355 5 None -53 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human Oxytocin receptor assessed as inhibition constantBinding affinity to human Oxytocin receptor assessed as inhibition constant
ChEMBL 452 3 0 7 4.3 Clc1ccc2c(c1)CC1(Cc3nnc([C@H]4CC[C@H](Oc5ccccn5)CC4)n3-2)OCCO1 10.1021/acs.jmedchem.3c01868
44334980 19463 0 None None None Human 6.8 pKi = 6.8 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 487 6 0 6 5.0 COc1cc(O[C@@H](C)c2ccncc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL105673 19463 0 None None None Human 6.8 pKi = 6.8 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 487 6 0 6 5.0 COc1cc(O[C@@H](C)c2ccncc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
1153925 144078 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 448 6 1 3 5.1 Cc1c(Cl)cccc1NC(=O)CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1 10.1021/jm050645f
CHEMBL196974 144078 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 448 6 1 3 5.1 Cc1c(Cl)cccc1NC(=O)CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1 10.1021/jm050645f
1135733 273445 9 None -1 2 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 436 6 0 4 3.5 COc1ccc(N(CC(=O)N2CCc3ccccc3C2)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
CHEMBL373167 273445 9 None -1 2 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 436 6 0 4 3.5 COc1ccc(N(CC(=O)N2CCc3ccccc3C2)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
44275210 195410 0 None -4 2 Rat 5.8 pKi = 5.8 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 491 5 0 5 3.8 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL25502 195410 0 None -4 2 Rat 5.8 pKi = 5.8 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 491 5 0 5 3.8 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)CC1 10.1016/s0960-894x(99)00181-x
9797987 237306 1 None -1 3 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 339 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm901812z
CHEMBL341490 237306 1 None -1 3 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 339 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm901812z
CHEMBL2369847 477604 0 None -16 4 Human 6.8 pKi = 6.8 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1087 18 12 14 -2.4 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
145961670 316908 0 None -5 2 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1139 19 14 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4126100 316908 0 None -5 2 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1139 19 14 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
44334970 19345 0 None None None Human 7.8 pKi = 7.8 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 424 5 0 5 4.2 COc1cc(OC(C)C)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL105039 19345 0 None None None Human 7.8 pKi = 7.8 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 424 5 0 5 4.2 COc1cc(OC(C)C)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL1790937 484815 0 None -2 2 Human 7.8 pKi = 7.8 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from near-term pregnant rhesus monkeyCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from near-term pregnant rhesus monkey
ChEMBL 755 6 5 7 1.9 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
135916070 450839 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 418 2 1 6 4.5 Cc1ccn(-c2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL601931 450839 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 418 2 1 6 4.5 Cc1ccn(-c2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
135916070 450839 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 418 2 1 6 4.5 Cc1ccn(-c2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)c(Cl)c2)n1 10.1021/jm901084f
CHEMBL601931 450839 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 418 2 1 6 4.5 Cc1ccn(-c2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)c(Cl)c2)n1 10.1021/jm901084f
21476314 232095 3 None None None Human 7.8 pKi = 7.8 Binding
Displacement of [3H]Oxytocin from human OXTR expressed in CHO cell membranes after 90 mins by liquid scintillation counting methodDisplacement of [3H]Oxytocin from human OXTR expressed in CHO cell membranes after 90 mins by liquid scintillation counting method
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(N)CCS(C)(=O)=O)C3(C)C)CC1 10.1016/j.bmc.2016.10.035
CHEMBL3392901 232095 3 None None None Human 7.8 pKi = 7.8 Binding
Displacement of [3H]Oxytocin from human OXTR expressed in CHO cell membranes after 90 mins by liquid scintillation counting methodDisplacement of [3H]Oxytocin from human OXTR expressed in CHO cell membranes after 90 mins by liquid scintillation counting method
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(N)CCS(C)(=O)=O)C3(C)C)CC1 10.1016/j.bmc.2016.10.035
54581530 125120 0 None -562 3 Human 7.8 pKi = 7.8 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 666 9 0 8 4.5 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCCC4)ccc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779409 125120 0 None -562 3 Human 7.8 pKi = 7.8 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 666 9 0 8 4.5 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCCC4)ccc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL292579 486388 0 None 32 2 Rat 7.8 pKi = 7.8 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 744 9 5 8 0.7 CC[C@@H](C)[C@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCN)NC(=O)[C@H]2CCNCN2C1=O 10.1021/jm00169a001
135475778 160568 0 None 223 2 Human 7.8 pKi = 7.8 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 540 10 2 6 4.2 CCCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
CHEMBL2113210 160568 0 None 223 2 Human 7.8 pKi = 7.8 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 540 10 2 6 4.2 CCCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
CHEMBL2372252 477728 0 None None None Rat 6.8 pKi = 6.8 Binding
Binding affinity against oxytocin receptorBinding affinity against oxytocin receptor
ChEMBL 1062 17 11 14 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SS[C@@H](C(=O)N2C(C(C)(C)C)CC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm990090m
114904 6013 43 None -5 5 Human 6.8 pKi = 6.8 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human. Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human.
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00023a002
2196 6013 43 None -5 5 Human 6.8 pKi = 6.8 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human. Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human.
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00023a002
CHEMBL296908 6013 43 None -5 5 Human 6.8 pKi = 6.8 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human. Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human.
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00023a002
114904 6013 43 None -5 5 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm901812z
2196 6013 43 None -5 5 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm901812z
CHEMBL296908 6013 43 None -5 5 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm901812z
54585431 125126 0 None -141 3 Human 6.8 pKi = 6.8 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 662 9 0 9 5.8 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCCC4)ccc3OC)(N3CCC[C@H]3c3ncco3)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779417 125126 0 None -141 3 Human 6.8 pKi = 6.8 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 662 9 0 9 5.8 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCCC4)ccc3OC)(N3CCC[C@H]3c3ncco3)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
135414270 160564 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 498 6 2 5 3.8 Cc1ccc(N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)S(=O)(=O)c2cccc3ccccc23)cc1 10.1021/jm050645f
CHEMBL2113206 160564 0 None None None Human 6.8 pKi = 6.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 498 6 2 5 3.8 Cc1ccc(N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)S(=O)(=O)c2cccc3ccccc23)cc1 10.1021/jm050645f
135997467 160572 0 None None None Human 5.8 pKi = 5.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 538 8 2 5 4.7 CCC(C)(C)c1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113214 160572 0 None None None Human 5.8 pKi = 5.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 538 8 2 5 4.7 CCC(C)(C)c1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
54585227 123947 0 None -104 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1042 18 12 15 -1.9 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(O)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765669 123947 0 None -104 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1042 18 12 15 -1.9 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(O)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL2370342 477651 0 None None None Human 7.8 pKi = 7.8 Binding
Binding affinity towards OT receptor in CHO cells expressing the human OT receptorBinding affinity towards OT receptor in CHO cells expressing the human OT receptor
ChEMBL 1323 36 15 17 -0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
135475778 160568 0 None 223 2 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 540 10 2 6 4.2 CCCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113210 160568 0 None 223 2 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 540 10 2 6 4.2 CCCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
135520202 271064 0 None 33 2 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 528 8 2 7 5.1 COc1ccc(S(=O)(=O)N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)c2ccc(Cl)cc2)cc1OC 10.1021/jm050645f
CHEMBL371223 271064 0 None 33 2 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 528 8 2 7 5.1 COc1ccc(S(=O)(=O)N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)c2ccc(Cl)cc2)cc1OC 10.1021/jm050645f
44297517 311660 0 None -120 3 Rat 7.8 pKi = 7.8 Binding
Tested for inhibition constant at OT receptor of rat mammary glandsTested for inhibition constant at OT receptor of rat mammary glands
ChEMBL 1343 39 15 16 -1.4 CN(C(=O)CCCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL405440 311660 0 None -120 3 Rat 7.8 pKi = 7.8 Binding
Tested for inhibition constant at OT receptor of rat mammary glandsTested for inhibition constant at OT receptor of rat mammary glands
ChEMBL 1343 39 15 16 -1.4 CN(C(=O)CCCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
19690978 219100 0 None None None Human 5.8 pKi = 5.8 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 548 7 0 5 6.6 COc1cc(OC(c2ccccc2)c2ccccc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL322162 219100 0 None None None Human 5.8 pKi = 5.8 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 548 7 0 5 6.6 COc1cc(OC(c2ccccc2)c2ccccc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
71457081 163802 0 None -31 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1309 24 5 14 10.2 CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCn2cc(CNC(=O)CCC(=O)NC3CCCN(C(=O)c4ccc(NC(=O)c5ccccc5-c5ccccc5)cc4)c4ccccc43)nn2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm3006146
71482251 163802 0 None -31 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1309 24 5 14 10.2 CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCn2cc(CNC(=O)CCC(=O)NC3CCCN(C(=O)c4ccc(NC(=O)c5ccccc5-c5ccccc5)cc4)c4ccccc43)nn2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm3006146
CHEMBL2172289 163802 0 None -31 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1309 24 5 14 10.2 CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCn2cc(CNC(=O)CCC(=O)NC3CCCN(C(=O)c4ccc(NC(=O)c5ccccc5-c5ccccc5)cc4)c4ccccc43)nn2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm3006146
2252 4546 39 None -5 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(98)00568-x
6918320 4546 39 None -5 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(98)00568-x
CHEMBL24781 4546 39 None -5 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(98)00568-x
2252 4546 39 None -5 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(99)00181-x
6918320 4546 39 None -5 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(99)00181-x
CHEMBL24781 4546 39 None -5 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(99)00181-x
2252 4546 39 None -5 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm00023a002
6918320 4546 39 None -5 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm00023a002
CHEMBL24781 4546 39 None -5 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm00023a002
2252 4546 39 None -5 5 Rat 7.7 pKi = 7.7 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901812z
6918320 4546 39 None -5 5 Rat 7.7 pKi = 7.7 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901812z
CHEMBL24781 4546 39 None -5 5 Rat 7.7 pKi = 7.7 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901812z
2202 5638 34 None -10 5 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.12.081
9895468 5638 34 None -10 5 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.12.081
CHEMBL582857 5638 34 None -10 5 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.12.081
DB12643 5638 34 None -10 5 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.12.081
2202 5638 34 None -10 5 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2009.09.050
9895468 5638 34 None -10 5 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2009.09.050
CHEMBL582857 5638 34 None -10 5 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2009.09.050
DB12643 5638 34 None -10 5 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2009.09.050
44278943 199858 0 None None None Human 7.7 pKi = 7.7 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 536 5 0 6 3.8 CS(=O)(=O)N1CCC[C@@H]1Cn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
CHEMBL284410 199858 0 None None None Human 7.7 pKi = 7.7 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 536 5 0 6 3.8 CS(=O)(=O)N1CCC[C@@H]1Cn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
44275099 199079 0 None None None Human 7.7 pKi = 7.7 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 558 11 2 5 4.1 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2cccc(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL278802 199079 0 None None None Human 7.7 pKi = 7.7 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 558 11 2 5 4.1 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2cccc(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
16109443 278920 0 None -1023 4 Rat 6.7 pKi = 6.7 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1040 18 14 15 -4.0 N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL385739 278920 0 None -1023 4 Rat 6.7 pKi = 6.7 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1040 18 14 15 -4.0 N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
3537 8682 25 None -3 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
5311500 8682 25 None -3 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
CHEMBL363910 8682 25 None -3 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
3537 8682 25 None -3 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
5311500 8682 25 None -3 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
CHEMBL363910 8682 25 None -3 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
44278944 199584 0 None None None Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 375 2 1 3 3.9 O=C(c1ccc2cc[nH]c2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
CHEMBL282577 199584 0 None None None Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 375 2 1 3 3.9 O=C(c1ccc2cc[nH]c2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
44279485 200426 0 None None None Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 501 3 0 5 4.9 CC(=O)N1CCCC(c2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)C1 10.1016/s0960-894x(02)00159-2
CHEMBL288774 200426 0 None None None Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 501 3 0 5 4.9 CC(=O)N1CCCC(c2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)C1 10.1016/s0960-894x(02)00159-2
44278929 215325 0 None None None Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 375 2 1 3 3.9 O=C(c1ccc2[nH]ccc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
CHEMBL31241 215325 0 None None None Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 375 2 1 3 3.9 O=C(c1ccc2[nH]ccc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
44279774 217620 0 None None None Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 537 5 0 6 4.2 CS(=O)(=O)N1CCC[C@@H]1Cc1coc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc12 10.1016/s0960-894x(02)00159-2
CHEMBL31941 217620 0 None None None Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 537 5 0 6 4.2 CS(=O)(=O)N1CCC[C@@H]1Cc1coc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc12 10.1016/s0960-894x(02)00159-2
44275002 183395 0 None None None Human 6.7 pKi = 6.7 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 573 11 3 6 2.6 CC(=O)CCCC(=O)NC1N=C(C)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL24353 183395 0 None None None Human 6.7 pKi = 6.7 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 573 11 3 6 2.6 CC(=O)CCCC(=O)NC1N=C(C)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
44274927 194749 0 None None None Human 6.7 pKi = 6.7 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 558 11 2 5 4.1 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2ccccc2Cl)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL25067 194749 0 None None None Human 6.7 pKi = 6.7 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 558 11 2 5 4.1 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2ccccc2Cl)C1=O 10.1016/s0960-894x(01)00202-5
10074886 19180 0 None None None Human 8.7 pKi = 8.7 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 505 6 0 6 5.1 COc1cc(O[C@H](C)c2ccncc2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL104237 19180 0 None None None Human 8.7 pKi = 8.7 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 505 6 0 6 5.1 COc1cc(O[C@H](C)c2ccncc2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
44214438 461726 0 None 3 2 Human 8.7 pKi = 8.7 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 630 6 0 7 5.2 COc1cc(OC2CCN(C3CCCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL66992 461726 0 None 3 2 Human 8.7 pKi = 8.7 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 630 6 0 7 5.2 COc1cc(OC2CCN(C3CCCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10416272 214451 4 None 630 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1021/jm901812z
CHEMBL31065 214451 4 None 630 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1021/jm901812z
10416272 214451 4 None 630 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1021/jm901812z
CHEMBL31065 214451 4 None 630 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1021/jm901812z
146681949 8624 35 None -5 8 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
2168 8624 35 None -5 8 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
2810 8624 35 None -5 8 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
644077 8624 35 None -5 8 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
CHEMBL373742 8624 35 None -5 8 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
DB00067 8624 35 None -5 8 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
P01185 8624 35 None -5 8 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
P01186 8624 35 None -5 8 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
P35455 8624 35 None -5 8 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1021/acs.jmedchem.8b01691
135469700 160561 0 None 7 3 Human 8.7 pKi = 8.7 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 555 10 2 7 2.9 CN(C)CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
CHEMBL2113203 160561 0 None 7 3 Human 8.7 pKi = 8.7 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 555 10 2 7 2.9 CN(C)CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
10507800 468517 0 None 5 2 Human 8.7 pKi = 8.7 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 600 8 0 7 4.7 CCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)ccc[n+]1[O-] 10.1021/jm9800797
CHEMBL66240 468517 0 None 5 2 Human 8.7 pKi = 8.7 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 600 8 0 7 4.7 CCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)ccc[n+]1[O-] 10.1021/jm9800797
18700187 199084 0 None -1 2 Rat 8.7 pKi = 8.7 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 577 9 0 7 4.0 O=C(Cc1ccc(OCCN2CCOCC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL278818 199084 0 None -1 2 Rat 8.7 pKi = 8.7 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 577 9 0 7 4.0 O=C(Cc1ccc(OCCN2CCOCC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
135469700 160561 0 None 7 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 555 10 2 7 2.9 CN(C)CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113203 160561 0 None 7 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 555 10 2 7 2.9 CN(C)CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
10675477 197143 0 None 6 2 Human 8.6 pKi = 8.6 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 630 6 0 7 5.2 COc1cc(OC2CCN([C@@H]3CCCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL265070 197143 0 None 6 2 Human 8.6 pKi = 8.6 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 630 6 0 7 5.2 COc1cc(OC2CCN([C@@H]3CCCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10746298 202175 0 None None None Human 8.6 pKi = 8.6 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 610 6 0 7 6.2 COc1cc(OC2CCN(c3cccc4ncccc34)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL302128 202175 0 None None None Human 8.6 pKi = 8.6 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 610 6 0 7 6.2 COc1cc(OC2CCN(c3cccc4ncccc34)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL2370343 477652 0 None None None Human 8.6 pKi = 8.6 Binding
Binding affinity towards OT receptor in CHO cells expressing the human OT receptorBinding affinity towards OT receptor in CHO cells expressing the human OT receptor
ChEMBL 1337 37 14 17 -0.3 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
CHEMBL2112248 485096 0 None -1 2 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from near-term pregnant rhesusCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from near-term pregnant rhesus
ChEMBL 754 6 5 8 1.5 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
18700090 194068 0 None 1 2 Human 8.6 pKi = 8.6 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 575 6 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL24682 194068 0 None 1 2 Human 8.6 pKi = 8.6 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 575 6 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
10722476 202160 0 None None None Human 8.6 pKi = 8.6 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 614 6 0 7 5.9 COc1cc(OC2CCN(C3CCCc4ncccc43)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL302029 202160 0 None None None Human 8.6 pKi = 8.6 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 614 6 0 7 5.9 COc1cc(OC2CCN(C3CCCc4ncccc43)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10603831 468902 0 None 3 2 Human 8.6 pKi = 8.6 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 614 9 0 7 5.1 CCCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)ccc[n+]1[O-] 10.1021/jm9800797
CHEMBL69202 468902 0 None 3 2 Human 8.6 pKi = 8.6 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 614 9 0 7 5.1 CCCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)ccc[n+]1[O-] 10.1021/jm9800797
44456469 315068 0 None None None Human 8.6 pKi = 8.6 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 544 8 2 5 4.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(-c2ccccn2)s1 10.1016/j.bmcl.2007.11.008
CHEMBL409878 315068 0 None None None Human 8.6 pKi = 8.6 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 544 8 2 5 4.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(-c2ccccn2)s1 10.1016/j.bmcl.2007.11.008
44581268 348947 0 None None None Human 8.6 pKi = 8.6 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 505 9 0 7 4.9 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C)cn2)c2ccc(OC)nc2)c(OC)c1 10.1016/j.bmcl.2008.11.018
CHEMBL456464 348947 0 None None None Human 8.6 pKi = 8.6 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 505 9 0 7 4.9 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C)cn2)c2ccc(OC)nc2)c(OC)c1 10.1016/j.bmcl.2008.11.018
44279910 199389 0 None 630 2 Human 8.6 pKi = 8.6 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 570 7 1 8 3.7 COc1cccn(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)c1=O 10.1016/s0960-894x(02)00160-9
CHEMBL281243 199389 0 None 630 2 Human 8.6 pKi = 8.6 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 570 7 1 8 3.7 COc1cccn(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)c1=O 10.1016/s0960-894x(02)00160-9
11591519 144344 0 None None None Human 8.6 pKi = 8.6 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 505 7 2 4 3.8 COc1ccc([C@@H](C(=O)NC(C)(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
11649100 144344 0 None None None Human 8.6 pKi = 8.6 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 505 7 2 4 3.8 COc1ccc([C@@H](C(=O)NC(C)(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL197822 144344 0 None None None Human 8.6 pKi = 8.6 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 505 7 2 4 3.8 COc1ccc([C@@H](C(=O)NC(C)(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL372128 144344 0 None None None Human 8.6 pKi = 8.6 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 505 7 2 4 3.8 COc1ccc([C@@H](C(=O)NC(C)(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
11677875 144698 0 None None None Human 8.6 pKi = 8.6 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 509 6 2 3 4.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)(C)C)c1ccc(Cl)cc1 10.1021/jm050557v
11706166 144698 0 None None None Human 8.6 pKi = 8.6 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 509 6 2 3 4.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)(C)C)c1ccc(Cl)cc1 10.1021/jm050557v
CHEMBL198964 144698 0 None None None Human 8.6 pKi = 8.6 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 509 6 2 3 4.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)(C)C)c1ccc(Cl)cc1 10.1021/jm050557v
CHEMBL381024 144698 0 None None None Human 8.6 pKi = 8.6 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 509 6 2 3 4.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)(C)C)c1ccc(Cl)cc1 10.1021/jm050557v
135399831 160552 0 None -1 3 Rat 8.6 pKi = 8.6 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)NC(=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113189 160552 0 None -1 3 Rat 8.6 pKi = 8.6 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)NC(=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
44275104 197597 0 None -33 4 Human 8.6 pKi = 8.6 Binding
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1127 32 14 14 -3.9 CN(C(=O)Cc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(N)=O 10.1021/jm9804782
CHEMBL269012 197597 0 None -33 4 Human 8.6 pKi = 8.6 Binding
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1127 32 14 14 -3.9 CN(C(=O)Cc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(N)=O 10.1021/jm9804782
18700090 194068 0 None -1 2 Rat 8.6 pKi = 8.6 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 575 6 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL24682 194068 0 None -1 2 Rat 8.6 pKi = 8.6 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 575 6 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
10579644 468901 0 None -2 2 Rat 7.7 pKi = 7.7 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 612 6 0 7 5.0 COc1cc(OC2CCN(C3CCCc4c3ccc[n+]4[O-])CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL69201 468901 0 None -2 2 Rat 7.7 pKi = 7.7 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 612 6 0 7 5.0 COc1cc(OC2CCN(C3CCCc4c3ccc[n+]4[O-])CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
135446053 160573 0 None 21 2 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 478 7 2 6 2.7 COc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
CHEMBL2113215 160573 0 None 21 2 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 478 7 2 6 2.7 COc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
54580516 125121 0 None -660 3 Human 7.7 pKi = 7.7 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 695 9 0 9 3.6 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCN(C)CC4)ccc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779410 125121 0 None -660 3 Human 7.7 pKi = 7.7 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 695 9 0 9 3.6 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCN(C)CC4)ccc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
44361406 78503 0 None -6 5 Rat 6.7 pKi = 6.7 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 451 7 1 5 3.4 CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
CHEMBL143304 78503 0 None -6 5 Rat 6.7 pKi = 6.7 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 451 7 1 5 3.4 CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
44361403 67461 1 None -8 5 Human 6.7 pKi = 6.7 Binding
Binding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from humanBinding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from human
ChEMBL 491 5 0 5 4.1 CC(=O)N1CCCC(COc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)C1 10.1021/jm00023a002
CHEMBL142324 67461 1 None -8 5 Human 6.7 pKi = 6.7 Binding
Binding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from humanBinding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from human
ChEMBL 491 5 0 5 4.1 CC(=O)N1CCCC(COc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)C1 10.1021/jm00023a002
CHEMBL2369838 477598 0 None -102 4 Human 6.7 pKi = 6.7 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1027 17 13 15 -4.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
CHEMBL338308 487001 0 None -4 2 Human 7.7 pKi = 7.7 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from nonlabor pregnant womenCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from nonlabor pregnant women
ChEMBL 742 9 4 8 1.5 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCN)NC(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
135461099 160574 0 None 177 2 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 506 9 2 6 3.5 CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
CHEMBL2113216 160574 0 None 177 2 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 506 9 2 6 3.5 CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
54584266 123943 0 None -32 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1145 20 12 15 0.2 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccccc2N)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765664 123943 0 None -32 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1145 20 12 15 0.2 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccccc2N)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
52947354 40875 11 None -2 3 Rat 6.7 pKi = 6.7 Binding
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cells
ChEMBL 338 4 1 4 2.9 CO/N=C1/C[C@@H](CO)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1021/jm901812z
CHEMBL1254025 40875 11 None -2 3 Rat 6.7 pKi = 6.7 Binding
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cells
ChEMBL 338 4 1 4 2.9 CO/N=C1/C[C@@H](CO)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1021/jm901812z
DB16259 40875 11 None -2 3 Rat 6.7 pKi = 6.7 Binding
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cells
ChEMBL 338 4 1 4 2.9 CO/N=C1/C[C@@H](CO)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1021/jm901812z
54582318 123946 0 None -56 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1210 29 12 15 1.7 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765668 123946 0 None -56 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1210 29 12 15 1.7 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
44361521 78556 0 None 1 3 Human 5.7 pKi = 5.7 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human. Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human.
ChEMBL 450 7 2 4 2.9 CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)NCc4ccccc43)CC2)cc1 10.1021/jm00023a002
CHEMBL143341 78556 0 None 1 3 Human 5.7 pKi = 5.7 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human. Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human.
ChEMBL 450 7 2 4 2.9 CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)NCc4ccccc43)CC2)cc1 10.1021/jm00023a002
44316241 197234 0 None -5248 8 Human 6.7 pKi = 6.7 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1053 18 13 14 -2.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
44419029 197234 0 None -5248 8 Human 6.7 pKi = 6.7 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1053 18 13 14 -2.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL265859 197234 0 None -5248 8 Human 6.7 pKi = 6.7 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1053 18 13 14 -2.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL268306 197234 0 None -5248 8 Human 6.7 pKi = 6.7 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1053 18 13 14 -2.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
54584267 123945 0 None -35 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1154 25 12 15 0.2 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765667 123945 0 None -35 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1154 25 12 15 0.2 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
16109441 274798 0 None -48 4 Rat 7.7 pKi = 7.7 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1026 19 12 15 -2.8 NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL375323 274798 0 None -48 4 Rat 7.7 pKi = 7.7 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1026 19 12 15 -2.8 NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
145963213 317022 0 None -3 2 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4127791 317022 0 None -3 2 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL2369840 477600 0 None -28 4 Human 6.7 pKi = 6.7 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1126 18 13 14 -1.9 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
CHEMBL2369829 477591 0 None -186 4 Human 6.7 pKi = 6.7 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1025 17 12 14 -3.2 CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
10444 4740 20 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145711714 4740 20 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4204210 4740 20 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
10602875 468553 0 None 1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 556 7 0 7 4.9 COc1cc(OC2CCN(Cc3ccccn3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL66567 468553 0 None 1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 556 7 0 7 4.9 COc1cc(OC2CCN(Cc3ccccn3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
114904 6013 43 None -8 5 Rat 6.6 pKi = 6.6 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00023a002
2196 6013 43 None -8 5 Rat 6.6 pKi = 6.6 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00023a002
CHEMBL296908 6013 43 None -8 5 Rat 6.6 pKi = 6.6 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00023a002
135506374 275287 21 None -3 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-oxytocin from human OTR expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-oxytocin from human OTR expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2017.10.059
CHEMBL3763342 275287 21 None -3 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-oxytocin from human OTR expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-oxytocin from human OTR expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2017.10.059
135506374 275287 21 None -3 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysisDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysis
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
CHEMBL3763342 275287 21 None -3 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysisDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysis
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
114904 6013 43 None -8 5 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm901812z
2196 6013 43 None -8 5 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm901812z
CHEMBL296908 6013 43 None -8 5 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm901812z
135613341 144599 4 None None None Human 6.6 pKi = 6.6 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 423 7 2 5 3.1 C/C(=N\NC(=O)CN(c1ccccc1)S(=O)(=O)c1ccccc1)c1ccccc1O 10.1021/jm050645f
CHEMBL198630 144599 4 None None None Human 6.6 pKi = 6.6 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 423 7 2 5 3.1 C/C(=N\NC(=O)CN(c1ccccc1)S(=O)(=O)c1ccccc1)c1ccccc1O 10.1021/jm050645f
135491793 145190 0 None None None Human 6.6 pKi = 6.6 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 498 6 2 5 5.8 Cc1ccc(N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)S(=O)(=O)c2ccc3ccccc3c2)cc1 10.1021/jm050645f
CHEMBL200729 145190 0 None None None Human 6.6 pKi = 6.6 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 498 6 2 5 5.8 Cc1ccc(N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)S(=O)(=O)c2ccc3ccccc3c2)cc1 10.1021/jm050645f
44361522 240294 0 None -4 5 Human 7.6 pKi = 7.6 Binding
Binding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from humanBinding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from human
ChEMBL 477 4 0 5 3.8 CC(=O)N1CCC(Oc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)CC1 10.1021/jm00023a002
CHEMBL358793 240294 0 None -4 5 Human 7.6 pKi = 7.6 Binding
Binding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from humanBinding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from human
ChEMBL 477 4 0 5 3.8 CC(=O)N1CCC(Oc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)CC1 10.1021/jm00023a002
44419028 197233 21 None -199 8 Human 6.6 pKi = 6.6 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1093 18 12 14 -1.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
CHEMBL265858 197233 21 None -199 8 Human 6.6 pKi = 6.6 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1093 18 12 14 -1.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
CHEMBL2372253 477729 0 None None None Rat 6.6 pKi = 6.6 Binding
Binding affinity against oxytocin receptorBinding affinity against oxytocin receptor
ChEMBL 1047 17 11 14 -1.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2C(C(C)(C)C)CC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm990090m
44275244 195608 0 None 2 2 Human 6.6 pKi = 6.6 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 424 6 0 5 3.8 COc1ccc(CCC(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(99)00181-x
CHEMBL25611 195608 0 None 2 2 Human 6.6 pKi = 6.6 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 424 6 0 5 3.8 COc1ccc(CCC(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(99)00181-x
44361521 78556 0 None -1 3 Rat 5.6 pKi = 5.6 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 450 7 2 4 2.9 CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)NCc4ccccc43)CC2)cc1 10.1021/jm00023a002
CHEMBL143341 78556 0 None -1 3 Rat 5.6 pKi = 5.6 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 450 7 2 4 2.9 CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)NCc4ccccc43)CC2)cc1 10.1021/jm00023a002
46233066 450837 0 None None None Human 6.6 pKi = 6.6 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 632 5 1 6 4.4 Cc1cc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
CHEMBL601930 450837 0 None None None Human 6.6 pKi = 6.6 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 632 5 1 6 4.4 Cc1cc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
10507277 468944 0 None -2 2 Rat 7.6 pKi = 7.6 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 570 7 0 7 5.2 COc1cc(OC2CCN(Cc3cccnc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL69520 468944 0 None -2 2 Rat 7.6 pKi = 7.6 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 570 7 0 7 5.2 COc1cc(OC2CCN(Cc3cccnc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
1103817 40884 7 None 3 4 Rat 7.6 pKi = 7.6 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
CHEMBL1254117 40884 7 None 3 4 Rat 7.6 pKi = 7.6 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
135508167 160548 0 None -3 3 Rat 7.6 pKi = 7.6 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 596 10 3 8 2.8 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(NCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113177 160548 0 None -3 3 Rat 7.6 pKi = 7.6 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 596 10 3 8 2.8 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(NCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
2202 5638 34 None -10 5 Human 7.6 pKi = 7.6 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2011.03.012
9895468 5638 34 None -10 5 Human 7.6 pKi = 7.6 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2011.03.012
CHEMBL582857 5638 34 None -10 5 Human 7.6 pKi = 7.6 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2011.03.012
DB12643 5638 34 None -10 5 Human 7.6 pKi = 7.6 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2011.03.012
44279676 215045 0 None None None Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 524 6 1 6 4.4 O=C(Cc1cccnc1)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
CHEMBL31163 215045 0 None None None Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 524 6 1 6 4.4 O=C(Cc1cccnc1)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
44279536 215195 0 None None None Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 559 6 1 7 2.7 CN(Cc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1)C(=O)CN1C(=O)CNC1=O 10.1016/s0960-894x(02)00159-2
CHEMBL31213 215195 0 None None None Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 559 6 1 7 2.7 CN(Cc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1)C(=O)CN1C(=O)CNC1=O 10.1016/s0960-894x(02)00159-2
44279368 217031 0 None None None Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 560 6 1 8 3.2 CC1OC(=O)N(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)C1=O 10.1016/s0960-894x(02)00159-2
CHEMBL31802 217031 0 None None None Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 560 6 1 8 3.2 CC1OC(=O)N(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)C1=O 10.1016/s0960-894x(02)00159-2
44279459 218855 0 None None None Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 487 3 0 5 4.9 CC(=O)N1CCC[C@@H]1c1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
CHEMBL32187 218855 0 None None None Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 487 3 0 5 4.9 CC(=O)N1CCC[C@@H]1c1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
44279238 318218 0 None None None Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 530 6 1 6 3.4 O=C(CN1CCCC1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
CHEMBL417133 318218 0 None None None Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 530 6 1 6 3.4 O=C(CN1CCCC1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
44280356 199504 0 None None None Human 7.6 pKi = 7.6 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 634 5 0 7 6.2 O=C(c1ccc2oc(CN3CCC[C@@H](n4cc(C(F)(F)F)ccc4=O)C3)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
CHEMBL281988 199504 0 None None None Human 7.6 pKi = 7.6 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 634 5 0 7 6.2 O=C(c1ccc2oc(CN3CCC[C@@H](n4cc(C(F)(F)F)ccc4=O)C3)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
44279689 200304 0 None None None Human 7.6 pKi = 7.6 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 606 6 1 6 4.5 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL287629 200304 0 None None None Human 7.6 pKi = 7.6 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 606 6 1 6 4.5 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
11569672 143964 0 None None None Human 7.6 pKi = 7.6 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm050557v
11656342 143964 0 None None None Human 7.6 pKi = 7.6 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm050557v
CHEMBL196603 143964 0 None None None Human 7.6 pKi = 7.6 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm050557v
CHEMBL371291 143964 0 None None None Human 7.6 pKi = 7.6 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm050557v
11577790 278159 0 None None None Human 7.6 pKi = 7.6 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 573 7 2 5 3.6 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc(N2CCN(C)CC2)cc1 10.1021/jm050557v
CHEMBL382065 278159 0 None None None Human 7.6 pKi = 7.6 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 573 7 2 5 3.6 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc(N2CCN(C)CC2)cc1 10.1021/jm050557v
44274620 194305 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 565 8 3 5 2.9 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
44274660 194305 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 565 8 3 5 2.9 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL24806 194305 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 565 8 3 5 2.9 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL422044 194305 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 565 8 3 5 2.9 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
10054193 199414 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 592 11 2 5 4.7 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2ccc(Cl)c(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL281403 199414 0 None None None Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 592 11 2 5 4.7 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2ccc(Cl)c(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL2369839 477599 0 None -16 4 Human 7.6 pKi = 7.6 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1054 18 13 15 -4.7 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
CHEMBL1790552 484810 0 None 1 2 Rat 5.6 pKi = 5.6 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 770 6 2 8 2.0 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN(C)N2C(=O)[C@H]2CCCN(C)N2C1=O 10.1021/jm00171a003
45103785 429849 0 None 1 2 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 584 4 1 5 4.6 Cc1cc(C(=O)N2Cc3cccn3Cc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
CHEMBL590175 429849 0 None 1 2 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 584 4 1 5 4.6 Cc1cc(C(=O)N2Cc3cccn3Cc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
44278986 200088 0 None None None Human 6.6 pKi = 6.6 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 376 2 0 4 4.2 O=C(c1ccc2occc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
CHEMBL286084 200088 0 None None None Human 6.6 pKi = 6.6 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 376 2 0 4 4.2 O=C(c1ccc2occc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
10413997 4534 5 None 1 2 Rat 7.6 pKi = 7.6 Binding
Tested against rat uterine OT receptorTested against rat uterine OT receptor
ChEMBL 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 10.1021/jm00077a002
2246 4534 5 None 1 2 Rat 7.6 pKi = 7.6 Binding
Tested against rat uterine OT receptorTested against rat uterine OT receptor
ChEMBL 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 10.1021/jm00077a002
CHEMBL338522 4534 5 None 1 2 Rat 7.6 pKi = 7.6 Binding
Tested against rat uterine OT receptorTested against rat uterine OT receptor
ChEMBL 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 10.1021/jm00077a002
44335148 19471 0 None None None Human 6.6 pKi = 6.6 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 512 5 0 5 5.9 COc1cc(OC2CCCc3ccccc32)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL105733 19471 0 None None None Human 6.6 pKi = 6.6 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 512 5 0 5 5.9 COc1cc(OC2CCCc3ccccc32)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
52946086 40867 0 None None None Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 457 7 2 5 3.4 CO/N=C1\C[C@@H](C(=O)NCC(O)c2ccccc2)N(C(=O)c2ccc(-c3ccccc3)cc2)C1 10.1021/jm901812z
CHEMBL1253935 40867 0 None None None Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 457 7 2 5 3.4 CO/N=C1\C[C@@H](C(=O)NCC(O)c2ccccc2)N(C(=O)c2ccc(-c3ccccc3)cc2)C1 10.1021/jm901812z
10722297 468477 0 None -5 2 Rat 7.6 pKi = 7.6 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 600 7 0 7 4.8 COc1cc(OC2CCN(Cc3ccc(C)[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL65949 468477 0 None -5 2 Rat 7.6 pKi = 7.6 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 600 7 0 7 4.8 COc1cc(OC2CCN(Cc3ccc(C)[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
2213 1072 37 None -22 5 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
3008 1072 37 None -22 5 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
5311010 1072 37 None -22 5 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
68613 1072 37 None -22 5 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
CHEMBL378642 1072 37 None -22 5 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
CHEMBL382301 1072 37 None -22 5 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
DB09059 1072 37 None -22 5 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
136961690 237392 0 None 1 3 Human 7.6 pKi = 7.6 Binding
Binding affinity to OTR (unknown origin)Binding affinity to OTR (unknown origin)
ChEMBL 412 3 1 6 4.2 Cc1ccn(Cc2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)cc2C)n1 10.1021/jm501395b
CHEMBL3416757 237392 0 None 1 3 Human 7.6 pKi = 7.6 Binding
Binding affinity to OTR (unknown origin)Binding affinity to OTR (unknown origin)
ChEMBL 412 3 1 6 4.2 Cc1ccn(Cc2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)cc2C)n1 10.1021/jm501395b
135916069 463841 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 398 2 1 6 4.1 Cc1ccn(-c2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)cc2C)n1 10.1021/jm901084f
CHEMBL605373 463841 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 398 2 1 6 4.1 Cc1ccn(-c2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)cc2C)n1 10.1021/jm901084f
54584477 125114 0 None -10 3 Human 6.6 pKi = 6.6 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 631 8 1 11 1.7 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3nccnc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
CHEMBL1779403 125114 0 None -10 3 Human 6.6 pKi = 6.6 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 631 8 1 11 1.7 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3nccnc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
11619807 145100 0 None -1 2 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 472 9 1 6 3.5 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccn2)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL200368 145100 0 None -1 2 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 472 9 1 6 3.5 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccn2)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
11619807 145100 0 None -1 2 Human 5.6 pKi = 5.6 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 472 9 1 6 3.5 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccn2)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
CHEMBL200368 145100 0 None -1 2 Human 5.6 pKi = 5.6 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 472 9 1 6 3.5 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccn2)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
44308876 468866 0 None -2 2 Rat 7.6 pKi = 7.6 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 556 7 0 7 4.9 COc1cc(OC2CCN(Cc3cccnc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL68914 468866 0 None -2 2 Rat 7.6 pKi = 7.6 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 556 7 0 7 4.9 COc1cc(OC2CCN(Cc3cccnc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
2192 4802 27 None 5 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
9690136 4802 27 None 5 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
CHEMBL1254024 4802 27 None 5 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
44579399 370412 0 None 19 2 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 368 8 0 7 3.6 CCOCc1nnc(-c2ccc(OCC)c(C)c2)n1-c1ccc(OC)nc1 10.1021/jm901812z
CHEMBL492029 370412 0 None 19 2 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 368 8 0 7 3.6 CCOCc1nnc(-c2ccc(OCC)c(C)c2)n1-c1ccc(OC)nc1 10.1021/jm901812z
2192 4802 27 None 5 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
9690136 4802 27 None 5 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
CHEMBL1254024 4802 27 None 5 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
57520031 155346 0 None 131 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 555 7 0 6 3.0 COc1cc(OC2CCN(S(C)(=O)=O)CC2)ccc1CC(=O)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmc.2012.02.019
CHEMBL2017979 155346 0 None 131 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 555 7 0 6 3.0 COc1cc(OC2CCN(S(C)(=O)=O)CC2)ccc1CC(=O)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmc.2012.02.019
54584478 125117 0 None -354 3 Human 7.6 pKi = 7.6 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 666 9 0 8 4.5 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccc(CN4CCCC4)cc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779406 125117 0 None -354 3 Human 7.6 pKi = 7.6 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 666 9 0 8 4.5 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccc(CN4CCCC4)cc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
10721511 202732 0 None 2 2 Human 7.5 pKi = 7.5 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 555 7 0 6 5.5 COc1cc(OC2CCN(Cc3ccccc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL304577 202732 0 None 2 2 Human 7.5 pKi = 7.5 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 555 7 0 6 5.5 COc1cc(OC2CCN(Cc3ccccc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10840517 468876 0 None -3 2 Rat 7.5 pKi = 7.5 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 556 7 0 7 4.9 COc1cc(OC2CCN(Cc3ccncc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL68978 468876 0 None -3 2 Rat 7.5 pKi = 7.5 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 556 7 0 7 4.9 COc1cc(OC2CCN(Cc3ccncc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10793202 468947 0 None -2 2 Rat 7.5 pKi = 7.5 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 572 7 0 7 4.1 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL69539 468947 0 None -2 2 Rat 7.5 pKi = 7.5 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 572 7 0 7 4.1 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
54584265 123942 0 None -54 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1026 18 11 14 -0.9 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765663 123942 0 None -54 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1026 18 11 14 -0.9 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
54581529 125119 0 None -112 3 Human 7.5 pKi = 7.5 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 696 10 0 9 4.5 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCCC4)ccc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
CHEMBL1779408 125119 0 None -112 3 Human 7.5 pKi = 7.5 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 696 10 0 9 4.5 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCCC4)ccc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
10510242 238988 0 None None None Rat 8.5 pKi = 8.5 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL 1023 17 11 15 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm9607156
11083629 238988 0 None None None Rat 8.5 pKi = 8.5 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL 1023 17 11 15 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm9607156
CHEMBL352836 238988 0 None None None Rat 8.5 pKi = 8.5 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL 1023 17 11 15 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm9607156
CHEMBL353396 238988 0 None None None Rat 8.5 pKi = 8.5 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL 1023 17 11 15 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm9607156
135414531 160566 0 None 3 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 586 13 2 8 3.1 COCCOCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113208 160566 0 None 3 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 586 13 2 8 3.1 COCCOCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
155532160 336257 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1006 21 13 15 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4467042 336257 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1006 21 13 15 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
135414531 160566 0 None 3 3 Human 8.5 pKi = 8.5 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 586 13 2 8 3.1 COCCOCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
CHEMBL2113208 160566 0 None 3 3 Human 8.5 pKi = 8.5 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 586 13 2 8 3.1 COCCOCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
44279410 196816 0 None None None Human 8.5 pKi = 8.5 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 559 6 1 7 2.7 CN1CC(=O)N(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)C1=O 10.1016/s0960-894x(02)00159-2
CHEMBL262384 196816 0 None None None Human 8.5 pKi = 8.5 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 559 6 1 7 2.7 CN1CC(=O)N(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)C1=O 10.1016/s0960-894x(02)00159-2
44456270 311352 0 None None None Human 8.5 pKi = 8.5 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 466 6 1 5 2.6 Cc1nc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)c(C)o1 10.1016/j.bmcl.2007.11.008
CHEMBL403477 311352 0 None None None Human 8.5 pKi = 8.5 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 466 6 1 5 2.6 Cc1nc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)c(C)o1 10.1016/j.bmcl.2007.11.008
11758421 199862 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 609 6 1 8 4.1 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cnc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL284442 199862 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 609 6 1 8 4.1 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cnc2o1 10.1016/s0960-894x(02)00160-9
44279542 216828 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 642 6 1 7 5.3 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccc(Cl)cc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL31651 216828 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 642 6 1 7 5.3 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccc(Cl)cc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
11569672 143964 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-oxytocin from human oxytocin receptorDisplacement of [3H]-oxytocin from human oxytocin receptor
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm901812z
11656342 143964 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-oxytocin from human oxytocin receptorDisplacement of [3H]-oxytocin from human oxytocin receptor
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm901812z
CHEMBL196603 143964 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-oxytocin from human oxytocin receptorDisplacement of [3H]-oxytocin from human oxytocin receptor
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm901812z
CHEMBL371291 143964 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-oxytocin from human oxytocin receptorDisplacement of [3H]-oxytocin from human oxytocin receptor
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm901812z
11569672 143964 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm060073e
11656342 143964 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm060073e
CHEMBL196603 143964 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm060073e
CHEMBL371291 143964 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm060073e
11569672 143964 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm050557v
11656342 143964 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm050557v
CHEMBL196603 143964 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm050557v
CHEMBL371291 143964 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N(C)C)cc1 10.1021/jm050557v
56949759 156983 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 464 6 2 5 2.1 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(O)nc1 10.1021/jm201287w
CHEMBL2037488 156983 0 None None None Human 8.5 pKi = 8.5 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 464 6 2 5 2.1 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(O)nc1 10.1021/jm201287w
3126 484342 1 None None None Rat 8.5 pKi = 8.5 Binding
Binding affinity against oxytocin receptorBinding affinity against oxytocin receptor
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm990090m
CHEMBL435716 484342 1 None None None Rat 8.5 pKi = 8.5 Binding
Binding affinity against oxytocin receptorBinding affinity against oxytocin receptor
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm990090m
10723001 202424 0 None -3 2 Rat 8.5 pKi = 8.5 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 658 7 0 7 5.3 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C(F)(F)F)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL303700 202424 0 None -3 2 Rat 8.5 pKi = 8.5 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 658 7 0 7 5.3 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C(F)(F)F)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10603858 468859 0 None None None Human 8.5 pKi = 8.5 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 616 6 0 7 4.8 COc1cc(OC2CCN(C3CCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL68816 468859 0 None None None Human 8.5 pKi = 8.5 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 616 6 0 7 4.8 COc1cc(OC2CCN(C3CCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL1790551 484809 0 None 229 2 Rat 8.5 pKi = 8.5 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 795 8 2 9 2.1 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2C[C@@H](CN(C)C)C=NN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00171a003
10627984 468607 0 None -4 2 Rat 8.5 pKi = 8.5 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 646 8 0 7 5.5 CCc1c(CN2CCC(Oc3cc(OC)c(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)cc3F)CC2)c(C)cc(C)[n+]1[O-] 10.1021/jm9800797
CHEMBL66985 468607 0 None -4 2 Rat 8.5 pKi = 8.5 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 646 8 0 7 5.5 CCc1c(CN2CCC(Oc3cc(OC)c(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)cc3F)CC2)c(C)cc(C)[n+]1[O-] 10.1021/jm9800797
CHEMBL435021 488610 4 None 1 2 Rat 8.5 pKi = 8.5 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from pregnant ratsCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from pregnant rats
ChEMBL 780 6 4 7 2.0 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CNCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10841081 202393 0 None 3 2 Human 8.5 pKi = 8.5 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL303487 202393 0 None 3 2 Human 8.5 pKi = 8.5 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
2249 4540 14 None 1 7 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1021/jm901812z
9872389 4540 14 None 1 7 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1021/jm901812z
CHEMBL1253853 4540 14 None 1 7 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1021/jm901812z
127049296 277954 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL3815099 277954 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
135466581 160557 0 None 120 2 Human 8.4 pKi = 8.4 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 512 8 2 6 3.4 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
CHEMBL2113198 160557 0 None 120 2 Human 8.4 pKi = 8.4 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 512 8 2 6 3.4 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
44335184 212985 0 None None None Human 8.4 pKi = 8.4 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 487 6 0 6 5.0 COc1cc(O[C@H](C)c2ccncc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL322187 212985 0 None None None Human 8.4 pKi = 8.4 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 487 6 0 6 5.0 COc1cc(O[C@H](C)c2ccncc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
135466581 160557 0 None 120 2 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 512 8 2 6 3.4 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113198 160557 0 None 120 2 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 512 8 2 6 3.4 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
44279369 199203 0 None None None Human 8.4 pKi = 8.4 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 573 6 1 7 3.1 CN1CCC(=O)N(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)C1=O 10.1016/s0960-894x(02)00159-2
CHEMBL279782 199203 0 None None None Human 8.4 pKi = 8.4 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 573 6 1 7 3.1 CN1CCC(=O)N(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)C1=O 10.1016/s0960-894x(02)00159-2
56950449 156710 0 None None None Human 8.4 pKi = 8.4 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 495 7 2 3 4.1 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccccc1Cl 10.1021/jm201287w
CHEMBL2035009 156710 0 None None None Human 8.4 pKi = 8.4 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 495 7 2 3 4.1 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccccc1Cl 10.1021/jm201287w
44581269 372851 0 None None None Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 446 7 0 6 4.3 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2ccccn2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL515818 372851 0 None None None Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 446 7 0 6 4.3 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2ccccn2)cn1 10.1016/j.bmcl.2008.11.018
44279590 219879 0 None 1000 2 Human 8.4 pKi = 8.4 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 609 6 1 8 4.1 O=C(Cn1cnc(C(F)(F)F)cc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL32404 219879 0 None 1000 2 Human 8.4 pKi = 8.4 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 609 6 1 8 4.1 O=C(Cn1cnc(C(F)(F)F)cc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
11569194 144330 0 None 63 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-oxytocin from human oxytocin receptorDisplacement of [3H]-oxytocin from human oxytocin receptor
ChEMBL 479 7 2 3 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(F)cc1 10.1021/jm901812z
11619939 144330 0 None 63 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-oxytocin from human oxytocin receptorDisplacement of [3H]-oxytocin from human oxytocin receptor
ChEMBL 479 7 2 3 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(F)cc1 10.1021/jm901812z
CHEMBL197793 144330 0 None 63 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-oxytocin from human oxytocin receptorDisplacement of [3H]-oxytocin from human oxytocin receptor
ChEMBL 479 7 2 3 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(F)cc1 10.1021/jm901812z
CHEMBL427353 144330 0 None 63 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-oxytocin from human oxytocin receptorDisplacement of [3H]-oxytocin from human oxytocin receptor
ChEMBL 479 7 2 3 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(F)cc1 10.1021/jm901812z
11341369 161068 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 519 6 2 5 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc2c(c1)OCO2 10.1021/jm060073e
CHEMBL211440 161068 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 519 6 2 5 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc2c(c1)OCO2 10.1021/jm060073e
11570523 161546 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 574 7 3 5 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc(N2CCC(O)CC2)cc1 10.1021/jm060073e
CHEMBL213112 161546 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 574 7 3 5 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc(N2CCC(O)CC2)cc1 10.1021/jm060073e
11634960 276572 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 517 6 2 4 3.7 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc2c(c1)CCO2 10.1021/jm060073e
CHEMBL378939 276572 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 517 6 2 4 3.7 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc2c(c1)CCO2 10.1021/jm060073e
11612607 142825 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 7 2 3 3.7 Cc1ccc([C@@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
11691416 142825 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 7 2 3 3.7 Cc1ccc([C@@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL194922 142825 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 7 2 3 3.7 Cc1ccc([C@@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL555148 142825 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 7 2 3 3.7 Cc1ccc([C@@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
11569194 144330 0 None 63 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 479 7 2 3 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(F)cc1 10.1021/jm050557v
11619939 144330 0 None 63 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 479 7 2 3 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(F)cc1 10.1021/jm050557v
CHEMBL197793 144330 0 None 63 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 479 7 2 3 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(F)cc1 10.1021/jm050557v
CHEMBL427353 144330 0 None 63 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 479 7 2 3 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(F)cc1 10.1021/jm050557v
11363194 198471 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 461 7 2 3 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccccc1 10.1021/jm050557v
11641200 198471 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 461 7 2 3 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccccc1 10.1021/jm050557v
CHEMBL273988 198471 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 461 7 2 3 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccccc1 10.1021/jm050557v
CHEMBL382518 198471 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 461 7 2 3 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccccc1 10.1021/jm050557v
11677260 273133 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 7 1 3 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C(C)C)c1ccccc1 10.1021/jm050557v
CHEMBL372978 273133 0 None None None Human 8.4 pKi = 8.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 7 1 3 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C(C)C)c1ccccc1 10.1021/jm050557v
CHEMBL1790548 484807 0 None 50 2 Rat 7.5 pKi = 7.5 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 742 6 4 8 1.3 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCNN2C(=O)[C@H]2CCCNN2C1=O 10.1021/jm00171a003
10627414 468768 0 None -5 2 Rat 7.5 pKi = 7.5 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 600 7 0 7 4.8 COc1cc(OC2CCN(Cc3c[n+]([O-])c(C)cc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL68199 468768 0 None -5 2 Rat 7.5 pKi = 7.5 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 600 7 0 7 4.8 COc1cc(OC2CCN(Cc3c[n+]([O-])c(C)cc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
11740743 38028 0 None -6 3 Human 7.5 pKi = 7.5 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 384 3 1 2 5.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/jm3006146
CHEMBL119793 38028 0 None -6 3 Human 7.5 pKi = 7.5 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 384 3 1 2 5.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/jm3006146
54583310 125811 0 None -25 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1542 24 16 22 1.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1789128 125811 0 None -25 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1542 24 16 22 1.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
135506374 275287 21 None -3 3 Human 7.5 pKi = 7.5 Binding
Displacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 275287 21 None -3 3 Human 7.5 pKi = 7.5 Binding
Displacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
44215484 352491 0 None -10 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 440 7 0 6 4.6 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCN1CCOCC1 10.1021/jm901812z
CHEMBL467154 352491 0 None -10 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 440 7 0 6 4.6 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCN1CCOCC1 10.1021/jm901812z
71451750 163805 0 None -1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1295 30 4 17 7.6 CCN(CC)c1ccc2c(-c3ccc(S(=O)(=O)[O-])cc3S(=O)(=O)NCCOCCOCCOCCn3cc(CNC(=O)CCC(=O)NC4CCCN(C(=O)c5ccc(NC(=O)c6ccccc6C)cc5)c5ccccc54)nn3)c3ccc(=[N+](CC)CC)cc-3oc2c1 10.1021/jm3006146
CHEMBL2172292 163805 0 None -1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1295 30 4 17 7.6 CCN(CC)c1ccc2c(-c3ccc(S(=O)(=O)[O-])cc3S(=O)(=O)NCCOCCOCCOCCn3cc(CNC(=O)CCC(=O)NC4CCCN(C(=O)c5ccc(NC(=O)c6ccccc6C)cc5)c5ccccc54)nn3)c3ccc(=[N+](CC)CC)cc-3oc2c1 10.1021/jm3006146
CHEMBL3814617 487603 0 None None None Human 7.5 pKi = 7.5 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1020 17 11 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)N(C)C(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
56950452 156713 0 None None None Human 7.5 pKi = 7.5 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 529 7 2 3 4.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccccc1C(F)(F)F 10.1021/jm201287w
CHEMBL2035012 156713 0 None None None Human 7.5 pKi = 7.5 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 529 7 2 3 4.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccccc1C(F)(F)F 10.1021/jm201287w
56950589 156714 0 None None None Human 7.5 pKi = 7.5 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 491 8 2 4 3.4 COc1ccccc1[C@H](C(=O)NC(C)C)N1C(=O)[C@@H](C2Cc3ccccc3C2)NC(=O)[C@H]1CC(C)C 10.1021/jm201287w
CHEMBL2035013 156714 0 None None None Human 7.5 pKi = 7.5 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 491 8 2 4 3.4 COc1ccccc1[C@H](C(=O)NC(C)C)N1C(=O)[C@@H](C2Cc3ccccc3C2)NC(=O)[C@H]1CC(C)C 10.1021/jm201287w
44404013 143997 0 None None None Human 7.5 pKi = 7.5 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 3 4 2.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(N)=O)cc1 10.1021/jm050557v
44404031 143997 0 None None None Human 7.5 pKi = 7.5 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 3 4 2.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(N)=O)cc1 10.1021/jm050557v
CHEMBL196688 143997 0 None None None Human 7.5 pKi = 7.5 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 3 4 2.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(N)=O)cc1 10.1021/jm050557v
CHEMBL197298 143997 0 None None None Human 7.5 pKi = 7.5 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 504 8 3 4 2.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(N)=O)cc1 10.1021/jm050557v
44275003 198922 0 None None None Human 7.5 pKi = 7.5 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 641 12 3 6 4.1 CC(=O)CCCC(=O)NC1N=C(C2CCCCC2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL277425 198922 0 None None None Human 7.5 pKi = 7.5 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 641 12 3 6 4.1 CC(=O)CCCC(=O)NC1N=C(C2CCCCC2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
44279509 199939 0 None None None Human 6.5 pKi = 6.5 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 496 6 1 6 3.0 CS(=O)(=O)NCCn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
CHEMBL285013 199939 0 None None None Human 6.5 pKi = 6.5 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 496 6 1 6 3.0 CS(=O)(=O)NCCn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
11525173 142558 0 None None None Human 6.5 pKi = 6.5 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 447 7 2 3 3.9 CC(C)C[C@@H]1CN[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccccc1 10.1021/jm050557v
CHEMBL194431 142558 0 None None None Human 6.5 pKi = 6.5 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 447 7 2 3 3.9 CC(C)C[C@@H]1CN[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccccc1 10.1021/jm050557v
44275048 195136 0 None None None Human 6.5 pKi = 6.5 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 524 11 2 5 3.4 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2ccccc2)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL25310 195136 0 None None None Human 6.5 pKi = 6.5 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 524 11 2 5 3.4 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2ccccc2)C1=O 10.1016/s0960-894x(01)00202-5
2213 1072 37 None -22 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to recombinant oxytocin receptorBinding affinity to recombinant oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2007.11.008
3008 1072 37 None -22 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to recombinant oxytocin receptorBinding affinity to recombinant oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2007.11.008
5311010 1072 37 None -22 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to recombinant oxytocin receptorBinding affinity to recombinant oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2007.11.008
68613 1072 37 None -22 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to recombinant oxytocin receptorBinding affinity to recombinant oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2007.11.008
CHEMBL378642 1072 37 None -22 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to recombinant oxytocin receptorBinding affinity to recombinant oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2007.11.008
CHEMBL382301 1072 37 None -22 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to recombinant oxytocin receptorBinding affinity to recombinant oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2007.11.008
DB09059 1072 37 None -22 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to recombinant oxytocin receptorBinding affinity to recombinant oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2007.11.008
10208363 144594 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 523 9 1 6 2.7 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3CC2C(N)=O)c2ccc(OC)cc2)cc1 10.1021/jm050645f
CHEMBL198622 144594 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 523 9 1 6 2.7 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3CC2C(N)=O)c2ccc(OC)cc2)cc1 10.1021/jm050645f
53358903 125107 0 None -1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 499 6 1 7 3.2 COc1ccc2c(c1)c(CC(=O)N1CCCNCC1)c(C)n2S(=O)(=O)c1ccc(OC)c(C)c1C 10.1016/j.bmcl.2011.04.104
CHEMBL1779235 125107 0 None -1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 499 6 1 7 3.2 COc1ccc2c(c1)c(CC(=O)N1CCCNCC1)c(C)n2S(=O)(=O)c1ccc(OC)c(C)c1C 10.1016/j.bmcl.2011.04.104
135461396 160555 0 None 3 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 626 13 2 8 2.2 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)N(CC(N)=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113196 160555 0 None 3 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 626 13 2 8 2.2 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)N(CC(N)=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
145976595 328683 0 None -8 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 408 2 1 4 4.9 Cc1ccn(C(=O)Nc2ccc(C(=O)N3CCCCc4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL4205046 328683 0 None -8 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 408 2 1 4 4.9 Cc1ccn(C(=O)Nc2ccc(C(=O)N3CCCCc4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
11366713 274628 0 None -724 8 Human 6.5 pKi = 6.5 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1054 19 13 15 -3.9 NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL375096 274628 0 None -724 8 Human 6.5 pKi = 6.5 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1054 19 13 15 -3.9 NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
44275617 197561 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 410 5 0 5 3.4 COc1ccc(CC(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(99)00181-x
CHEMBL26877 197561 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 410 5 0 5 3.4 COc1ccc(CC(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(99)00181-x
CHEMBL338308 487001 0 None -4 2 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from near-term pregnant rhesus monkeyCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from near-term pregnant rhesus monkey
ChEMBL 742 9 4 8 1.5 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCN)NC(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
135469685 160569 0 None -4 3 Rat 7.5 pKi = 7.5 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 542 10 2 7 3.0 COCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113211 160569 0 None -4 3 Rat 7.5 pKi = 7.5 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 542 10 2 7 3.0 COCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL3814120 487598 0 None None None Human 7.5 pKi = 7.5 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1034 17 10 15 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
44361403 67461 1 None -14 5 Rat 6.5 pKi = 6.5 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 491 5 0 5 4.1 CC(=O)N1CCCC(COc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)C1 10.1021/jm00023a002
CHEMBL142324 67461 1 None -14 5 Rat 6.5 pKi = 6.5 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 491 5 0 5 4.1 CC(=O)N1CCCC(COc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)C1 10.1021/jm00023a002
145964296 329079 0 None -1 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 329 2 0 3 4.1 O=C(c1ccc(-c2ncccn2)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
CHEMBL4209952 329079 0 None -1 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 329 2 0 3 4.1 O=C(c1ccc(-c2ncccn2)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
44419039 274799 0 None -27542 8 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1096 20 14 15 -4.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm060928n
CHEMBL375324 274799 0 None -27542 8 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1096 20 14 15 -4.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm060928n
10602875 468553 0 None -1 2 Rat 7.4 pKi = 7.4 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 556 7 0 7 4.9 COc1cc(OC2CCN(Cc3ccccn3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL66567 468553 0 None -1 2 Rat 7.4 pKi = 7.4 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 556 7 0 7 4.9 COc1cc(OC2CCN(Cc3ccccn3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
44275233 199134 0 None -3 2 Rat 7.4 pKi = 7.4 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 521 6 0 6 3.8 COc1cc(OC2CCN(C(C)=O)CC2)ccc1CC(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL279230 199134 0 None -3 2 Rat 7.4 pKi = 7.4 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 521 6 0 6 3.8 COc1cc(OC2CCN(C(C)=O)CC2)ccc1CC(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
135461089 145109 4 None None None Human 7.4 pKi = 7.4 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 478 8 2 6 4.8 CCOc1ccc(S(=O)(=O)N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)c2ccccc2)cc1 10.1021/jm050645f
CHEMBL200403 145109 4 None None None Human 7.4 pKi = 7.4 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 478 8 2 6 4.8 CCOc1ccc(S(=O)(=O)N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)c2ccccc2)cc1 10.1021/jm050645f
CHEMBL491224 145109 4 None None None Human 7.4 pKi = 7.4 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 478 8 2 6 4.8 CCOc1ccc(S(=O)(=O)N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)c2ccccc2)cc1 10.1021/jm050645f
135438380 160570 0 None 58 2 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 510 8 2 5 4.0 CCCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113212 160570 0 None 58 2 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 510 8 2 5 4.0 CCCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2369848 477605 0 None -77 4 Human 6.4 pKi = 6.4 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1093 18 12 15 -2.3 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2cccs2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
44275617 197561 0 None -1 2 Rat 7.4 pKi = 7.4 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 410 5 0 5 3.4 COc1ccc(CC(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(99)00181-x
CHEMBL26877 197561 0 None -1 2 Rat 7.4 pKi = 7.4 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 410 5 0 5 3.4 COc1ccc(CC(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(99)00181-x
135446051 160562 0 None 13 2 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 474 6 2 6 3.1 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1cccs1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113204 160562 0 None 13 2 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 474 6 2 6 3.1 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1cccs1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
16109447 164761 0 None -40 4 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1012 18 12 15 -3.2 NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL219272 164761 0 None -40 4 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1012 18 12 15 -3.2 NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
145970757 329707 0 None -1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 307 4 0 1 5.0 CCCCc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
CHEMBL4218211 329707 0 None -1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 307 4 0 1 5.0 CCCCc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
44297505 330720 0 None -173 3 Rat 7.4 pKi = 7.4 Binding
Tested for inhibition constant at OT receptor of rat mammary glandsTested for inhibition constant at OT receptor of rat mammary glands
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL424905 330720 0 None -173 3 Rat 7.4 pKi = 7.4 Binding
Tested for inhibition constant at OT receptor of rat mammary glandsTested for inhibition constant at OT receptor of rat mammary glands
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
9981665 232117 5 None 1 6 Rat 6.4 pKi = 6.4 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 459 5 2 4 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm901812z
CHEMBL341339 232117 5 None 1 6 Rat 6.4 pKi = 6.4 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue
ChEMBL 459 5 2 4 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm901812z
54584268 123948 0 None -446 4 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1226 29 13 16 0.7 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(O)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765671 123948 0 None -446 4 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1226 29 13 16 0.7 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(O)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
53364234 136389 0 None -1584 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]OT from human OT receptor expressed in CHO cellsDisplacement of [3H]OT from human OT receptor expressed in CHO cells
ChEMBL 485 8 2 3 4.2 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807273 136389 0 None -1584 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]OT from human OT receptor expressed in CHO cellsDisplacement of [3H]OT from human OT receptor expressed in CHO cells
ChEMBL 485 8 2 3 4.2 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2011.05.092
145965794 329318 0 None None None Human 6.4 pKi = 6.4 Binding
Displacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 462 5 3 7 2.6 COC(=O)CNC(=O)NCc1ccc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)cc1C 10.1021/acs.jmedchem.8b00697
CHEMBL4212928 329318 0 None None None Human 6.4 pKi = 6.4 Binding
Displacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 462 5 3 7 2.6 COC(=O)CNC(=O)NCc1ccc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)cc1C 10.1021/acs.jmedchem.8b00697
44279555 202338 0 None None None Human 7.4 pKi = 7.4 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 510 6 0 6 3.3 CN(CCn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21)S(C)(=O)=O 10.1016/s0960-894x(02)00159-2
CHEMBL30315 202338 0 None None None Human 7.4 pKi = 7.4 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 510 6 0 6 3.3 CN(CCn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21)S(C)(=O)=O 10.1016/s0960-894x(02)00159-2
44280013 203036 0 None None None Human 7.4 pKi = 7.4 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 461 5 1 5 3.9 CC(=O)NCCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
CHEMBL30667 203036 0 None None None Human 7.4 pKi = 7.4 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 461 5 1 5 3.9 CC(=O)NCCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
56950590 156715 0 None None None Human 7.4 pKi = 7.4 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 545 8 2 4 4.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccccc1OC(F)(F)F 10.1021/jm201287w
CHEMBL2035014 156715 0 None None None Human 7.4 pKi = 7.4 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 545 8 2 4 4.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccccc1OC(F)(F)F 10.1021/jm201287w
56950591 156716 0 None None None Human 7.4 pKi = 7.4 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 537 8 2 3 5.1 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccccc1-c1ccccc1 10.1021/jm201287w
CHEMBL2035015 156716 0 None None None Human 7.4 pKi = 7.4 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 537 8 2 3 5.1 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccccc1-c1ccccc1 10.1021/jm201287w
44456003 197939 0 None None None Human 7.4 pKi = 7.4 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 508 8 3 5 2.4 CNC(=O)c1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)o1 10.1016/j.bmcl.2007.11.008
CHEMBL271057 197939 0 None None None Human 7.4 pKi = 7.4 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 508 8 3 5 2.4 CNC(=O)c1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)o1 10.1016/j.bmcl.2007.11.008
44581682 372670 0 None None None Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 452 8 0 8 3.5 COc1ccc(S(=O)(=O)N(Cc2noc(-c3ccccc3)n2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL514287 372670 0 None None None Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 452 8 0 8 3.5 COc1ccc(S(=O)(=O)N(Cc2noc(-c3ccccc3)n2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44581647 372806 0 None None None Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 438 7 0 7 4.0 COc1ccc(N(Cc2nc(-c3ccccc3)cs2)S(=O)(=O)c2ccccn2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL515384 372806 0 None None None Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 438 7 0 7 4.0 COc1ccc(N(Cc2nc(-c3ccccc3)cs2)S(=O)(=O)c2ccccn2)cn1 10.1016/j.bmcl.2008.11.018
2213 1072 37 None -22 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm060073e
3008 1072 37 None -22 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm060073e
5311010 1072 37 None -22 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm060073e
68613 1072 37 None -22 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm060073e
CHEMBL378642 1072 37 None -22 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm060073e
CHEMBL382301 1072 37 None -22 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm060073e
DB09059 1072 37 None -22 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm060073e
11591519 144344 0 None None None Human 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 505 7 2 4 3.8 COc1ccc([C@@H](C(=O)NC(C)(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
11649100 144344 0 None None None Human 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 505 7 2 4 3.8 COc1ccc([C@@H](C(=O)NC(C)(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL197822 144344 0 None None None Human 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 505 7 2 4 3.8 COc1ccc([C@@H](C(=O)NC(C)(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL372128 144344 0 None None None Human 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 505 7 2 4 3.8 COc1ccc([C@@H](C(=O)NC(C)(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
2213 1072 37 None -20 5 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from rat OTRDisplacement of [3H]oxytocin from rat OTR
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm060073e
3008 1072 37 None -20 5 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from rat OTRDisplacement of [3H]oxytocin from rat OTR
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm060073e
5311010 1072 37 None -20 5 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from rat OTRDisplacement of [3H]oxytocin from rat OTR
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm060073e
68613 1072 37 None -20 5 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from rat OTRDisplacement of [3H]oxytocin from rat OTR
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm060073e
CHEMBL378642 1072 37 None -20 5 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from rat OTRDisplacement of [3H]oxytocin from rat OTR
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm060073e
CHEMBL382301 1072 37 None -20 5 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from rat OTRDisplacement of [3H]oxytocin from rat OTR
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm060073e
DB09059 1072 37 None -20 5 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]oxytocin from rat OTRDisplacement of [3H]oxytocin from rat OTR
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm060073e
44274659 196309 0 None None None Human 7.4 pKi = 7.4 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 650 10 3 7 2.2 NC(=O)[C@H](Cc1ccc(Cl)c(Cl)c1)NC(=O)CN1C(=O)C(NC(=O)CN2CCOCC2)N=C(c2ccccc2)c2ccccc21 10.1016/s0960-894x(01)00202-5
CHEMBL25942 196309 0 None None None Human 7.4 pKi = 7.4 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 650 10 3 7 2.2 NC(=O)[C@H](Cc1ccc(Cl)c(Cl)c1)NC(=O)CN1C(=O)C(NC(=O)CN2CCOCC2)N=C(c2ccccc2)c2ccccc21 10.1016/s0960-894x(01)00202-5
44275210 195410 0 None 4 2 Human 6.4 pKi = 6.4 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 491 5 0 5 3.8 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL25502 195410 0 None 4 2 Human 6.4 pKi = 6.4 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 491 5 0 5 3.8 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)CC1 10.1016/s0960-894x(99)00181-x
47177173 329382 0 None -8 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 377 1 0 1 4.3 O=C(c1ccc(I)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
CHEMBL4213812 329382 0 None -8 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 377 1 0 1 4.3 O=C(c1ccc(I)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
2213 1072 37 None -22 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2008.11.064
3008 1072 37 None -22 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2008.11.064
5311010 1072 37 None -22 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2008.11.064
68613 1072 37 None -22 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2008.11.064
CHEMBL378642 1072 37 None -22 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2008.11.064
CHEMBL382301 1072 37 None -22 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2008.11.064
DB09059 1072 37 None -22 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1016/j.bmcl.2008.11.064
44279752 213320 0 None None None Human 6.4 pKi = 6.4 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 564 5 0 6 4.4 Cc1c(C)n(C[C@H]2CCCN2S(C)(=O)=O)c2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc12 10.1016/s0960-894x(02)00159-2
CHEMBL30865 213320 0 None None None Human 6.4 pKi = 6.4 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 564 5 0 6 4.4 Cc1c(C)n(C[C@H]2CCCN2S(C)(=O)=O)c2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc12 10.1016/s0960-894x(02)00159-2
44279348 216888 0 None None None Human 6.4 pKi = 6.4 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 376 2 0 4 4.2 O=C(c1ccc2ccoc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
CHEMBL31691 216888 0 None None None Human 6.4 pKi = 6.4 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 376 2 0 4 4.2 O=C(c1ccc2ccoc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
44279454 217060 0 None None None Human 6.4 pKi = 6.4 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 460 5 1 5 3.5 CC(=O)NCCn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
CHEMBL31823 217060 0 None None None Human 6.4 pKi = 6.4 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 460 5 1 5 3.5 CC(=O)NCCn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
44279519 220145 0 None None None Human 6.4 pKi = 6.4 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 511 6 0 7 2.7 CN(CCn1cnc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21)S(C)(=O)=O 10.1016/s0960-894x(02)00159-2
CHEMBL32567 220145 0 None None None Human 6.4 pKi = 6.4 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 511 6 0 7 2.7 CN(CCn1cnc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21)S(C)(=O)=O 10.1016/s0960-894x(02)00159-2
2253 4548 22 None -5 6 Human 8.4 pKi = 8.4 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm9800797
5311202 4548 22 None -5 6 Human 8.4 pKi = 8.4 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm9800797
CHEMBL306645 4548 22 None -5 6 Human 8.4 pKi = 8.4 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm9800797
10579886 213336 0 None -4 2 Rat 8.4 pKi = 8.4 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 632 7 0 7 5.2 COc1cc(OC2CCN(Cc3c(C)cc(C)[n+]([O-])c3C)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL308673 213336 0 None -4 2 Rat 8.4 pKi = 8.4 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 632 7 0 7 5.2 COc1cc(OC2CCN(Cc3c(C)cc(C)[n+]([O-])c3C)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
11340891 6755 33 None 891 2 Human 8.4 pKi = 8.4 Binding
Binding affinity to recombinant oxytocin receptorBinding affinity to recombinant oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
8403 6755 33 None 891 2 Human 8.4 pKi = 8.4 Binding
Binding affinity to recombinant oxytocin receptorBinding affinity to recombinant oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
CHEMBL429736 6755 33 None 891 2 Human 8.4 pKi = 8.4 Binding
Binding affinity to recombinant oxytocin receptorBinding affinity to recombinant oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
DB11818 6755 33 None 891 2 Human 8.4 pKi = 8.4 Binding
Binding affinity to recombinant oxytocin receptorBinding affinity to recombinant oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
135530014 160549 0 None 151 2 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 526 9 3 6 2.9 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(CCCO)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113179 160549 0 None 151 2 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 526 9 3 6 2.9 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(CCCO)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
10651439 202957 0 None 2 2 Human 8.4 pKi = 8.4 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 614 7 0 7 5.1 COc1cc(OC2CCN(Cc3c(C)cc(C)[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL306010 202957 0 None 2 2 Human 8.4 pKi = 8.4 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 614 7 0 7 5.1 COc1cc(OC2CCN(Cc3c(C)cc(C)[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
44297632 202117 0 None 57 2 Rat 8.4 pKi = 8.4 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 780 6 3 6 2.9 CC[C@@H](C)[C@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)N2CCN(CC2)C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00169a001
CHEMBL301708 202117 0 None 57 2 Rat 8.4 pKi = 8.4 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 780 6 3 6 2.9 CC[C@@H](C)[C@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)N2CCN(CC2)C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00169a001
10555563 202203 0 None -4 2 Rat 8.4 pKi = 8.4 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 600 7 0 7 4.8 COc1cc(OC2CCN(Cc3c(C)cc[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL302297 202203 0 None -4 2 Rat 8.4 pKi = 8.4 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 600 7 0 7 4.8 COc1cc(OC2CCN(Cc3c(C)cc[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
15840433 194848 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 448 5 0 4 4.3 O=C(Cc1ccccc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL25120 194848 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 448 5 0 4 4.3 O=C(Cc1ccccc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL435021 488610 4 None -1 2 Human 8.4 pKi = 8.4 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from nonlabor pregnant womenCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from nonlabor pregnant women
ChEMBL 780 6 4 7 2.0 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CNCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
2252 4546 39 None -1 5 Human 8.3 pKi = 8.3 Binding
Binding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from humanBinding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from human
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm00023a002
6918320 4546 39 None -1 5 Human 8.3 pKi = 8.3 Binding
Binding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from humanBinding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from human
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm00023a002
CHEMBL24781 4546 39 None -1 5 Human 8.3 pKi = 8.3 Binding
Binding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from humanBinding affinity was evaluated by measuring the displacement of [3H]OT (oxytocin) from specific binding sites in uterine tissue obtained from human
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm00023a002
135493119 160559 0 None -4 3 Rat 8.3 pKi = 8.3 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113201 160559 0 None -4 3 Rat 8.3 pKi = 8.3 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
2252 4546 39 None -1 5 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901812z
6918320 4546 39 None -1 5 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901812z
CHEMBL24781 4546 39 None -1 5 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901812z
CHEMBL435021 488610 4 None -1 2 Human 8.3 pKi = 8.3 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from near-term pregnant rhesus monkeyCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from near-term pregnant rhesus monkey
ChEMBL 780 6 4 7 2.0 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CNCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
2252 4546 39 None -1 5 Human 8.3 pKi = 8.3 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm9800797
6918320 4546 39 None -1 5 Human 8.3 pKi = 8.3 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm9800797
CHEMBL24781 4546 39 None -1 5 Human 8.3 pKi = 8.3 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm9800797
10651225 213109 0 None None None Human 8.3 pKi = 8.3 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 600 6 0 7 5.5 COc1cc(OC2CCN(C3CCc4ncccc43)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL308460 213109 0 None None None Human 8.3 pKi = 8.3 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 600 6 0 7 5.5 COc1cc(OC2CCN(C3CCc4ncccc43)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
44297516 316841 0 None -19 3 Rat 8.3 pKi = 8.3 Binding
Tested for inhibition constant at OT receptor of rat mammary glandsTested for inhibition constant at OT receptor of rat mammary glands
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL412192 316841 0 None -19 3 Rat 8.3 pKi = 8.3 Binding
Tested for inhibition constant at OT receptor of rat mammary glandsTested for inhibition constant at OT receptor of rat mammary glands
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
2253 4548 22 None -5 6 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm901812z
5311202 4548 22 None -5 6 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm901812z
CHEMBL306645 4548 22 None -5 6 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm901812z
16109440 317156 0 None -162 4 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 997 16 11 14 -2.3 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL412973 317156 0 None -162 4 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 997 16 11 14 -2.3 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
145970269 328552 0 None None None Human 6.4 pKi = 6.4 Binding
Displacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 475 5 3 6 2.5 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=O)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4203314 328552 0 None None None Human 6.4 pKi = 6.4 Binding
Displacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 475 5 3 6 2.5 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=O)N(C)C 10.1021/acs.jmedchem.8b00697
54584476 125111 0 None -32 4 Human 7.4 pKi = 7.4 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 630 8 1 10 2.3 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cccnc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
CHEMBL1779400 125111 0 None -32 4 Human 7.4 pKi = 7.4 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 630 8 1 10 2.3 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cccnc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
16109444 316992 0 None -537 4 Rat 6.4 pKi = 6.4 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1037 16 11 14 -1.3 NCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL412742 316992 0 None -537 4 Rat 6.4 pKi = 6.4 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1037 16 11 14 -1.3 NCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
44335300 18983 0 None -5 2 Rat 7.4 pKi = 7.4 Binding
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 486 6 0 5 5.6 COc1cc(OC(C)c2ccccc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL102994 18983 0 None -5 2 Rat 7.4 pKi = 7.4 Binding
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 486 6 0 5 5.6 COc1cc(OC(C)c2ccccc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
151171 2408 36 None -19 5 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting method
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1021/acs.jmedchem.8b00697
2203 2408 36 None -19 5 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting method
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1021/acs.jmedchem.8b00697
732 2408 36 None -19 5 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting method
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1021/acs.jmedchem.8b00697
CHEMBL1755 2408 36 None -19 5 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting method
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1021/acs.jmedchem.8b00697
DB00872 2408 36 None -19 5 Rat 7.4 pKi = 7.4 Binding
Displacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting method
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1021/acs.jmedchem.8b00697
135399794 160553 0 None None None Human 6.4 pKi = 6.4 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 506 8 2 6 3.5 CCOc1ccc(S(=O)(=O)N(c2ccc(C)cc2)C(C)C(=O)N/N=C2\C(=O)Nc3ccccc32)cc1 10.1021/jm050645f
CHEMBL2113194 160553 0 None None None Human 6.4 pKi = 6.4 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 506 8 2 6 3.5 CCOc1ccc(S(=O)(=O)N(c2ccc(C)cc2)C(C)C(=O)N/N=C2\C(=O)Nc3ccccc32)cc1 10.1021/jm050645f
54585429 125115 0 None -7 4 Human 7.4 pKi = 7.4 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 661 9 1 12 1.7 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cnc(OC)nc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
CHEMBL1779404 125115 0 None -7 4 Human 7.4 pKi = 7.4 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 661 9 1 12 1.7 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cnc(OC)nc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
54586391 125116 0 None -54 2 Human 7.4 pKi = 7.4 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 696 10 0 9 4.5 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccc(CN4CCCC4)cc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
CHEMBL1779405 125116 0 None -54 2 Human 7.4 pKi = 7.4 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 696 10 0 9 4.5 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccc(CN4CCCC4)cc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
999998 277908 10 None -1 2 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 420 5 0 3 3.8 Cc1ccc(N(CC(=O)N2CCc3ccccc3C2)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
CHEMBL381433 277908 10 None -1 2 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 420 5 0 3 3.8 Cc1ccc(N(CC(=O)N2CCc3ccccc3C2)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
44316235 316115 0 None -7 4 Human 7.3 pKi = 7.3 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1011 16 12 14 -3.6 C[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL411148 316115 0 None -7 4 Human 7.3 pKi = 7.3 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1011 16 12 14 -3.6 C[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm030611c
44316241 197234 0 None -12022 8 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1053 18 13 14 -2.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
44419029 197234 0 None -12022 8 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1053 18 13 14 -2.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL265859 197234 0 None -12022 8 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1053 18 13 14 -2.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL268306 197234 0 None -12022 8 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1053 18 13 14 -2.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL2369834 477594 0 None -37 4 Human 6.3 pKi = 6.3 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1040 18 13 15 -4.3 NCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL2372926 485914 0 None 5 2 Rat 7.3 pKi = 7.3 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 784 8 2 7 3.5 CCOc1ccc(C[C@H]2NC(=O)[C@@H]3CCCN3C(=O)[C@@H](Cc3ccccc3)N(C)C(=O)[C@@H]3CCCCN3C(=O)[C@H]3CCCCN3C(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm00169a001
CHEMBL2372928 485916 0 None 10 2 Rat 7.3 pKi = 7.3 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 782 9 5 7 2.4 CC[C@@H](C)[C@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCN)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00169a001
CHEMBL339493 487019 0 None None None Rat 6.3 pKi = 6.3 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 664 4 2 6 1.9 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](C)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00169a001
135644174 144033 4 None -8 2 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 457 7 2 5 3.8 C/C(=N\NC(=O)CN(c1cccc(Cl)c1)S(=O)(=O)c1ccccc1)c1ccccc1O 10.1021/jm050645f
CHEMBL196816 144033 4 None -8 2 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 457 7 2 5 3.8 C/C(=N\NC(=O)CN(c1cccc(Cl)c1)S(=O)(=O)c1ccccc1)c1ccccc1O 10.1021/jm050645f
71451752 163806 0 None -9 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1295 30 4 17 7.6 CCN(CC)c1ccc2c(-c3ccc(S(=O)(=O)NCCOCCOCCOCCn4cc(CNC(=O)CCC(=O)NC5CCCN(C(=O)c6ccc(NC(=O)c7ccccc7C)cc6)c6ccccc65)nn4)cc3S(=O)(=O)[O-])c3ccc(=[N+](CC)CC)cc-3oc2c1 10.1021/jm3006146
CHEMBL2172293 163806 0 None -9 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1295 30 4 17 7.6 CCN(CC)c1ccc2c(-c3ccc(S(=O)(=O)NCCOCCOCCOCCn4cc(CNC(=O)CCC(=O)NC5CCCN(C(=O)c6ccc(NC(=O)c7ccccc7C)cc6)c6ccccc65)nn4)cc3S(=O)(=O)[O-])c3ccc(=[N+](CC)CC)cc-3oc2c1 10.1021/jm3006146
5311065 484177 30 None -4 8 Human 8.3 pKi = 8.3 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm030611c
817 484177 30 None -4 8 Human 8.3 pKi = 8.3 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm030611c
CHEMBL1429 484177 30 None -4 8 Human 8.3 pKi = 8.3 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm030611c
DB00035 484177 30 None -4 8 Human 8.3 pKi = 8.3 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm030611c
11627894 142520 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 529 7 2 3 4.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(F)(F)F)cc1 10.1021/jm050557v
11663715 142520 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 529 7 2 3 4.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(F)(F)F)cc1 10.1021/jm050557v
CHEMBL194233 142520 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 529 7 2 3 4.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(F)(F)F)cc1 10.1021/jm050557v
CHEMBL198329 142520 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 529 7 2 3 4.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(F)(F)F)cc1 10.1021/jm050557v
11385982 142544 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 6 2 3 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccccc1 10.1021/jm050557v
11408910 142544 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 6 2 3 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccccc1 10.1021/jm050557v
CHEMBL194374 142544 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 6 2 3 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccccc1 10.1021/jm050557v
CHEMBL198328 142544 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 6 2 3 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccccc1 10.1021/jm050557v
11577662 144024 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 559 7 2 4 4.7 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc(OC(F)(F)F)cc1 10.1021/jm050557v
11606502 144024 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 559 7 2 4 4.7 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc(OC(F)(F)F)cc1 10.1021/jm050557v
CHEMBL196780 144024 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 559 7 2 4 4.7 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc(OC(F)(F)F)cc1 10.1021/jm050557v
CHEMBL372516 144024 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 559 7 2 4 4.7 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccc(OC(F)(F)F)cc1 10.1021/jm050557v
56949908 156989 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 460 6 1 4 2.4 Cc1ccc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC2CC2)cn1 10.1021/jm201287w
CHEMBL2037494 156989 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 460 6 1 4 2.4 Cc1ccc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC2CC2)cn1 10.1021/jm201287w
56949909 156990 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 502 6 1 5 2.2 Cc1ccc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC2CC2)cn1 10.1021/jm201287w
CHEMBL2037495 156990 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 502 6 1 5 2.2 Cc1ccc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC2CC2)cn1 10.1021/jm201287w
121301508 350186 8 None -8 4 Human 8.3 pKi = 8.3 Binding
Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)
ChEMBL 542 7 2 9 3.6 C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1 10.6019/CHEMBL5463729
CHEMBL4594444 350186 8 None -8 4 Human 8.3 pKi = 8.3 Binding
Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)
ChEMBL 542 7 2 9 3.6 C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1 10.6019/CHEMBL5463729
DB16279 350186 8 None -8 4 Human 8.3 pKi = 8.3 Binding
Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)
ChEMBL 542 7 2 9 3.6 C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1 10.6019/CHEMBL5463729
10627414 468768 0 None 5 2 Human 8.3 pKi = 8.3 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 600 7 0 7 4.8 COc1cc(OC2CCN(Cc3c[n+]([O-])c(C)cc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL68199 468768 0 None 5 2 Human 8.3 pKi = 8.3 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 600 7 0 7 4.8 COc1cc(OC2CCN(Cc3c[n+]([O-])c(C)cc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10531717 203009 0 None -4 2 Rat 8.3 pKi = 8.3 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 604 7 0 7 4.6 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL306416 203009 0 None -4 2 Rat 8.3 pKi = 8.3 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 604 7 0 7 4.6 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL2112249 485097 2 None -8 2 Human 8.3 pKi = 8.3 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from nonlabor pregnant womenCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from nonlabor pregnant women
ChEMBL 766 6 4 7 2.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
121301508 350186 8 None -8 4 Human 8.3 pKi = 8.3 Binding
Radiometric OXTR binding assay (Eurofins #260900)Radiometric OXTR binding assay (Eurofins #260900)
ChEMBL 542 7 2 9 3.6 C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1 10.6019/CHEMBL5463729
CHEMBL4594444 350186 8 None -8 4 Human 8.3 pKi = 8.3 Binding
Radiometric OXTR binding assay (Eurofins #260900)Radiometric OXTR binding assay (Eurofins #260900)
ChEMBL 542 7 2 9 3.6 C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1 10.6019/CHEMBL5463729
DB16279 350186 8 None -8 4 Human 8.3 pKi = 8.3 Binding
Radiometric OXTR binding assay (Eurofins #260900)Radiometric OXTR binding assay (Eurofins #260900)
ChEMBL 542 7 2 9 3.6 C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1 10.6019/CHEMBL5463729
10483105 174420 1 None 34 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human OT receptorBinding affinity to human OT receptor
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1016/j.bmcl.2012.10.116
CHEMBL2391300 174420 1 None 34 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human OT receptorBinding affinity to human OT receptor
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1016/j.bmcl.2012.10.116
10722297 468477 0 None 5 2 Human 8.3 pKi = 8.3 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 600 7 0 7 4.8 COc1cc(OC2CCN(Cc3ccc(C)[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL65949 468477 0 None 5 2 Human 8.3 pKi = 8.3 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 600 7 0 7 4.8 COc1cc(OC2CCN(Cc3ccc(C)[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL54443 489222 0 None 70 2 Rat 8.3 pKi = 8.3 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 756 6 6 8 0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]2CCNCN2C1=O 10.1021/jm00169a001
10005688 19410 0 None 2 2 Human 8.3 pKi = 8.3 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 487 6 0 6 5.0 COc1cc(OC(C)c2cccnc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL105406 19410 0 None 2 2 Human 8.3 pKi = 8.3 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 487 6 0 6 5.0 COc1cc(OC(C)c2cccnc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL3814395 487602 0 None None None Human 8.3 pKi = 8.3 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1020 18 12 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
10746141 468478 0 None 2 2 Human 8.3 pKi = 8.3 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 600 6 0 7 4.1 COc1cc(OC2CCN(C(=O)c3ccc[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL65950 468478 0 None 2 2 Human 8.3 pKi = 8.3 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 600 6 0 7 4.1 COc1cc(OC2CCN(C(=O)c3ccc[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
57519947 155340 0 None 91 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 707 9 0 6 4.3 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OC/C=C\I)c2)CC1 10.1016/j.bmc.2012.02.019
CHEMBL2017868 155340 0 None 91 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 707 9 0 6 4.3 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OC/C=C\I)c2)CC1 10.1016/j.bmc.2012.02.019
CHEMBL300103 486408 0 None 81 2 Rat 8.2 pKi = 8.2 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 741 6 3 7 1.8 CC[C@H](C)[C@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCNCN2C1=O 10.1021/jm00169a001
52947410 40894 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 390 4 0 6 3.9 CO/N=C1/C[C@H](c2nc(C)no2)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1021/jm901812z
CHEMBL1254210 40894 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 390 4 0 6 3.9 CO/N=C1/C[C@H](c2nc(C)no2)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1021/jm901812z
145962220 317117 0 None 33 2 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2cccc(c2)CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4129142 317117 0 None 33 2 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2cccc(c2)CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
44279980 199367 0 None None None Human 7.3 pKi = 7.3 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 621 6 1 7 4.4 Cn1c(CNC(=O)Cn2cc(C(F)(F)F)ccc2=O)cc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc21 10.1016/s0960-894x(02)00160-9
CHEMBL281106 199367 0 None None None Human 7.3 pKi = 7.3 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 621 6 1 7 4.4 Cn1c(CNC(=O)Cn2cc(C(F)(F)F)ccc2=O)cc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc21 10.1016/s0960-894x(02)00160-9
11612607 142825 0 None None None Human 7.3 pKi = 7.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 7 2 3 3.7 Cc1ccc([C@@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
11691416 142825 0 None None None Human 7.3 pKi = 7.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 7 2 3 3.7 Cc1ccc([C@@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL194922 142825 0 None None None Human 7.3 pKi = 7.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 7 2 3 3.7 Cc1ccc([C@@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL555148 142825 0 None None None Human 7.3 pKi = 7.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 7 2 3 3.7 Cc1ccc([C@@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
11363194 198471 0 None None None Human 7.3 pKi = 7.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 461 7 2 3 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccccc1 10.1021/jm050557v
11641200 198471 0 None None None Human 7.3 pKi = 7.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 461 7 2 3 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccccc1 10.1021/jm050557v
CHEMBL273988 198471 0 None None None Human 7.3 pKi = 7.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 461 7 2 3 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccccc1 10.1021/jm050557v
CHEMBL382518 198471 0 None None None Human 7.3 pKi = 7.3 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 461 7 2 3 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccccc1 10.1021/jm050557v
11519251 331145 0 None 3 2 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 521 9 1 5 3.4 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3CC2CC(N)=O)c2ccc(C)cc2)cc1 10.1021/jm050645f
CHEMBL427190 331145 0 None 3 2 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 521 9 1 5 3.4 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3CC2CC(N)=O)c2ccc(C)cc2)cc1 10.1021/jm050645f
44274621 197021 0 None None None Human 6.3 pKi = 6.3 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 601 9 3 6 2.3 CS(=O)(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL26398 197021 0 None None None Human 6.3 pKi = 6.3 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 601 9 3 6 2.3 CS(=O)(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
135506374 275287 21 None -1 3 Mouse 7.3 pKi = 7.3 Binding
Displacement of [Tyrosyl-2,6-3H]Oxytocin from recombinant mouse OTR expressed in CHO-K1 cells after 180 mins by liquid scintillation counting methodDisplacement of [Tyrosyl-2,6-3H]Oxytocin from recombinant mouse OTR expressed in CHO-K1 cells after 180 mins by liquid scintillation counting method
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.7b00965
CHEMBL3763342 275287 21 None -1 3 Mouse 7.3 pKi = 7.3 Binding
Displacement of [Tyrosyl-2,6-3H]Oxytocin from recombinant mouse OTR expressed in CHO-K1 cells after 180 mins by liquid scintillation counting methodDisplacement of [Tyrosyl-2,6-3H]Oxytocin from recombinant mouse OTR expressed in CHO-K1 cells after 180 mins by liquid scintillation counting method
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.7b00965
11692335 144207 0 None 3 2 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 537 10 1 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3CC2CC(N)=O)c2ccc(OC)cc2)cc1 10.1021/jm050645f
CHEMBL197378 144207 0 None 3 2 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 537 10 1 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3CC2CC(N)=O)c2ccc(OC)cc2)cc1 10.1021/jm050645f
44275244 195608 0 None -2 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 424 6 0 5 3.8 COc1ccc(CCC(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(99)00181-x
CHEMBL25611 195608 0 None -2 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 424 6 0 5 3.8 COc1ccc(CCC(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(99)00181-x
10650710 468577 0 None -3 2 Rat 7.3 pKi = 7.3 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 570 7 0 7 5.5 COc1cc(OC2CCN(C(C)c3cccnc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL66749 468577 0 None -3 2 Rat 7.3 pKi = 7.3 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 570 7 0 7 5.5 COc1cc(OC2CCN(C(C)c3cccnc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
9981665 232117 5 None -1 6 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 459 5 2 4 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm901812z
CHEMBL341339 232117 5 None -1 6 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 459 5 2 4 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm901812z
19691009 217054 0 None None None Human 7.3 pKi = 7.3 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 535 6 0 6 4.5 COc1cc(OC(C)C2CCN(C(C)=O)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL318174 217054 0 None None None Human 7.3 pKi = 7.3 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 535 6 0 6 4.5 COc1cc(OC(C)C2CCN(C(C)=O)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL2372251 477727 0 None None None Rat 6.3 pKi = 6.3 Binding
Binding affinity against oxytocin receptorBinding affinity against oxytocin receptor
ChEMBL 1005 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SS[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm990090m
16109445 274649 0 None -213 4 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1011 17 11 14 -1.9 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL375188 274649 0 None -213 4 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1011 17 11 14 -1.9 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
16109438 196913 0 None -181 4 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1051 17 11 14 -1.0 NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL263090 196913 0 None -181 4 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1051 17 11 14 -1.0 NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
45483204 404679 0 None -19 5 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL572709 404679 0 None -19 5 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
44316236 470360 0 None -24 4 Human 6.3 pKi = 6.3 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 997 16 12 14 -4.0 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)NCC(=O)N[C@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
CHEMBL80877 470360 0 None -24 4 Human 6.3 pKi = 6.3 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 997 16 12 14 -4.0 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)NCC(=O)N[C@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
44243143 40903 0 None 8 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 372 5 0 6 4.3 COc1ccc(-n2c(C)nnc2-c2ccc(-c3ccccc3OC)cc2)cn1 10.1021/jm901812z
CHEMBL1254297 40903 0 None 8 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 372 5 0 6 4.3 COc1ccc(-n2c(C)nnc2-c2ccc(-c3ccccc3OC)cc2)cn1 10.1021/jm901812z
44334971 18948 0 None None None Human 7.2 pKi = 7.2 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 500 7 0 5 6.0 CCC(Oc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1)c1ccccc1 10.1016/s0960-894x(98)00568-x
CHEMBL102762 18948 0 None None None Human 7.2 pKi = 7.2 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 500 7 0 5 6.0 CCC(Oc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1)c1ccccc1 10.1016/s0960-894x(98)00568-x
135506374 275287 21 None -3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysisDisplacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysis
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
CHEMBL3763342 275287 21 None -3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysisDisplacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysis
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
135506374 275287 21 None -3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [Tyrosyl-2,6-3H]Oxytocin from recombinant human OTR expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting methodDisplacement of [Tyrosyl-2,6-3H]Oxytocin from recombinant human OTR expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting method
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.7b00965
CHEMBL3763342 275287 21 None -3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [Tyrosyl-2,6-3H]Oxytocin from recombinant human OTR expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting methodDisplacement of [Tyrosyl-2,6-3H]Oxytocin from recombinant human OTR expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting method
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.7b00965
135506374 275287 21 None -3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [Tyrosyl-2,6-3H]oxytocin from recombinant human OTR expressed in CHO-DUKX-A2 cells incubated for 180 mins by scintillation counting based whole cell radioligand binding assayDisplacement of [Tyrosyl-2,6-3H]oxytocin from recombinant human OTR expressed in CHO-DUKX-A2 cells incubated for 180 mins by scintillation counting based whole cell radioligand binding assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 275287 21 None -3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [Tyrosyl-2,6-3H]oxytocin from recombinant human OTR expressed in CHO-DUKX-A2 cells incubated for 180 mins by scintillation counting based whole cell radioligand binding assayDisplacement of [Tyrosyl-2,6-3H]oxytocin from recombinant human OTR expressed in CHO-DUKX-A2 cells incubated for 180 mins by scintillation counting based whole cell radioligand binding assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
16109437 175275 0 None -309 4 Rat 6.2 pKi = 6.2 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1065 18 11 14 -0.6 NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL221485 175275 0 None -309 4 Rat 6.2 pKi = 6.2 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1065 18 11 14 -0.6 NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
10510242 238988 0 None None None Rat 8.2 pKi = 8.2 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL 1023 17 11 15 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm9607156
11083629 238988 0 None None None Rat 8.2 pKi = 8.2 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL 1023 17 11 15 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm9607156
CHEMBL352836 238988 0 None None None Rat 8.2 pKi = 8.2 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL 1023 17 11 15 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm9607156
CHEMBL353396 238988 0 None None None Rat 8.2 pKi = 8.2 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL 1023 17 11 15 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm9607156
15840433 194848 0 None -1 2 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 448 5 0 4 4.3 O=C(Cc1ccccc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL25120 194848 0 None -1 2 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 448 5 0 4 4.3 O=C(Cc1ccccc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL1790937 484815 0 None 2 2 Rat 8.2 pKi = 8.2 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from pregnant ratsCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from pregnant rats
ChEMBL 755 6 5 7 1.9 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
CHEMBL338308 487001 0 None 4 2 Rat 8.2 pKi = 8.2 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from pregnant ratsCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from pregnant rats
ChEMBL 742 9 4 8 1.5 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCN)NC(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
11257380 352525 0 None 64 2 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1021/jm901812z
CHEMBL467378 352525 0 None 64 2 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1021/jm901812z
146681949 8624 35 None -5 8 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1016/j.bmc.2018.03.019
2168 8624 35 None -5 8 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1016/j.bmc.2018.03.019
2810 8624 35 None -5 8 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1016/j.bmc.2018.03.019
644077 8624 35 None -5 8 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1016/j.bmc.2018.03.019
CHEMBL373742 8624 35 None -5 8 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1016/j.bmc.2018.03.019
DB00067 8624 35 None -5 8 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1016/j.bmc.2018.03.019
P01185 8624 35 None -5 8 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1016/j.bmc.2018.03.019
P01186 8624 35 None -5 8 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1016/j.bmc.2018.03.019
P35455 8624 35 None -5 8 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10.1016/j.bmc.2018.03.019
136961690 237392 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetate
ChEMBL 412 3 1 6 4.2 Cc1ccn(Cc2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)cc2C)n1 10.1021/jm501395b
CHEMBL3416757 237392 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetate
ChEMBL 412 3 1 6 4.2 Cc1ccn(Cc2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)cc2C)n1 10.1021/jm501395b
56668257 125926 0 None 35 2 Human 8.2 pKi = 8.2 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1484 18 15 21 3.2 CC[C@@H](C)[C@H]1NC(=O)[C@@](C)(c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@H](C(N)=O)c2ccc(O)cc2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@@H](C)O)NC1=O 10.1021/jm010526+
CHEMBL1790713 125926 0 None 35 2 Human 8.2 pKi = 8.2 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1484 18 15 21 3.2 CC[C@@H](C)[C@H]1NC(=O)[C@@](C)(c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@H](C(N)=O)c2ccc(O)cc2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@@H](C)O)NC1=O 10.1021/jm010526+
44279179 200261 0 None None None Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 540 6 1 7 3.7 O=C(Cn1ccccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
CHEMBL287325 200261 0 None None None Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 540 6 1 7 3.7 O=C(Cn1ccccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
44279411 216579 0 None None None Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 545 6 2 7 2.4 O=C(CN1C(=O)CNC1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
CHEMBL31476 216579 0 None None None Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 545 6 2 7 2.4 O=C(CN1C(=O)CNC1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
44456382 197743 0 None None None Human 8.2 pKi = 8.2 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 467 7 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1cccs1 10.1016/j.bmcl.2007.11.008
CHEMBL270013 197743 0 None None None Human 8.2 pKi = 8.2 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 467 7 2 4 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1cccs1 10.1016/j.bmcl.2007.11.008
44456036 197984 0 None None None Human 8.2 pKi = 8.2 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 451 7 2 4 3.0 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccco1 10.1016/j.bmcl.2007.11.008
CHEMBL271266 197984 0 None None None Human 8.2 pKi = 8.2 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 451 7 2 4 3.0 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccco1 10.1016/j.bmcl.2007.11.008
44456034 308722 0 None None None Human 8.2 pKi = 8.2 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(C)n1 10.1016/j.bmcl.2007.11.008
CHEMBL401858 308722 0 None None None Human 8.2 pKi = 8.2 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(C)n1 10.1016/j.bmcl.2007.11.008
44581266 349398 0 None 7 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 479 8 0 6 4.7 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3F)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL457544 349398 0 None 7 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 479 8 0 6 4.7 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3F)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44581686 372703 0 None None None Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 523 8 0 7 4.3 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2ccc(S(C)(=O)=O)cc2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL514586 372703 0 None None None Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 523 8 0 7 4.3 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2ccc(S(C)(=O)=O)cc2)cn1 10.1016/j.bmcl.2008.11.018
2252 4546 39 None -1 5 Human 8.2 pKi = 8.2 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00160-9
6918320 4546 39 None -1 5 Human 8.2 pKi = 8.2 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00160-9
CHEMBL24781 4546 39 None -1 5 Human 8.2 pKi = 8.2 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00160-9
44279909 199356 0 None None None Human 8.2 pKi = 8.2 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 590 6 1 7 4.8 O=C(Cn1ccc2ccccc2c1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL281044 199356 0 None None None Human 8.2 pKi = 8.2 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 590 6 1 7 4.8 O=C(Cn1ccc2ccccc2c1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
44279710 199572 0 None None None Human 8.2 pKi = 8.2 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 6 1 7 4.8 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccc(F)cc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL282494 199572 0 None None None Human 8.2 pKi = 8.2 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 6 1 7 4.8 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccc(F)cc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
44279711 199657 0 None None None Human 8.2 pKi = 8.2 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 6 1 7 4.8 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5cc(F)ccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL283039 199657 0 None None None Human 8.2 pKi = 8.2 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 6 1 7 4.8 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5cc(F)ccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
44279179 200261 0 None None None Human 8.2 pKi = 8.2 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 540 6 1 7 3.7 O=C(Cn1ccccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL287325 200261 0 None None None Human 8.2 pKi = 8.2 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 540 6 1 7 3.7 O=C(Cn1ccccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
11613469 142084 0 None None None Human 8.2 pKi = 8.2 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 532 7 3 4 3.8 CC(=O)Nc1cccc([C@H](C(=O)NC(C)(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)c1 10.1021/jm050557v
CHEMBL193773 142084 0 None None None Human 8.2 pKi = 8.2 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 532 7 3 4 3.8 CC(=O)Nc1cccc([C@H](C(=O)NC(C)(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)c1 10.1021/jm050557v
CHEMBL2112249 485097 2 None -8 2 Human 8.2 pKi = 8.2 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from near-term pregnant rhesus monkeyCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from near-term pregnant rhesus monkey
ChEMBL 766 6 4 7 2.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
2042 8014 41 None -1 6 Human 8.2 pKi = 8.2 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetate
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
2176 8014 41 None -1 6 Human 8.2 pKi = 8.2 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetate
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
439302 8014 41 None -1 6 Human 8.2 pKi = 8.2 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetate
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
CHEMBL395429 8014 41 None -1 6 Human 8.2 pKi = 8.2 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetate
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
136961690 237392 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetate
ChEMBL 412 3 1 6 4.2 Cc1ccn(Cc2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)cc2C)n1 10.1021/jm501395b
CHEMBL3416757 237392 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetate
ChEMBL 412 3 1 6 4.2 Cc1ccn(Cc2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)cc2C)n1 10.1021/jm501395b
10699323 468907 0 None 2 2 Human 8.2 pKi = 8.2 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 640 7 0 7 5.2 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C(F)(F)F)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL69265 468907 0 None 2 2 Human 8.2 pKi = 8.2 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 640 7 0 7 5.2 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C(F)(F)F)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL3814165 487600 0 None None None Human 8.2 pKi = 8.2 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1020 17 11 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
2042 8014 41 None -1 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmcl.2008.11.064
2176 8014 41 None -1 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmcl.2008.11.064
439302 8014 41 None -1 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmcl.2008.11.064
CHEMBL395429 8014 41 None -1 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1016/j.bmcl.2008.11.064
135475964 145086 0 None 53 2 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 467 9 2 6 3.4 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccc2O)c2ccc(C)cc2)cc1 10.1021/jm050645f
CHEMBL200329 145086 0 None 53 2 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 467 9 2 6 3.4 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccc2O)c2ccc(C)cc2)cc1 10.1021/jm050645f
145974527 329683 0 None 1 2 Human 7.2 pKi = 7.2 Binding
Displacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 491 5 3 6 3.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4217872 329683 0 None 1 2 Human 7.2 pKi = 7.2 Binding
Displacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged OTR receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 491 5 3 6 3.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=S)N(C)C 10.1021/acs.jmedchem.8b00697
135414288 160571 0 None 79 2 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 524 6 2 5 4.3 CC(C)(C)c1ccc(S(=O)(=O)N(CC(=O)N/N=C2/C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113213 160571 0 None 79 2 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 524 6 2 5 4.3 CC(C)(C)c1ccc(S(=O)(=O)N(CC(=O)N/N=C2/C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
10413997 4534 5 None -1 2 Human 7.2 pKi = 7.2 Binding
Tested against human uterine OT receptorTested against human uterine OT receptor
ChEMBL 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 10.1021/jm00077a002
2246 4534 5 None -1 2 Human 7.2 pKi = 7.2 Binding
Tested against human uterine OT receptorTested against human uterine OT receptor
ChEMBL 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 10.1021/jm00077a002
CHEMBL338522 4534 5 None -1 2 Human 7.2 pKi = 7.2 Binding
Tested against human uterine OT receptorTested against human uterine OT receptor
ChEMBL 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 10.1021/jm00077a002
54581528 125112 0 None -16 3 Human 7.2 pKi = 7.2 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 614 8 0 9 3.3 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cccnc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
CHEMBL1779401 125112 0 None -16 3 Human 7.2 pKi = 7.2 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 614 8 0 9 3.3 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cccnc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
1107812 144643 7 None None None Human 6.2 pKi = 6.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 488 8 1 5 4.8 COc1ccc(S(=O)(=O)N(CC(=O)Nc2cccc(Cl)c2C)c2ccc(C)cc2)cc1OC 10.1021/jm050645f
CHEMBL198780 144643 7 None None None Human 6.2 pKi = 6.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 488 8 1 5 4.8 COc1ccc(S(=O)(=O)N(CC(=O)Nc2cccc(Cl)c2C)c2ccc(C)cc2)cc1OC 10.1021/jm050645f
10411308 462175 0 None -39 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm3006146
CHEMBL603708 462175 0 None -39 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm3006146
44279151 199616 0 None None None Human 7.2 pKi = 7.2 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 552 5 0 7 3.3 CS(=O)(=O)N1CCN(Cc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)CC1 10.1016/s0960-894x(02)00159-2
CHEMBL282781 199616 0 None None None Human 7.2 pKi = 7.2 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 552 5 0 7 3.3 CS(=O)(=O)N1CCN(Cc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)CC1 10.1016/s0960-894x(02)00159-2
44279568 200220 0 None None None Human 7.2 pKi = 7.2 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 474 5 0 5 3.9 CC(=O)N(C)CCn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
CHEMBL286979 200220 0 None None None Human 7.2 pKi = 7.2 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 474 5 0 5 3.9 CC(=O)N(C)CCn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
44279165 215820 0 None None None Human 7.2 pKi = 7.2 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 447 4 1 5 3.8 CC(=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
CHEMBL31350 215820 0 None None None Human 7.2 pKi = 7.2 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 447 4 1 5 3.8 CC(=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00159-2
44279483 216760 0 None None None Human 7.2 pKi = 7.2 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 501 3 0 5 4.9 CC(=O)N1CCC(c2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)CC1 10.1016/s0960-894x(02)00159-2
CHEMBL31606 216760 0 None None None Human 7.2 pKi = 7.2 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 501 3 0 5 4.9 CC(=O)N1CCC(c2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)CC1 10.1016/s0960-894x(02)00159-2
44581683 350130 0 None None None Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 423 7 0 8 2.9 COc1ccc(N(Cc2nc(-c3ccccc3)no2)S(=O)(=O)c2ccccn2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL459291 350130 0 None None None Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 423 7 0 8 2.9 COc1ccc(N(Cc2nc(-c3ccccc3)no2)S(=O)(=O)c2ccccn2)cn1 10.1016/j.bmcl.2008.11.018
44581684 372648 0 None None None Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 437 7 0 6 4.6 COc1ccc(N(Cc2csc(-c3ccccc3)n2)S(=O)(=O)c2ccccn2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL514113 372648 0 None None None Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 437 7 0 6 4.6 COc1ccc(N(Cc2csc(-c3ccccc3)n2)S(=O)(=O)c2ccccn2)cc1 10.1016/j.bmcl.2008.11.018
44279795 200187 0 None None None Human 7.2 pKi = 7.2 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 628 5 0 7 6.5 O=C(c1ccc2oc(-c3cncc(Cn4cc(C(F)(F)F)ccc4=O)c3)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
CHEMBL286771 200187 0 None None None Human 7.2 pKi = 7.2 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 628 5 0 7 6.5 O=C(c1ccc2oc(-c3cncc(Cn4cc(C(F)(F)F)ccc4=O)c3)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
11598556 142559 0 None None None Human 7.2 pKi = 7.2 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 501 9 1 3 4.3 C=CCN1C(=O)[C@@H](CC(C)C)N([C@@H](C(=O)NC(C)C)c2ccccc2)C(=O)[C@H]1C1Cc2ccccc2C1 10.1021/jm050557v
CHEMBL194432 142559 0 None None None Human 7.2 pKi = 7.2 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 501 9 1 3 4.3 C=CCN1C(=O)[C@@H](CC(C)C)N([C@@H](C(=O)NC(C)C)c2ccccc2)C(=O)[C@H]1C1Cc2ccccc2C1 10.1021/jm050557v
11488952 159212 0 None -31 3 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]oxytocin from rat OTRDisplacement of [3H]oxytocin from rat OTR
ChEMBL 501 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc2occc2c1 10.1021/jm060073e
CHEMBL208787 159212 0 None -31 3 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]oxytocin from rat OTRDisplacement of [3H]oxytocin from rat OTR
ChEMBL 501 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc2occc2c1 10.1021/jm060073e
135520373 160560 0 None 56 2 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 513 8 2 7 2.8 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113202 160560 0 None 56 2 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 513 8 2 7 2.8 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
44419030 317154 22 None -407 4 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1025 18 11 14 -1.5 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL412972 317154 22 None -407 4 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1025 18 11 14 -1.5 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
135520373 160560 0 None 56 2 Human 7.2 pKi = 7.2 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 513 8 2 7 2.8 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
CHEMBL2113202 160560 0 None 56 2 Human 7.2 pKi = 7.2 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 513 8 2 7 2.8 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
10721511 202732 0 None -2 2 Rat 7.2 pKi = 7.2 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 555 7 0 6 5.5 COc1cc(OC2CCN(Cc3ccccc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL304577 202732 0 None -2 2 Rat 7.2 pKi = 7.2 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 555 7 0 6 5.5 COc1cc(OC2CCN(Cc3ccccc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
119369 5304 49 None -5 6 Human 6.2 pKi = 6.2 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1021/jm3006146
2197 5304 49 None -5 6 Human 6.2 pKi = 6.2 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1021/jm3006146
4004 5304 49 None -5 6 Human 6.2 pKi = 6.2 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1021/jm3006146
CHEMBL420762 5304 49 None -5 6 Human 6.2 pKi = 6.2 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1021/jm3006146
CHEMBL2369835 477595 0 None -4 4 Human 6.2 pKi = 6.2 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1069 19 13 15 -3.7 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
71451749 163801 0 None -25 2 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1205 25 7 15 9.2 O=C(CCC(=O)NC1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc21)NCc1cn(CCOCCOCCOCCNC(=S)Nc2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)O)c2)nn1 10.1021/jm3006146
CHEMBL2172288 163801 0 None -25 2 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1205 25 7 15 9.2 O=C(CCC(=O)NC1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc21)NCc1cn(CCOCCOCCOCCNC(=S)Nc2ccc(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c(C(=O)O)c2)nn1 10.1021/jm3006146
135515655 24368 7 None None None Human 7.2 pKi = 7.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 423 7 2 5 3.0 Cc1ccc(N(CC(=O)N/N=C/c2ccccc2O)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
CHEMBL115305 24368 7 None None None Human 7.2 pKi = 7.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 423 7 2 5 3.0 Cc1ccc(N(CC(=O)N/N=C/c2ccccc2O)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
135537472 145202 2 None None None Human 7.2 pKi = 7.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 443 7 2 5 3.4 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1)N/N=C/c1ccccc1O 10.1021/jm050645f
CHEMBL200792 145202 2 None None None Human 7.2 pKi = 7.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 443 7 2 5 3.4 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1)N/N=C/c1ccccc1O 10.1021/jm050645f
CHEMBL3813858 487595 0 None None None Human 7.2 pKi = 7.2 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1034 17 10 15 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
145974638 329526 0 None -4 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 347 2 1 4 3.7 Cc1ccn(-c2ccc(C(=O)N3CCCC(O)c4ccccc43)cc2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL4215696 329526 0 None -4 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 347 2 1 4 3.7 Cc1ccn(-c2ccc(C(=O)N3CCCC(O)c4ccccc43)cc2)n1 10.1021/acs.jmedchem.8b00697
44361522 240294 0 None -12 5 Rat 7.2 pKi = 7.2 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 477 4 0 5 3.8 CC(=O)N1CCC(Oc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)CC1 10.1021/jm00023a002
CHEMBL358793 240294 0 None -12 5 Rat 7.2 pKi = 7.2 Binding
Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from ratsBinding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats
ChEMBL 477 4 0 5 3.8 CC(=O)N1CCC(Oc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)CC1 10.1021/jm00023a002
10579644 468901 0 None 2 2 Human 8.2 pKi = 8.2 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 612 6 0 7 5.0 COc1cc(OC2CCN(C3CCCc4c3ccc[n+]4[O-])CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL69201 468901 0 None 2 2 Human 8.2 pKi = 8.2 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 612 6 0 7 5.0 COc1cc(OC2CCN(C3CCCc4c3ccc[n+]4[O-])CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
135508167 160548 0 None 3 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 596 10 3 8 2.8 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(NCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113177 160548 0 None 3 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 596 10 3 8 2.8 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(NCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
135469685 160569 0 None 4 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 542 10 2 7 3.0 COCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113211 160569 0 None 4 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 542 10 2 7 3.0 COCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
54586392 125118 0 None -177 3 Human 8.2 pKi = 8.2 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 695 9 0 9 3.6 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccc(CN4CCN(C)CC4)cc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779407 125118 0 None -177 3 Human 8.2 pKi = 8.2 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 695 9 0 9 3.6 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccc(CN4CCN(C)CC4)cc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
135469685 160569 0 None 4 3 Human 8.2 pKi = 8.2 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 542 10 2 7 3.0 COCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
CHEMBL2113211 160569 0 None 4 3 Human 8.2 pKi = 8.2 Binding
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 542 10 2 7 3.0 COCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
CHEMBL1790546 484183 0 None 85 2 Rat 8.1 pKi = 8.1 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 738 6 2 8 2.3 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCC=NN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00171a003
2241 4522 5 None -2 4 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards rat uterine receptor was determined using [3H]oxytocin as radioligandBinding affinity towards rat uterine receptor was determined using [3H]oxytocin as radioligand
ChEMBL 738 6 2 8 2.3 CC[C@@H]([C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N(C(=O)[C@H]2N(C(=O)[C@@H]3N(C1=O)N=CCC3)N=CCC2)C)Cc1ccccc1)C 10.1021/jm00099a019
9810632 4522 5 None -2 4 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards rat uterine receptor was determined using [3H]oxytocin as radioligandBinding affinity towards rat uterine receptor was determined using [3H]oxytocin as radioligand
ChEMBL 738 6 2 8 2.3 CC[C@@H]([C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N(C(=O)[C@H]2N(C(=O)[C@@H]3N(C1=O)N=CCC3)N=CCC2)C)Cc1ccccc1)C 10.1021/jm00099a019
CHEMBL127686 4522 5 None -2 4 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards rat uterine receptor was determined using [3H]oxytocin as radioligandBinding affinity towards rat uterine receptor was determined using [3H]oxytocin as radioligand
ChEMBL 738 6 2 8 2.3 CC[C@@H]([C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N(C(=O)[C@H]2N(C(=O)[C@@H]3N(C1=O)N=CCC3)N=CCC2)C)Cc1ccccc1)C 10.1021/jm00099a019
2241 4522 5 None -2 4 Rat 8.1 pKi = 8.1 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 738 6 2 8 2.3 CC[C@@H]([C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N(C(=O)[C@H]2N(C(=O)[C@@H]3N(C1=O)N=CCC3)N=CCC2)C)Cc1ccccc1)C 10.1021/jm00169a001
9810632 4522 5 None -2 4 Rat 8.1 pKi = 8.1 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 738 6 2 8 2.3 CC[C@@H]([C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N(C(=O)[C@H]2N(C(=O)[C@@H]3N(C1=O)N=CCC3)N=CCC2)C)Cc1ccccc1)C 10.1021/jm00169a001
CHEMBL127686 4522 5 None -2 4 Rat 8.1 pKi = 8.1 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 738 6 2 8 2.3 CC[C@@H]([C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N(C(=O)[C@H]2N(C(=O)[C@@H]3N(C1=O)N=CCC3)N=CCC2)C)Cc1ccccc1)C 10.1021/jm00169a001
11756466 19427 0 None 1 2 Human 8.1 pKi = 8.1 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 521 6 0 6 4.4 COc1cc(O[C@H](C)c2cc[n+]([O-])cc2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL105514 19427 0 None 1 2 Human 8.1 pKi = 8.1 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 521 6 0 6 4.4 COc1cc(O[C@H](C)c2cc[n+]([O-])cc2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
53319051 119141 0 None None None Human 8.1 pKi = 8.1 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1174 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Te][Te]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630525 119141 0 None None None Human 8.1 pKi = 8.1 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1174 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Te][Te]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
44214438 461726 0 None -3 2 Rat 8.1 pKi = 8.1 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 630 6 0 7 5.2 COc1cc(OC2CCN(C3CCCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL66992 461726 0 None -3 2 Rat 8.1 pKi = 8.1 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 630 6 0 7 5.2 COc1cc(OC2CCN(C3CCCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10840517 468876 0 None 3 2 Human 8.1 pKi = 8.1 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 556 7 0 7 4.9 COc1cc(OC2CCN(Cc3ccncc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL68978 468876 0 None 3 2 Human 8.1 pKi = 8.1 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 556 7 0 7 4.9 COc1cc(OC2CCN(Cc3ccncc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL52176 489105 0 None 229 2 Rat 8.1 pKi = 8.1 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 755 6 5 7 1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]2CCCCN2C1=O 10.1021/jm00169a001
44335300 18983 0 None 5 2 Human 8.1 pKi = 8.1 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 486 6 0 5 5.6 COc1cc(OC(C)c2ccccc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL102994 18983 0 None 5 2 Human 8.1 pKi = 8.1 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 486 6 0 5 5.6 COc1cc(OC(C)c2ccccc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
56950450 156711 0 None None None Human 8.1 pKi = 8.1 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 475 7 2 3 3.7 Cc1ccccc1[C@H](C(=O)NC(C)C)N1C(=O)[C@@H](C2Cc3ccccc3C2)NC(=O)[C@H]1CC(C)C 10.1021/jm201287w
CHEMBL2035010 156711 0 None None None Human 8.1 pKi = 8.1 Binding
Antagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysisAntagonist activity at human oxytocin receptor assessed as inhibition of oxytocin binding by FLIPR analysis
ChEMBL 475 7 2 3 3.7 Cc1ccccc1[C@H](C(=O)NC(C)C)N1C(=O)[C@@H](C2Cc3ccccc3C2)NC(=O)[C@H]1CC(C)C 10.1021/jm201287w
44581242 349863 0 None 3 3 Human 8.1 pKi = 8.1 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 475 8 0 6 4.9 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL458635 349863 0 None 3 3 Human 8.1 pKi = 8.1 Binding
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 475 8 0 6 4.9 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44279521 200235 0 None None None Human 8.1 pKi = 8.1 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 6 1 7 4.8 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(F)cc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL287101 200235 0 None None None Human 8.1 pKi = 8.1 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 6 1 7 4.8 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(F)cc2o1 10.1016/s0960-894x(02)00160-9
44279709 213533 0 None None None Human 8.1 pKi = 8.1 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 6 1 7 4.8 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5cccc(F)c54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL30910 213533 0 None None None Human 8.1 pKi = 8.1 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 6 1 7 4.8 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5cccc(F)c54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
44459838 199816 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 635 12 3 6 3.6 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL284120 199816 0 None None None Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 635 12 3 6 3.6 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
2204 8913 7 None -229 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-oxytocin from OTR receptor in human USMC cell membranesDisplacement of [3H]-oxytocin from OTR receptor in human USMC cell membranes
ChEMBL 616 5 1 5 6.4 O=C(N1CCC(CC1)N1CCCCC1)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccoc1C 10.1021/acs.jmedchem.8b00697
9917025 8913 7 None -229 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-oxytocin from OTR receptor in human USMC cell membranesDisplacement of [3H]-oxytocin from OTR receptor in human USMC cell membranes
ChEMBL 616 5 1 5 6.4 O=C(N1CCC(CC1)N1CCCCC1)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccoc1C 10.1021/acs.jmedchem.8b00697
CHEMBL3307200 8913 7 None -229 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-oxytocin from OTR receptor in human USMC cell membranesDisplacement of [3H]-oxytocin from OTR receptor in human USMC cell membranes
ChEMBL 616 5 1 5 6.4 O=C(N1CCC(CC1)N1CCCCC1)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccoc1C 10.1021/acs.jmedchem.8b00697
19691006 19509 0 None None None Human 7.1 pKi = 7.1 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 493 6 1 6 4.2 COc1cc(OC(C)C2CCNCC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL105960 19509 0 None None None Human 7.1 pKi = 7.1 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 493 6 1 6 4.2 COc1cc(OC(C)C2CCNCC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
44334990 217810 0 None None None Human 7.1 pKi = 7.1 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 472 6 0 5 5.0 COc1cc(OCc2ccccc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL319646 217810 0 None None None Human 7.1 pKi = 7.1 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 472 6 0 5 5.0 COc1cc(OCc2ccccc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
137212770 275439 0 None -28 2 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysisDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysis
ChEMBL 532 10 1 8 4.4 COc1cc(CN2CCN(CCCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
CHEMBL3765356 275439 0 None -28 2 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysisDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysis
ChEMBL 532 10 1 8 4.4 COc1cc(CN2CCN(CCCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
15951937 237441 0 None -1905 3 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK cell membranes after 1 hr by scintillation proximity assay
ChEMBL 366 1 1 2 4.5 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
CHEMBL3416861 237441 0 None -1905 3 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK cell membranes after 1 hr by scintillation proximity assay
ChEMBL 366 1 1 2 4.5 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
2213 1072 37 None -20 5 Rat 7.1 pKi = 7.1 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
3008 1072 37 None -20 5 Rat 7.1 pKi = 7.1 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
5311010 1072 37 None -20 5 Rat 7.1 pKi = 7.1 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
68613 1072 37 None -20 5 Rat 7.1 pKi = 7.1 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
CHEMBL378642 1072 37 None -20 5 Rat 7.1 pKi = 7.1 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
CHEMBL382301 1072 37 None -20 5 Rat 7.1 pKi = 7.1 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
DB09059 1072 37 None -20 5 Rat 7.1 pKi = 7.1 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10.1021/jm050645f
11620428 278509 0 None 2 2 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 509 9 1 6 2.9 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3C2C(N)=O)c2ccc(OC)cc2)cc1 10.1021/jm050645f
CHEMBL383149 278509 0 None 2 2 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 509 9 1 6 2.9 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3C2C(N)=O)c2ccc(OC)cc2)cc1 10.1021/jm050645f
70685423 155348 0 None None None Human 7.1 pKi = 7.1 Binding
Displacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 541 6 1 6 2.7 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(O)c2)CC1 10.1016/j.bmc.2012.02.019
CHEMBL2017980 155348 0 None None None Human 7.1 pKi = 7.1 Binding
Displacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 541 6 1 6 2.7 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(O)c2)CC1 10.1016/j.bmc.2012.02.019
44279168 200119 0 None None None Human 7.1 pKi = 7.1 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 516 4 0 6 3.9 CC(=O)N1CCN(Cc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)CC1 10.1016/s0960-894x(02)00159-2
CHEMBL28627 200119 0 None None None Human 7.1 pKi = 7.1 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 516 4 0 6 3.9 CC(=O)N1CCN(Cc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)CC1 10.1016/s0960-894x(02)00159-2
44279482 217934 0 None None None Human 7.1 pKi = 7.1 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 537 4 0 6 4.3 CS(=O)(=O)N1CCC(c2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)CC1 10.1016/s0960-894x(02)00159-2
CHEMBL31978 217934 0 None None None Human 7.1 pKi = 7.1 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 537 4 0 6 4.3 CS(=O)(=O)N1CCC(c2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)CC1 10.1016/s0960-894x(02)00159-2
44279574 199612 0 None None None Human 7.1 pKi = 7.1 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 625 6 1 8 4.6 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1nc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2s1 10.1016/s0960-894x(02)00160-9
CHEMBL282767 199612 0 None None None Human 7.1 pKi = 7.1 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 625 6 1 8 4.6 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1nc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2s1 10.1016/s0960-894x(02)00160-9
11627894 142520 0 None None None Human 7.1 pKi = 7.1 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 529 7 2 3 4.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(F)(F)F)cc1 10.1021/jm050557v
11663715 142520 0 None None None Human 7.1 pKi = 7.1 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 529 7 2 3 4.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(F)(F)F)cc1 10.1021/jm050557v
CHEMBL194233 142520 0 None None None Human 7.1 pKi = 7.1 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 529 7 2 3 4.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(F)(F)F)cc1 10.1021/jm050557v
CHEMBL198329 142520 0 None None None Human 7.1 pKi = 7.1 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 529 7 2 3 4.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(C(F)(F)F)cc1 10.1021/jm050557v
11385982 142544 0 None None None Human 7.1 pKi = 7.1 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 6 2 3 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccccc1 10.1021/jm050557v
11408910 142544 0 None None None Human 7.1 pKi = 7.1 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 6 2 3 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccccc1 10.1021/jm050557v
CHEMBL194374 142544 0 None None None Human 7.1 pKi = 7.1 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 6 2 3 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccccc1 10.1021/jm050557v
CHEMBL198328 142544 0 None None None Human 7.1 pKi = 7.1 Binding
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 475 6 2 3 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccccc1 10.1021/jm050557v
44274944 333340 0 None None None Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 585 12 3 6 2.4 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(F)cc2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL436540 333340 0 None None None Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 585 12 3 6 2.4 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(F)cc2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
44279556 200229 0 None None None Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 389 2 1 3 4.2 Cc1c[nH]c2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc12 10.1016/s0960-894x(02)00159-2
CHEMBL287067 200229 0 None None None Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 389 2 1 3 4.2 Cc1c[nH]c2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc12 10.1016/s0960-894x(02)00159-2
44279260 216817 0 None None None Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 376 2 1 4 3.3 O=C(c1ccc2[nH]ccc2n1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
CHEMBL31645 216817 0 None None None Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 376 2 1 4 3.3 O=C(c1ccc2[nH]ccc2n1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
44278973 218206 0 None None None Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 393 2 0 5 4.1 O=C(c1ccc2ncsc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
CHEMBL32054 218206 0 None None None Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 393 2 0 5 4.1 O=C(c1ccc2ncsc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
44279714 202938 0 None None None Human 6.1 pKi = 6.1 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 634 5 0 7 6.2 O=C(c1ccc2oc(CN3CCC(n4cc(C(F)(F)F)ccc4=O)CC3)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
CHEMBL30587 202938 0 None None None Human 6.1 pKi = 6.1 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 634 5 0 7 6.2 O=C(c1ccc2oc(CN3CCC(n4cc(C(F)(F)F)ccc4=O)CC3)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
44279794 216694 0 None None None Human 6.1 pKi = 6.1 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 627 5 0 6 7.1 O=C(c1ccc2oc(-c3cccc(Cn4cc(C(F)(F)F)ccc4=O)c3)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
CHEMBL31556 216694 0 None None None Human 6.1 pKi = 6.1 Binding
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 627 5 0 6 7.1 O=C(c1ccc2oc(-c3cccc(Cn4cc(C(F)(F)F)ccc4=O)c3)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
44274620 194305 0 None None None Human 6.1 pKi = 6.1 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 565 8 3 5 2.9 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
44274660 194305 0 None None None Human 6.1 pKi = 6.1 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 565 8 3 5 2.9 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL24806 194305 0 None None None Human 6.1 pKi = 6.1 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 565 8 3 5 2.9 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL422044 194305 0 None None None Human 6.1 pKi = 6.1 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 565 8 3 5 2.9 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
44274928 199007 0 None None None Human 6.1 pKi = 6.1 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 573 12 3 6 3.0 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](CC2CCCCC2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL278093 199007 0 None None None Human 6.1 pKi = 6.1 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 573 12 3 6 3.0 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](CC2CCCCC2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
44275001 199057 0 None None None Human 6.1 pKi = 6.1 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 639 13 3 8 2.4 CC(=O)CCCC(=O)NC1N=C(Cn2ccnc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL278619 199057 0 None None None Human 6.1 pKi = 6.1 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 639 13 3 8 2.4 CC(=O)CCCC(=O)NC1N=C(Cn2ccnc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00202-5
44275012 199104 0 None None None Human 6.1 pKi = 6.1 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 508 7 2 7 2.7 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCc2nc(-c3ccccc3)no2)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL278988 199104 0 None None None Human 6.1 pKi = 6.1 Binding
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 508 7 2 7 2.7 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCc2nc(-c3ccccc3)no2)C1=O 10.1016/s0960-894x(01)00202-5
10817776 468809 0 None -5 2 Rat 8.1 pKi = 8.1 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 628 8 0 7 5.3 CCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)c(C)cc(C)[n+]1[O-] 10.1021/jm9800797
CHEMBL68480 468809 0 None -5 2 Rat 8.1 pKi = 8.1 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 628 8 0 7 5.3 CCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)c(C)cc(C)[n+]1[O-] 10.1021/jm9800797
135476004 160551 0 None -8 3 Rat 8.1 pKi = 8.1 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113185 160551 0 None -8 3 Rat 8.1 pKi = 8.1 Binding
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL1790547 484806 0 None 57 2 Rat 8.1 pKi = 8.1 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 736 6 2 8 2.0 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2C=CC=NN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00171a003
CHEMBL300642 486409 0 None 32 2 Rat 8.1 pKi = 8.1 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 779 6 3 6 3.6 CC[C@H](C)[C@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00169a001
10675476 461752 0 None -5 2 Rat 8.1 pKi = 8.1 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 630 6 0 7 5.2 COc1cc(OC2CCN([C@H]3CCCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL68800 461752 0 None -5 2 Rat 8.1 pKi = 8.1 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 630 6 0 7 5.2 COc1cc(OC2CCN([C@H]3CCCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10603831 468902 0 None -3 2 Rat 8.1 pKi = 8.1 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 614 9 0 7 5.1 CCCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)ccc[n+]1[O-] 10.1021/jm9800797
CHEMBL69202 468902 0 None -3 2 Rat 8.1 pKi = 8.1 Binding
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 614 9 0 7 5.1 CCCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)ccc[n+]1[O-] 10.1021/jm9800797
135438362 160565 0 None 70 2 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 468 6 2 5 3.0 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113207 160565 0 None 70 2 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 468 6 2 5 3.0 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
1134627 145178 9 None -11 2 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 444 7 1 4 4.5 COc1ccc(N(CC(=O)Nc2ccc(Cl)cc2C)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
CHEMBL200682 145178 9 None -11 2 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 444 7 1 4 4.5 COc1ccc(N(CC(=O)Nc2ccc(Cl)cc2C)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
145976546 328610 0 None -7 2 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 381 2 1 4 4.3 Cc1ccn(-c2ccc(C(=O)N3CCCC(O)c4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL4204008 328610 0 None -7 2 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 381 2 1 4 4.3 Cc1ccn(-c2ccc(C(=O)N3CCCC(O)c4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
137212772 275327 0 None -12 2 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-oxytocin from human OTR expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-oxytocin from human OTR expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
CHEMBL3763951 275327 0 None -12 2 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-oxytocin from human OTR expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-oxytocin from human OTR expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
137212772 275327 0 None -12 2 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysisDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysis
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
CHEMBL3763951 275327 0 None -12 2 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysisDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysis
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
71455302 163803 0 None -194 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1441 33 5 17 10.3 CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCn2cc(CNC(=O)CCC(=O)NC3CCCN(C(=O)c4ccc(NC(=O)c5ccccc5-c5ccccc5)cc4)c4ccccc43)nn2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm3006146
71482380 163803 0 None -194 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1441 33 5 17 10.3 CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCn2cc(CNC(=O)CCC(=O)NC3CCCN(C(=O)c4ccc(NC(=O)c5ccccc5-c5ccccc5)cc4)c4ccccc43)nn2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm3006146
CHEMBL2172290 163803 0 None -194 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 1441 33 5 17 10.3 CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCn2cc(CNC(=O)CCC(=O)NC3CCCN(C(=O)c4ccc(NC(=O)c5ccccc5-c5ccccc5)cc4)c4ccccc43)nn2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm3006146
10837896 468941 0 None None None Human 7.1 pKi = 7.1 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 465 5 1 6 3.6 COc1cc(OC2CCNCC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL69498 468941 0 None None None Human 7.1 pKi = 7.1 Binding
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 465 5 1 6 3.6 COc1cc(OC2CCNCC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
44419025 175267 18 None -3311 8 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
44419026 175267 18 None -3311 8 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
74992363 175267 18 None -3311 8 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL221436 175267 18 None -3311 8 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL435323 175267 18 None -3311 8 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL6015151 175267 18 None -3311 8 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL339118 487010 0 None 19 2 Rat 7.1 pKi = 7.1 Binding
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL 740 6 2 6 3.1 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00169a001
137212776 275320 0 None -128 2 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]-oxytocin from human OTR expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-oxytocin from human OTR expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 532 10 3 8 4.6 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2017.10.059
CHEMBL3763823 275320 0 None -128 2 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]-oxytocin from human OTR expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-oxytocin from human OTR expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 532 10 3 8 4.6 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2017.10.059
137212776 275320 0 None -128 2 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysisDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysis
ChEMBL 532 10 3 8 4.6 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2015.11.050
CHEMBL3763823 275320 0 None -128 2 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysisDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate reader analysis
ChEMBL 532 10 3 8 4.6 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2015.11.050
145978570 328785 0 None -2 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 331 2 0 3 4.2 Cc1ccn(-c2ccc(C(=O)N3CCCCc4ccccc43)cc2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL4206233 328785 0 None -2 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 331 2 0 3 4.2 Cc1ccn(-c2ccc(C(=O)N3CCCCc4ccccc43)cc2)n1 10.1021/acs.jmedchem.8b00697
46233065 451524 0 None -1 2 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 548 4 2 5 4.1 Cc1cc(C(=O)N2CCCNc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
CHEMBL602671 451524 0 None -1 2 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 548 4 2 5 4.1 Cc1cc(C(=O)N2CCCNc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
73346892 180193 0 None None None Human 6.1 pKi = 6.1 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 975 17 12 14 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL2369424 180193 0 None None None Human 6.1 pKi = 6.1 Binding
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 975 17 12 14 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
44275618 198042 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 396 4 0 5 3.5 COc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(98)00568-x
CHEMBL27157 198042 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 396 4 0 5 3.5 COc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(98)00568-x
44275618 198042 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 396 4 0 5 3.5 COc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(99)00181-x
CHEMBL27157 198042 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 396 4 0 5 3.5 COc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(99)00181-x
CHEMBL1790543 484805 0 None 61 2 Rat 7.1 pKi = 7.1 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 756 6 4 8 0.8 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCC(=O)NN2C(=O)[C@H]2CCCNN2C1=O 10.1021/jm00171a003
54580518 125129 0 None -69 3 Human 7.1 pKi = 7.1 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 691 9 0 10 4.9 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCN(C)CC4)ccc3OC)(N3CCC[C@H]3c3ncco3)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779420 125129 0 None -69 3 Human 7.1 pKi = 7.1 Binding
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 691 9 0 10 4.9 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCN(C)CC4)ccc3OC)(N3CCC[C@H]3c3ncco3)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
25212177 348862 6 None 7 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 463 7 0 7 3.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)c(C)n2)cn1 10.1021/jm901812z
CHEMBL456263 348862 6 None 7 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 463 7 0 7 3.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)c(C)n2)cn1 10.1021/jm901812z
2252 4546 39 None -1 5 Human 8.0 pKi = 8.0 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(98)00568-x
6918320 4546 39 None -1 5 Human 8.0 pKi = 8.0 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(98)00568-x
CHEMBL24781 4546 39 None -1 5 Human 8.0 pKi = 8.0 Binding
Binding affinity against cloned human oxytocin receptor from human embryonic kidney cellsBinding affinity against cloned human oxytocin receptor from human embryonic kidney cells
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(98)00568-x
2252 4546 39 None -1 5 Human 8.0 pKi = 8.0 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(99)00181-x
6918320 4546 39 None -1 5 Human 8.0 pKi = 8.0 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(99)00181-x
CHEMBL24781 4546 39 None -1 5 Human 8.0 pKi = 8.0 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(99)00181-x
CHEMBL1790937 484815 0 None -2 2 Human 8.0 pKi = 8.0 Binding
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from nonlabor pregnant womenCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from nonlabor pregnant women
ChEMBL 755 6 5 7 1.9 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
11683187 444222 42 None 117 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/jm901812z
CHEMBL594828 444222 42 None 117 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/jm901812z
11683187 444222 42 None 117 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/jm901812z
CHEMBL594828 444222 42 None 117 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/jm901812z
2042 8014 41 None -1 6 Human 8.0 pKi = 8.0 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetate
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
2176 8014 41 None -1 6 Human 8.0 pKi = 8.0 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetate
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
439302 8014 41 None -1 6 Human 8.0 pKi = 8.0 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetate
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
CHEMBL395429 8014 41 None -1 6 Human 8.0 pKi = 8.0 Binding
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetate
ChEMBL 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10.1021/jm501395b
CHEMBL1790542 484804 0 None 346 2 Rat 8.0 pKi = 8.0 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 754 6 3 8 1.3 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCC(=O)NN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00171a003
44275233 199134 0 None 3 2 Human 8.0 pKi = 8.0 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 521 6 0 6 3.8 COc1cc(OC2CCN(C(C)=O)CC2)ccc1CC(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL279230 199134 0 None 3 2 Human 8.0 pKi = 8.0 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 521 6 0 6 3.8 COc1cc(OC2CCN(C(C)=O)CC2)ccc1CC(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
11756466 19427 0 None -1 2 Rat 8.0 pKi = 8 Binding
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 521 6 0 6 4.4 COc1cc(O[C@H](C)c2cc[n+]([O-])cc2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL105514 19427 0 None -1 2 Rat 8.0 pKi = 8 Binding
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 521 6 0 6 4.4 COc1cc(O[C@H](C)c2cc[n+]([O-])cc2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
1103932 40883 8 None None None Human 7.1 pKi = 7.1 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 434 6 2 5 2.4 O=C(CN(c1ccccc1)S(=O)(=O)c1ccccc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL1254116 40883 8 None None None Human 7.1 pKi = 7.1 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 434 6 2 5 2.4 O=C(CN(c1ccccc1)S(=O)(=O)c1ccccc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
1103932 40883 8 None None None Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 434 6 2 5 2.4 O=C(CN(c1ccccc1)S(=O)(=O)c1ccccc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm901812z
CHEMBL1254116 40883 8 None None None Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 434 6 2 5 2.4 O=C(CN(c1ccccc1)S(=O)(=O)c1ccccc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm901812z
CHEMBL2369831 477593 1 None -91 4 Human 7.0 pKi = 7.0 Binding
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1041 17 13 15 -4.2 C[C@@H](O)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
1368921 145113 6 None None None Human 7.0 pKi = 7.0 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 428 6 1 3 4.8 Cc1ccc(N(CC(=O)Nc2cccc(Cl)c2C)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
CHEMBL200415 145113 6 None None None Human 7.0 pKi = 7.0 Binding
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 428 6 1 3 4.8 Cc1ccc(N(CC(=O)Nc2cccc(Cl)c2C)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
52947354 40875 11 None 2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 338 4 1 4 2.9 CO/N=C1/C[C@@H](CO)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1021/jm901812z
CHEMBL1254025 40875 11 None 2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 338 4 1 4 2.9 CO/N=C1/C[C@@H](CO)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1021/jm901812z
DB16259 40875 11 None 2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 338 4 1 4 2.9 CO/N=C1/C[C@@H](CO)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1021/jm901812z
54580303 125812 0 None -6 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1558 24 17 23 0.3 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(O)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1789152 125812 0 None -6 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1558 24 17 23 0.3 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(O)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
135506374 275287 21 None -3 3 Human 6.0 pKi = 6.0 Binding
Displacement of [tyrosyl-2,6-3H] oxytocin from OTR (unknown origin) expressed in HEK293 cell membranes incubated for 60 minsDisplacement of [tyrosyl-2,6-3H] oxytocin from OTR (unknown origin) expressed in HEK293 cell membranes incubated for 60 mins
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 275287 21 None -3 3 Human 6.0 pKi = 6.0 Binding
Displacement of [tyrosyl-2,6-3H] oxytocin from OTR (unknown origin) expressed in HEK293 cell membranes incubated for 60 minsDisplacement of [tyrosyl-2,6-3H] oxytocin from OTR (unknown origin) expressed in HEK293 cell membranes incubated for 60 mins
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3814232 487601 0 None None None Human 7.0 pKi = 7.0 Binding
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 1034 18 11 15 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
11366713 274628 0 None -2238 8 Rat 6.0 pKi = 6 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1054 19 13 15 -3.9 NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL375096 274628 0 None -2238 8 Rat 6.0 pKi = 6 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1054 19 13 15 -3.9 NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
3484 7856 0 None None None Human 10.4 pKd = 10.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 626 8 0 6 3.9 O=C(N1CCC(CC1)N1C(=O)CCc2c1cccc2)Cc1ccc(cc1OCC(F)(F)F)OC1CCN(CC1)[35S](=O)(=O)C 12176104
73755057 7856 0 None None None Human 10.4 pKd = 10.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 626 8 0 6 3.9 O=C(N1CCC(CC1)N1C(=O)CCc2c1cccc2)Cc1ccc(cc1OCC(F)(F)F)OC1CCN(CC1)[35S](=O)(=O)C 12176104
3756 7534 0 None None None Human 8.3 pKd = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12942128
2042 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 6278592
2042 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7475979
2042 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7774575
2042 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7921228
2176 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 6278592
2176 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7475979
2176 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7774575
2176 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7921228
439302 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 6278592
439302 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7475979
439302 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7774575
439302 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7921228
CHEMBL395429 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 6278592
CHEMBL395429 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7475979
CHEMBL395429 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7774575
CHEMBL395429 8014 41 None 40 4 Human 8.9 pKd = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7921228
3778 7644 0 None None None Human 10.0 pKd None 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
10124389 7880 0 None -3 5 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1085 31 16 16 -5.9 NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 11337500
10124389 7880 0 None -3 5 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1085 31 16 16 -5.9 NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 7774575
2175 7880 0 None -3 5 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1085 31 16 16 -5.9 NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 11337500
2175 7880 0 None -3 5 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1085 31 16 16 -5.9 NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 7774575
2218 2789 0 None 1 2 Human 9.6 pKd None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11337500
2220 2791 0 None 7 2 Human 9.9 pKd None 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11337500
2220 2791 0 None 7 2 Human 9.9 pKd None 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
2220 2791 0 None 7 2 Human 9.9 pKd None 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8955347
119369 5304 49 None -5 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
Drug Central 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
2197 5304 49 None -5 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
Drug Central 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
4004 5304 49 None -5 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
Drug Central 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
CHEMBL420762 5304 49 None -5 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to oxytocin receptorBinding affinity to oxytocin receptor
Drug Central 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
151171 2408 36 None -19 5 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting method
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
2203 2408 36 None -19 5 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting method
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
732 2408 36 None -19 5 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting method
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
CHEMBL1755 2408 36 None -19 5 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting method
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
DB00872 2408 36 None -19 5 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]OT from OTR in Wistar rat uterus membranes incubated for 60 mins by microplate scintillation counting method
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
2213 1072 37 None -20 5 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C None
3008 1072 37 None -20 5 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C None
5311010 1072 37 None -20 5 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C None
68613 1072 37 None -20 5 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C None
CHEMBL378642 1072 37 None -20 5 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C None
CHEMBL382301 1072 37 None -20 5 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C None
DB09059 1072 37 None -20 5 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C None
5311065 484177 30 None -4 8 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O None
817 484177 30 None -4 8 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O None
CHEMBL1429 484177 30 None -4 8 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O None
DB00035 484177 30 None -4 8 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O None
2213 1072 37 None -22 5 Human 8.1 pKi = 8.1 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
Drug Central 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C None
3008 1072 37 None -22 5 Human 8.1 pKi = 8.1 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
Drug Central 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C None
5311010 1072 37 None -22 5 Human 8.1 pKi = 8.1 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
Drug Central 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C None
68613 1072 37 None -22 5 Human 8.1 pKi = 8.1 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
Drug Central 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C None
CHEMBL378642 1072 37 None -22 5 Human 8.1 pKi = 8.1 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
Drug Central 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C None
CHEMBL382301 1072 37 None -22 5 Human 8.1 pKi = 8.1 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
Drug Central 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C None
DB09059 1072 37 None -22 5 Human 8.1 pKi = 8.1 Binding
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
Drug Central 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C None
11169 1650 39 None 1 2 Human 8.1 pKi = 8.1 Binding
oxytocin receptors expressed in COS-7 cellsoxytocin receptors expressed in COS-7 cells
Drug Central 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C None
165708555 1650 39 None 1 2 Human 8.1 pKi = 8.1 Binding
oxytocin receptors expressed in COS-7 cellsoxytocin receptors expressed in COS-7 cells
Drug Central 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C None
16681432 1650 39 None 1 2 Human 8.1 pKi = 8.1 Binding
oxytocin receptors expressed in COS-7 cellsoxytocin receptors expressed in COS-7 cells
Drug Central 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C None
495 1650 39 None 1 2 Human 8.1 pKi = 8.1 Binding
oxytocin receptors expressed in COS-7 cellsoxytocin receptors expressed in COS-7 cells
Drug Central 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C None
CHEMBL3301668 1650 39 None 1 2 Human 8.1 pKi = 8.1 Binding
oxytocin receptors expressed in COS-7 cellsoxytocin receptors expressed in COS-7 cells
Drug Central 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C None
DB01282 1650 39 None 1 2 Human 8.1 pKi = 8.1 Binding
oxytocin receptors expressed in COS-7 cellsoxytocin receptors expressed in COS-7 cells
Drug Central 987 18 10 13 -2.5 CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C None
146681949 8624 35 None -5 8 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
2168 8624 35 None -5 8 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
2810 8624 35 None -5 8 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
644077 8624 35 None -5 8 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
CHEMBL373742 8624 35 None -5 8 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
DB00067 8624 35 None -5 8 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
P01185 8624 35 None -5 8 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
P01186 8624 35 None -5 8 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
P35455 8624 35 None -5 8 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
146681949 8624 35 None -4 8 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
2168 8624 35 None -4 8 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
2810 8624 35 None -4 8 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
644077 8624 35 None -4 8 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
CHEMBL373742 8624 35 None -4 8 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
DB00067 8624 35 None -4 8 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
P01185 8624 35 None -4 8 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
P01186 8624 35 None -4 8 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
P35455 8624 35 None -4 8 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
Drug Central 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N None
5311065 484177 30 None -2 8 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
Drug Central 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O None
817 484177 30 None -2 8 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
Drug Central 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O None
CHEMBL1429 484177 30 None -2 8 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
Drug Central 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O None
DB00035 484177 30 None -2 8 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
Drug Central 1068 19 14 15 -4.1 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O None
3126 484342 1 None None None Rat 8.0 pKi = 8.0 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
Drug Central 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O None
CHEMBL435716 484342 1 None None None Rat 8.0 pKi = 8.0 Binding
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
Drug Central 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O None
2042 6074 0 None -1 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
2174 6074 0 None -1 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
439302 6074 0 None -1 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
CHEMBL395429 6074 0 None -1 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
DB00107 6074 0 None -1 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
P01178 6074 0 None -1 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
P01179 6074 0 None -1 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
P35454 6074 0 None -1 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
2042 6074 0 None 1 7 Human 8.0 pKi = 8.0 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
2174 6074 0 None 1 7 Human 8.0 pKi = 8.0 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
439302 6074 0 None 1 7 Human 8.0 pKi = 8.0 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
CHEMBL395429 6074 0 None 1 7 Human 8.0 pKi = 8.0 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
DB00107 6074 0 None 1 7 Human 8.0 pKi = 8.0 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
P01178 6074 0 None 1 7 Human 8.0 pKi = 8.0 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
P01179 6074 0 None 1 7 Human 8.0 pKi = 8.0 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
P35454 6074 0 None 1 7 Human 8.0 pKi = 8.0 Binding
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
Drug Central 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C None
10444 4740 20 None 5 3 Human 6.7 pKi = 6.7 Binding
Binding affinity determined by a TR-FRET binding assay on HEK cells expressing SNAP-tagged OT receptors using 20 nM fluorescent DY647 and increasing concentration of competitor.Binding affinity determined by a TR-FRET binding assay on HEK cells expressing SNAP-tagged OT receptors using 20 nM fluorescent DY647 and increasing concentration of competitor.
Guide to Pharmacology 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 30199637
145711714 4740 20 None 5 3 Human 6.7 pKi = 6.7 Binding
Binding affinity determined by a TR-FRET binding assay on HEK cells expressing SNAP-tagged OT receptors using 20 nM fluorescent DY647 and increasing concentration of competitor.Binding affinity determined by a TR-FRET binding assay on HEK cells expressing SNAP-tagged OT receptors using 20 nM fluorescent DY647 and increasing concentration of competitor.
Guide to Pharmacology 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 30199637
CHEMBL4204210 4740 20 None 5 3 Human 6.7 pKi = 6.7 Binding
Binding affinity determined by a TR-FRET binding assay on HEK cells expressing SNAP-tagged OT receptors using 20 nM fluorescent DY647 and increasing concentration of competitor.Binding affinity determined by a TR-FRET binding assay on HEK cells expressing SNAP-tagged OT receptors using 20 nM fluorescent DY647 and increasing concentration of competitor.
Guide to Pharmacology 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 30199637
8529 6823 0 None -10000 3 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 439 4 0 4 3.9 CN(CCN1CC(c2c1cc(Cl)cc2)C(=O)N1CCC2(CC1)OCc1c2cccc1)C 25654260
91827367 6823 0 None -10000 3 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 439 4 0 4 3.9 CN(CCN1CC(c2c1cc(Cl)cc2)C(=O)N1CCC2(CC1)OCc1c2cccc1)C 25654260
10615 1182 36 None -10000 3 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 31951127
46200932 1182 36 None -10000 3 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 31951127
CHEMBL4297183 1182 36 None -10000 3 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 31951127
DB14823 1182 36 None -10000 3 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 31951127
2179 8306 0 None 44 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 939 28 14 15 -4.8 CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)CS)CC(=O)N)[C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](C=S)N)Cc1ccc(cc1)O)C 23723434
2179 8306 0 None 44 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 939 28 14 15 -4.8 CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)CS)CC(=O)N)[C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](C=S)N)Cc1ccc(cc1)O)C 2827511
2179 8306 0 None 44 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 939 28 14 15 -4.8 CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)CS)CC(=O)N)[C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](C=S)N)Cc1ccc(cc1)O)C 7475979
2179 8306 0 None 44 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 939 28 14 15 -4.8 CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)CS)CC(=O)N)[C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](C=S)N)Cc1ccc(cc1)O)C 8955347
3080871 8306 0 None 44 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 939 28 14 15 -4.8 CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)CS)CC(=O)N)[C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](C=S)N)Cc1ccc(cc1)O)C 23723434
3080871 8306 0 None 44 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 939 28 14 15 -4.8 CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)CS)CC(=O)N)[C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](C=S)N)Cc1ccc(cc1)O)C 2827511
3080871 8306 0 None 44 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 939 28 14 15 -4.8 CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)CS)CC(=O)N)[C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](C=S)N)Cc1ccc(cc1)O)C 7475979
3080871 8306 0 None 44 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 939 28 14 15 -4.8 CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)CS)CC(=O)N)[C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](C=S)N)Cc1ccc(cc1)O)C 8955347
2253 4548 22 None -5 6 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 9622556
5311202 4548 22 None -5 6 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 9622556
CHEMBL306645 4548 22 None -5 6 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 9622556
3870 2853 0 None None None Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
2252 4546 39 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 16158071
6918320 4546 39 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 16158071
CHEMBL24781 4546 39 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 16158071
2042 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10519430
2042 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
2042 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 16158071
2042 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7475979
2042 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7774575
2042 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 8955347
2174 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10519430
2174 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
2174 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 16158071
2174 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7475979
2174 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7774575
2174 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 8955347
439302 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10519430
439302 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
439302 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 16158071
439302 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7475979
439302 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7774575
439302 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 8955347
CHEMBL395429 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10519430
CHEMBL395429 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
CHEMBL395429 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 16158071
CHEMBL395429 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7475979
CHEMBL395429 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7774575
CHEMBL395429 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 8955347
DB00107 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10519430
DB00107 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
DB00107 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 16158071
DB00107 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7475979
DB00107 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7774575
DB00107 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 8955347
P01178 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10519430
P01178 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
P01178 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 16158071
P01178 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7475979
P01178 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7774575
P01178 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 8955347
P01179 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10519430
P01179 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
P01179 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 16158071
P01179 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7475979
P01179 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7774575
P01179 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 8955347
P35454 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 10519430
P35454 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
P35454 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 16158071
P35454 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7475979
P35454 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 7774575
P35454 6074 0 None 1 7 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 8955347
10461270 7472 18 None 2 5 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 14722330
2201 7472 18 None 2 5 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 14722330
CHEMBL1615640 7472 18 None 2 5 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 14722330
11340891 6755 33 None 891 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 17395790
11340891 6755 33 None 891 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 18032036
8403 6755 33 None 891 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 17395790
8403 6755 33 None 891 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 18032036
CHEMBL429736 6755 33 None 891 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 17395790
CHEMBL429736 6755 33 None 891 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 18032036
DB11818 6755 33 None 891 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 17395790
DB11818 6755 33 None 891 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 18032036
2169 963 0 None 7 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1049 19 14 16 -5.6 CC[C@@H](C1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCCC1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)C 7774575
2169 963 0 None 7 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1049 19 14 16 -5.6 CC[C@@H](C1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCCC1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)C 8955347
68649 963 0 None 7 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1049 19 14 16 -5.6 CC[C@@H](C1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCCC1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)C 7774575
68649 963 0 None 7 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1049 19 14 16 -5.6 CC[C@@H](C1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCCC1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)C 8955347
2188 2768 0 None -316 4 Rat 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 17300166
2186 2766 0 None -501 4 Rat 6.4 pKi None 6.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 17300166
2242 4526 0 None None None Human 6.6 pKi None 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 459 5 2 4 3.4 OC(=O)CC1(O)CC2C(C1(CC2)CS(=O)(=O)N1CCC2(CC1)C=Cc1c2cccc1)(C)C 7475979
3083288 4526 0 None None None Human 6.6 pKi None 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 459 5 2 4 3.4 OC(=O)CC1(O)CC2C(C1(CC2)CS(=O)(=O)N1CCC2(CC1)C=Cc1c2cccc1)(C)C 7475979
2190 2975 0 None -398 4 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
2200 6732 0 None -89 4 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10519430
2200 6732 0 None -89 4 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 16158071
60943 6732 0 None -89 4 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10519430
60943 6732 0 None -89 4 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 16158071
CHEMBL419667 6732 0 None -89 4 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10519430
CHEMBL419667 6732 0 None -89 4 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 16158071
DB13929 6732 0 None -89 4 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10519430
DB13929 6732 0 None -89 4 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 16158071
2213 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10519430
2213 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 12660315
2213 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 14722330
2213 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 15880385
2213 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 7475979
3008 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10519430
3008 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 12660315
3008 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 14722330
3008 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 15880385
3008 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 7475979
5311010 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10519430
5311010 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 12660315
5311010 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 14722330
5311010 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 15880385
5311010 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 7475979
68613 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10519430
68613 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 12660315
68613 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 14722330
68613 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 15880385
68613 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 7475979
CHEMBL378642 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10519430
CHEMBL378642 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 12660315
CHEMBL378642 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 14722330
CHEMBL378642 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 15880385
CHEMBL378642 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 7475979
CHEMBL382301 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10519430
CHEMBL382301 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 12660315
CHEMBL382301 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 14722330
CHEMBL382301 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 15880385
CHEMBL382301 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 7475979
DB09059 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 10519430
DB09059 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 12660315
DB09059 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 14722330
DB09059 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 15880385
DB09059 1072 37 None -22 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 7475979
114904 6013 43 None -5 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 7475979
2196 6013 43 None -5 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 7475979
CHEMBL296908 6013 43 None -5 5 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 7475979
2189 2977 0 None -316 4 Rat 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 17300166
2192 4802 27 None -5 3 Rat 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 12660315
9690136 4802 27 None -5 3 Rat 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 12660315
CHEMBL1254024 4802 27 None -5 3 Rat 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 12660315
2213 1072 37 None -20 5 Rat 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 12660315
3008 1072 37 None -20 5 Rat 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 12660315
5311010 1072 37 None -20 5 Rat 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 12660315
68613 1072 37 None -20 5 Rat 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 12660315
CHEMBL378642 1072 37 None -20 5 Rat 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 12660315
CHEMBL382301 1072 37 None -20 5 Rat 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 12660315
DB09059 1072 37 None -20 5 Rat 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 993 18 11 15 -3.0 NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C 12660315
16051933 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7475979
16051933 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7774575
2181 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7475979
2181 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7774575
2182 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7475979
2182 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7774575
27991 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7475979
27991 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7774575
46783812 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7475979
46783812 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7774575
CHEMBL264448 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7475979
CHEMBL264448 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7774575
CHEMBL376685 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7475979
CHEMBL376685 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7774575
DB00035 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7475979
DB00035 2746 7 None -9 7 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 7774575
2191 2979 0 None -398 4 Rat 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 17300166
2187 2764 0 None -89 4 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
2187 2764 0 None -89 4 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16158071
10413997 4534 5 None -1 2 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 7475979
2246 4534 5 None -1 2 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 7475979
CHEMBL338522 4534 5 None -1 2 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 7475979
2192 4802 27 None 5 3 Human 7.7 pKi None 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 12660315
9690136 4802 27 None 5 3 Human 7.7 pKi None 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 12660315
CHEMBL1254024 4802 27 None 5 3 Human 7.7 pKi None 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 12660315
2202 5638 34 None -10 5 Human 7.8 pKi None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 11861823
2202 5638 34 None -10 5 Human 7.8 pKi None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 16158071
9895468 5638 34 None -10 5 Human 7.8 pKi None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 11861823
9895468 5638 34 None -10 5 Human 7.8 pKi None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 16158071
CHEMBL582857 5638 34 None -10 5 Human 7.8 pKi None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 11861823
CHEMBL582857 5638 34 None -10 5 Human 7.8 pKi None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 16158071
DB12643 5638 34 None -10 5 Human 7.8 pKi None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 11861823
DB12643 5638 34 None -10 5 Human 7.8 pKi None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 16158071
2247 4536 0 None None None Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7475979
2249 4540 14 None -2 7 Human 8.1 pKi None 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 7475979
9872389 4540 14 None -2 7 Human 8.1 pKi None 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 7475979
CHEMBL1253853 4540 14 None -2 7 Human 8.1 pKi None 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 7475979
146681949 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10519430
146681949 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 11337500
146681949 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 12446593
146681949 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 15084136
146681949 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 16158071
146681949 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7475979
146681949 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7774575
146681949 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 8955347
2168 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10519430
2168 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 11337500
2168 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 12446593
2168 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 15084136
2168 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 16158071
2168 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7475979
2168 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7774575
2168 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 8955347
2810 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10519430
2810 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 11337500
2810 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 12446593
2810 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 15084136
2810 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 16158071
2810 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7475979
2810 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7774575
2810 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 8955347
644077 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10519430
644077 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 11337500
644077 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 12446593
644077 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 15084136
644077 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 16158071
644077 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7475979
644077 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7774575
644077 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 8955347
CHEMBL373742 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10519430
CHEMBL373742 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 11337500
CHEMBL373742 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 12446593
CHEMBL373742 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 15084136
CHEMBL373742 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 16158071
CHEMBL373742 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7475979
CHEMBL373742 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7774575
CHEMBL373742 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 8955347
DB00067 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10519430
DB00067 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 11337500
DB00067 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 12446593
DB00067 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 15084136
DB00067 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 16158071
DB00067 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7475979
DB00067 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7774575
DB00067 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 8955347
P01185 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10519430
P01185 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 11337500
P01185 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 12446593
P01185 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 15084136
P01185 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 16158071
P01185 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7475979
P01185 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7774575
P01185 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 8955347
P01186 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10519430
P01186 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 11337500
P01186 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 12446593
P01186 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 15084136
P01186 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 16158071
P01186 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7475979
P01186 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7774575
P01186 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 8955347
P35455 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 10519430
P35455 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 11337500
P35455 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 12446593
P35455 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 15084136
P35455 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 16158071
P35455 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7475979
P35455 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 7774575
P35455 8624 35 None -5 8 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1083 19 14 16 -5.4 NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N 8955347
16051933 2746 7 None -9 7 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 15084136
2181 2746 7 None -9 7 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 15084136
2182 2746 7 None -9 7 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 15084136
27991 2746 7 None -9 7 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 15084136
46783812 2746 7 None -9 7 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 15084136
CHEMBL264448 2746 7 None -9 7 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 15084136
CHEMBL376685 2746 7 None -9 7 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 15084136
DB00035 2746 7 None -9 7 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1068 19 13 15 -4.3 NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O 15084136
2223 2784 0 None -3 4 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1151 20 12 15 -2.3 COc1ccc(cc1)C[C@H]1NC(=O)CC2(CCCCC2)SSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N 7475979
6917952 2784 0 None -3 4 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1151 20 12 15 -2.3 COc1ccc(cc1)C[C@H]1NC(=O)CC2(CCCCC2)SSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N 7475979
196819 4528 0 None None None Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 755 14 5 8 1.7 C=C[C@@H]([C@@H](C(=O)N1CCCC[C@]1(C=O)C(=O)N1CCCCC1)NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1cnc[nH]1)N)C 7475979
2243 4528 0 None None None Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 755 14 5 8 1.7 C=C[C@@H]([C@@H](C(=O)N1CCCC[C@]1(C=O)C(=O)N1CCCCC1)NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1cnc[nH]1)N)C 7475979
2248 4538 0 None None None Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7475979
2241 4522 5 None 2 4 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 738 6 2 8 2.3 CC[C@@H]([C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N(C(=O)[C@H]2N(C(=O)[C@@H]3N(C1=O)N=CCC3)N=CCC2)C)Cc1ccccc1)C 7475979
9810632 4522 5 None 2 4 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 738 6 2 8 2.3 CC[C@@H]([C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N(C(=O)[C@H]2N(C(=O)[C@@H]3N(C1=O)N=CCC3)N=CCC2)C)Cc1ccccc1)C 7475979
CHEMBL127686 4522 5 None 2 4 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 738 6 2 8 2.3 CC[C@@H]([C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N(C(=O)[C@H]2N(C(=O)[C@@H]3N(C1=O)N=CCC3)N=CCC2)C)Cc1ccccc1)C 7475979
2250 4542 0 None None None Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7475979
2251 4544 0 None None None Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7475979
188397 4532 0 None None None Human 8.6 pKi None 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 768 14 3 10 2.3 CC[C@@H]([C@@H](C(=O)[C@@]1(C=O)CCCN1C(=O)[C@@H](CC1=NC(N=C1)(C(=O)N1CCCCC1)C(=O)N1CCCCC1)N)NC(=O)[C@H](Cc1ccc2c(c1)cccc2)N)C 7475979
2245 4532 0 None None None Human 8.6 pKi None 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 768 14 3 10 2.3 CC[C@@H]([C@@H](C(=O)[C@@]1(C=O)CCCN1C(=O)[C@@H](CC1=NC(N=C1)(C(=O)N1CCCCC1)C(=O)N1CCCCC1)N)NC(=O)[C@H](Cc1ccc2c(c1)cccc2)N)C 7475979
2042 6074 0 None -1 7 Rat 8.7 pKi None 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
2174 6074 0 None -1 7 Rat 8.7 pKi None 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
439302 6074 0 None -1 7 Rat 8.7 pKi None 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
CHEMBL395429 6074 0 None -1 7 Rat 8.7 pKi None 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
DB00107 6074 0 None -1 7 Rat 8.7 pKi None 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
P01178 6074 0 None -1 7 Rat 8.7 pKi None 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
P01179 6074 0 None -1 7 Rat 8.7 pKi None 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
P35454 6074 0 None -1 7 Rat 8.7 pKi None 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1006 17 12 15 -3.6 CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C 12660315
164712 6321 0 None 50 3 Human 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1040 17 12 15 -3.4 CC(C[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1)C 7774575
164712 6321 0 None 50 3 Human 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1040 17 12 15 -3.4 CC(C[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1)C 8955347
2178 6321 0 None 50 3 Human 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1040 17 12 15 -3.4 CC(C[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1)C 7774575
2178 6321 0 None 50 3 Human 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1040 17 12 15 -3.4 CC(C[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1)C 8955347
CHEMBL3272682 6321 0 None 50 3 Human 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1040 17 12 15 -3.4 CC(C[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1)C 7774575
CHEMBL3272682 6321 0 None 50 3 Human 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 1040 17 12 15 -3.4 CC(C[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1)C 8955347
2239 2222 0 None 501 3 Human 8.9 pKi None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 16250654
6918854 2222 0 None 501 3 Human 8.9 pKi None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 16250654
CHEMBL196478 2222 0 None 501 3 Human 8.9 pKi None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 16250654
2219 2788 0 None 1 4 Human 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11337500
135413562 4496 12 None 1 5 Human 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 16302826
135413562 4496 12 None -1 5 Rat 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 16302826
2194 4496 12 None 1 5 Human 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 16302826
2194 4496 12 None -1 5 Rat 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 16302826
CHEMBL445816 4496 12 None 1 5 Human 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 16302826
CHEMBL445816 4496 12 None -1 5 Rat 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 16302826
2244 4530 0 None None None Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7475979
2221 2793 0 None 17 4 Human 9.6 pKi None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15880385
2221 2793 0 None 17 4 Human 9.6 pKi None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16158071